[{"N\/R\/U":"N","Applicant":"Amgen Inc.","BLA_Number":"761024","Proprietary_Name":"Amjevita","Proper_Name":"adalimumab-atto","License_Type":"351(k) Biosimilar","Strength":"20MG\/0.2ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/14\/2023","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":"15","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"N","Applicant":"Amgen Inc.","BLA_Number":"761024","Proprietary_Name":"Amjevita","Proper_Name":"adalimumab-atto","License_Type":"351(k) Biosimilar","Strength":"40MG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/14\/2023","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":"15","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"6","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"N","Applicant":"Amgen Inc.","BLA_Number":"761024","Proprietary_Name":"Amjevita","Proper_Name":"adalimumab-atto","License_Type":"351(k) Biosimilar","Strength":"80MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/14\/2023","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":"15","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"7","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"N","Applicant":"Amgen Inc.","BLA_Number":"761024","Proprietary_Name":"Amjevita","Proper_Name":"adalimumab-atto","License_Type":"351(k) Biosimilar","Strength":"40MG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/14\/2023","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":"15","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"8","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"N","Applicant":"Amgen Inc.","BLA_Number":"761024","Proprietary_Name":"Amjevita","Proper_Name":"adalimumab-atto","License_Type":"351(k) Biosimilar","Strength":"80MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/14\/2023","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":"15","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"9","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"Novartis Pharmaceuticals Corporation","BLA_Number":"125504","Proprietary_Name":"Cosentyx","Proper_Name":"secukinumab","License_Type":"351(a)","Strength":"300MG\/2ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/11\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"44","Submission_Type":"Supplement","License_Number":"1244","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"Organon USA LLC, a subsidiary of Organon & Co.","BLA_Number":"021211","Proprietary_Name":"Follistim AQ Cartridge","Proper_Name":"follitropin beta","License_Type":"351(a)","Strength":"300IU\/0.36ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/23\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2331","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"Organon USA LLC, a subsidiary of Organon & Co.","BLA_Number":"021211","Proprietary_Name":"Follistim AQ Cartridge","Proper_Name":"follitropin beta","License_Type":"351(a)","Strength":"175IU\/0.21ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Cartridge","Status":"Disc","Licensure":"Licensed","Approval_Date":"2\/11\/2005","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"2","Submission_Type":"Supplement","License_Number":"2331","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"Organon USA LLC, a subsidiary of Organon & Co.","BLA_Number":"021211","Proprietary_Name":"Follistim AQ Cartridge","Proper_Name":"follitropin beta","License_Type":"351(a)","Strength":"600IU\/0.72ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/23\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2331","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"Organon USA LLC, a subsidiary of Organon & Co.","BLA_Number":"021211","Proprietary_Name":"Follistim AQ Cartridge","Proper_Name":"follitropin beta","License_Type":"351(a)","Strength":"900IU\/1.08ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/11\/2005","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"2","Submission_Type":"Supplement","License_Number":"2331","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"N","Applicant":"Janssen Biotech, Inc.","BLA_Number":"761342","Proprietary_Name":"Talvey","Proper_Name":"talquetamab-tgvs","License_Type":"351(a)","Strength":"3MG\/1.5ML (2MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/9\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1864","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"N","Applicant":"Janssen Biotech, Inc.","BLA_Number":"761342","Proprietary_Name":"Talvey","Proper_Name":"talquetamab-tgvs","License_Type":"351(a)","Strength":"40MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/9\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1864","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"N","Applicant":"Pfizer Inc.","BLA_Number":"761345","Proprietary_Name":"Elrexfio","Proper_Name":"elranatamab-bcmm","License_Type":"351(a)","Strength":"76MG\/1.9ML (40MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/14\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2001","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"N","Applicant":"Pfizer Inc.","BLA_Number":"761345","Proprietary_Name":"Elrexfio","Proper_Name":"elranatamab-bcmm","License_Type":"351(a)","Strength":"44MG\/1.1ML (40MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/14\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2001","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"N","Applicant":"Regeneron Pharmaceuticals, Inc.","BLA_Number":"761339","Proprietary_Name":"Veopoz","Proper_Name":"pozelimab-bbfg","License_Type":"351(a)","Strength":"400MG\/2ML (200MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/18\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1760","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"N","Applicant":"Regeneron Pharmaceuticals, Inc.","BLA_Number":"761355","Proprietary_Name":"Eylea HD","Proper_Name":"aflibercept","License_Type":"351(a)","Strength":"8MG\/0.07ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravitreal","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/18\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1760","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"ALK-Abello, Inc.","BLA_Number":"103059","Proprietary_Name":null,"Proper_Name":"Pollens - Weeds and Garden Plants, Ragweed, Short Ambrosia artemisiifolia","License_Type":"351(a)","Strength":"1:20W\/V","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"ALK-Abello, Inc.","BLA_Number":"103059","Proprietary_Name":null,"Proper_Name":"Pollens - Weeds and Garden Plants, Ragweed, Short Ambrosia artemisiifolia","License_Type":"351(a)","Strength":"1:20W\/V","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"Sanofi Pasteur SA","BLA_Number":"103932","Proprietary_Name":"Imogam","Proper_Name":"Rabies Immune Globulin (Human)","License_Type":"351(a)","Strength":"150IU\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"3\/6\/2001","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5000","Submission_Type":"Supplement","License_Number":"1724","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"ALK - Abello A\/S","BLA_Number":"103969","Proprietary_Name":"Pharmalgen","Proper_Name":"Venoms, Honey Bee Venom","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"10\/8\/1991","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1292","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"ALK - Abello A\/S","BLA_Number":"103969","Proprietary_Name":"Pharmalgen","Proper_Name":"Venoms, Honey Bee Venom","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"10\/8\/1991","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1292","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"ALK - Abello A\/S","BLA_Number":"103970","Proprietary_Name":"Pharmalgen","Proper_Name":"Venoms, Mixed Vespid Venom Protein","License_Type":"351(a)","Strength":"300UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"10\/8\/1991","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1292","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"ALK - Abello A\/S","BLA_Number":"103970","Proprietary_Name":"Pharmalgen","Proper_Name":"Venoms, Mixed Vespid Venom Protein","License_Type":"351(a)","Strength":"300UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"10\/8\/1991","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1292","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"ALK - Abello A\/S","BLA_Number":"103971","Proprietary_Name":"Pharmalgen","Proper_Name":"Venoms, Wasp Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"10\/8\/1991","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1292","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"ALK - Abello A\/S","BLA_Number":"103971","Proprietary_Name":"Pharmalgen","Proper_Name":"Venoms, Wasp Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"10\/8\/1991","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1292","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"ALK - Abello A\/S","BLA_Number":"103972","Proprietary_Name":"Pharmalgen","Proper_Name":"Venoms, White Faced Hornet Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"10\/8\/1991","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1292","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"ALK - Abello A\/S","BLA_Number":"103972","Proprietary_Name":"Pharmalgen","Proper_Name":"Venoms, White Faced Hornet Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"10\/8\/1991","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1292","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"ALK - Abello A\/S","BLA_Number":"103973","Proprietary_Name":"Pharmalgen","Proper_Name":"Venoms, Yellow Hornet Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"10\/8\/1991","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1292","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"ALK - Abello A\/S","BLA_Number":"103973","Proprietary_Name":"Pharmalgen","Proper_Name":"Venoms, Yellow Hornet Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"10\/8\/1991","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1292","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"ALK - Abello A\/S","BLA_Number":"103974","Proprietary_Name":"Pharmalgen","Proper_Name":"Venoms, Yellow Jacket Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"10\/8\/1991","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1292","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"ALK - Abello A\/S","BLA_Number":"103974","Proprietary_Name":"Pharmalgen","Proper_Name":"Venoms, Yellow Jacket Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"10\/8\/1991","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1292","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"Ferring Pharmaceuticals A\/S","BLA_Number":"125700","Proprietary_Name":"Adstiladrin","Proper_Name":"nadofaragene firadenovec-vncg","License_Type":"351(a)","Strength":"3x10^11 viral particles (vp)\/mL","Dosage_Form":"For Suspension","Route_of_Administration":"Intravesical","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/16\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2222","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":"12\/16\/2022","Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":"12\/16\/2034","Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"Biomarin Pharmaceutical Inc.","BLA_Number":"125720","Proprietary_Name":"Roctavian","Proper_Name":"valoctocogene roxaparvovec-rvox","License_Type":"351(a)","Strength":"16X 10E13GENOMES PER ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/29\/2023","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"1649","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/29\/2030"},{"N\/R\/U":"N","Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125776","Proprietary_Name":"Balfaxar","Proper_Name":"Prothrombin complex concentrate, human-lans","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/21\/2023","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"1646","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":null,"BLA_Number":"000nan","Proprietary_Name":null,"Proper_Name":null,"License_Type":null,"Strength":null,"Dosage_Form":null,"Route_of_Administration":null,"Product_Presentation":null,"Status":null,"Licensure":null,"Approval_Date":null,"Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":null,"License_Number":null,"Product_Number":null,"Center":null,"Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"N\/R\/U","Applicant":"Applicant","BLA_Number":"BLA Number","Proprietary_Name":"Proprietary Name","Proper_Name":"Proper Name","License_Type":"License Type","Strength":"Strength","Dosage_Form":"Dosage Form","Route_of_Administration":"Route of Administration","Product_Presentation":"Product Presentation","Status":"Status","Licensure":"Licensure","Approval_Date":"Approval Date","Ref._Product_Proper_Name":"Ref. Product Proper Name","Ref._Product_Proprietary_Name":"Ref. Product Proprietary Name","Supplement_Number":"Supplement Number","Submission_Type":"Submission Type","License_Number":"License Number","Product_Number":"Product Number","Center":"Center","Date_of_First_Licensure":"Date of First Licensure","Exclusivity_Expiration_Date":"Exclusivity Expiration Date","First_Interchangeable_Exclusivity_Exp._Date":"First Interchangeable Exclusivity Exp. Date","Ref._Product_Exclusivity_Exp._Date":"Ref. Product Exclusivity Exp. Date","Orphan_Exclusivity_Exp._Date":"Orphan Exclusivity Exp. Date"},{"N\/R\/U":null,"Applicant":null,"BLA_Number":"000nan","Proprietary_Name":null,"Proper_Name":null,"License_Type":null,"Strength":null,"Dosage_Form":null,"Route_of_Administration":null,"Product_Presentation":null,"Status":null,"Licensure":null,"Approval_Date":null,"Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":null,"License_Number":null,"Product_Number":null,"Center":null,"Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bristol-Myers Squibb Company","BLA_Number":"125118","Proprietary_Name":"Orencia","Proper_Name":"abatacept","License_Type":"351(a)","Strength":"250MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/23\/2005","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1713","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/15\/2028"},{"N\/R\/U":null,"Applicant":"Bristol-Myers Squibb Company","BLA_Number":"125118","Proprietary_Name":"Orencia","Proper_Name":"abatacept","License_Type":"351(a)","Strength":"125MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/29\/2011","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"122","Submission_Type":"Supplement","License_Number":"1713","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/15\/2028"},{"N\/R\/U":null,"Applicant":"Bristol-Myers Squibb Company","BLA_Number":"125118","Proprietary_Name":"Orencia","Proper_Name":"abatacept","License_Type":"351(a)","Strength":"125MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/7\/2016","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"200","Submission_Type":"Supplement","License_Number":"1713","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/15\/2028"},{"N\/R\/U":null,"Applicant":"Bristol-Myers Squibb Company","BLA_Number":"125118","Proprietary_Name":"Orencia","Proper_Name":"abatacept","License_Type":"351(a)","Strength":"50MG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/30\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"211","Submission_Type":"Supplement","License_Number":"1713","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/15\/2028"},{"N\/R\/U":null,"Applicant":"Bristol-Myers Squibb Company","BLA_Number":"125118","Proprietary_Name":"Orencia","Proper_Name":"abatacept","License_Type":"351(a)","Strength":"87.5MG\/0.7ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/30\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"211","Submission_Type":"Supplement","License_Number":"1713","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/15\/2028"},{"N\/R\/U":null,"Applicant":"Janssen Biotech, Inc.","BLA_Number":"103575","Proprietary_Name":"Reopro","Proper_Name":"abciximab","License_Type":"351(a)","Strength":"\t2MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"12\/22\/1994","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1864","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Ipsen Biopharm Limited","BLA_Number":"125274","Proprietary_Name":"Dysport","Proper_Name":"abobotulinumtoxinA","License_Type":"351(a)","Strength":"300UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/29\/2009","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1787","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/29\/2023"},{"N\/R\/U":null,"Applicant":"Ipsen Biopharm Limited","BLA_Number":"125274","Proprietary_Name":"Dysport","Proper_Name":"abobotulinumtoxinA","License_Type":"351(a)","Strength":"500UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/29\/2009","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1787","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/29\/2023"},{"N\/R\/U":null,"Applicant":"AbbVie Inc.","BLA_Number":"125057","Proprietary_Name":"Humira","Proper_Name":"adalimumab","License_Type":"351(a)","Strength":"40MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/31\/2002","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1889","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/24\/2028"},{"N\/R\/U":null,"Applicant":"AbbVie Inc.","BLA_Number":"125057","Proprietary_Name":"Humira","Proper_Name":"adalimumab","License_Type":"351(a)","Strength":"40MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/31\/2002","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1889","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/24\/2028"},{"N\/R\/U":null,"Applicant":"AbbVie Inc.","BLA_Number":"125057","Proprietary_Name":"Humira","Proper_Name":"adalimumab","License_Type":"351(a)","Strength":"20MG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"2\/21\/2008","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"114","Submission_Type":"Supplement","License_Number":"1889","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/24\/2028"},{"N\/R\/U":null,"Applicant":"AbbVie Inc.","BLA_Number":"125057","Proprietary_Name":"Humira","Proper_Name":"adalimumab","License_Type":"351(a)","Strength":"40MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/24\/2013","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"322","Submission_Type":"Supplement","License_Number":"1889","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/24\/2028"},{"N\/R\/U":null,"Applicant":"AbbVie Inc.","BLA_Number":"125057","Proprietary_Name":"Humira","Proper_Name":"adalimumab","License_Type":"351(a)","Strength":"10MG\/0.2ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"9\/23\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"356","Submission_Type":"Supplement","License_Number":"1889","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/24\/2028"},{"N\/R\/U":null,"Applicant":"AbbVie Inc.","BLA_Number":"125057","Proprietary_Name":"Humira","Proper_Name":"adalimumab","License_Type":"351(a)","Strength":"40MG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/23\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"394","Submission_Type":"Supplement","License_Number":"1889","Product_Number":"6","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/24\/2028"},{"N\/R\/U":null,"Applicant":"AbbVie Inc.","BLA_Number":"125057","Proprietary_Name":"Humira","Proper_Name":"adalimumab","License_Type":"351(a)","Strength":"40MG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/9\/2016","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"398","Submission_Type":"Supplement","License_Number":"1889","Product_Number":"7","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/24\/2028"},{"N\/R\/U":null,"Applicant":"AbbVie Inc.","BLA_Number":"125057","Proprietary_Name":"Humira","Proper_Name":"adalimumab","License_Type":"351(a)","Strength":"80MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/17\/2016","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"400","Submission_Type":"Supplement","License_Number":"1889","Product_Number":"8","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/24\/2028"},{"N\/R\/U":null,"Applicant":"AbbVie Inc.","BLA_Number":"125057","Proprietary_Name":"Humira","Proper_Name":"adalimumab","License_Type":"351(a)","Strength":"80MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/21\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"401","Submission_Type":"Supplement","License_Number":"1889","Product_Number":"9","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/24\/2028"},{"N\/R\/U":null,"Applicant":"AbbVie Inc.","BLA_Number":"125057","Proprietary_Name":"Humira","Proper_Name":"adalimumab","License_Type":"351(a)","Strength":"20MG\/0.2ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/28\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"402","Submission_Type":"Supplement","License_Number":"1889","Product_Number":"10","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/24\/2028"},{"N\/R\/U":null,"Applicant":"AbbVie Inc.","BLA_Number":"125057","Proprietary_Name":"Humira","Proper_Name":"adalimumab","License_Type":"351(a)","Strength":"10MG\/0.1ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/28\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"402","Submission_Type":"Supplement","License_Number":"1889","Product_Number":"11","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/24\/2028"},{"N\/R\/U":null,"Applicant":"Boehringer Ingelheim Pharmaceuticals, Inc.","BLA_Number":"761058","Proprietary_Name":"Cyltezo","Proper_Name":"adalimumab-adbm","License_Type":"351(k) Interchangeable","Strength":"40MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/25\/2017","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2006","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":"Date TBD","Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Boehringer Ingelheim Pharmaceuticals, Inc.","BLA_Number":"761058","Proprietary_Name":"Cyltezo","Proper_Name":"adalimumab-adbm","License_Type":"351(k) Interchangeable","Strength":"20MG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/13\/2018","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":"2","Submission_Type":"Supplement","License_Number":"2006","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":"Date TBD","Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Boehringer Ingelheim Pharmaceuticals, Inc.","BLA_Number":"761058","Proprietary_Name":"Cyltezo","Proper_Name":"adalimumab-adbm","License_Type":"351(k) Interchangeable","Strength":"10MG\/0.2ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/18\/2022","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":"11","Submission_Type":"Supplement","License_Number":"2006","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":"Date TBD","Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Boehringer Ingelheim Pharmaceuticals, Inc.","BLA_Number":"761058","Proprietary_Name":"Cyltezo","Proper_Name":"adalimumab-adbm","License_Type":"351(k) Interchangeable","Strength":"40MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/18\/2023","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":"16","Submission_Type":"Supplement","License_Number":"2006","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":"Date TBD","Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Samsung Bioepis Co., Ltd.","BLA_Number":"761059","Proprietary_Name":"Hadlima","Proper_Name":"adalimumab-bwwd","License_Type":"351(k) Biosimilar","Strength":"40MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/23\/2019","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2046","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Samsung Bioepis Co., Ltd.","BLA_Number":"761059","Proprietary_Name":"Hadlima","Proper_Name":"adalimumab-bwwd","License_Type":"351(k) Biosimilar","Strength":"40MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/23\/2019","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2046","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Samsung Bioepis Co., Ltd.","BLA_Number":"761059","Proprietary_Name":"Hadlima","Proper_Name":"adalimumab-bwwd","License_Type":"351(k) Biosimilar","Strength":"40MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/17\/2022","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":"4","Submission_Type":"Supplement","License_Number":"2046","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Samsung Bioepis Co., Ltd.","BLA_Number":"761059","Proprietary_Name":"Hadlima","Proper_Name":"adalimumab-bwwd","License_Type":"351(k) Biosimilar","Strength":"40MG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/15\/2022","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":"5","Submission_Type":"Supplement","License_Number":"2046","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Samsung Bioepis Co., Ltd.","BLA_Number":"761059","Proprietary_Name":"Hadlima","Proper_Name":"adalimumab-bwwd","License_Type":"351(k) Biosimilar","Strength":"40MG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/15\/2022","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":"5","Submission_Type":"Supplement","License_Number":"2046","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sandoz Inc.","BLA_Number":"761071","Proprietary_Name":"Hyrimoz","Proper_Name":"adalimumab-adaz","License_Type":"351(k) Biosimilar","Strength":"40MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/30\/2018","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2003","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sandoz Inc.","BLA_Number":"761071","Proprietary_Name":"Hyrimoz","Proper_Name":"adalimumab-adaz","License_Type":"351(k) Biosimilar","Strength":"40MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/30\/2018","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2003","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sandoz Inc.","BLA_Number":"761071","Proprietary_Name":"Hyrimoz","Proper_Name":"adalimumab-adaz","License_Type":"351(k) Biosimilar","Strength":"10MG\/0.2ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/28\/2022","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":"11","Submission_Type":"Supplement","License_Number":"2003","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sandoz Inc.","BLA_Number":"761071","Proprietary_Name":"Hyrimoz","Proper_Name":"adalimumab-adaz","License_Type":"351(k) Biosimilar","Strength":"40MG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/20\/2023","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":"14","Submission_Type":"Supplement","License_Number":"2003","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sandoz Inc.","BLA_Number":"761071","Proprietary_Name":"Hyrimoz","Proper_Name":"adalimumab-adaz","License_Type":"351(k) Biosimilar","Strength":"80MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/20\/2023","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":"14","Submission_Type":"Supplement","License_Number":"2003","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sandoz Inc.","BLA_Number":"761071","Proprietary_Name":"Hyrimoz","Proper_Name":"adalimumab-adaz","License_Type":"351(k) Biosimilar","Strength":"20MG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/20\/2023","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":"14","Submission_Type":"Supplement","License_Number":"2003","Product_Number":"6","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sandoz Inc.","BLA_Number":"761071","Proprietary_Name":"Hyrimoz","Proper_Name":"adalimumab-adaz","License_Type":"351(k) Biosimilar","Strength":"40MG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/20\/2023","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":"14","Submission_Type":"Supplement","License_Number":"2003","Product_Number":"7","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sandoz Inc.","BLA_Number":"761071","Proprietary_Name":"Hyrimoz","Proper_Name":"adalimumab-adaz","License_Type":"351(k) Biosimilar","Strength":"80MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/20\/2023","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":"14","Submission_Type":"Supplement","License_Number":"2003","Product_Number":"8","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sandoz Inc.","BLA_Number":"761071","Proprietary_Name":"Hyrimoz","Proper_Name":"adalimumab-adaz","License_Type":"351(k) Biosimilar","Strength":"10MG\/0.1ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/20\/2023","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":"14","Submission_Type":"Supplement","License_Number":"2003","Product_Number":"9","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sandoz Inc.","BLA_Number":"761071","Proprietary_Name":"Hyrimoz","Proper_Name":"adalimumab-adaz","License_Type":"351(k) Biosimilar","Strength":"20MG\/0.2ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/20\/2023","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":"14","Submission_Type":"Supplement","License_Number":"2003","Product_Number":"10","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Pfizer Inc.","BLA_Number":"761118","Proprietary_Name":"Abrilada","Proper_Name":"adalimumab-afzb","License_Type":"351(k) Biosimilar","Strength":"40MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/15\/2019","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2001","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Pfizer Inc.","BLA_Number":"761118","Proprietary_Name":"Abrilada","Proper_Name":"adalimumab-afzb","License_Type":"351(k) Biosimilar","Strength":"40MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/15\/2019","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2001","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Pfizer Inc.","BLA_Number":"761118","Proprietary_Name":"Abrilada","Proper_Name":"adalimumab-afzb","License_Type":"351(k) Biosimilar","Strength":"20MG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/15\/2019","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2001","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Pfizer Inc.","BLA_Number":"761118","Proprietary_Name":"Abrilada","Proper_Name":"adalimumab-afzb","License_Type":"351(k) Biosimilar","Strength":"10MG\/0.2ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/15\/2019","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2001","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Pfizer Inc.","BLA_Number":"761118","Proprietary_Name":"Abrilada","Proper_Name":"adalimumab-afzb","License_Type":"351(k) Biosimilar","Strength":"40MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/15\/2019","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2001","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"761024","Proprietary_Name":"Amjevita","Proper_Name":"adalimumab-atto","License_Type":"351(k) Biosimilar","Strength":"20MG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/23\/2016","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"761024","Proprietary_Name":"Amjevita","Proper_Name":"adalimumab-atto","License_Type":"351(k) Biosimilar","Strength":"40MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/23\/2016","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"761024","Proprietary_Name":"Amjevita","Proper_Name":"adalimumab-atto","License_Type":"351(k) Biosimilar","Strength":"40MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/23\/2016","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"761024","Proprietary_Name":"Amjevita","Proper_Name":"adalimumab-atto","License_Type":"351(k) Biosimilar","Strength":"10MG\/0.2ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/6\/2023","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":"11","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"N","Applicant":"Amgen Inc.","BLA_Number":"761024","Proprietary_Name":"Amjevita","Proper_Name":"adalimumab-atto","License_Type":"351(k) Biosimilar","Strength":"20MG\/0.2ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/14\/2023","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":"15","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"N","Applicant":"Amgen Inc.","BLA_Number":"761024","Proprietary_Name":"Amjevita","Proper_Name":"adalimumab-atto","License_Type":"351(k) Biosimilar","Strength":"40MG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/14\/2023","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":"15","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"6","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"N","Applicant":"Amgen Inc.","BLA_Number":"761024","Proprietary_Name":"Amjevita","Proper_Name":"adalimumab-atto","License_Type":"351(k) Biosimilar","Strength":"80MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/14\/2023","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":"15","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"7","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"N","Applicant":"Amgen Inc.","BLA_Number":"761024","Proprietary_Name":"Amjevita","Proper_Name":"adalimumab-atto","License_Type":"351(k) Biosimilar","Strength":"40MG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/14\/2023","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":"15","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"8","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"N","Applicant":"Amgen Inc.","BLA_Number":"761024","Proprietary_Name":"Amjevita","Proper_Name":"adalimumab-atto","License_Type":"351(k) Biosimilar","Strength":"80MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/14\/2023","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":"15","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"9","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"125427","Proprietary_Name":"Kadcyla","Proper_Name":"ado-trastuzumab emtansine","License_Type":"351(a)","Strength":"100MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/22\/2013","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"125427","Proprietary_Name":"Kadcyla","Proper_Name":"ado-trastuzumab emtansine","License_Type":"351(a)","Strength":"160MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/22\/2013","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Regeneron Pharmaceuticals, Inc.","BLA_Number":"125387","Proprietary_Name":"Eylea","Proper_Name":"aflibercept","License_Type":"351(a)","Strength":"2MG\/0.05ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravitreal","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/18\/2011","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1760","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/8\/2030"},{"N\/R\/U":null,"Applicant":"Regeneron Pharmaceuticals, Inc.","BLA_Number":"125387","Proprietary_Name":"Eylea","Proper_Name":"aflibercept","License_Type":"351(a)","Strength":"2MG\/0.05ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravitreal","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/16\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"58","Submission_Type":"Supplement","License_Number":"1760","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/8\/2030"},{"N\/R\/U":null,"Applicant":"Genzyme Corporation","BLA_Number":"103979","Proprietary_Name":"Fabrazyme","Proper_Name":"agalsidase beta","License_Type":"351(a)","Strength":"35MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/24\/2003","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1596","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/11\/2028"},{"N\/R\/U":null,"Applicant":"Genzyme Corporation","BLA_Number":"103979","Proprietary_Name":"Fabrazyme","Proper_Name":"agalsidase beta","License_Type":"351(a)","Strength":"5MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/10\/2003","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5001","Submission_Type":"Supplement","License_Number":"1596","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/11\/2028"},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline LLC","BLA_Number":"125431","Proprietary_Name":"Tanzeum","Proper_Name":"albiglutide","License_Type":"351(a)","Strength":"30MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"4\/15\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1727","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline LLC","BLA_Number":"125431","Proprietary_Name":"Tanzeum","Proper_Name":"albiglutide","License_Type":"351(a)","Strength":"50MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"4\/15\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1727","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Clinigen, Inc.","BLA_Number":"103293","Proprietary_Name":"Proleukin","Proper_Name":"aldesleukin","License_Type":"351(a)","Strength":"22MILLION INTERNATIONAL UNITS (1.3MG)","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/5\/1992","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2154","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"1\/9\/2005"},{"N\/R\/U":null,"Applicant":"Astellas Pharma US, Inc.","BLA_Number":"125036","Proprietary_Name":"Amevive","Proper_Name":"alefacept","License_Type":"351(a)","Strength":"7.5MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"1\/30\/2003","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1748","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Astellas Pharma US, Inc.","BLA_Number":"125036","Proprietary_Name":"Amevive","Proper_Name":"alefacept","License_Type":"351(a)","Strength":"15MG","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"1\/30\/2003","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1748","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genzyme Corporation","BLA_Number":"103948","Proprietary_Name":"Campath ","Proper_Name":"alemtuzumab","License_Type":"351(a)","Strength":"30MG (10MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Ampule","Status":"Disc","Licensure":"Licensed","Approval_Date":"5\/7\/2001","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1596","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/7\/2008"},{"N\/R\/U":null,"Applicant":"Genzyme Corporation","BLA_Number":"103948","Proprietary_Name":"Campath ","Proper_Name":"alemtuzumab","License_Type":"351(a)","Strength":"30MG\/1ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/12\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5034","Submission_Type":"Supplement","License_Number":"1596","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/7\/2008"},{"N\/R\/U":null,"Applicant":"Genzyme Corporation","BLA_Number":"103948","Proprietary_Name":"Lemtrada","Proper_Name":"alemtuzumab","License_Type":"351(a)","Strength":"12MG\/1.2ML (10MG\/ML)","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/14\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5139","Submission_Type":"Supplement","License_Number":"1596","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/7\/2008"},{"N\/R\/U":null,"Applicant":"Genzyme Corporation","BLA_Number":"125141","Proprietary_Name":"Myozyme","Proper_Name":"alglucosidase alfa","License_Type":"351(a)","Strength":"50MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"4\/28\/2006","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1596","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"4\/28\/2013"},{"N\/R\/U":null,"Applicant":"Genzyme Corporation","BLA_Number":"125291","Proprietary_Name":"Lumizyme","Proper_Name":"alglucosidase alfa","License_Type":"351(a)","Strength":"50MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/24\/2010","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1596","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Regeneron Pharmaceuticals, Inc.","BLA_Number":"125559","Proprietary_Name":"Praluent","Proper_Name":"alirocumab","License_Type":"351(a)","Strength":"75MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/24\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1760","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"4\/1\/2028"},{"N\/R\/U":null,"Applicant":"Regeneron Pharmaceuticals, Inc.","BLA_Number":"125559","Proprietary_Name":"Praluent","Proper_Name":"alirocumab","License_Type":"351(a)","Strength":"150MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/24\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1760","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"4\/1\/2028"},{"N\/R\/U":null,"Applicant":"Regeneron Pharmaceuticals, Inc.","BLA_Number":"125559","Proprietary_Name":"Praluent","Proper_Name":"alirocumab","License_Type":"351(a)","Strength":"75MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"7\/24\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1760","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"4\/1\/2028"},{"N\/R\/U":null,"Applicant":"Regeneron Pharmaceuticals, Inc.","BLA_Number":"125559","Proprietary_Name":"Praluent","Proper_Name":"alirocumab","License_Type":"351(a)","Strength":"150MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"7\/24\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1760","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"4\/1\/2028"},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"103172","Proprietary_Name":"Activase","Proper_Name":"alteplase","License_Type":"351(a)","Strength":"50MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/13\/1987","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"103172","Proprietary_Name":"Activase","Proper_Name":"alteplase","License_Type":"351(a)","Strength":"100MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/13\/1987","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"103172","Proprietary_Name":"Cathflo Activase","Proper_Name":"alteplase","License_Type":"351(a)","Strength":"2MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/4\/2001","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5003","Submission_Type":"Supplement","License_Number":"1048","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Swedish Orphan Biovitrum AB (publ)","BLA_Number":"103950","Proprietary_Name":"Kineret","Proper_Name":"anakinra","License_Type":"351(a)","Strength":"100MG\/0.67ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/14\/2001","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1859","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/18\/2027"},{"N\/R\/U":null,"Applicant":"Alexion Pharmaceuticals, Inc.","BLA_Number":"125513","Proprietary_Name":"Strensiq","Proper_Name":"asfotase alfa","License_Type":"351(a)","Strength":"18MG\/0.45ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/23\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1743","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"10\/23\/2022"},{"N\/R\/U":null,"Applicant":"Alexion Pharmaceuticals, Inc.","BLA_Number":"125513","Proprietary_Name":"Strensiq","Proper_Name":"asfotase alfa","License_Type":"351(a)","Strength":"28MG\/0.7ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/23\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1743","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"10\/23\/2022"},{"N\/R\/U":null,"Applicant":"Alexion Pharmaceuticals, Inc.","BLA_Number":"125513","Proprietary_Name":"Strensiq","Proper_Name":"asfotase alfa","License_Type":"351(a)","Strength":"40MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/23\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1743","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"10\/23\/2022"},{"N\/R\/U":null,"Applicant":"Alexion Pharmaceuticals, Inc.","BLA_Number":"125513","Proprietary_Name":"Strensiq","Proper_Name":"asfotase alfa","License_Type":"351(a)","Strength":"80MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/23\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1743","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"10\/23\/2022"},{"N\/R\/U":null,"Applicant":"Recordati Rare Diseases, Inc.","BLA_Number":"101063","Proprietary_Name":"Elspar","Proper_Name":"asparaginase","License_Type":"351(a)","Strength":"10,000INTERNATIONAL UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous, Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"1\/10\/1978","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1899","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jazz Pharmaceuticals, Inc.","BLA_Number":"125359","Proprietary_Name":"Erwinaze","Proper_Name":"asparaginase Erwinia chrysanthemi","License_Type":"351(a)","Strength":"10,000INTERNATIONAL UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous, Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"11\/18\/2011","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1901","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"761034","Proprietary_Name":"Tecentriq","Proper_Name":"atezolizumab","License_Type":"351(a)","Strength":"1200MG\/20ML (60MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/18\/2016","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/9\/2029"},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"761034","Proprietary_Name":"Tecentriq","Proper_Name":"atezolizumab","License_Type":"351(a)","Strength":"840MG\/14ML (60MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/8\/2019","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"18","Submission_Type":"Supplement","License_Number":"1048","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/9\/2029"},{"N\/R\/U":null,"Applicant":"EMD Serono, Inc.","BLA_Number":"761049","Proprietary_Name":"Bavencio","Proper_Name":"avelumab","License_Type":"351(a)","Strength":"200MG\/10ML (20MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/23\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1773","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/23\/2024"},{"N\/R\/U":null,"Applicant":"Novartis Pharmaceuticals Corporation","BLA_Number":"103764","Proprietary_Name":"Simulect","Proper_Name":"basiliximab","License_Type":"351(a)","Strength":"20MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/12\/1998","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1244","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/12\/2005"},{"N\/R\/U":null,"Applicant":"Novartis Pharmaceuticals Corporation","BLA_Number":"103764","Proprietary_Name":"Simulect","Proper_Name":"basiliximab","License_Type":"351(a)","Strength":"10MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/2\/2003","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5037","Submission_Type":"Supplement","License_Number":"1244","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/12\/2005"},{"N\/R\/U":null,"Applicant":"Smith & Nephew, Inc.","BLA_Number":"103691","Proprietary_Name":"Regranex","Proper_Name":"becaplermin","License_Type":"351(a)","Strength":"0.01%","Dosage_Form":"Gel","Route_of_Administration":"Topical","Product_Presentation":"Tube","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/16\/1997","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2004","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bristol-Myers Squibb Company","BLA_Number":"125288","Proprietary_Name":"Nulojix","Proper_Name":"belatacept","License_Type":"351(a)","Strength":"250MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/15\/2011","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1713","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/15\/2018"},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline LLC","BLA_Number":"125370","Proprietary_Name":"Benlysta","Proper_Name":"belimumab","License_Type":"351(a)","Strength":"120MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/9\/2011","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1727","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline LLC","BLA_Number":"125370","Proprietary_Name":"Benlysta","Proper_Name":"belimumab","License_Type":"351(a)","Strength":"400MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/9\/2011","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1727","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline LLC","BLA_Number":"761043","Proprietary_Name":"Benlysta","Proper_Name":"belimumab","License_Type":"351(a)","Strength":"200MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/20\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1727","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline LLC","BLA_Number":"761043","Proprietary_Name":"Benlysta","Proper_Name":"belimumab","License_Type":"351(a)","Strength":"200MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/20\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1727","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"AstraZeneca AB","BLA_Number":"761070","Proprietary_Name":"Fasenra","Proper_Name":"benralizumab","License_Type":"351(a)","Strength":"30MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/14\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2059","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"AstraZeneca AB","BLA_Number":"761070","Proprietary_Name":"Fasenra","Proper_Name":"benralizumab","License_Type":"351(a)","Strength":"30MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/3\/2019","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5","Submission_Type":"Supplement","License_Number":"2059","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"125085","Proprietary_Name":"Avastin","Proper_Name":"bevacizumab","License_Type":"351(a)","Strength":"100MG\/4ML (25MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/26\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/29\/2027"},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"125085","Proprietary_Name":"Avastin","Proper_Name":"bevacizumab","License_Type":"351(a)","Strength":"400MG\/16ML (25MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/26\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/29\/2027"},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"761028","Proprietary_Name":"Mvasi","Proper_Name":"bevacizumab-awwb","License_Type":"351(k) Biosimilar","Strength":"100MG\/4ML (25MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/14\/2017","Ref._Product_Proper_Name":"bevacizumab","Ref._Product_Proprietary_Name":"Avastin","Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"761028","Proprietary_Name":"Mvasi","Proper_Name":"bevacizumab-awwb","License_Type":"351(k) Biosimilar","Strength":"400MG\/16ML (25MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/14\/2017","Ref._Product_Proper_Name":"bevacizumab","Ref._Product_Proprietary_Name":"Avastin","Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Pfizer Inc.","BLA_Number":"761099","Proprietary_Name":"Zirabev","Proper_Name":"bevacizumab-bvzr","License_Type":"351(k) Biosimilar","Strength":"100MG\/4ML (25MG\/ML)","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/27\/2019","Ref._Product_Proper_Name":"bevacizumab","Ref._Product_Proprietary_Name":"Avastin","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2001","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Pfizer Inc.","BLA_Number":"761099","Proprietary_Name":"Zirabev","Proper_Name":"bevacizumab-bvzr","License_Type":"351(k) Biosimilar","Strength":"400MG\/16ML (25MG\/ML)","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/27\/2019","Ref._Product_Proper_Name":"bevacizumab","Ref._Product_Proprietary_Name":"Avastin","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2001","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"761046","Proprietary_Name":"Zinplava","Proper_Name":"bezlotoxumab","License_Type":"351(a)","Strength":"1,000MG\/40ML (25MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/21\/2016","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"125557","Proprietary_Name":"Blincyto","Proper_Name":"blinatumomab","License_Type":"351(a)","Strength":"35MCG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/3\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/29\/2025"},{"N\/R\/U":null,"Applicant":"Seagen Inc.","BLA_Number":"125388","Proprietary_Name":"Adcetris","Proper_Name":"brentuximab vedotin","License_Type":"351(a)","Strength":"50MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/19\/2011","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2257","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/10\/2029"},{"N\/R\/U":null,"Applicant":"Valeant Pharmaceuticals Luxembourg S.\u00e0.r.l.","BLA_Number":"761032","Proprietary_Name":"Siliq","Proper_Name":"brodalumab","License_Type":"351(a)","Strength":"210MG\/1.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/15\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2053","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novartis Pharmaceuticals Corporation","BLA_Number":"761125","Proprietary_Name":"Beovu","Proper_Name":"brolucizumab-dbll","License_Type":"351(a)","Strength":"6MG\/0.05ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravitreal","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/7\/2019","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1244","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novartis Pharmaceuticals Corporation","BLA_Number":"761125","Proprietary_Name":"Beovu","Proper_Name":"brolucizumab-dbll","License_Type":"351(a)","Strength":"6MG\/0.05ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravitreal","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/27\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"8","Submission_Type":"Supplement","License_Number":"1244","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Kyowa Kirin, Inc.","BLA_Number":"761068","Proprietary_Name":"Crysvita","Proper_Name":"burosumab-twza","License_Type":"351(a)","Strength":"10MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/17\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2077","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/27\/2026"},{"N\/R\/U":null,"Applicant":"Kyowa Kirin, Inc.","BLA_Number":"761068","Proprietary_Name":"Crysvita","Proper_Name":"burosumab-twza","License_Type":"351(a)","Strength":"20MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/17\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2077","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/27\/2026"},{"N\/R\/U":null,"Applicant":"Kyowa Kirin, Inc.","BLA_Number":"761068","Proprietary_Name":"Crysvita","Proper_Name":"burosumab-twza","License_Type":"351(a)","Strength":"30MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/17\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2077","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/27\/2026"},{"N\/R\/U":null,"Applicant":"Servier Pharmaceuticals LLC","BLA_Number":"761102","Proprietary_Name":"Asparlas","Proper_Name":"calaspargase pegol-mknl","License_Type":"351(a)","Strength":"3,750UNITS\/5ML (750UNITS\/ML)","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/20\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2125","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/1\/2001"},{"N\/R\/U":null,"Applicant":"Novartis Pharmaceuticals Corporation","BLA_Number":"125319","Proprietary_Name":"Ilaris","Proper_Name":"canakinumab","License_Type":"351(a)","Strength":"150MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/17\/2009","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1244","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/16\/2027"},{"N\/R\/U":null,"Applicant":"Novartis Pharmaceuticals Corporation","BLA_Number":"125319","Proprietary_Name":"Ilaris","Proper_Name":"canakinumab","License_Type":"351(a)","Strength":"150MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/22\/2016","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"88","Submission_Type":"Supplement","License_Number":"1244","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/16\/2027"},{"N\/R\/U":null,"Applicant":"Ablynx NV","BLA_Number":"761112","Proprietary_Name":"Cablivi","Proper_Name":"caplacizumab-yhdp","License_Type":"351(a)","Strength":"11MG","Dosage_Form":"For injection","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/6\/2019","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2085","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/6\/2026"},{"N\/R\/U":null,"Applicant":"Aytu BioScience, Inc.","BLA_Number":"103608","Proprietary_Name":"ProstaScint","Proper_Name":"capromab pendetide","License_Type":"351(a)","Strength":"0.5MG\/1ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"10\/28\/1996","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2035","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Regeneron Pharmaceuticals, Inc.","BLA_Number":"761097","Proprietary_Name":"Libtayo","Proper_Name":"cemiplimab-rwlc","License_Type":"351(a)","Strength":"350MG\/7ML (50MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/28\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1760","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Domp\u00e9 farmaceutici S.p.A.","BLA_Number":"761094","Proprietary_Name":"Oxervate","Proper_Name":"cenegermin-bkbj","License_Type":"351(a)","Strength":"0.002% (20MCG\/ML)","Dosage_Form":"Solution","Route_of_Administration":"Topical","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/22\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2074","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"8\/22\/2025"},{"N\/R\/U":null,"Applicant":"BioMarin Pharmaceutical Inc.","BLA_Number":"761052","Proprietary_Name":"Brineura","Proper_Name":"cerliponase alfa","License_Type":"351(a)","Strength":"150MG\/5ML (30MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intraventricular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/27\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1649","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"4\/27\/2024"},{"N\/R\/U":null,"Applicant":"UCB, Inc.","BLA_Number":"125160","Proprietary_Name":"Cimzia","Proper_Name":"certolizumab pegol","License_Type":"351(a)","Strength":"200MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/22\/2008","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1736","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"UCB, Inc.","BLA_Number":"125160","Proprietary_Name":"Cimzia","Proper_Name":"certolizumab pegol","License_Type":"351(a)","Strength":"200MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/28\/2019","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"237","Submission_Type":"Supplement","License_Number":"1736","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"125084","Proprietary_Name":"Erbitux","Proper_Name":"cetuximab","License_Type":"351(a)","Strength":"100MG\/50ML (2MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/12\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1827","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/1\/2013"},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"125084","Proprietary_Name":"Erbitux","Proper_Name":"cetuximab","License_Type":"351(a)","Strength":"200MG\/100ML (2MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/28\/2007","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"79","Submission_Type":"Supplement","License_Number":"1827","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/1\/2013"},{"N\/R\/U":null,"Applicant":"Smith & Nephew, Inc.","BLA_Number":"101995","Proprietary_Name":"Santyl","Proper_Name":"collagenase","License_Type":"351(a)","Strength":"250UNITS\/GRAM","Dosage_Form":"Ointment","Route_of_Administration":"Topical","Product_Presentation":"Tube","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/4\/1965","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2004","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Auxilium Pharmaceuticals, Inc.","BLA_Number":"125338","Proprietary_Name":"Xiaflex","Proper_Name":"collagenase clostridium histolyticum","License_Type":"351(a)","Strength":"0.9MG","Dosage_Form":"For Injection","Route_of_Administration":"Intralesional","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/2\/2010","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1816","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/6\/2020"},{"N\/R\/U":null,"Applicant":"Novartis Pharmaceuticals Corporation","BLA_Number":"761128","Proprietary_Name":"Adakveo","Proper_Name":"crizanlizumab-tmca","License_Type":"351(a)","Strength":"100MG\/10ML (10MG\/ML)","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/15\/2019","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1244","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/15\/2026"},{"N\/R\/U":null,"Applicant":"Hoffmann-La Roche Inc.","BLA_Number":"103749","Proprietary_Name":"Zenapax","Proper_Name":"daclizumab","License_Type":"351(a)","Strength":"25MG\/5ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"12\/10\/1997","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":null,"License_Number":"136","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Biogen Inc.","BLA_Number":"761029","Proprietary_Name":"Zinbryta","Proper_Name":"daclizumab","License_Type":"351(a)","Strength":"150MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"5\/27\/2016","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1697","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Biogen Inc.","BLA_Number":"761029","Proprietary_Name":"Zinbryta","Proper_Name":"daclizumab","License_Type":"351(a)","Strength":"150MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"5\/26\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"1","Submission_Type":"Supplement","License_Number":"1697","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Janssen Biotech, Inc.","BLA_Number":"761036","Proprietary_Name":"Darzalex","Proper_Name":"daratumumab","License_Type":"351(a)","Strength":"100MG\/5ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/16\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1864","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/26\/2026"},{"N\/R\/U":null,"Applicant":"Janssen Biotech, Inc.","BLA_Number":"761036","Proprietary_Name":"Darzalex","Proper_Name":"daratumumab","License_Type":"351(a)","Strength":"400MG\/20ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/16\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1864","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/26\/2026"},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"25MCG\/1ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/17\/2001","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"40MCG\/1ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/17\/2001","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"60MCG\/1ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/17\/2001","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"100MCG\/1ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/17\/2001","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"200MCG\/1ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/17\/2001","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"25MCG\/1ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"9\/17\/2001","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"6","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"40MCG\/1ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"9\/17\/2001","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"7","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"60MCG\/1ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"9\/17\/2001","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"8","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"100MCG\/1ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"9\/17\/2001","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"9","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"200MCG\/1ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"9\/17\/2001","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"10","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"150MCG\/0.75ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"7\/19\/2002","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5001","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"11","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"300MCG\/1ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"7\/19\/2002","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5001","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"12","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"500MCG\/1ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"7\/19\/2002","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5001","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"13","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"60MCG\/0.3ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/17\/2002","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5022","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"14","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"100MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/17\/2002","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5022","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"15","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"150MCG\/0.3ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/17\/2002","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5022","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"16","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"200MCG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/17\/2002","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5022","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"17","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"300MCG\/0.6ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/17\/2002","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5022","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"18","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"500MCG\/1ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/17\/2002","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5022","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"19","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"25MCG\/0.42ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/12\/2003","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5055","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"20","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"25MCG\/0.42ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/12\/2003","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5055","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"21","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"40MCG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/12\/2003","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5055","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"22","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"40MCG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/12\/2003","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5055","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"23","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"60MCG\/0.3ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/12\/2003","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5055","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"24","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"100MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/12\/2003","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5055","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"25","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"150MCG\/0.3ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/12\/2003","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5055","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"26","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"200MCG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/12\/2003","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5055","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"27","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"300MCG\/0.6ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/12\/2003","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5055","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"28","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"500MCG\/1ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/12\/2003","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5055","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"29","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"150MCG\/0.75ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/12\/2003","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5055","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"30","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"300MCG\/1ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/12\/2003","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5055","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"31","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"500MCG\/1ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/12\/2003","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5055","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"32","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"25MCG\/0.42ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/29\/2006","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5113","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"33","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"40MCG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/29\/2006","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5113","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"34","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"60MCG\/0.3ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/29\/2006","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5113","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"35","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"100MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/29\/2006","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5113","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"36","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"150MCG\/0.3ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/29\/2006","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5113","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"37","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"200MCG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/29\/2006","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5113","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"38","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"300MCG\/0.6ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/29\/2006","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5113","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"39","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"500MCG\/1ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/29\/2006","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5113","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"40","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"25MCG\/0.42ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/29\/2006","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5113","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"41","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"40MCG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/29\/2006","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5113","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"42","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"60MCG\/0.3ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/29\/2006","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5113","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"43","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"100MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/29\/2006","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5113","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"44","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"150MCG\/0.3ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/29\/2006","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5113","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"45","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"200MCG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/29\/2006","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5113","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"46","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"300MCG\/0.6ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/29\/2006","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5113","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"47","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"500MCG\/1ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/29\/2006","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5113","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"48","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103951","Proprietary_Name":"Aranesp","Proper_Name":"darbepoetin alpha","License_Type":"351(a)","Strength":"10MCG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":null,"Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Supplement","License_Number":"1080","Product_Number":"49","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eisai, Incorporated","BLA_Number":"103767","Proprietary_Name":"Ontak","Proper_Name":"denileukin diftitox","License_Type":"351(a)","Strength":"150MCG\/ML (300MCG\/2ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"2\/5\/1999","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1862","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/5\/2006"},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"125320","Proprietary_Name":"Prolia","Proper_Name":"denosumab","License_Type":"351(a)","Strength":"60MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/1\/2010","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"125320","Proprietary_Name":"Prolia","Proper_Name":"denosumab","License_Type":"351(a)","Strength":"60MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/1\/2010","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"125320","Proprietary_Name":"Xgeva","Proper_Name":"denosumab","License_Type":"351(a)","Strength":"120MG\/1.7ML (70MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/18\/2010","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"7","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/5\/2021"},{"N\/R\/U":null,"Applicant":"United Therapeutics Corporation","BLA_Number":"125516","Proprietary_Name":"Unituxin","Proper_Name":"dinutuximab","License_Type":"351(a)","Strength":"17.5MG\/5ML (3.5MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/10\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1993","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/10\/2022"},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"103532","Proprietary_Name":"Pulmozyme","Proper_Name":"dornase alfa","License_Type":"351(a)","Strength":"2.5MG\/2.5ML","Dosage_Form":"Solution","Route_of_Administration":"Inhalation","Product_Presentation":"Ampule","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/30\/1993","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/30\/2000"},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"125029","Proprietary_Name":"Xigris","Proper_Name":"drotrecogin alfa","License_Type":"351(a)","Strength":"5MG","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"11\/21\/2001","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1611","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"125029","Proprietary_Name":"Xigris","Proper_Name":"drotrecogin alfa","License_Type":"351(a)","Strength":"20MG","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"11\/21\/2001","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1611","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"125469","Proprietary_Name":"Trulicity","Proper_Name":"dulaglutide","License_Type":"351(a)","Strength":"0.75MG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/18\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"125469","Proprietary_Name":"Trulicity","Proper_Name":"dulaglutide","License_Type":"351(a)","Strength":"1.5MG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/18\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"125469","Proprietary_Name":"Trulicity","Proper_Name":"dulaglutide","License_Type":"351(a)","Strength":"0.75MG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"9\/18\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"125469","Proprietary_Name":"Trulicity","Proper_Name":"dulaglutide","License_Type":"351(a)","Strength":"1.5MG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"9\/18\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"125469","Proprietary_Name":"Trulicity","Proper_Name":"dulaglutide","License_Type":"351(a)","Strength":"3MG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/4\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"36","Submission_Type":"Supplement","License_Number":"1891","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"125469","Proprietary_Name":"Trulicity","Proper_Name":"dulaglutide","License_Type":"351(a)","Strength":"4.5MG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/4\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"36","Submission_Type":"Supplement","License_Number":"1891","Product_Number":"6","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Regeneron Pharmaceuticals, Inc.","BLA_Number":"761055","Proprietary_Name":"Dupixent","Proper_Name":"dupilumab","License_Type":"351(a)","Strength":"300MG\/2ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/28\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1760","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/20\/2029"},{"N\/R\/U":null,"Applicant":"Regeneron Pharmaceuticals, Inc.","BLA_Number":"761055","Proprietary_Name":"Dupixent","Proper_Name":"dupilumab","License_Type":"351(a)","Strength":"300MG\/2ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"3\/28\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1760","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/20\/2029"},{"N\/R\/U":null,"Applicant":"Regeneron Pharmaceuticals, Inc.","BLA_Number":"761055","Proprietary_Name":"Dupixent","Proper_Name":"dupilumab","License_Type":"351(a)","Strength":"200MG\/1.14ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/19\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"7","Submission_Type":"Supplement","License_Number":"1760","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/20\/2029"},{"N\/R\/U":null,"Applicant":"Regeneron Pharmaceuticals, Inc.","BLA_Number":"761055","Proprietary_Name":"Dupixent","Proper_Name":"dupilumab","License_Type":"351(a)","Strength":"300MG\/2ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/18\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"17","Submission_Type":"Supplement","License_Number":"1760","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/20\/2029"},{"N\/R\/U":null,"Applicant":"Regeneron Pharmaceuticals, Inc.","BLA_Number":"761055","Proprietary_Name":"Dupixent","Proper_Name":"dupilumab","License_Type":"351(a)","Strength":"200MG\/1.14ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"16","Submission_Type":"Supplement","License_Number":"1760","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/20\/2029"},{"N\/R\/U":null,"Applicant":"Regeneron Pharmaceuticals, Inc.","BLA_Number":"761055","Proprietary_Name":"Dupixent","Proper_Name":"dupilumab","License_Type":"351(a)","Strength":"100MG\/0.67ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/20\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"31","Submission_Type":"Supplement","License_Number":"1760","Product_Number":"6","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/20\/2029"},{"N\/R\/U":null,"Applicant":"AstraZeneca UK Ltd","BLA_Number":"761069","Proprietary_Name":"Imfinzi","Proper_Name":"durvalumab","License_Type":"351(a)","Strength":"500MG\/10ML (50MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/1\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2043","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"10\/21\/2029"},{"N\/R\/U":null,"Applicant":"AstraZeneca UK Ltd","BLA_Number":"761069","Proprietary_Name":"Imfinzi","Proper_Name":"durvalumab","License_Type":"351(a)","Strength":"120MG\/2.4ML (50MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/1\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2043","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"10\/21\/2029"},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125277","Proprietary_Name":"Kalbitor","Proper_Name":"ecallantide","License_Type":"351(a)","Strength":"10MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/1\/2009","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1898","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/28\/2021"},{"N\/R\/U":null,"Applicant":"Alexion Pharmaceuticals, Inc.","BLA_Number":"125166","Proprietary_Name":"Soliris","Proper_Name":"eculizumab","License_Type":"351(a)","Strength":"300MG\/30ML (10MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/16\/2007","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1743","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/27\/2026"},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"125075","Proprietary_Name":"Raptiva","Proper_Name":"efalizumab","License_Type":"351(a)","Strength":"125MG","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"10\/27\/2003","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":null,"License_Number":"1048","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Chiesi USA, Inc.","BLA_Number":"761092","Proprietary_Name":"Revcovi","Proper_Name":"elapegademase-lvlr","License_Type":"351(a)","Strength":"2.4MG\/1.5ML (1.6MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/5\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2150","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"10\/5\/2025"},{"N\/R\/U":null,"Applicant":"BioMarin Pharmaceutical Inc.","BLA_Number":"125460","Proprietary_Name":"Vimizim","Proper_Name":"elosulfase alfa","License_Type":"351(a)","Strength":"5MG\/5ML (1MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/14\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1649","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/14\/2021"},{"N\/R\/U":null,"Applicant":"Bristol-Myers Squibb Company","BLA_Number":"761035","Proprietary_Name":"Empliciti","Proper_Name":"elotuzumab","License_Type":"351(a)","Strength":"300MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/30\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1713","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/6\/2025"},{"N\/R\/U":null,"Applicant":"Bristol-Myers Squibb Company","BLA_Number":"761035","Proprietary_Name":"Empliciti","Proper_Name":"elotuzumab","License_Type":"351(a)","Strength":"400MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/30\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1713","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/6\/2025"},{"N\/R\/U":null,"Applicant":"Swedish Orphan Biovitrum AB (publ)","BLA_Number":"761107","Proprietary_Name":"Gamifant","Proper_Name":"emapalumab-lzsg","License_Type":"351(a)","Strength":"10MG\/2ML (5MG\/ML)","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/20\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1859","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/20\/2025"},{"N\/R\/U":null,"Applicant":"Swedish Orphan Biovitrum AB (publ)","BLA_Number":"761107","Proprietary_Name":"Gamifant","Proper_Name":"emapalumab-lzsg","License_Type":"351(a)","Strength":"50MG\/10ML (5MG\/ML)","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/20\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1859","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/20\/2025"},{"N\/R\/U":null,"Applicant":"Swedish Orphan Biovitrum AB (publ)","BLA_Number":"761107","Proprietary_Name":"Gamifant","Proper_Name":"emapalumab-lzsg","License_Type":"351(a)","Strength":"100MG\/20ML (5MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/26\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"4","Submission_Type":"Supplement","License_Number":"1859","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/20\/2025"},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"761083","Proprietary_Name":"Hemlibra","Proper_Name":"emicizumab-kxwh","License_Type":"351(a)","Strength":"30MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/16\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"10\/4\/2025"},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"761083","Proprietary_Name":"Hemlibra","Proper_Name":"emicizumab-kxwh","License_Type":"351(a)","Strength":"60MG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/16\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"10\/4\/2025"},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"761083","Proprietary_Name":"Hemlibra","Proper_Name":"emicizumab-kxwh","License_Type":"351(a)","Strength":"105MG\/0.7ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/16\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"10\/4\/2025"},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"761083","Proprietary_Name":"Hemlibra","Proper_Name":"emicizumab-kxwh","License_Type":"351(a)","Strength":"150MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/16\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"10\/4\/2025"},{"N\/R\/U":null,"Applicant":"Astellas Pharma US, Inc.","BLA_Number":"761137","Proprietary_Name":"Padcev","Proper_Name":"enfortumab vedotin-ejfv","License_Type":"351(a)","Strength":"20MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/18\/2019","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2124","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Astellas Pharma US, Inc.","BLA_Number":"761137","Proprietary_Name":"Padcev","Proper_Name":"enfortumab vedotin-ejfv","License_Type":"351(a)","Strength":"30MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/18\/2019","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2124","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103234","Proprietary_Name":"Epogen\/Procrit","Proper_Name":"epoetin alfa","License_Type":"351(a)","Strength":"10,000UNITS\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/1\/1989","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/31\/1997"},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103234","Proprietary_Name":"Epogen\/Procrit","Proper_Name":"epoetin alfa","License_Type":"351(a)","Strength":"2,000UNITS\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/1\/1989","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/31\/1997"},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103234","Proprietary_Name":"Epogen\/Procrit","Proper_Name":"epoetin alfa","License_Type":"351(a)","Strength":"3,000UNITS\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/1\/1989","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/31\/1997"},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103234","Proprietary_Name":"Epogen\/Procrit","Proper_Name":"epoetin alfa","License_Type":"351(a)","Strength":"4,000UNITS\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/1\/1989","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"7","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/31\/1997"},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103234","Proprietary_Name":"Epogen\/Procrit","Proper_Name":"epoetin alfa","License_Type":"351(a)","Strength":"20,000UNITS\/2ML (10,000UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":null,"Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Supplement","License_Number":"1080","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/31\/1997"},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103234","Proprietary_Name":"Epogen\/Procrit","Proper_Name":"epoetin alfa","License_Type":"351(a)","Strength":"20,000UNITS\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":null,"Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Supplement","License_Number":"1080","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/31\/1997"},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103234","Proprietary_Name":"Procrit","Proper_Name":"epoetin alfa","License_Type":"351(a)","Strength":"40,000UNITS\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":null,"Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Supplement","License_Number":"1080","Product_Number":"6","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/31\/1997"},{"N\/R\/U":null,"Applicant":"Hospira Inc., a Pfizer Company","BLA_Number":"125545","Proprietary_Name":"Retacrit","Proper_Name":"epoetin alfa-epbx","License_Type":"351(k) Biosimilar","Strength":"2,000UNITS\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/15\/2018","Ref._Product_Proper_Name":"epoetin alfa","Ref._Product_Proprietary_Name":"Procrit","Supplement_Number":null,"Submission_Type":"Original","License_Number":"1974","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Hospira Inc., a Pfizer Company","BLA_Number":"125545","Proprietary_Name":"Retacrit","Proper_Name":"epoetin alfa-epbx","License_Type":"351(k) Biosimilar","Strength":"3,000UNITS\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/15\/2018","Ref._Product_Proper_Name":"epoetin alfa","Ref._Product_Proprietary_Name":"Procrit","Supplement_Number":null,"Submission_Type":"Original","License_Number":"1974","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Hospira Inc., a Pfizer Company","BLA_Number":"125545","Proprietary_Name":"Retacrit","Proper_Name":"epoetin alfa-epbx","License_Type":"351(k) Biosimilar","Strength":"4,000UNITS\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/15\/2018","Ref._Product_Proper_Name":"epoetin alfa","Ref._Product_Proprietary_Name":"Procrit","Supplement_Number":null,"Submission_Type":"Original","License_Number":"1974","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Hospira Inc., a Pfizer Company","BLA_Number":"125545","Proprietary_Name":"Retacrit","Proper_Name":"epoetin alfa-epbx","License_Type":"351(k) Biosimilar","Strength":"10,000UNITS\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/15\/2018","Ref._Product_Proper_Name":"epoetin alfa","Ref._Product_Proprietary_Name":"Procrit","Supplement_Number":null,"Submission_Type":"Original","License_Number":"1974","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Hospira Inc., a Pfizer Company","BLA_Number":"125545","Proprietary_Name":"Retacrit","Proper_Name":"epoetin alfa-epbx","License_Type":"351(k) Biosimilar","Strength":"40,000UNITS\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/15\/2018","Ref._Product_Proper_Name":"epoetin alfa","Ref._Product_Proprietary_Name":"Procrit","Supplement_Number":null,"Submission_Type":"Original","License_Number":"1974","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Hospira Inc., a Pfizer Company","BLA_Number":"125545","Proprietary_Name":"Retacrit","Proper_Name":"epoetin alfa-epbx","License_Type":"351(k) Biosimilar","Strength":"20,000UNITS\/2ML (10,000UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/30\/2020","Ref._Product_Proper_Name":"epoetin alfa","Ref._Product_Proprietary_Name":"Procrit","Supplement_Number":"5","Submission_Type":"Supplement","License_Number":"1974","Product_Number":"6","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Hospira Inc., a Pfizer Company","BLA_Number":"125545","Proprietary_Name":"Retacrit","Proper_Name":"epoetin alfa-epbx","License_Type":"351(k) Biosimilar","Strength":"20,000UNITS\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/30\/2020","Ref._Product_Proper_Name":"epoetin alfa","Ref._Product_Proprietary_Name":"Procrit","Supplement_Number":"5","Submission_Type":"Supplement","License_Number":"1974","Product_Number":"7","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"761077","Proprietary_Name":"Aimovig","Proper_Name":"erenumab-aooe","License_Type":"351(a)","Strength":"70MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/17\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"761077","Proprietary_Name":"Aimovig","Proper_Name":"erenumab-aooe","License_Type":"351(a)","Strength":"70MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"5\/17\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"761077","Proprietary_Name":"Aimovig","Proper_Name":"erenumab-aooe","License_Type":"351(a)","Strength":"140MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/11\/2019","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"1","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"761077","Proprietary_Name":"Aimovig","Proper_Name":"erenumab-aooe","License_Type":"351(a)","Strength":"140MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"3\/11\/2019","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"1","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Immunex Corporation","BLA_Number":"103795","Proprietary_Name":"Enbrel","Proper_Name":"etanercept","License_Type":"351(a)","Strength":"25MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"11\/2\/1998","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1132","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/27\/2006"},{"N\/R\/U":null,"Applicant":"Immunex Corporation","BLA_Number":"103795","Proprietary_Name":"Enbrel","Proper_Name":"etanercept","License_Type":"351(a)","Strength":"25MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/27\/1999","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"1001","Submission_Type":"Supplement","License_Number":"1132","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/27\/2006"},{"N\/R\/U":null,"Applicant":"Immunex Corporation","BLA_Number":"103795","Proprietary_Name":"Enbrel","Proper_Name":"etanercept","License_Type":"351(a)","Strength":"50MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/27\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5184","Submission_Type":"Supplement","License_Number":"1132","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/27\/2006"},{"N\/R\/U":null,"Applicant":"Immunex Corporation","BLA_Number":"103795","Proprietary_Name":"Enbrel","Proper_Name":"etanercept","License_Type":"351(a)","Strength":"25MG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/1\/2007","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5322","Submission_Type":"Supplement","License_Number":"1132","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/27\/2006"},{"N\/R\/U":null,"Applicant":"Immunex Corporation","BLA_Number":"103795","Proprietary_Name":"Enbrel Mini","Proper_Name":"etanercept","License_Type":"351(a)","Strength":"50MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/14\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5556","Submission_Type":"Supplement","License_Number":"1132","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/27\/2006"},{"N\/R\/U":null,"Applicant":"Immunex Corporation","BLA_Number":"103795","Proprietary_Name":"Enbrel","Proper_Name":"etanercept","License_Type":"351(a)","Strength":"25MG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/5\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5577","Submission_Type":"Supplement","License_Number":"1132","Product_Number":"7","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/27\/2006"},{"N\/R\/U":null,"Applicant":"Immunex Corporation","BLA_Number":"103795","Proprietary_Name":"Enbrel","Proper_Name":"etanercept","License_Type":"351(a)","Strength":"50MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":null,"Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Supplement","License_Number":"1132","Product_Number":"6","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/27\/2006"},{"N\/R\/U":null,"Applicant":"Sandoz Inc.","BLA_Number":"761042","Proprietary_Name":"Erelzi","Proper_Name":"etanercept-szzs","License_Type":"351(k) Biosimilar","Strength":"25MG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"8\/30\/2016","Ref._Product_Proper_Name":"etanercept","Ref._Product_Proprietary_Name":"Enbrel","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2003","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sandoz Inc.","BLA_Number":"761042","Proprietary_Name":"Erelzi","Proper_Name":"etanercept-szzs","License_Type":"351(k) Biosimilar","Strength":"50MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"8\/30\/2016","Ref._Product_Proper_Name":"etanercept","Ref._Product_Proprietary_Name":"Enbrel","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2003","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sandoz Inc.","BLA_Number":"761042","Proprietary_Name":"Erelzi Sensoready","Proper_Name":"etanercept-szzs","License_Type":"351(k) Biosimilar","Strength":"50MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"8\/30\/2016","Ref._Product_Proper_Name":"etanercept","Ref._Product_Proprietary_Name":"Enbrel","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2003","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sandoz Inc.","BLA_Number":"761042","Proprietary_Name":"Erelzi","Proper_Name":"etanercept-szzs","License_Type":"351(k) Biosimilar","Strength":"25MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"11\/10\/2022","Ref._Product_Proper_Name":"etanercept","Ref._Product_Proprietary_Name":"Enbrel","Supplement_Number":"18","Submission_Type":"Supplement","License_Number":"2003","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Samsung Bioepis Co., Ltd.","BLA_Number":"761066","Proprietary_Name":"Eticovo","Proper_Name":"etanercept-ykro","License_Type":"351(k) Biosimilar","Strength":"50MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"4\/25\/2019","Ref._Product_Proper_Name":"etanercept","Ref._Product_Proprietary_Name":"Enbrel","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2046","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Samsung Bioepis Co., Ltd.","BLA_Number":"761066","Proprietary_Name":"Eticovo","Proper_Name":"etanercept-ykro","License_Type":"351(k) Biosimilar","Strength":"25MG\/0.5ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"4\/25\/2019","Ref._Product_Proper_Name":"etanercept","Ref._Product_Proprietary_Name":"Enbrel","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2046","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"125522","Proprietary_Name":"Repatha","Proper_Name":"evolocumab","License_Type":"351(a)","Strength":"140MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/27\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/24\/2028"},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"125522","Proprietary_Name":"Repatha","Proper_Name":"evolocumab","License_Type":"351(a)","Strength":"140MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/27\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/24\/2028"},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"125522","Proprietary_Name":"Repatha","Proper_Name":"evolocumab","License_Type":"351(a)","Strength":"420MG\/3.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/8\/2016","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"1","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/24\/2028"},{"N\/R\/U":null,"Applicant":"Daiichi Sankyo, Inc","BLA_Number":"761139","Proprietary_Name":"Enhertu","Proper_Name":"fam-trastuzumab deruxtecan-nxki","License_Type":"351(a)","Strength":"100MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/20\/2019","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2128","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"1\/15\/2028"},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103353","Proprietary_Name":"Neupogen","Proper_Name":"filgrastim","License_Type":"351(a)","Strength":"300MCG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/20\/1991","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/30\/2022"},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103353","Proprietary_Name":"Neupogen","Proper_Name":"filgrastim","License_Type":"351(a)","Strength":"480MCG\/1.6ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/20\/1991","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/30\/2022"},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103353","Proprietary_Name":"Neupogen","Proper_Name":"filgrastim","License_Type":"351(a)","Strength":"300MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/28\/2000","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"1043","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/30\/2022"},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"103353","Proprietary_Name":"Neupogen","Proper_Name":"filgrastim","License_Type":"351(a)","Strength":"480MCG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/28\/2000","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"1043","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/30\/2022"},{"N\/R\/U":null,"Applicant":"Sandoz Inc.","BLA_Number":"125553","Proprietary_Name":"Zarxio","Proper_Name":"filgrastim-sndz","License_Type":"351(k) Biosimilar","Strength":"300MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/6\/2015","Ref._Product_Proper_Name":"filgrastim","Ref._Product_Proprietary_Name":"Neupogen","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2003","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sandoz Inc.","BLA_Number":"125553","Proprietary_Name":"Zarxio","Proper_Name":"filgrastim-sndz","License_Type":"351(k) Biosimilar","Strength":"480MCG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/6\/2015","Ref._Product_Proper_Name":"filgrastim","Ref._Product_Proprietary_Name":"Neupogen","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2003","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Hospira Inc., a Pfizer Company","BLA_Number":"761080","Proprietary_Name":"Nivestym","Proper_Name":"filgrastim-aafi","License_Type":"351(k) Biosimilar","Strength":"300MCG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/20\/2018","Ref._Product_Proper_Name":"filgrastim","Ref._Product_Proprietary_Name":"Neupogen","Supplement_Number":null,"Submission_Type":"Original","License_Number":"1974","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Hospira Inc., a Pfizer Company","BLA_Number":"761080","Proprietary_Name":"Nivestym","Proper_Name":"filgrastim-aafi","License_Type":"351(k) Biosimilar","Strength":"480MCG\/1.6ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/20\/2018","Ref._Product_Proper_Name":"filgrastim","Ref._Product_Proprietary_Name":"Neupogen","Supplement_Number":null,"Submission_Type":"Original","License_Number":"1974","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Hospira Inc., a Pfizer Company","BLA_Number":"761080","Proprietary_Name":"Nivestym","Proper_Name":"filgrastim-aafi","License_Type":"351(k) Biosimilar","Strength":"300MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/20\/2018","Ref._Product_Proper_Name":"filgrastim","Ref._Product_Proprietary_Name":"Neupogen","Supplement_Number":null,"Submission_Type":"Original","License_Number":"1974","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Hospira Inc., a Pfizer Company","BLA_Number":"761080","Proprietary_Name":"Nivestym","Proper_Name":"filgrastim-aafi","License_Type":"351(k) Biosimilar","Strength":"480MCG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/20\/2018","Ref._Product_Proper_Name":"filgrastim","Ref._Product_Proprietary_Name":"Neupogen","Supplement_Number":null,"Submission_Type":"Original","License_Number":"1974","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Teva Branded Pharmaceutical Products R&D, Inc.","BLA_Number":"761089","Proprietary_Name":"Ajovy","Proper_Name":"fremanezumab-vfrm","License_Type":"351(a)","Strength":"225MG\/1.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/14\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2016","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Teva Branded Pharmaceutical Products R&D, Inc.","BLA_Number":"761089","Proprietary_Name":"Ajovy","Proper_Name":"fremanezumab-vfrm","License_Type":"351(a)","Strength":"225MG\/1.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/27\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"2","Submission_Type":"Supplement","License_Number":"2016","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"761063","Proprietary_Name":"Emgality","Proper_Name":"galcanezumab-gnlm","License_Type":"351(a)","Strength":"120MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/27\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"761063","Proprietary_Name":"Emgality","Proper_Name":"galcanezumab-gnlm","License_Type":"351(a)","Strength":"120MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/27\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"761063","Proprietary_Name":"Emgality","Proper_Name":"galcanezumab-gnlm","License_Type":"351(a)","Strength":"100MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/4\/2019","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"3","Submission_Type":"Supplement","License_Number":"1891","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"BioMarin Pharmaceutical Inc.","BLA_Number":"125117","Proprietary_Name":"Naglazyme           ","Proper_Name":"galsulfase                      ","License_Type":"351(a)","Strength":"5MG\/5ML (1MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/31\/2005","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1649","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/31\/2012"},{"N\/R\/U":null,"Applicant":"Wyeth Pharmaceuticals LLC","BLA_Number":"761060","Proprietary_Name":"Mylotarg","Proper_Name":"gemtuzumab ozogamicin","License_Type":"351(a)","Strength":"4.5MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/1\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"3","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/1\/2024"},{"N\/R\/U":null,"Applicant":"BTG International Inc.","BLA_Number":"125327","Proprietary_Name":"Voraxaze","Proper_Name":"glucarpidase","License_Type":"351(a)","Strength":"1,000UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/17\/2012","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1861","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"1\/17\/2019"},{"N\/R\/U":null,"Applicant":"Janssen Biotech, Inc.","BLA_Number":"125289","Proprietary_Name":"Simponi","Proper_Name":"golimumab","License_Type":"351(a)","Strength":"50MG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/24\/2009","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1864","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Janssen Biotech, Inc.","BLA_Number":"125289","Proprietary_Name":"Simponi","Proper_Name":"golimumab","License_Type":"351(a)","Strength":"50MG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/24\/2009","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1864","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Janssen Biotech, Inc.","BLA_Number":"125289","Proprietary_Name":"Simponi","Proper_Name":"golimumab","License_Type":"351(a)","Strength":"100MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/15\/2013","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"77","Submission_Type":"Supplement","License_Number":"1864","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Janssen Biotech, Inc.","BLA_Number":"125289","Proprietary_Name":"Simponi","Proper_Name":"golimumab","License_Type":"351(a)","Strength":"100MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/15\/2013","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"77","Submission_Type":"Supplement","License_Number":"1864","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Janssen Biotech, Inc.","BLA_Number":"125433","Proprietary_Name":"Simponi Aria","Proper_Name":"golimumab","License_Type":"351(a)","Strength":"50MG\/4ML (12.5MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/18\/2013","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1864","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/29\/2027"},{"N\/R\/U":null,"Applicant":"Janssen Biotech, Inc.","BLA_Number":"761061","Proprietary_Name":"Tremfya","Proper_Name":"guselkumab","License_Type":"351(a)","Strength":"100MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/13\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1864","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Janssen Biotech, Inc.","BLA_Number":"761061","Proprietary_Name":"Tremfya","Proper_Name":"guselkumab","License_Type":"351(a)","Strength":"100MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/29\/2019","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"1","Submission_Type":"Supplement","License_Number":"1864","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Theratechnologies Inc.","BLA_Number":"761065","Proprietary_Name":"Trogarzo","Proper_Name":"ibalizumab-uiyk","License_Type":"351(a)","Strength":"200MG\/1.33ML (150MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/6\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2091","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/6\/2025"},{"N\/R\/U":null,"Applicant":"Acrotech Biopharma Inc.","BLA_Number":"125019","Proprietary_Name":"Zevalin","Proper_Name":"ibritumomab tiuxetan","License_Type":"351(a)","Strength":"3.2MG\/2ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/19\/2002","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2159","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/19\/2009"},{"N\/R\/U":null,"Applicant":"Boehringer Ingelheim Pharmaceuticals, Inc.","BLA_Number":"761025","Proprietary_Name":"Praxbind","Proper_Name":"idarucizumab","License_Type":"351(a)","Strength":"2.5G\/50ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/16\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2006","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"10\/16\/2022"},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125151","Proprietary_Name":"Elaprase","Proper_Name":"idursulfase","License_Type":"351(a)","Strength":"6MG\/3ML (2MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/24\/2006","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1898","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/24\/2013"},{"N\/R\/U":null,"Applicant":"Merz Pharmaceuticals GmbH c\/o Merz Pharmaceuticals LLC","BLA_Number":"125360","Proprietary_Name":"Xeomin","Proper_Name":"incobotulinumtoxinA","License_Type":"351(a)","Strength":"50UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular, Intraglandular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/30\/2010","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1830","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merz Pharmaceuticals GmbH c\/o Merz Pharmaceuticals LLC","BLA_Number":"125360","Proprietary_Name":"Xeomin","Proper_Name":"incobotulinumtoxinA","License_Type":"351(a)","Strength":"100UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular, Intraglandular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/30\/2010","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1830","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merz Pharmaceuticals GmbH c\/o Merz Pharmaceuticals LLC","BLA_Number":"125360","Proprietary_Name":"Xeomin","Proper_Name":"incobotulinumtoxinA","License_Type":"351(a)","Strength":"200UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular, Intraglandular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/20\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"66","Submission_Type":"Supplement","License_Number":"1830","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Janssen Biotech, Inc.","BLA_Number":"103772","Proprietary_Name":"Remicade","Proper_Name":"infliximab","License_Type":"351(a)","Strength":"100MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/24\/1998","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1864","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/23\/2018"},{"N\/R\/U":null,"Applicant":"CELLTRION, Inc.","BLA_Number":"125544","Proprietary_Name":"Inflectra","Proper_Name":"infliximab-dyyb","License_Type":"351(k) Biosimilar","Strength":"100MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/5\/2016","Ref._Product_Proper_Name":"infliximab","Ref._Product_Proprietary_Name":"Remicade","Supplement_Number":null,"Submission_Type":"Original","License_Number":"1996","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Samsung Bioepis Co., Ltd.","BLA_Number":"761054","Proprietary_Name":"Renflexis","Proper_Name":"infliximab-abda","License_Type":"351(k) Biosimilar","Strength":"100MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/21\/2017","Ref._Product_Proper_Name":"infliximab","Ref._Product_Proprietary_Name":"Remicade","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2046","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Pfizer Ireland Pharmaceuticals","BLA_Number":"761072","Proprietary_Name":"Ixifi","Proper_Name":"infliximab-qbtx","License_Type":"351(k) Biosimilar","Strength":"100MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/13\/2017","Ref._Product_Proper_Name":"infliximab","Ref._Product_Proprietary_Name":"Remicade","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2060","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"761086","Proprietary_Name":"Avsola","Proper_Name":"infliximab-axxq","License_Type":"351(k) Biosimilar","Strength":"100MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/6\/2019","Ref._Product_Proper_Name":"infliximab","Ref._Product_Proprietary_Name":"Remicade","Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Wyeth Pharmaceuticals LLC","BLA_Number":"761040","Proprietary_Name":"Besponsa","Proper_Name":"inotuzumab ozogamicin","License_Type":"351(a)","Strength":"0.9MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/17\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"3","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"8\/17\/2024"},{"N\/R\/U":null,"Applicant":"Hoffmann-La Roche Inc.","BLA_Number":"103145","Proprietary_Name":"Roferon-A","Proper_Name":"interferon alfa-2a","License_Type":"351(a)","Strength":"3MIU\/0.5ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/4\/1986","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":null,"License_Number":"136","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103132","Proprietary_Name":"Intron A","Proper_Name":"interferon alfa-2b","License_Type":"351(a)","Strength":"3MIU","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular, Intravenous, Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/4\/1986","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/21\/1995"},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103132","Proprietary_Name":"Intron A","Proper_Name":"interferon alfa-2b","License_Type":"351(a)","Strength":"5MIU","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular, Intravenous, Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/4\/1986","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/21\/1995"},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103132","Proprietary_Name":"Intron A","Proper_Name":"interferon alfa-2b","License_Type":"351(a)","Strength":"10MIU","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous, Intravenous, Intralesional, Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/4\/1986","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/21\/1995"},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103132","Proprietary_Name":"Intron A","Proper_Name":"interferon alfa-2b","License_Type":"351(a)","Strength":"18MIU","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular, Intravenous, Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":null,"Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Supplement","License_Number":"2","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/21\/1995"},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103132","Proprietary_Name":"Intron A","Proper_Name":"interferon alfa-2b","License_Type":"351(a)","Strength":"25MIU","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular, Intravenous, Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/4\/1986","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/21\/1995"},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103132","Proprietary_Name":"Intron A","Proper_Name":"interferon alfa-2b","License_Type":"351(a)","Strength":"50MIU","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular, Intravenous, Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":null,"Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Supplement","License_Number":"2","Product_Number":"6","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/21\/1995"},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103132","Proprietary_Name":"Intron A","Proper_Name":"interferon alfa-2b","License_Type":"351(a)","Strength":"3MIU","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous, Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":null,"Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Supplement","License_Number":"2","Product_Number":"7","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/21\/1995"},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103132","Proprietary_Name":"Intron A","Proper_Name":"interferon alfa-2b","License_Type":"351(a)","Strength":"5MIU","Dosage_Form":"Injection ","Route_of_Administration":"Intralesional, Intramuscular, Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":null,"Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Supplement","License_Number":"2","Product_Number":"8","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/21\/1995"},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103132","Proprietary_Name":"Intron A","Proper_Name":"interferon alfa-2b","License_Type":"351(a)","Strength":"10MIU","Dosage_Form":"Injection ","Route_of_Administration":"Intralesional, Intramuscular, Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":null,"Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Supplement","License_Number":"2","Product_Number":"9","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/21\/1995"},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103132","Proprietary_Name":"Intron A","Proper_Name":"interferon alfa-2b","License_Type":"351(a)","Strength":"18MIU","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous, Intramuscular","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":null,"Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Supplement","License_Number":"2","Product_Number":"10","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/21\/1995"},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103132","Proprietary_Name":"Intron A","Proper_Name":"interferon alfa-2b","License_Type":"351(a)","Strength":"25MIU","Dosage_Form":"Injection ","Route_of_Administration":"Intralesional, Intramuscular, Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":null,"Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Supplement","License_Number":"2","Product_Number":"11","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/21\/1995"},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103132","Proprietary_Name":"Intron A","Proper_Name":"interferon alfa-2b","License_Type":"351(a)","Strength":"3MIU","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":null,"Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Supplement","License_Number":"2","Product_Number":"12","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/21\/1995"},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103132","Proprietary_Name":"Intron A","Proper_Name":"interferon alfa-2b","License_Type":"351(a)","Strength":"5MIU","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":null,"Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Supplement","License_Number":"2","Product_Number":"13","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/21\/1995"},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103132","Proprietary_Name":"Intron A","Proper_Name":"interferon alfa-2b","License_Type":"351(a)","Strength":"10MIU","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":null,"Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Supplement","License_Number":"2","Product_Number":"14","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/21\/1995"},{"N\/R\/U":null,"Applicant":"Kadmon Pharmaceuticals LLC","BLA_Number":"103663","Proprietary_Name":"Infergen","Proper_Name":"interferon alfacon-1","License_Type":"351(a)","Strength":"9MCG\/0.3ML (30MCG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"10\/6\/1997","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":null,"License_Number":"1867","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"AIM ImmunoTech Inc.","BLA_Number":"103158","Proprietary_Name":"Alferon N Injection","Proper_Name":"interferon alfa-n3 (human leukocyte derived)","License_Type":"351(a)","Strength":"5MILLION IU\/1ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"10\/10\/1989","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1703","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Biogen Inc.","BLA_Number":"103628","Proprietary_Name":"Avonex","Proper_Name":"interferon beta-1a","License_Type":"351(a)","Strength":"30MCG","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"5\/17\/1996","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1697","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/17\/2003"},{"N\/R\/U":null,"Applicant":"Biogen Inc.","BLA_Number":"103628","Proprietary_Name":"Avonex","Proper_Name":"interferon beta-1a","License_Type":"351(a)","Strength":"30MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/28\/2003","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5021","Submission_Type":"Supplement","License_Number":"1697","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/17\/2003"},{"N\/R\/U":null,"Applicant":"Biogen Inc.","BLA_Number":"103628","Proprietary_Name":"Avonex","Proper_Name":"interferon beta-1a","License_Type":"351(a)","Strength":"30MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Intramuscular","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/27\/2012","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5191","Submission_Type":"Supplement","License_Number":"1697","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/17\/2003"},{"N\/R\/U":null,"Applicant":"EMD Serono, Inc.","BLA_Number":"103780","Proprietary_Name":"Rebif","Proper_Name":"interferon beta-1a","License_Type":"351(a)","Strength":"22MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/7\/2002","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1773","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"EMD Serono, Inc.","BLA_Number":"103780","Proprietary_Name":"Rebif","Proper_Name":"interferon beta-1a","License_Type":"351(a)","Strength":"44MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/7\/2002","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1773","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"EMD Serono, Inc.","BLA_Number":"103780","Proprietary_Name":"Rebif","Proper_Name":"interferon beta-1a","License_Type":"351(a)","Strength":"8.8MCG\/0.2ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/17\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5052","Submission_Type":"Supplement","License_Number":"1773","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"EMD Serono, Inc.","BLA_Number":"103780","Proprietary_Name":"Rebif","Proper_Name":"interferon beta-1a","License_Type":"351(a)","Strength":"8.8MCG\/0.2ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/21\/2012","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5121","Submission_Type":"Supplement","License_Number":"1773","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"EMD Serono, Inc.","BLA_Number":"103780","Proprietary_Name":"Rebif","Proper_Name":"interferon beta-1a","License_Type":"351(a)","Strength":"22MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/21\/2012","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5121","Submission_Type":"Supplement","License_Number":"1773","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"EMD Serono, Inc.","BLA_Number":"103780","Proprietary_Name":"Rebif","Proper_Name":"interferon beta-1a","License_Type":"351(a)","Strength":"44MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/21\/2012","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5121","Submission_Type":"Supplement","License_Number":"1773","Product_Number":"6","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bayer HealthCare Pharmaceuticals Inc.","BLA_Number":"103471","Proprietary_Name":"Betaseron","Proper_Name":"interferon beta-1b","License_Type":"351(a)","Strength":"0.3MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/23\/1993","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1778","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novartis Pharmaceuticals Corporation","BLA_Number":"125290","Proprietary_Name":"Extavia","Proper_Name":"interferon beta-1b","License_Type":"351(a)","Strength":"0.3MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"8\/14\/2009","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1244","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Horizon Therapeutics Ireland DAC","BLA_Number":"103836","Proprietary_Name":"Actimmune","Proper_Name":"interferon gamma-1b","License_Type":"351(a)","Strength":"100MCG(2MILLION INTERNATIONAL UNITS)\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/25\/1999","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2022","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/10\/2007"},{"N\/R\/U":null,"Applicant":"Bristol-Myers Squibb Company","BLA_Number":"125377","Proprietary_Name":"Yervoy","Proper_Name":"ipilimumab","License_Type":"351(a)","Strength":"50MG\/10ML (5MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/25\/2011","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1713","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"10\/2\/2027"},{"N\/R\/U":null,"Applicant":"Bristol-Myers Squibb Company","BLA_Number":"125377","Proprietary_Name":"Yervoy","Proper_Name":"ipilimumab","License_Type":"351(a)","Strength":"200MG\/40ML (5MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/25\/2011","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1713","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"10\/2\/2027"},{"N\/R\/U":null,"Applicant":"Sanofi-Aventis U.S. LLC","BLA_Number":"761113","Proprietary_Name":"Sarclisa","Proper_Name":"isatuximab-irfc","License_Type":"351(a)","Strength":"100MG\/5ML (20MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/2\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1752","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/31\/2028"},{"N\/R\/U":null,"Applicant":"Sanofi-Aventis U.S. LLC","BLA_Number":"761113","Proprietary_Name":"Sarclisa","Proper_Name":"isatuximab-irfc","License_Type":"351(a)","Strength":"500MG\/25ML (20MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/2\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1752","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/31\/2028"},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"125521","Proprietary_Name":"Taltz","Proper_Name":"ixekizumab","License_Type":"351(a)","Strength":"80MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/22\/2016","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"125521","Proprietary_Name":"Taltz","Proper_Name":"ixekizumab","License_Type":"351(a)","Strength":"80MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/22\/2016","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"761090","Proprietary_Name":"Takhzyro","Proper_Name":"lanadelumab-flyo","License_Type":"351(a)","Strength":"300MG\/2ML (150MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/23\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1898","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/3\/2030"},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"761090","Proprietary_Name":"Takhzyro","Proper_Name":"lanadelumab-flyo","License_Type":"351(a)","Strength":"300MG\/2ML (150MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/8\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"3","Submission_Type":"Supplement","License_Number":"1898","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/3\/2030"},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"761090","Proprietary_Name":"Takhzyro","Proper_Name":"lanadelumab-flyo","License_Type":"351(a)","Strength":"150MG\/1ML (150MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/3\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"10","Submission_Type":"Supplement","License_Number":"1898","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/3\/2030"},{"N\/R\/U":null,"Applicant":"BioMarin Pharmaceutical Inc.","BLA_Number":"125058","Proprietary_Name":"Aldurazyme","Proper_Name":"laronidase","License_Type":"351(a)","Strength":"2.9MG\/5ML (0.58MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/30\/2003","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1649","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"4\/30\/2010"},{"N\/R\/U":null,"Applicant":"Celgene Corporation, a Bristol-Myers Squibb Company","BLA_Number":"761136","Proprietary_Name":"Reblozyl","Proper_Name":"luspatercept-aamt","License_Type":"351(a)","Strength":"25MG\/VIAL","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/8\/2019","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2252","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"4\/3\/2027"},{"N\/R\/U":null,"Applicant":"Celgene Corporation, a Bristol-Myers Squibb Company","BLA_Number":"761136","Proprietary_Name":"Reblozyl","Proper_Name":"luspatercept-aamt","License_Type":"351(a)","Strength":"75MG\/VIAL","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/8\/2019","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2252","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"4\/3\/2027"},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline LLC","BLA_Number":"125526","Proprietary_Name":"Nucala","Proper_Name":"mepolizumab","License_Type":"351(a)","Strength":"100MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/4\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1727","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/25\/2027"},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline LLC","BLA_Number":"125526","Proprietary_Name":"Nucala","Proper_Name":"mepolizumab","License_Type":"351(a)","Strength":"100MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/6\/2019","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"13","Submission_Type":"Supplement","License_Number":"1727","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/25\/2027"},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline LLC","BLA_Number":"125526","Proprietary_Name":"Nucala","Proper_Name":"mepolizumab","License_Type":"351(a)","Strength":"100MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/6\/2019","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"13","Submission_Type":"Supplement","License_Number":"1727","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/25\/2027"},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline LLC","BLA_Number":"125526","Proprietary_Name":"Nucala","Proper_Name":"mepolizumab","License_Type":"351(a)","Strength":"40MG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/22\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"19","Submission_Type":"Supplement","License_Number":"1727","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline LLC","BLA_Number":"761122","Proprietary_Name":"Nucala","Proper_Name":"mepolizumab","License_Type":"351(a)","Strength":"100MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/6\/2019","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1727","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline LLC","BLA_Number":"761122","Proprietary_Name":"Nucala","Proper_Name":"mepolizumab","License_Type":"351(a)","Strength":"100MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/6\/2019","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1727","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline LLC","BLA_Number":"761122","Proprietary_Name":"Nucala","Proper_Name":"mepolizumab","License_Type":"351(a)","Strength":"100MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/6\/2019","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1727","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline LLC","BLA_Number":"761122","Proprietary_Name":"Nucala","Proper_Name":"mepolizumab","License_Type":"351(a)","Strength":"40MG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/22\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"8","Submission_Type":"Supplement","License_Number":"1727","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Vifor (International) Inc.","BLA_Number":"125164","Proprietary_Name":"Mircera","Proper_Name":"methoxy polyethylene glycol-epoetin beta","License_Type":"351(a)","Strength":"50MCG\/0.3ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/14\/2007","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2039","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Vifor (International) Inc.","BLA_Number":"125164","Proprietary_Name":"Mircera","Proper_Name":"methoxy polyethylene glycol-epoetin beta","License_Type":"351(a)","Strength":"75MCG\/0.3ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/14\/2007","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2039","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Vifor (International) Inc.","BLA_Number":"125164","Proprietary_Name":"Mircera","Proper_Name":"methoxy polyethylene glycol-epoetin beta","License_Type":"351(a)","Strength":"100MCG\/0.3ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/14\/2007","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2039","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Vifor (International) Inc.","BLA_Number":"125164","Proprietary_Name":"Mircera","Proper_Name":"methoxy polyethylene glycol-epoetin beta","License_Type":"351(a)","Strength":"150MCG\/0.3ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/14\/2007","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2039","Product_Number":"6","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Vifor (International) Inc.","BLA_Number":"125164","Proprietary_Name":"Mircera","Proper_Name":"methoxy polyethylene glycol-epoetin beta","License_Type":"351(a)","Strength":"200MCG\/0.3ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/14\/2007","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2039","Product_Number":"7","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Vifor (International) Inc.","BLA_Number":"125164","Proprietary_Name":"Mircera","Proper_Name":"methoxy polyethylene glycol-epoetin beta","License_Type":"351(a)","Strength":"250MCG\/0.3ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/14\/2007","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2039","Product_Number":"8","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Vifor (International) Inc.","BLA_Number":"125164","Proprietary_Name":"Mircera","Proper_Name":"methoxy polyethylene glycol-epoetin beta","License_Type":"351(a)","Strength":"50MCG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"11\/14\/2007","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2039","Product_Number":"10","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Vifor (International) Inc.","BLA_Number":"125164","Proprietary_Name":"Mircera","Proper_Name":"methoxy polyethylene glycol-epoetin beta","License_Type":"351(a)","Strength":"100MCG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"11\/14\/2007","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2039","Product_Number":"11","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Vifor (International) Inc.","BLA_Number":"125164","Proprietary_Name":"Mircera","Proper_Name":"methoxy polyethylene glycol-epoetin beta","License_Type":"351(a)","Strength":"200MCG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"11\/14\/2007","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2039","Product_Number":"12","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Vifor (International) Inc.","BLA_Number":"125164","Proprietary_Name":"Mircera","Proper_Name":"methoxy polyethylene glycol-epoetin beta","License_Type":"351(a)","Strength":"300MCG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"11\/14\/2007","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2039","Product_Number":"13","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Vifor (International) Inc.","BLA_Number":"125164","Proprietary_Name":"Mircera","Proper_Name":"methoxy polyethylene glycol-epoetin beta","License_Type":"351(a)","Strength":"400MCG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"11\/14\/2007","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2039","Product_Number":"14","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Vifor (International) Inc.","BLA_Number":"125164","Proprietary_Name":"Mircera","Proper_Name":"methoxy polyethylene glycol-epoetin beta","License_Type":"351(a)","Strength":"600MCG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"11\/14\/2007","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2039","Product_Number":"15","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Vifor (International) Inc.","BLA_Number":"125164","Proprietary_Name":"Mircera","Proper_Name":"methoxy polyethylene glycol-epoetin beta","License_Type":"351(a)","Strength":"1,000MCG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"11\/14\/2007","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2039","Product_Number":"16","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Vifor (International) Inc.","BLA_Number":"125164","Proprietary_Name":"Mircera","Proper_Name":"methoxy polyethylene glycol-epoetin beta","License_Type":"351(a)","Strength":"400MCG\/0.6ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"11\/14\/2007","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2039","Product_Number":"17","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Vifor (International) Inc.","BLA_Number":"125164","Proprietary_Name":"Mircera","Proper_Name":"methoxy polyethylene glycol-epoetin beta","License_Type":"351(a)","Strength":"600MCG\/0.6ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"11\/14\/2007","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2039","Product_Number":"18","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Vifor (International) Inc.","BLA_Number":"125164","Proprietary_Name":"Mircera","Proper_Name":"methoxy polyethylene glycol-epoetin beta","License_Type":"351(a)","Strength":"800MCG\/0.6ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"11\/14\/2007","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2039","Product_Number":"19","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Vifor (International) Inc.","BLA_Number":"125164","Proprietary_Name":"Mircera","Proper_Name":"methoxy polyethylene glycol-epoetin beta","License_Type":"351(a)","Strength":"30MCG\/0.3ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/28\/2016","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"73","Submission_Type":"Supplement","License_Number":"2039","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Vifor (International) Inc.","BLA_Number":"125164","Proprietary_Name":"Mircera","Proper_Name":"methoxy polyethylene glycol-epoetin beta","License_Type":"351(a)","Strength":"120MCG\/0.3ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/28\/2016","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"73","Submission_Type":"Supplement","License_Number":"2039","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Vifor (International) Inc.","BLA_Number":"125164","Proprietary_Name":"Mircera","Proper_Name":"methoxy polyethylene glycol-epoetin beta","License_Type":"351(a)","Strength":"360MCG\/0.6ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/28\/2016","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"73","Submission_Type":"Supplement","License_Number":"2039","Product_Number":"9","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amryt Pharmaceuticals DAC","BLA_Number":"125390","Proprietary_Name":"Myalept","Proper_Name":"metreleptin","License_Type":"351(a)","Strength":"11.3MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/24\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2208","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/24\/2021"},{"N\/R\/U":null,"Applicant":"Kyowa Kirin, Inc.","BLA_Number":"761051","Proprietary_Name":"Poteligeo","Proper_Name":"mogamulizumab-kpkc","License_Type":"351(a)","Strength":"20MG\/5ML (4MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/8\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2077","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"8\/8\/2025"},{"N\/R\/U":null,"Applicant":"Innate Pharma, Inc.","BLA_Number":"761104","Proprietary_Name":"Lumoxiti","Proper_Name":"moxetumomab pasudotox-tdfk","License_Type":"351(a)","Strength":"1MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"9\/13\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2206","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/13\/2025"},{"N\/R\/U":null,"Applicant":"Centocor Ortho Biotech Products, L.P.","BLA_Number":"103463","Proprietary_Name":"Orthoclone OKT3","Proper_Name":"muromanab-CD3","License_Type":"351(a)","Strength":"1MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Ampule","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"9\/14\/1992","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":null,"License_Number":"1824","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Biogen Inc.","BLA_Number":"125104","Proprietary_Name":"Tysabri","Proper_Name":"natalizumab","License_Type":"351(a)","Strength":"300MG\/15ML (20MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/23\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1697","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"125547","Proprietary_Name":"Portrazza","Proper_Name":"necitumumab","License_Type":"351(a)","Strength":"800MG\/50ML (16MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/24\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/24\/2022"},{"N\/R\/U":null,"Applicant":"Bristol-Myers Squibb Company","BLA_Number":"125554","Proprietary_Name":"Opdivo","Proper_Name":"nivolumab","License_Type":"351(a)","Strength":"40MG\/4ML (10MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/22\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1713","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/15\/2030"},{"N\/R\/U":null,"Applicant":"Bristol-Myers Squibb Company","BLA_Number":"125554","Proprietary_Name":"Opdivo","Proper_Name":"nivolumab","License_Type":"351(a)","Strength":"100MG\/10ML (10MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/22\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1713","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/15\/2030"},{"N\/R\/U":null,"Applicant":"Bristol-Myers Squibb Company","BLA_Number":"125554","Proprietary_Name":"Opdivo","Proper_Name":"nivolumab","License_Type":"351(a)","Strength":"240MG\/24ML (10MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/4\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"43","Submission_Type":"Supplement","License_Number":"1713","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/15\/2030"},{"N\/R\/U":null,"Applicant":"Bristol-Myers Squibb Company","BLA_Number":"125554","Proprietary_Name":"Opdivo","Proper_Name":"nivolumab","License_Type":"351(a)","Strength":"120MG\/12ML (10MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/27\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"103","Submission_Type":"Supplement","License_Number":"1713","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/15\/2030"},{"N\/R\/U":null,"Applicant":"Boehringer Ingelheim Pharma GmbH & Co. KG","BLA_Number":"103769","Proprietary_Name":"Verluma","Proper_Name":"nofetumomab","License_Type":"351(a)","Strength":"10MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":null,"Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"10\/13\/1998","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":null,"License_Number":"1251","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Elusys Therapeutics, Inc.","BLA_Number":"125509","Proprietary_Name":"Anthim","Proper_Name":"obiltoxaximab","License_Type":"351(a)","Strength":"600MG\/6ML (100MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/18\/2016","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1907","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/18\/2023"},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"125486","Proprietary_Name":"Gazyva","Proper_Name":"obinutuzumab","License_Type":"351(a)","Strength":"1,000MG\/40ML (25MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/1\/2013","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/16\/2024"},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"761053","Proprietary_Name":"Ocrevus","Proper_Name":"ocrelizumab","License_Type":"351(a)","Strength":"300MG\/10ML (30MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/28\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ThromboGenics Inc.","BLA_Number":"125422","Proprietary_Name":"Jetrea","Proper_Name":"ocriplasmin","License_Type":"351(a)","Strength":"0.5MG\/0.2ML (2.5MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravitreal","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"10\/17\/2012","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1866","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ThromboGenics Inc.","BLA_Number":"125422","Proprietary_Name":"Jetrea","Proper_Name":"ocriplasmin","License_Type":"351(a)","Strength":"0.375MG\/0.3ML (1.25MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravitreal","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"2\/22\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"38","Submission_Type":"Supplement","License_Number":"1866","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novartis Pharmaceuticals Corporation","BLA_Number":"125326","Proprietary_Name":"Arzerra","Proper_Name":"ofatumumab","License_Type":"351(a)","Strength":"100MG\/5ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"10\/26\/2009","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1244","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"1\/19\/2023"},{"N\/R\/U":null,"Applicant":"Novartis Pharmaceuticals Corporation","BLA_Number":"125326","Proprietary_Name":"Arzerra","Proper_Name":"ofatumumab","License_Type":"351(a)","Strength":"1,000MG\/50ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"4\/1\/2011","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"14","Submission_Type":"Supplement","License_Number":"1244","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"1\/19\/2023"},{"N\/R\/U":null,"Applicant":"Novartis Pharmaceuticals Corporation","BLA_Number":"125326","Proprietary_Name":"Kesimpta","Proper_Name":"ofatumumab","License_Type":"351(a)","Strength":"20MG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/20\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"70","Submission_Type":"Supplement","License_Number":"1244","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novartis Pharmaceuticals Corporation","BLA_Number":"125326","Proprietary_Name":"Kesimpta","Proper_Name":"ofatumumab","License_Type":"351(a)","Strength":"20MG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"8\/20\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"70","Submission_Type":"Supplement","License_Number":"1244","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"761038","Proprietary_Name":"Lartruvo","Proper_Name":"olaratumab","License_Type":"351(a)","Strength":"500MG\/50ML (10MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"10\/19\/2016","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/25\/2020"},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"761038","Proprietary_Name":"Lartruvo","Proper_Name":"olaratumab","License_Type":"351(a)","Strength":"190MG\/19ML (10MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"7\/10\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"1","Submission_Type":"Supplement","License_Number":"1891","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/25\/2020"},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"103976","Proprietary_Name":"Xolair","Proper_Name":"omalizumab","License_Type":"351(a)","Strength":"150MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/20\/2003","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"103976","Proprietary_Name":"Xolair","Proper_Name":"omalizumab","License_Type":"351(a)","Strength":"75MG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/28\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5231","Submission_Type":"Supplement","License_Number":"1048","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"103976","Proprietary_Name":"Xolair","Proper_Name":"omalizumab","License_Type":"351(a)","Strength":"150MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/28\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5231","Submission_Type":"Supplement","License_Number":"1048","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergan, Inc.","BLA_Number":"103000","Proprietary_Name":"Botox Cosmetic","Proper_Name":"onabotulinumtoxinA","License_Type":"351(a)","Strength":"50UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/9\/1991","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1145","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/20\/2026"},{"N\/R\/U":null,"Applicant":"Allergan, Inc.","BLA_Number":"103000","Proprietary_Name":"Botox Cosmetic","Proper_Name":"onabotulinumtoxinA","License_Type":"351(a)","Strength":"100UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/9\/1991","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1145","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/20\/2026"},{"N\/R\/U":null,"Applicant":"Allergan, Inc.","BLA_Number":"103000","Proprietary_Name":"Botox ","Proper_Name":"onabotulinumtoxinA","License_Type":"351(a)","Strength":"50UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Injection, Intramuscular, Intradermal, Intradetrusor","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/9\/1991","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1145","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/20\/2026"},{"N\/R\/U":null,"Applicant":"Allergan, Inc.","BLA_Number":"103000","Proprietary_Name":"Botox ","Proper_Name":"onabotulinumtoxinA","License_Type":"351(a)","Strength":"100UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Injection, Intramuscular, Intradermal, Intradetrusor","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/9\/1991","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1145","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/20\/2026"},{"N\/R\/U":null,"Applicant":"Allergan, Inc.","BLA_Number":"103000","Proprietary_Name":"Botox ","Proper_Name":"onabotulinumtoxinA","License_Type":"351(a)","Strength":"200UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Injection, Intramuscular, Intradermal, Intradetrusor","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/9\/1991","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1145","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/20\/2026"},{"N\/R\/U":null,"Applicant":"Wyeth Pharmaceuticals Inc.","BLA_Number":"103694","Proprietary_Name":"Neumega","Proper_Name":"oprelvekin","License_Type":"351(a)","Strength":"5MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"11\/25\/1997","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"3","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Swedish Orphan Biovitrum AB (publ)","BLA_Number":"125103","Proprietary_Name":"Kepivance","Proper_Name":"palifermin","License_Type":"351(a)","Strength":"6.25MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/15\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1859","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Swedish Orphan Biovitrum AB (publ)","BLA_Number":"103770","Proprietary_Name":"Synagis","Proper_Name":"palivizumab","License_Type":"351(a)","Strength":"50MG","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/19\/1998","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1859","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Swedish Orphan Biovitrum AB (publ)","BLA_Number":"103770","Proprietary_Name":"Synagis","Proper_Name":"palivizumab","License_Type":"351(a)","Strength":"100MG","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/19\/1998","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1859","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Swedish Orphan Biovitrum AB (publ)","BLA_Number":"103770","Proprietary_Name":"Synagis","Proper_Name":"palivizumab","License_Type":"351(a)","Strength":"50MG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/23\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5059","Submission_Type":"Supplement","License_Number":"1859","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Swedish Orphan Biovitrum AB (publ)","BLA_Number":"103770","Proprietary_Name":"Synagis","Proper_Name":"palivizumab","License_Type":"351(a)","Strength":"100MG\/1ML","Dosage_Form":"Injection ","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/23\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5059","Submission_Type":"Supplement","License_Number":"1859","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"125147","Proprietary_Name":"Vectibix","Proper_Name":"panitumumab","License_Type":"351(a)","Strength":"100MG\/5ML (20MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/27\/2006","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"125147","Proprietary_Name":"Vectibix","Proper_Name":"panitumumab","License_Type":"351(a)","Strength":"400MG\/20ML (20MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/27\/2006","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"125147","Proprietary_Name":"Vectibix","Proper_Name":"panitumumab","License_Type":"351(a)","Strength":"200MG\/10ML (20MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"9\/27\/2006","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125511","Proprietary_Name":"Natpara","Proper_Name":"parathyroid hormone","License_Type":"351(a)","Strength":"25MCG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/23\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1898","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"1\/23\/2022"},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125511","Proprietary_Name":"Natpara","Proper_Name":"parathyroid hormone","License_Type":"351(a)","Strength":"50MCG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/23\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1898","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"1\/23\/2022"},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125511","Proprietary_Name":"Natpara","Proper_Name":"parathyroid hormone","License_Type":"351(a)","Strength":"75MCG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/23\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1898","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"1\/23\/2022"},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125511","Proprietary_Name":"Natpara","Proper_Name":"parathyroid hormone","License_Type":"351(a)","Strength":"100MCG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/23\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1898","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"1\/23\/2022"},{"N\/R\/U":null,"Applicant":"Servier Pharmaceuticals LLC","BLA_Number":"103411","Proprietary_Name":"Oncaspar","Proper_Name":"pegaspargase","License_Type":"351(a)","Strength":"3,750IU\/5ML(750IU\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/1\/1994","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2125","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/1\/2001"},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"125031","Proprietary_Name":"Neulasta","Proper_Name":"pegfilgrastim","License_Type":"351(a)","Strength":"6MG\/0.6ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/31\/2002","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/13\/2022"},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"125031","Proprietary_Name":"Neulasta Onpro","Proper_Name":"pegfilgrastim","License_Type":"351(a)","Strength":"6MG\/0.6ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/23\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"175","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/13\/2022"},{"N\/R\/U":null,"Applicant":"Coherus BioSciences, Inc.","BLA_Number":"761039","Proprietary_Name":"Udenyca","Proper_Name":"pegfilgrastim-cbqv","License_Type":"351(k) Biosimilar","Strength":"6MG\/0.6ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/2\/2018","Ref._Product_Proper_Name":"pegfilgrastim","Ref._Product_Proprietary_Name":"Neulasta","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2023","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Coherus BioSciences, Inc.","BLA_Number":"761039","Proprietary_Name":"Udenyca","Proper_Name":"pegfilgrastim-cbqv","License_Type":"351(k) Biosimilar","Strength":"6MG\/0.6ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/3\/2023","Ref._Product_Proper_Name":"pegfilgrastim","Ref._Product_Proprietary_Name":"Neulasta","Supplement_Number":"13","Submission_Type":"Supplement","License_Number":"2023","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sandoz Inc.","BLA_Number":"761045","Proprietary_Name":"Ziextenzo","Proper_Name":"pegfilgrastim-bmez","License_Type":"351(k) Biosimilar","Strength":"6MG\/0.6ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/4\/2019","Ref._Product_Proper_Name":"pegfilgrastim","Ref._Product_Proprietary_Name":"Neulasta","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2003","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Biocon Biologics Inc.","BLA_Number":"761075","Proprietary_Name":"Fulphila","Proper_Name":"pegfilgrastim-jmdb","License_Type":"351(k) Biosimilar","Strength":"6MG\/0.6ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/4\/2018","Ref._Product_Proper_Name":"pegfilgrastim","Ref._Product_Proprietary_Name":"Neulasta","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2324","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"zr pharma& GmbH","BLA_Number":"103964","Proprietary_Name":"Pegasys","Proper_Name":"peginterferon alfa-2a","License_Type":"351(a)","Strength":"180MCG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/16\/2002","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2291","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"zr pharma& GmbH","BLA_Number":"103964","Proprietary_Name":"Pegasys","Proper_Name":"peginterferon alfa-2a","License_Type":"351(a)","Strength":"180MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/7\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5011","Submission_Type":"Supplement","License_Number":"2291","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"zr pharma& GmbH","BLA_Number":"103964","Proprietary_Name":"Pegasys","Proper_Name":"peginterferon alfa-2a","License_Type":"351(a)","Strength":"180MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"9\/29\/2011","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5204","Submission_Type":"Supplement","License_Number":"2291","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"zr pharma& GmbH","BLA_Number":"103964","Proprietary_Name":"Pegasys","Proper_Name":"peginterferon alfa-2a","License_Type":"351(a)","Strength":"135MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"9\/29\/2011","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5204","Submission_Type":"Supplement","License_Number":"2291","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Hoffmann-La Roche Inc.","BLA_Number":"125083","Proprietary_Name":"Pegasys Copegus Combination Pack","Proper_Name":"peginterferon alfa-2a and ribavirin","License_Type":"351(a)","Strength":"180MCG\/0.5ML & 800MG","Dosage_Form":null,"Route_of_Administration":null,"Product_Presentation":null,"Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/4\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"136","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Hoffmann-La Roche Inc.","BLA_Number":"125083","Proprietary_Name":"Pegasys Copegus Combination Pack","Proper_Name":"peginterferon alfa-2a and ribavirin","License_Type":"351(a)","Strength":"180MCG\/0.5ML &1000MG","Dosage_Form":null,"Route_of_Administration":null,"Product_Presentation":null,"Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/4\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"136","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Hoffmann-La Roche Inc.","BLA_Number":"125083","Proprietary_Name":"Pegasys Copegus Combination Pack","Proper_Name":"peginterferon alfa-2a and ribavirin","License_Type":"351(a)","Strength":"180MCG\/0.5ML & 1200MG","Dosage_Form":null,"Route_of_Administration":null,"Product_Presentation":null,"Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/4\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"136","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103949","Proprietary_Name":"Pegintron","Proper_Name":"peginterferon alfa-2b","License_Type":"351(a)","Strength":"50MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"1\/19\/2001","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103949","Proprietary_Name":"Pegintron","Proper_Name":"peginterferon alfa-2b","License_Type":"351(a)","Strength":"80MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"1\/19\/2001","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2","Product_Number":"7","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103949","Proprietary_Name":"Pegintron","Proper_Name":"peginterferon alfa-2b","License_Type":"351(a)","Strength":"120MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"1\/19\/2001","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2","Product_Number":"9","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103949","Proprietary_Name":"Pegintron","Proper_Name":"peginterferon alfa-2b","License_Type":"351(a)","Strength":"\n150MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"1\/19\/2001","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2","Product_Number":"11","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103949","Proprietary_Name":"Pegintron","Proper_Name":"peginterferon alfa-2b","License_Type":"351(a)","Strength":"50MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"1\/19\/2001","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103949","Proprietary_Name":"Pegintron","Proper_Name":"peginterferon alfa-2b","License_Type":"351(a)","Strength":"80MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"1\/19\/2001","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2","Product_Number":"6","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103949","Proprietary_Name":"Pegintron","Proper_Name":"peginterferon alfa-2b","License_Type":"351(a)","Strength":"\n120MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"1\/19\/2001","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2","Product_Number":"8","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103949","Proprietary_Name":"Pegintron","Proper_Name":"peginterferon alfa-2b","License_Type":"351(a)","Strength":"\n150MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"1\/19\/2001","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2","Product_Number":"10","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Schering Corporation a subsidiary of Merck & Co., Inc.","BLA_Number":"125196","Proprietary_Name":"PegIntron\/ Rebetol Combo Pack","Proper_Name":"peginterferon alfa-2b and ribavirin","License_Type":"351(a)","Strength":"50MCG\/0.5ML & 200MG","Dosage_Form":null,"Route_of_Administration":null,"Product_Presentation":null,"Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/13\/2008","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"994","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Schering Corporation a subsidiary of Merck & Co., Inc.","BLA_Number":"125196","Proprietary_Name":"PegIntron\/ Rebetol Combo Pack","Proper_Name":"peginterferon alfa-2b and ribavirin","License_Type":"351(a)","Strength":"80MCG\/0.5ML & 200MG","Dosage_Form":null,"Route_of_Administration":null,"Product_Presentation":null,"Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/13\/2008","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"994","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Schering Corporation a subsidiary of Merck & Co., Inc.","BLA_Number":"125196","Proprietary_Name":"PegIntron\/ Rebetol Combo Pack","Proper_Name":"peginterferon alfa-2b and ribavirin","License_Type":"351(a)","Strength":"120MCG\/0.5ML & 200MG","Dosage_Form":null,"Route_of_Administration":null,"Product_Presentation":null,"Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/13\/2008","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"994","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Schering Corporation a subsidiary of Merck & Co., Inc.","BLA_Number":"125196","Proprietary_Name":"PegIntron\/ Rebetol Combo Pack","Proper_Name":"peginterferon alfa-2b and ribavirin","License_Type":"351(a)","Strength":"150MCG\/0.5ML & 200MG","Dosage_Form":null,"Route_of_Administration":null,"Product_Presentation":null,"Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/13\/2008","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"994","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Biogen Inc.","BLA_Number":"125499","Proprietary_Name":"Plegridy","Proper_Name":"peginterferon beta-1a","License_Type":"351(a)","Strength":"125MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/15\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1697","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Biogen Inc.","BLA_Number":"125499","Proprietary_Name":"Plegridy","Proper_Name":"peginterferon beta-1a","License_Type":"351(a)","Strength":"63MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/15\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1697","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Biogen Inc.","BLA_Number":"125499","Proprietary_Name":"Plegridy","Proper_Name":"peginterferon beta-1a","License_Type":"351(a)","Strength":"94MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/15\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1697","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Biogen Inc.","BLA_Number":"125499","Proprietary_Name":"Plegridy","Proper_Name":"peginterferon beta-1a","License_Type":"351(a)","Strength":"125MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous, Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/15\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1697","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Biogen Inc.","BLA_Number":"125499","Proprietary_Name":"Plegridy","Proper_Name":"peginterferon beta-1a","License_Type":"351(a)","Strength":"63MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/15\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1697","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Biogen Inc.","BLA_Number":"125499","Proprietary_Name":"Plegridy","Proper_Name":"peginterferon beta-1a","License_Type":"351(a)","Strength":"94MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/15\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1697","Product_Number":"6","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Horizon Therapeutics Ireland DAC","BLA_Number":"125293","Proprietary_Name":"Krystexxa","Proper_Name":"pegloticase","License_Type":"351(a)","Strength":"8MG\/1ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/14\/2010","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2022","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/14\/2017"},{"N\/R\/U":null,"Applicant":"BioMarin Pharmaceutical Inc.","BLA_Number":"761079","Proprietary_Name":"Palynziq","Proper_Name":"pegvaliase-pqpz","License_Type":"351(a)","Strength":"2.5MG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/24\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1649","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/24\/2025"},{"N\/R\/U":null,"Applicant":"BioMarin Pharmaceutical Inc.","BLA_Number":"761079","Proprietary_Name":"Palynziq","Proper_Name":"pegvaliase-pqpz","License_Type":"351(a)","Strength":"10MG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/24\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1649","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/24\/2025"},{"N\/R\/U":null,"Applicant":"BioMarin Pharmaceutical Inc.","BLA_Number":"761079","Proprietary_Name":"Palynziq","Proper_Name":"pegvaliase-pqpz","License_Type":"351(a)","Strength":"20MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/24\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1649","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/24\/2025"},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"125514","Proprietary_Name":"Keytruda","Proper_Name":"pembrolizumab","License_Type":"351(a)","Strength":"50MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"9\/4\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/3\/2028"},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"125514","Proprietary_Name":"Keytruda","Proper_Name":"pembrolizumab","License_Type":"351(a)","Strength":"100MG\/4ML (25MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/15\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"1","Submission_Type":"Supplement","License_Number":"2","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/3\/2028"},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"125409","Proprietary_Name":"Perjeta","Proper_Name":"pertuzumab","License_Type":"351(a)","Strength":"420MG\/14ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/8\/2012","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":"6\/8\/2012","Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":"6\/8\/2024","Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"761121","Proprietary_Name":"Polivy","Proper_Name":"polatuzumab vedotin-piiq","License_Type":"351(a)","Strength":"140MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/10\/2019","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"4\/19\/2030"},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"761121","Proprietary_Name":"Polivy","Proper_Name":"polatuzumab vedotin-piiq","License_Type":"351(a)","Strength":"30MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/18\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"3","Submission_Type":"Supplement","License_Number":"1048","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"4\/19\/2030"},{"N\/R\/U":null,"Applicant":"Evolus Inc.","BLA_Number":"761085","Proprietary_Name":"Jeuveau","Proper_Name":"prabotulinumtoxinA-xvfs","License_Type":"351(a)","Strength":"100UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/1\/2019","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2070","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"125477","Proprietary_Name":"Cyramza","Proper_Name":"ramucirumab","License_Type":"351(a)","Strength":"100MG\/10ML (10MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/21\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/10\/2026"},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"125477","Proprietary_Name":"Cyramza","Proper_Name":"ramucirumab","License_Type":"351(a)","Strength":"500MG\/50ML (10MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/21\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/10\/2026"},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"125156","Proprietary_Name":"Lucentis","Proper_Name":"ranibizumab","License_Type":"351(a)","Strength":"10MG\/ML (0.5MG\/0.05ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravitreal","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/30\/2006","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"125156","Proprietary_Name":"Lucentis","Proper_Name":"ranibizumab","License_Type":"351(a)","Strength":"10MG\/ML (0.5MG\/0.05ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravitreal","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/13\/2016","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"110","Submission_Type":"Supplement","License_Number":"1048","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"125156","Proprietary_Name":"Lucentis","Proper_Name":"ranibizumab","License_Type":"351(a)","Strength":"6MG\/ML (0.3MG\/0.05ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravitreal","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/10\/2012","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"76","Submission_Type":"Supplement","License_Number":"1048","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"125156","Proprietary_Name":"Lucentis","Proper_Name":"ranibizumab","License_Type":"351(a)","Strength":"6MG\/ML (0.3MG\/0.05ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravitreal","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/20\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"117","Submission_Type":"Supplement","License_Number":"1048","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi-Aventis U.S. LLC","BLA_Number":"103946","Proprietary_Name":"Elitek","Proper_Name":"rasburicase","License_Type":"351(a)","Strength":"1.5MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/12\/2002","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1752","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/12\/2009"},{"N\/R\/U":null,"Applicant":"Sanofi-Aventis U.S. LLC","BLA_Number":"103946","Proprietary_Name":"Elitek","Proper_Name":"rasburicase","License_Type":"351(a)","Strength":"7.5MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/6\/2006","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5020","Submission_Type":"Supplement","License_Number":"1752","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/12\/2009"},{"N\/R\/U":null,"Applicant":"Alexion Pharmaceuticals, Inc.","BLA_Number":"761108","Proprietary_Name":"Ultomiris","Proper_Name":"ravulizumab-cwvz","License_Type":"351(a)","Strength":"300MG\/30ML (10MG\/ML)","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/21\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1743","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/7\/2028"},{"N\/R\/U":null,"Applicant":"Alexion Pharmaceuticals, Inc.","BLA_Number":"761108","Proprietary_Name":"Ultomiris","Proper_Name":"ravulizumab-cwvz","License_Type":"351(a)","Strength":"300MG\/3ML (100MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/9\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5","Submission_Type":"Supplement","License_Number":"1743","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/7\/2028"},{"N\/R\/U":null,"Applicant":"Alexion Pharmaceuticals, Inc.","BLA_Number":"761108","Proprietary_Name":"Ultomiris","Proper_Name":"ravulizumab-cwvz","License_Type":"351(a)","Strength":"1,100MG\/11ML (100MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/9\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5","Submission_Type":"Supplement","License_Number":"1743","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/7\/2028"},{"N\/R\/U":null,"Applicant":"Alexion Pharmaceuticals, Inc.","BLA_Number":"761108","Proprietary_Name":"Ultomiris","Proper_Name":"ravulizumab-cwvz","License_Type":"351(a)","Strength":"245MG\/3.5ML (70MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/22\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"21","Submission_Type":"Supplement","License_Number":"1743","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/7\/2028"},{"N\/R\/U":null,"Applicant":"Emergent Manufacturing Operations Baltimore LLC","BLA_Number":"125349","Proprietary_Name":null,"Proper_Name":"raxibacumab","License_Type":"351(a)","Strength":"1,700MG\/34ML (50MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/14\/2012","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2083","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/14\/2019"},{"N\/R\/U":null,"Applicant":"Teva Respiratory, LLC","BLA_Number":"761033","Proprietary_Name":"Cinqair","Proper_Name":"reslizumab","License_Type":"351(a)","Strength":"100MG\/10ML (10MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/23\/2016","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2047","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Chiesi USA, Inc.","BLA_Number":"103786","Proprietary_Name":"Retavase","Proper_Name":"reteplase","License_Type":"351(a)","Strength":"10UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/30\/1996","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2150","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Kiniksa Pharmaceuticals (UK), Ltd.","BLA_Number":"125249","Proprietary_Name":"Arcalyst","Proper_Name":"rilonacept","License_Type":"351(a)","Strength":"220MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/27\/2008","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2236","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/18\/2028"},{"N\/R\/U":null,"Applicant":"Solstice NeuroSciences, LLC","BLA_Number":"103846","Proprietary_Name":"Myobloc","Proper_Name":"rimabotulinumtoxinB","License_Type":"351(a)","Strength":"2,500UNITS\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Intramuscular, Intraglandular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/8\/2000","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1718","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/8\/2007"},{"N\/R\/U":null,"Applicant":"Solstice NeuroSciences, LLC","BLA_Number":"103846","Proprietary_Name":"Myobloc","Proper_Name":"rimabotulinumtoxinB","License_Type":"351(a)","Strength":"5,000UNITS\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intramuscular, Intraglandular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/8\/2000","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1718","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/8\/2007"},{"N\/R\/U":null,"Applicant":"Solstice NeuroSciences, LLC","BLA_Number":"103846","Proprietary_Name":"Myobloc","Proper_Name":"rimabotulinumtoxinB","License_Type":"351(a)","Strength":"10,000UNITS\/2ML (5,000UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intramuscular, Intraglandular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/8\/2000","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1718","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/8\/2007"},{"N\/R\/U":null,"Applicant":"AbbVie Inc.","BLA_Number":"761105","Proprietary_Name":"Skyrizi","Proper_Name":"risankizumab-rzaa","License_Type":"351(a)","Strength":"75MG\/0.83ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"4\/23\/2019","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1889","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"AbbVie Inc.","BLA_Number":"761105","Proprietary_Name":"Skyrizi","Proper_Name":"risankizumab-rzaa","License_Type":"351(a)","Strength":"150MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/26\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"9","Submission_Type":"Supplement","License_Number":"1889","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"AbbVie Inc.","BLA_Number":"761105","Proprietary_Name":"Skyrizi","Proper_Name":"risankizumab-rzaa","License_Type":"351(a)","Strength":"150MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/26\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"10","Submission_Type":"Supplement","License_Number":"1889","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"AbbVie Inc.","BLA_Number":"761105","Proprietary_Name":"Skyrizi","Proper_Name":"risankizumab-rzaa","License_Type":"351(a)","Strength":"180MG\/1.2ML (150MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/23\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"18","Submission_Type":"Supplement","License_Number":"1889","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"AbbVie Inc.","BLA_Number":"761105","Proprietary_Name":"Skyrizi","Proper_Name":"risankizumab-rzaa","License_Type":"351(a)","Strength":"360MG\/2.4ML (150MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/16\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"16","Submission_Type":"Supplement","License_Number":"1889","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"AbbVie Inc.","BLA_Number":"761262","Proprietary_Name":"Skyrizi","Proper_Name":"risankizumab-rzaa","License_Type":"351(a)","Strength":"600MG\/10ML (60MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/16\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1889","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"AbbVie Inc.","BLA_Number":"761105","Proprietary_Name":"Skyrizi","Proper_Name":"risankizumab-rzaa","License_Type":"351(a)","Strength":"90MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/22\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"24","Submission_Type":"Supplement","License_Number":"1889","Product_Number":"6","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"103705","Proprietary_Name":"Rituxan","Proper_Name":"rituximab","License_Type":"351(a)","Strength":"100MG\/10ML (10MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/26\/1997","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/2\/2028"},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"103705","Proprietary_Name":"Rituxan","Proper_Name":"rituximab","License_Type":"351(a)","Strength":"500MG\/50ML (10MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/26\/1997","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/2\/2028"},{"N\/R\/U":null,"Applicant":"IDEC Pharmaceuticals Corp.","BLA_Number":"103737","Proprietary_Name":"Rituxan","Proper_Name":"rituximab","License_Type":"351(a)","Strength":"100MG\/10ML (10MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"2\/19\/2002","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":null,"License_Number":"1235","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"IDEC Pharmaceuticals Corp.","BLA_Number":"103737","Proprietary_Name":"Rituxan","Proper_Name":"rituximab","License_Type":"351(a)","Strength":"500MG\/50ML (10MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"2\/19\/2002","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":null,"License_Number":"1235","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CELLTRION, Inc.","BLA_Number":"761088","Proprietary_Name":"Truxima","Proper_Name":"rituximab-abbs","License_Type":"351(k) Biosimilar","Strength":"100MG\/10ML (10MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/28\/2018","Ref._Product_Proper_Name":"rituximab","Ref._Product_Proprietary_Name":"Rituxan","Supplement_Number":null,"Submission_Type":"Original","License_Number":"1996","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CELLTRION, Inc.","BLA_Number":"761088","Proprietary_Name":"Truxima","Proper_Name":"rituximab-abbs","License_Type":"351(k) Biosimilar","Strength":"500MG\/50ML (10MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/28\/2018","Ref._Product_Proper_Name":"rituximab","Ref._Product_Proprietary_Name":"Rituxan","Supplement_Number":null,"Submission_Type":"Original","License_Number":"1996","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Pfizer Ireland Pharmaceuticals","BLA_Number":"761103","Proprietary_Name":"Ruxience","Proper_Name":"rituximab-pvvr","License_Type":"351(k) Biosimilar","Strength":"100MG\/10ML (10MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/23\/2019","Ref._Product_Proper_Name":"rituximab","Ref._Product_Proprietary_Name":"Rituxan","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2060","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Pfizer Ireland Pharmaceuticals","BLA_Number":"761103","Proprietary_Name":"Ruxience","Proper_Name":"rituximab-pvvr","License_Type":"351(k) Biosimilar","Strength":"500MG\/50ML (10MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/23\/2019","Ref._Product_Proper_Name":"rituximab","Ref._Product_Proprietary_Name":"Rituxan","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2060","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"761064","Proprietary_Name":"Rituxan Hycela","Proper_Name":"rituximab and hyaluronidase human","License_Type":"351(a)","Strength":"1,400MG\/11.7ML; 23,400UNITS\/11.7ML (120MG\/2,000UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/22\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/22\/2024"},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"761064","Proprietary_Name":"Rituxan Hycela","Proper_Name":"rituximab and hyaluronidase human","License_Type":"351(a)","Strength":"1,600MG\/13.4ML; 26,800UNITS\/13.4ML (120MG\/2,000UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/22\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/22\/2024"},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"125268","Proprietary_Name":"Nplate","Proper_Name":"romiplostim","License_Type":"351(a)","Strength":"250MCG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/22\/2008","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"1\/28\/2028"},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"125268","Proprietary_Name":"Nplate","Proper_Name":"romiplostim","License_Type":"351(a)","Strength":"500MCG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/22\/2008","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"1\/28\/2028"},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"125268","Proprietary_Name":"Nplate","Proper_Name":"romiplostim","License_Type":"351(a)","Strength":"125MCG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/22\/2019","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"165","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"1\/28\/2028"},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"761062","Proprietary_Name":"Evenity","Proper_Name":"romosozumab-aqqg","License_Type":"351(a)","Strength":"105MG\/1.17ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/9\/2019","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Partner Therapeutics, Inc.","BLA_Number":"103362","Proprietary_Name":"Leukine","Proper_Name":"sargramostim","License_Type":"351(a)","Strength":"250MCG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/5\/1991","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2087","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/29\/2025"},{"N\/R\/U":null,"Applicant":"Partner Therapeutics, Inc.","BLA_Number":"103362","Proprietary_Name":"Leukine","Proper_Name":"sargramostim","License_Type":"351(a)","Strength":"500MCG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"3\/5\/1991","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2087","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/29\/2025"},{"N\/R\/U":null,"Applicant":"Sanofi-Aventis U.S. LLC","BLA_Number":"761037","Proprietary_Name":"Kevzara","Proper_Name":"sarilumab","License_Type":"351(a)","Strength":"150MG\/1.14ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/22\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1752","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi-Aventis U.S. LLC","BLA_Number":"761037","Proprietary_Name":"Kevzara","Proper_Name":"sarilumab","License_Type":"351(a)","Strength":"200MG\/1.14ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/22\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1752","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi-Aventis U.S. LLC","BLA_Number":"761037","Proprietary_Name":"Kevzara","Proper_Name":"sarilumab","License_Type":"351(a)","Strength":"150MG\/1.14ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/13\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"1","Submission_Type":"Supplement","License_Number":"1752","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi-Aventis U.S. LLC","BLA_Number":"761037","Proprietary_Name":"Kevzara","Proper_Name":"sarilumab","License_Type":"351(a)","Strength":"200MG\/1.14ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/13\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"1","Submission_Type":"Supplement","License_Number":"1752","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Alexion Pharmaceuticals, Inc.","BLA_Number":"125561","Proprietary_Name":"Kanuma","Proper_Name":"sebelipase alfa","License_Type":"351(a)","Strength":"20MG\/10ML (2MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/8\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1743","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/8\/2022"},{"N\/R\/U":null,"Applicant":"Novartis Pharmaceuticals Corporation","BLA_Number":"125504","Proprietary_Name":"Cosentyx","Proper_Name":"secukinumab","License_Type":"351(a)","Strength":"150MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/21\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1244","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novartis Pharmaceuticals Corporation","BLA_Number":"125504","Proprietary_Name":"Cosentyx","Proper_Name":"secukinumab","License_Type":"351(a)","Strength":"150MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/21\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1244","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novartis Pharmaceuticals Corporation","BLA_Number":"125504","Proprietary_Name":"Cosentyx","Proper_Name":"secukinumab","License_Type":"351(a)","Strength":"150MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"1\/21\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1244","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novartis Pharmaceuticals Corporation","BLA_Number":"125504","Proprietary_Name":"Cosentyx","Proper_Name":"secukinumab","License_Type":"351(a)","Strength":"75MG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/28\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"43","Submission_Type":"Supplement","License_Number":"1244","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"Novartis Pharmaceuticals Corporation","BLA_Number":"125504","Proprietary_Name":"Cosentyx","Proper_Name":"secukinumab","License_Type":"351(a)","Strength":"300MG\/2ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/11\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"44","Submission_Type":"Supplement","License_Number":"1244","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novartis Pharmaceuticals Corporation","BLA_Number":"125504","Proprietary_Name":"Cosentyx","Proper_Name":"secukinumab","License_Type":"351(a)","Strength":"300MG\/2ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"5\/11\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"44","Submission_Type":"Supplement","License_Number":"1244","Product_Number":"6","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"EUSA Pharma (UK) Limited","BLA_Number":"125496","Proprietary_Name":"Sylvant","Proper_Name":"siltuximab","License_Type":"351(a)","Strength":"100MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/23\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2145","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"4\/23\/2021"},{"N\/R\/U":null,"Applicant":"EUSA Pharma (UK) Limited","BLA_Number":"125496","Proprietary_Name":"Sylvant","Proper_Name":"siltuximab","License_Type":"351(a)","Strength":"400MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/23\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2145","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"4\/23\/2021"},{"N\/R\/U":null,"Applicant":"Stemline Therapeutics, Inc.","BLA_Number":"761116","Proprietary_Name":"Elzonris","Proper_Name":"tagraxofusp-erzs","License_Type":"351(a)","Strength":"1,000MCG\/1ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/21\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2088","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/21\/2025"},{"N\/R\/U":null,"Applicant":"UAB Teva Baltics","BLA_Number":"125294","Proprietary_Name":"Granix","Proper_Name":"tbo-filgrastim","License_Type":"351(a)","Strength":"300MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/29\/2012","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1803","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":"8\/29\/2012","Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":"8\/29\/2024","Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"UAB Teva Baltics","BLA_Number":"125294","Proprietary_Name":"Granix","Proper_Name":"tbo-filgrastim","License_Type":"351(a)","Strength":"480MCG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/29\/2012","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1803","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":"8\/29\/2012","Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":"8\/29\/2024","Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"UAB Teva Baltics","BLA_Number":"125294","Proprietary_Name":"Granix","Proper_Name":"tbo-filgrastim","License_Type":"351(a)","Strength":"300MCG\/1ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/31\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"45","Submission_Type":"Supplement","License_Number":"1803","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"UAB Teva Baltics","BLA_Number":"125294","Proprietary_Name":"Granix","Proper_Name":"tbo-filgrastim","License_Type":"351(a)","Strength":"480MCG\/1.6ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/31\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"45","Submission_Type":"Supplement","License_Number":"1803","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Palatin Technologies, Inc.","BLA_Number":"103928","Proprietary_Name":"NeutroSpec","Proper_Name":"technetium 99m tc fanolesomab","License_Type":"351(a)","Strength":"0.25MG","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"7\/2\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":null,"License_Number":"1588","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"103909","Proprietary_Name":"TNKase","Proper_Name":"tenecteplase","License_Type":"351(a)","Strength":"50MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/2\/2000","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Horizon Therapeutics Ireland DAC","BLA_Number":"761143","Proprietary_Name":"Tepezza","Proper_Name":"teprotumumab-trbw","License_Type":"351(a)","Strength":"500MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/21\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2022","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"1\/21\/2027"},{"N\/R\/U":null,"Applicant":"Sun Pharmaceutical Industries Limited","BLA_Number":"761067","Proprietary_Name":"Ilumya","Proper_Name":"tildrakizumab-asmn","License_Type":"351(a)","Strength":"100MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/20\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2092","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"125276","Proprietary_Name":"Actemra","Proper_Name":"tocilizumab","License_Type":"351(a)","Strength":"80MG\/4ML (20MG\/ML)\n","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/8\/2010","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"8\/30\/2024"},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"125276","Proprietary_Name":"Actemra","Proper_Name":"tocilizumab","License_Type":"351(a)","Strength":"200MG\/10ML (20MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/8\/2010","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"8\/30\/2024"},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"125276","Proprietary_Name":"Actemra","Proper_Name":"tocilizumab","License_Type":"351(a)","Strength":"400MG\/20ML (20MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/8\/2010","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"8\/30\/2024"},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"125472","Proprietary_Name":"Actemra","Proper_Name":"tocilizumab","License_Type":"351(a)","Strength":"162MG\/0.9ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/21\/2013","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/4\/2028"},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"125472","Proprietary_Name":"Actemra","Proper_Name":"tocilizumab","License_Type":"351(a)","Strength":"162MG\/0.9ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/19\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"29","Submission_Type":"Supplement","License_Number":"1048","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/4\/2028"},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline LLC","BLA_Number":"125011","Proprietary_Name":"Bexxar","Proper_Name":"tositumomab and iodine I-131 tositumomab","License_Type":"351(a)","Strength":"35MG","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/27\/2003","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1727","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline LLC","BLA_Number":"125011","Proprietary_Name":"Bexxar","Proper_Name":"tositumomab and iodine I-131 tositumomab","License_Type":"351(a)","Strength":"225MG","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/27\/2003","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1727","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"103792","Proprietary_Name":"Herceptin","Proper_Name":"trastuzumab","License_Type":"351(a)","Strength":"420MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"9\/25\/1998","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"10\/20\/2017"},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"103792","Proprietary_Name":"Herceptin","Proper_Name":"trastuzumab","License_Type":"351(a)","Strength":"150MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/10\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5336","Submission_Type":"Supplement","License_Number":"1048","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"10\/20\/2017"},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"761073","Proprietary_Name":"Kanjinti","Proper_Name":"trastuzumab-anns","License_Type":"351(k) Biosimilar","Strength":"420MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/13\/2019","Ref._Product_Proper_Name":"trastuzumab","Ref._Product_Proprietary_Name":"Herceptin","Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"761073","Proprietary_Name":"Kanjinti","Proper_Name":"trastuzumab-anns","License_Type":"351(k) Biosimilar","Strength":"150MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/25\/2019","Ref._Product_Proper_Name":"trastuzumab","Ref._Product_Proprietary_Name":"Herceptin","Supplement_Number":"1","Submission_Type":"Supplement","License_Number":"1080","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Biocon Biologics Inc.","BLA_Number":"761074","Proprietary_Name":"Ogivri","Proper_Name":"trastuzumab-dkst","License_Type":"351(k) Biosimilar","Strength":"420MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/1\/2017","Ref._Product_Proper_Name":"trastuzumab","Ref._Product_Proprietary_Name":"Herceptin","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2324","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Biocon Biologics Inc.","BLA_Number":"761074","Proprietary_Name":"Ogivri","Proper_Name":"trastuzumab-dkst","License_Type":"351(k) Biosimilar","Strength":"150MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/17\/2019","Ref._Product_Proper_Name":"trastuzumab","Ref._Product_Proprietary_Name":"Herceptin","Supplement_Number":"4","Submission_Type":"Supplement","License_Number":"2324","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Pfizer Ireland Pharmaceuticals","BLA_Number":"761081","Proprietary_Name":"Trazimera","Proper_Name":"trastuzumab-qyyp","License_Type":"351(k) Biosimilar","Strength":"420MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/11\/2019","Ref._Product_Proper_Name":"trastuzumab","Ref._Product_Proprietary_Name":"Herceptin","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2060","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Pfizer Ireland Pharmaceuticals","BLA_Number":"761081","Proprietary_Name":"Trazimera","Proper_Name":"trastuzumab-qyyp","License_Type":"351(k) Biosimilar","Strength":"150MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/30\/2020","Ref._Product_Proper_Name":"trastuzumab","Ref._Product_Proprietary_Name":"Herceptin","Supplement_Number":"8","Submission_Type":"Supplement","License_Number":"2060","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CELLTRION, Inc.","BLA_Number":"761091","Proprietary_Name":"Herzuma","Proper_Name":"trastuzumab-pkrb","License_Type":"351(k) Biosimilar","Strength":"420MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/14\/2018","Ref._Product_Proper_Name":"trastuzumab","Ref._Product_Proprietary_Name":"Herceptin","Supplement_Number":null,"Submission_Type":"Original","License_Number":"1996","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CELLTRION, Inc.","BLA_Number":"761091","Proprietary_Name":"Herzuma","Proper_Name":"trastuzumab-pkrb","License_Type":"351(k) Biosimilar","Strength":"150MG","Dosage_Form":"For injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/16\/2019","Ref._Product_Proper_Name":"trastuzumab","Ref._Product_Proprietary_Name":"Herceptin","Supplement_Number":"1","Submission_Type":"Supplement","License_Number":"1996","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Samsung Bioepis Co., Ltd.","BLA_Number":"761100","Proprietary_Name":"Ontruzant","Proper_Name":"trastuzumab-dttb","License_Type":"351(k) Biosimilar","Strength":"150MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/18\/2019","Ref._Product_Proper_Name":"trastuzumab","Ref._Product_Proprietary_Name":"Herceptin","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2046","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Samsung Bioepis Co., Ltd.","BLA_Number":"761100","Proprietary_Name":"Ontruzant","Proper_Name":"trastuzumab-dttb","License_Type":"351(k) Biosimilar","Strength":"420MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/20\/2020","Ref._Product_Proper_Name":"trastuzumab","Ref._Product_Proprietary_Name":"Herceptin","Supplement_Number":"5","Submission_Type":"Supplement","License_Number":"2046","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"761106","Proprietary_Name":"Herceptin Hylecta","Proper_Name":"trastuzumab and hyaluronidase-oysk","License_Type":"351(a)","Strength":"600MG\/5ML;10,000 UNITS\/5ML (120MG\/2,000UNITS\/ML)","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/28\/2019","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Janssen Biotech, Inc.","BLA_Number":"125261","Proprietary_Name":"Stelara","Proper_Name":"ustekinumab","License_Type":"351(a)","Strength":"45MG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/25\/2009","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1864","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Janssen Biotech, Inc.","BLA_Number":"125261","Proprietary_Name":"Stelara","Proper_Name":"ustekinumab","License_Type":"351(a)","Strength":"90MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"9\/25\/2009","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1864","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Janssen Biotech, Inc.","BLA_Number":"125261","Proprietary_Name":"Stelara","Proper_Name":"ustekinumab","License_Type":"351(a)","Strength":"45MG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/30\/2009","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"1","Submission_Type":"Supplement","License_Number":"1864","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Janssen Biotech, Inc.","BLA_Number":"125261","Proprietary_Name":"Stelara","Proper_Name":"ustekinumab","License_Type":"351(a)","Strength":"90MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/30\/2009","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"1","Submission_Type":"Supplement","License_Number":"1864","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Janssen Biotech, Inc.","BLA_Number":"761044","Proprietary_Name":"Stelara","Proper_Name":"ustekinumab","License_Type":"351(a)","Strength":"130MG\/26ML (5MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/23\/2016","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1864","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125476","Proprietary_Name":"Entyvio","Proper_Name":"vedolizumab","License_Type":"351(a)","Strength":"300MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/20\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1898","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Ultragenyx Pharamceutical Inc.","BLA_Number":"761047","Proprietary_Name":"Mepsevii","Proper_Name":"vestronidase alfa-vjbk","License_Type":"351(a)","Strength":"10MG\/5ML (2MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/15\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2040","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/15\/2024"},{"N\/R\/U":null,"Applicant":"Sanofi-Aventis U.S. LLC","BLA_Number":"125418","Proprietary_Name":"Zaltrap","Proper_Name":"Ziv-Aflibercept","License_Type":"351(a)","Strength":"100MG\/4ML (25MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/3\/2012","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1752","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi-Aventis U.S. LLC","BLA_Number":"125418","Proprietary_Name":"Zaltrap","Proper_Name":"Ziv-Aflibercept","License_Type":"351(a)","Strength":"200MG\/8ML (25MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/3\/2012","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1752","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Gilead Sciences, Inc.","BLA_Number":"761115","Proprietary_Name":"Trodelvy","Proper_Name":"sacituzumab govitecan-hziy","License_Type":"351(a)","Strength":"180MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/22\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2258","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Janssen Biotech, Inc.","BLA_Number":"761145","Proprietary_Name":"Darzalex Faspro","Proper_Name":"daratumumab and hyaluronidase-fihj","License_Type":"351(a)","Strength":"1800MG\/15ML; 30,000UNITS\/15ML (120MG\/2,000UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/1\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1864","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"1\/15\/2028"},{"N\/R\/U":null,"Applicant":"Iso-Tex Diagnostics, Inc. ","BLA_Number":"017835","Proprietary_Name":"Chromalbin","Proper_Name":"albumin chromated CR-51 serum","License_Type":"351(a)","Strength":"100uCi","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"2\/23\/1976","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2189","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Iso-Tex Diagnostics, Inc. ","BLA_Number":"017835","Proprietary_Name":"Chromalbin","Proper_Name":"albumin chromated CR-51 serum","License_Type":"351(a)","Strength":"250uCi","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"2\/23\/1976","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2189","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Iso-Tex Diagnostics, Inc. ","BLA_Number":"017835","Proprietary_Name":"Chromalbin","Proper_Name":"albumin chromated CR-51 serum","License_Type":"351(a)","Strength":"500uCi","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"2\/23\/1976","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2189","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bayer HealthCare Pharmaceuticals Inc.","BLA_Number":"020304","Proprietary_Name":"Trasylol","Proper_Name":"aprotinin","License_Type":"351(a)","Strength":"1,000,000KIU\/100ML (10,000KIU\/ML) ","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/29\/1993","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1778","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/29\/2000"},{"N\/R\/U":null,"Applicant":"Bayer HealthCare Pharmaceuticals Inc.","BLA_Number":"020304","Proprietary_Name":"Trasylol","Proper_Name":"aprotinin","License_Type":"351(a)","Strength":"2,000,000KIU\/200ML (10,000KIU\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/29\/1993","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1778","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/29\/2000"},{"N\/R\/U":null,"Applicant":"AbbVie Inc.","BLA_Number":"020032","Proprietary_Name":"Survanta","Proper_Name":"beractant","License_Type":"351(a)","Strength":"100MG\/4ML (25MG\/ML)","Dosage_Form":"Suspension","Route_of_Administration":"Intratracheal","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/1\/1991","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1889","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/2\/1998"},{"N\/R\/U":null,"Applicant":"AbbVie Inc.","BLA_Number":"020032","Proprietary_Name":"Survanta","Proper_Name":"beractant","License_Type":"351(a)","Strength":" 200MG\/8ML (25MG\/ML)","Dosage_Form":"Suspension","Route_of_Administration":"Intratracheal","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/1\/1991","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1889","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/2\/1998"},{"N\/R\/U":null,"Applicant":"ONY Biotech Inc.","BLA_Number":"020521","Proprietary_Name":"Infasurf","Proper_Name":"calfactant","License_Type":"351(a)","Strength":"105MG\/3ML (35MG\/ML)","Dosage_Form":"Suspension","Route_of_Administration":"Intratracheal","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/12\/2002","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"8","Submission_Type":"Supplement","License_Number":"2192","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ONY Biotech Inc.","BLA_Number":"020521","Proprietary_Name":"Infasurf","Proper_Name":"calfactant","License_Type":"351(a)","Strength":"210MG\/6ML (35MG\/ML)","Dosage_Form":"Suspension","Route_of_Administration":"Intratracheal","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/1\/1998","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2192","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ONY Biotech Inc.","BLA_Number":"020521","Proprietary_Name":"Infasurf","Proper_Name":"calfactant","License_Type":"351(a)","Strength":"420MG\/12ML (35MG\/ML)","Dosage_Form":"Suspension","Route_of_Administration":"Intratracheal","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":null,"Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Supplement","License_Number":"2192","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Organon USA LLC, a subsidiary of Organon & Co.","BLA_Number":"017692","Proprietary_Name":"Pregnyl","Proper_Name":"chorionic gonadotropin","License_Type":"351(a)","Strength":"10,000UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/20\/1976","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2331","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"EMD Serono, Inc.","BLA_Number":"021149","Proprietary_Name":"Ovidrel","Proper_Name":"choriogonadotropin alfa","License_Type":"351(a)","Strength":"250MCG","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"9\/20\/2000","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1773","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"EMD Serono, Inc.","BLA_Number":"021149","Proprietary_Name":"Ovidrel","Proper_Name":"choriogonadotropin alfa","License_Type":"351(a)","Strength":"250MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/14\/2003","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"6","Submission_Type":"Supplement","License_Number":"1773","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Ferring Pharmaceuticals Inc.","BLA_Number":"017016","Proprietary_Name":"Novarel","Proper_Name":"chorionic gonadotropin","License_Type":"351(a)","Strength":"20,000UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"1\/15\/1974","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2112","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Ferring Pharmaceuticals Inc.","BLA_Number":"017016","Proprietary_Name":"Novarel","Proper_Name":"chorionic gonadotropin","License_Type":"351(a)","Strength":"5,000UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/15\/1974","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2112","Product_Number":"6","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Ferring Pharmaceuticals Inc.","BLA_Number":"017016","Proprietary_Name":"Novarel","Proper_Name":"chorionic gonadotropin","License_Type":"351(a)","Strength":"10,000UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"1\/15\/1974","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2112","Product_Number":"7","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Ferring Pharmaceuticals Inc.","BLA_Number":"017016","Proprietary_Name":"Novarel","Proper_Name":"chorionic gonadotropin","License_Type":"351(a)","Strength":"2,000UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/27\/1984","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"132","Submission_Type":"Supplement","License_Number":"2112","Product_Number":"9","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Ferring Pharmaceuticals Inc.","BLA_Number":"017016","Proprietary_Name":"Novarel","Proper_Name":"chorionic gonadotropin","License_Type":"351(a)","Strength":"15,000UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"2\/15\/1985","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"131","Submission_Type":"Supplement","License_Number":"2112","Product_Number":"10","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Ferring Pharmaceuticals Inc.","BLA_Number":"017016","Proprietary_Name":"Novarel","Proper_Name":"chorionic gonadotropin","License_Type":"351(a)","Strength":"2,000UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"2\/16\/1990","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"136","Submission_Type":"Supplement","License_Number":"2112","Product_Number":"11","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bel-Mar Laboratories, Inc.","BLA_Number":"017054","Proprietary_Name":"Chorionic Gonadotropin","Proper_Name":"chorionic gonadotropin","License_Type":"351(a)","Strength":"5,000UNITS","Dosage_Form":"Injection ","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"3\/26\/1974","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2182","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bel-Mar Laboratories, Inc.","BLA_Number":"017054","Proprietary_Name":"Chorionic Gonadotropin","Proper_Name":"chorionic gonadotropin","License_Type":"351(a)","Strength":"10,000UNITS","Dosage_Form":"Injection ","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"3\/26\/1974","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2182","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Ferring Pharmaceuticals Inc.","BLA_Number":"017055","Proprietary_Name":"A.P.L.","Proper_Name":"chorionic gonadotropin","License_Type":"351(a)","Strength":"5,000UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/13\/1974","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2112","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Ferring Pharmaceuticals Inc.","BLA_Number":"017055","Proprietary_Name":"A.P.L.","Proper_Name":"chorionic gonadotropin","License_Type":"351(a)","Strength":"10,000UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/13\/1974","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2112","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Ferring Pharmaceuticals Inc.","BLA_Number":"017055","Proprietary_Name":"A.P.L.","Proper_Name":"chorionic gonadotropin","License_Type":"351(a)","Strength":"20,000UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/13\/1974","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2112","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Fresenius Kabi USA, LLC","BLA_Number":"017067","Proprietary_Name":"Chorionic Gonadotropin","Proper_Name":"chorionic gonadotropin","License_Type":"351(a)","Strength":"5,000UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"3\/5\/1973","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2146","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Fresenius Kabi USA, LLC","BLA_Number":"017067","Proprietary_Name":"Chorionic Gonadotropin","Proper_Name":"chorionic gonadotropin","License_Type":"351(a)","Strength":"10,000UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/5\/1973","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2146","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Fresenius Kabi USA, LLC","BLA_Number":"017067","Proprietary_Name":"Chorionic Gonadotropin","Proper_Name":"chorionic gonadotropin","License_Type":"351(a)","Strength":"15,0000UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"3\/5\/1973","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2146","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Fresenius Kabi USA, LLC","BLA_Number":"017067","Proprietary_Name":"Chorionic Gonadotropin","Proper_Name":"chorionic gonadotropin","License_Type":"351(a)","Strength":"20,000UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"3\/5\/1973","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2146","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"DisCure Medical, LLC","BLA_Number":"018663","Proprietary_Name":"Chymodiactin","Proper_Name":"chymopapain","License_Type":"351(a)","Strength":"10,000UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intrathecal","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"11\/10\/1982","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2185","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"DisCure Medical, LLC","BLA_Number":"018663","Proprietary_Name":"Chymodiactin","Proper_Name":"chymopapain","License_Type":"351(a)","Strength":"4,000UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intrathecal","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"8\/21\/1984","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"11,12","Submission_Type":"Supplement","License_Number":"2185","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Ferring Pharmaceuticals Inc.","BLA_Number":"020162","Proprietary_Name":"Acthrel","Proper_Name":"corticorelin ovine triflutate","License_Type":"351(a)","Strength":"100MCG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"5\/23\/1996","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2112","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/23\/2003"},{"N\/R\/U":null,"Applicant":"Bausch Health US, LLC","BLA_Number":"021271","Proprietary_Name":"Iprivask","Proper_Name":"desirudin","License_Type":"351(a)","Strength":"15MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"4\/4\/2003","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2181","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Parke-Davis, a Division of Pfizer Inc.","BLA_Number":"050294","Proprietary_Name":"Elase-chloromycetin","Proper_Name":"fibrinolysin and desoxyribonuclease combined [bovine], with chloramphenicol","License_Type":"351(a)","Strength":"10MG\/GM; 666UNITS\/GM; 1UNIT\/GM","Dosage_Form":"Ointment","Route_of_Administration":"Topical","Product_Presentation":"Tube","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"4\/1\/1964","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2205","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"Organon USA LLC, a subsidiary of Organon & Co.","BLA_Number":"021211","Proprietary_Name":"Follistim AQ Cartridge","Proper_Name":"follitropin beta","License_Type":"351(a)","Strength":"300IU\/0.36ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/23\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2331","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"Organon USA LLC, a subsidiary of Organon & Co.","BLA_Number":"021211","Proprietary_Name":"Follistim AQ Cartridge","Proper_Name":"follitropin beta","License_Type":"351(a)","Strength":"175IU\/0.21ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Cartridge","Status":"Disc","Licensure":"Licensed","Approval_Date":"2\/11\/2005","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"2","Submission_Type":"Supplement","License_Number":"2331","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"Organon USA LLC, a subsidiary of Organon & Co.","BLA_Number":"021211","Proprietary_Name":"Follistim AQ Cartridge","Proper_Name":"follitropin beta","License_Type":"351(a)","Strength":"600IU\/0.72ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/23\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2331","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"Organon USA LLC, a subsidiary of Organon & Co.","BLA_Number":"021211","Proprietary_Name":"Follistim AQ Cartridge","Proper_Name":"follitropin beta","License_Type":"351(a)","Strength":"900IU\/1.08ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/11\/2005","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"2","Submission_Type":"Supplement","License_Number":"2331","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"EMD Serono, Inc.","BLA_Number":"020378","Proprietary_Name":"Gonal-f","Proper_Name":"follitropin alfa","License_Type":"351(a)","Strength":"75IU","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Ampule","Status":"Disc","Licensure":"Licensed","Approval_Date":"9\/29\/1997","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1773","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/24\/2007"},{"N\/R\/U":null,"Applicant":"EMD Serono, Inc.","BLA_Number":"020378","Proprietary_Name":"Gonal-f","Proper_Name":"follitropin alfa","License_Type":"351(a)","Strength":"150IU","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Ampule","Status":"Disc","Licensure":"Licensed","Approval_Date":"9\/29\/1997","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1773","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/24\/2007"},{"N\/R\/U":null,"Applicant":"EMD Serono, Inc.","BLA_Number":"020378","Proprietary_Name":"Gonal-f","Proper_Name":"follitropin alfa","License_Type":"351(a)","Strength":"37.5IU","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Ampule","Status":"Disc","Licensure":"Licensed","Approval_Date":"3\/25\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"15","Submission_Type":"Supplement","License_Number":"1773","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/24\/2007"},{"N\/R\/U":null,"Applicant":"EMD Serono, Inc.","BLA_Number":"020378","Proprietary_Name":"Gonal-f","Proper_Name":"follitropin alfa","License_Type":"351(a)","Strength":"1,050IU (600IU\/ML)","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/28\/2001","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"9","Submission_Type":"Supplement","License_Number":"1773","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/24\/2007"},{"N\/R\/U":null,"Applicant":"EMD Serono, Inc.","BLA_Number":"020378","Proprietary_Name":"Gonal-f","Proper_Name":"follitropin alfa","License_Type":"351(a)","Strength":"450IU (600IU\/ML)","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/26\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"16","Submission_Type":"Supplement","License_Number":"1773","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/24\/2007"},{"N\/R\/U":null,"Applicant":"EMD Serono, Inc.","BLA_Number":"021684","Proprietary_Name":"Gonal-f RFF RediJect","Proper_Name":"follitropin alfa","License_Type":"351(a)","Strength":"300IU\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/25\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1773","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"EMD Serono, Inc.","BLA_Number":"021684","Proprietary_Name":"Gonal-f RFF RediJect","Proper_Name":"follitropin alfa","License_Type":"351(a)","Strength":"450IU\/0.75ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/25\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1773","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"EMD Serono, Inc.","BLA_Number":"021684","Proprietary_Name":"Gonal-f RFF RediJect","Proper_Name":"follitropin alfa","License_Type":"351(a)","Strength":"900IU\/1.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/25\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1773","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"EMD Serono, Inc.","BLA_Number":"021765","Proprietary_Name":"Gonal-f RFF","Proper_Name":"follitropin alfa","License_Type":"351(a)","Strength":"37.5IU","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"3\/25\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1773","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"EMD Serono, Inc.","BLA_Number":"021765","Proprietary_Name":"Gonal-f RFF","Proper_Name":"follitropin alfa","License_Type":"351(a)","Strength":"75IU","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/25\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1773","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"EMD Serono, Inc.","BLA_Number":"021765","Proprietary_Name":"Gonal-f RFF","Proper_Name":"follitropin alfa","License_Type":"351(a)","Strength":"150IU","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"3\/25\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1773","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Organon USA Inc., a subsidiary of Merck & Co., Inc.","BLA_Number":"020582","Proprietary_Name":"Follistim","Proper_Name":"follitropin beta","License_Type":"351(a)","Strength":"75IU","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous, Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"9\/29\/1997","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2193","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Organon USA Inc., a subsidiary of Merck & Co., Inc.","BLA_Number":"020582","Proprietary_Name":"Follistim","Proper_Name":"follitropin beta","License_Type":"351(a)","Strength":"150IU","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous, Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"9\/29\/1997","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2193","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Organon USA Inc., a subsidiary of Merck & Co., Inc.","BLA_Number":"021273","Proprietary_Name":"Follistim AQ","Proper_Name":"follitropin beta","License_Type":"351(a)","Strength":"75IU\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous, Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"8\/26\/2005","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2193","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Organon USA Inc., a subsidiary of Merck & Co., Inc.","BLA_Number":"021273","Proprietary_Name":"Follistim AQ","Proper_Name":"follitropin beta","License_Type":"351(a)","Strength":"150IU\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous, Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"8\/26\/2005","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2193","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"018781","Proprietary_Name":"Humulin N","Proper_Name":"insulin isophane human","License_Type":"351(a)","Strength":"1,000UNITS\/10ML (100UNITS\/ML)","Dosage_Form":"Injectable Suspension","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"OTC","Licensure":"Licensed","Approval_Date":"10\/28\/1982","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"018781","Proprietary_Name":"Humulin N","Proper_Name":"insulin isophane human","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injectable Suspension","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"OTC","Licensure":"Licensed","Approval_Date":"10\/28\/1982","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"018781","Proprietary_Name":"Humulin N","Proper_Name":"insulin isophane human","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injectable Suspension","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"OTC","Licensure":"Licensed","Approval_Date":"11\/7\/2013","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"118","Submission_Type":"Supplement","License_Number":"1891","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"019717","Proprietary_Name":"Humulin 70\/30","Proper_Name":"insulin isophane human and insulin human","License_Type":"351(a)","Strength":" 700UNITS\/10ML (70UNITS\/ML); 300UNITS\/10ML (30UNITS\/ML)","Dosage_Form":"Injectable Suspension","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"OTC","Licensure":"Licensed","Approval_Date":"4\/25\/1989","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"019717","Proprietary_Name":"Humulin 70\/30","Proper_Name":"insulin isophane human and insulin human","License_Type":"351(a)","Strength":"210UNITS\/3ML (70UNITS\/ML); 90UNITS\/3ML (30UNITS\/ML)","Dosage_Form":"Injectable Suspension","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"OTC","Licensure":"Licensed","Approval_Date":"4\/25\/1989","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"019717","Proprietary_Name":"Humulin 70\/30","Proper_Name":"insulin isophane human and insulin human","License_Type":"351(a)","Strength":"210UNITS\/3ML (70UNITS\/ML); 90UNITS\/3ML (30UNITS\/ML)","Dosage_Form":"Injectable Suspension","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"OTC","Licensure":"Licensed","Approval_Date":"11\/7\/2013","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"98","Submission_Type":"Supplement","License_Number":"1891","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bausch & Lomb Incorporated","BLA_Number":"021640","Proprietary_Name":"Vitrase","Proper_Name":"hyaluronidase","License_Type":"351(a)","Strength":"6,200UNITS\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"5\/5\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2180","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bausch & Lomb Incorporated","BLA_Number":"021640","Proprietary_Name":"Vitrase","Proper_Name":"hyaluronidase","License_Type":"351(a)","Strength":"200UNITS\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/2\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"3","Submission_Type":"Supplement","License_Number":"2180","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amphastar Pharmaceuticals, Inc.","BLA_Number":"021665","Proprietary_Name":"Amphadase","Proper_Name":"hyaluronidase","License_Type":"351(a)","Strength":"150UNITS\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/26\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2179","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Akorn, Inc.","BLA_Number":"021716","Proprietary_Name":"Hydase","Proper_Name":"hyaluronidase","License_Type":"351(a)","Strength":"150UNITS\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"10\/25\/2005","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2173","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Halozyme Therapeutics, Inc.","BLA_Number":"021859","Proprietary_Name":"Hylenex recombinant","Proper_Name":"hyaluronidase human","License_Type":"351(a)","Strength":"150UNITS\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Infiltration, Interstitial, Intramuscular, Intraocular, Peribulbar, Retrobulbar, Soft Tissue, Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/2\/2005","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2187","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genzyme Corporation","BLA_Number":"020367","Proprietary_Name":"Cerezyme","Proper_Name":"imiglucerase","License_Type":"351(a)","Strength":"200UNITS\/VIAL","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"5\/23\/1994","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1596","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/23\/2001"},{"N\/R\/U":null,"Applicant":"Genzyme Corporation","BLA_Number":"020367","Proprietary_Name":"Cerezyme","Proper_Name":"imiglucerase","License_Type":"351(a)","Strength":"400UNITS\/VIAL","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/22\/1999","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"34","Submission_Type":"Supplement","License_Number":"1596","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/23\/2001"},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"020986","Proprietary_Name":"Novolog","Proper_Name":"insulin aspart","License_Type":"351(a)","Strength":"1,000UNITS\/10ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/7\/2000","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1261","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"020986","Proprietary_Name":"Novolog","Proper_Name":"insulin aspart","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/7\/2000","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1261","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"020986","Proprietary_Name":"Novolog","Proper_Name":"insulin aspart","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/19\/2001","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"1","Submission_Type":"Supplement","License_Number":"1261","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"020986","Proprietary_Name":"Novolog","Proper_Name":"insulin aspart","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"4\/23\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"23","Submission_Type":"Supplement","License_Number":"1261","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"020986","Proprietary_Name":"Novolog","Proper_Name":"insulin aspart","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"10\/31\/2013","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"61","Submission_Type":"Supplement","License_Number":"1261","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"208751","Proprietary_Name":"Fiasp","Proper_Name":"insulin aspart","License_Type":"351(a)","Strength":"1000UNITS\/10ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1261","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"208751","Proprietary_Name":"Fiasp","Proper_Name":"insulin aspart","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1261","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"208751","Proprietary_Name":"Fiasp","Proper_Name":"insulin aspart","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/24\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"3","Submission_Type":"Supplement","License_Number":"1261","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"208751","Proprietary_Name":"Fiasp","Proper_Name":"insulin aspart","License_Type":"351(a)","Strength":"160UNITS\/1.6ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/21\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"20","Submission_Type":"Supplement","License_Number":"1261","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"021172","Proprietary_Name":"Novolog Mix 70\/30","Proper_Name":"insulin aspart protamine and insulin aspart","License_Type":"351(a)","Strength":"700UNITS\/10ML (70UNITS\/ML); 300UNITS\/10ML (30UNITS\/ML)","Dosage_Form":"Injectable Suspension","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/1\/2001","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1261","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"021172","Proprietary_Name":"Novolog Mix 70\/30","Proper_Name":"insulin aspart protamine and insulin aspart","License_Type":"351(a)","Strength":"210UNITS\/3ML (70UNITS\/ML); 90UNITS\/3ML (30UNITS\/ML)","Dosage_Form":"Injectable Suspension","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"11\/1\/2001","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1261","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"021172","Proprietary_Name":"Novolog Mix 70\/30","Proper_Name":"insulin aspart protamine and insulin aspart","License_Type":"351(a)","Strength":"210UNITS\/3ML (70UNITS\/ML); 90UNITS\/3ML (30UNITS\/ML)","Dosage_Form":"Injectable Suspension","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"11\/1\/2001","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1261","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"021172","Proprietary_Name":"Novolog Mix 70\/30","Proper_Name":"insulin aspart protamine and insulin aspart","License_Type":"351(a)","Strength":"210UNITS\/3ML (70UNITS\/ML); 90UNITS\/3ML (30UNITS\/ML)","Dosage_Form":"Injectable Suspension","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/3\/2002","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"1","Submission_Type":"Supplement","License_Number":"1261","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"021810","Proprietary_Name":"Novolog Mix 50\/50","Proper_Name":"insulin aspart protamine and insulin aspart","License_Type":"351(a)","Strength":"150UNITS\/3ML (50UNITS\/ML); 150UNITS\/3ML (50UNITS\/ML)","Dosage_Form":"Injectable Suspension","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Cartridge","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"8\/26\/2008","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1261","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"021810","Proprietary_Name":"Novolog Mix 50\/50","Proper_Name":"insulin aspart protamine and insulin aspart","License_Type":"351(a)","Strength":"150UNITS\/3ML (50UNITS\/ML); 150UNITS\/3ML (50UNITS\/ML)","Dosage_Form":"Injectable Suspension","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"8\/26\/2008","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1261","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"203314","Proprietary_Name":"Tresiba","Proper_Name":"insulin degludec","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/25\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1261","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"203314","Proprietary_Name":"Tresiba","Proper_Name":"insulin degludec","License_Type":"351(a)","Strength":"600UNITS\/3ML (200UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/25\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1261","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"203314","Proprietary_Name":"Tresiba","Proper_Name":"insulin degludec","License_Type":"351(a)","Strength":"1,000UNITS\/10ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/21\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"10","Submission_Type":"Supplement","License_Number":"1261","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"203313","Proprietary_Name":"Ryzodeg 70\/30","Proper_Name":"insulin degludec and insulin aspart","License_Type":"351(a)","Strength":"210UNITS\/3ML (70UNITS\/ML); 90UNIT\/3ML (30UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"9\/25\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1261","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"208583","Proprietary_Name":"Xultophy 100\/3.6","Proper_Name":"insulin degludec and liraglutide","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML); 10.8MG\/3ML (3.6MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/21\/2016","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1261","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"021536","Proprietary_Name":"Levemir","Proper_Name":"insulin detemir","License_Type":"351(a)","Strength":"1,000UNITS\/10ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/16\/2005","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1261","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"021536","Proprietary_Name":"Levemir","Proper_Name":"insulin detemir","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/16\/2005","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1261","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"021536","Proprietary_Name":"Levemir","Proper_Name":"insulin detemir","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/16\/2005","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1261","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"021536","Proprietary_Name":"Levemir","Proper_Name":"insulin detemir","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Cartridge","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/16\/2005","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1261","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"021536","Proprietary_Name":"Levemir","Proper_Name":"insulin detemir","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"10\/31\/2013","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"33","Submission_Type":"Supplement","License_Number":"1261","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi-Aventis U.S. LLC","BLA_Number":"021081","Proprietary_Name":"Lantus","Proper_Name":"insulin glargine","License_Type":"351(a)","Strength":"1,000UNITS\/10ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/20\/2000","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1752","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi-Aventis U.S. LLC","BLA_Number":"021081","Proprietary_Name":"Lantus","Proper_Name":"insulin glargine","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/25\/2007","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"24","Submission_Type":"Supplement","License_Number":"1752","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi-Aventis U.S. LLC","BLA_Number":"021081","Proprietary_Name":"Lantus","Proper_Name":"insulin glargine","License_Type":"351(a)","Strength":"500UNITS\/5ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"4\/20\/2000","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1752","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi-Aventis U.S. LLC","BLA_Number":"021081","Proprietary_Name":"Lantus","Proper_Name":"insulin glargine","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Cartridge","Status":"Disc","Licensure":"Licensed","Approval_Date":"4\/20\/2000","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1752","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Mylan Pharmaceuticals Inc.","BLA_Number":"761201","Proprietary_Name":"Semglee","Proper_Name":"insulin glargine-yfgn","License_Type":"351(k) Interchangeable","Strength":"1,000UNITS\/10ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/28\/2021","Ref._Product_Proper_Name":"insulin glargine","Ref._Product_Proprietary_Name":"Lantus","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2210","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":"11\/15\/2022","Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Mylan Pharmaceuticals Inc.","BLA_Number":"761201","Proprietary_Name":"Semglee","Proper_Name":"insulin glargine-yfgn","License_Type":"351(k) Interchangeable","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/28\/2021","Ref._Product_Proper_Name":"insulin glargine","Ref._Product_Proprietary_Name":"Lantus","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2210","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":"11\/15\/2022","Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"205692","Proprietary_Name":"Basaglar","Proper_Name":"insulin glargine","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/16\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"205692","Proprietary_Name":"Basaglar","Proper_Name":"insulin glargine","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/15\/2019","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"21","Submission_Type":"Supplement","License_Number":"1891","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi-Aventis U.S. LLC","BLA_Number":"206538","Proprietary_Name":"Toujeo","Proper_Name":"insulin glargine","License_Type":"351(a)","Strength":"450UNITS\/1.5ML (300UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/25\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1752","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi-Aventis U.S. LLC","BLA_Number":"206538","Proprietary_Name":"Toujeo","Proper_Name":"insulin glargine","License_Type":"351(a)","Strength":"900UNITS\/3ML (300UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/26\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"6","Submission_Type":"Supplement","License_Number":"1752","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi-Aventis U.S. LLC","BLA_Number":"208673","Proprietary_Name":"Soliqua 100\/33","Proper_Name":"insulin glargine and lixisenatide","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML); 99MCG\/3ML (33MCG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/21\/2016","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1752","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi-Aventis U.S. LLC","BLA_Number":"021629","Proprietary_Name":"Apidra","Proper_Name":"insulin glulisine","License_Type":"351(a)","Strength":"1,000UNITS\/10ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/16\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1752","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi-Aventis U.S. LLC","BLA_Number":"021629","Proprietary_Name":"Apidra","Proper_Name":"insulin glulisine","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Cartridge","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/20\/2005","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"2","Submission_Type":"Supplement","License_Number":"1752","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi-Aventis U.S. LLC","BLA_Number":"021629","Proprietary_Name":"Apidra","Proper_Name":"insulin glulisine","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/24\/2009","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"8","Submission_Type":"Supplement","License_Number":"1752","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"018780","Proprietary_Name":"Humulin R U-500","Proper_Name":"insulin human","License_Type":"351(a)","Strength":"1,500UNITS\/3ML (500UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/29\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"152","Submission_Type":"Supplement","License_Number":"1891","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"018780","Proprietary_Name":"Humulin R U-500","Proper_Name":"insulin human","License_Type":"351(a)","Strength":"10,000UNITS\/20ML (500UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/31\/1994","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"42","Submission_Type":"Supplement","License_Number":"1891","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"018780","Proprietary_Name":"Humulin R U-100","Proper_Name":"insulin human","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"OTC","Licensure":"Licensed","Approval_Date":"5\/25\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"126","Submission_Type":"Supplement","License_Number":"1891","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"018780","Proprietary_Name":"Humulin R U-100","Proper_Name":"insulin human","License_Type":"351(a)","Strength":"1,000UNITS\/10ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"OTC","Licensure":"Licensed","Approval_Date":"10\/28\/1982","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"018780","Proprietary_Name":"Humulin R U-100","Proper_Name":"insulin human","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"8\/6\/1998","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"58","Submission_Type":"Supplement","License_Number":"1891","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Mannkind Corporation","BLA_Number":"022472","Proprietary_Name":"Afrezza","Proper_Name":"insulin human","License_Type":"351(a)","Strength":"4UNITS\/INH","Dosage_Form":"Powder","Route_of_Administration":"Inhalation","Product_Presentation":"Single-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/27\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2190","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Mannkind Corporation","BLA_Number":"022472","Proprietary_Name":"Afrezza","Proper_Name":"insulin human","License_Type":"351(a)","Strength":"8UNITS\/INH","Dosage_Form":"Powder","Route_of_Administration":"Inhalation","Product_Presentation":"Single-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/27\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2190","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Mannkind Corporation","BLA_Number":"022472","Proprietary_Name":"Afrezza","Proper_Name":"insulin human","License_Type":"351(a)","Strength":"12UNITS\/INH","Dosage_Form":"Powder","Route_of_Administration":"Inhalation","Product_Presentation":"Single-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/17\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"3","Submission_Type":"Supplement","License_Number":"2190","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Baxter Healthcare Corporation","BLA_Number":"208157","Proprietary_Name":"Myxredlin","Proper_Name":"insulin human ","License_Type":"351(a)","Strength":"100UNITS\/100ML (1UNIT\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Container","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/20\/2019","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"140","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"020563","Proprietary_Name":"Humalog","Proper_Name":"insulin lispro","License_Type":"351(a)","Strength":"1,000UNITS\/10ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1996","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"020563","Proprietary_Name":"Humalog","Proper_Name":"insulin lispro","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1996","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"6","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"020563","Proprietary_Name":"Humalog","Proper_Name":"insulin lispro","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Cartridge","Status":"Disc","Licensure":"Licensed","Approval_Date":"8\/6\/1998","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"6","Submission_Type":"Supplement","License_Number":"1891","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"020563","Proprietary_Name":"Humalog","Proper_Name":"insulin lispro","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/6\/2007","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"75","Submission_Type":"Supplement","License_Number":"1891","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"020563","Proprietary_Name":"Humalog","Proper_Name":"insulin lispro","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/6\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"176","Submission_Type":"Supplement","License_Number":"1891","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"020563","Proprietary_Name":"Humalog","Proper_Name":"insulin lispro","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/15\/2019","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"196","Submission_Type":"Supplement","License_Number":"1891","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"205747","Proprietary_Name":"Humalog","Proper_Name":"insulin lispro","License_Type":"351(a)","Strength":"600UNITS\/3ML (200UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/26\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi-Aventis U.S. LLC","BLA_Number":"209196","Proprietary_Name":"Admelog","Proper_Name":"insulin lispro","License_Type":"351(a)","Strength":"1,000UNITS\/10ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/11\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1752","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi-Aventis U.S. LLC","BLA_Number":"209196","Proprietary_Name":"Admelog","Proper_Name":"insulin lispro","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/11\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1752","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi-Aventis U.S. LLC","BLA_Number":"209196","Proprietary_Name":"Admelog","Proper_Name":"insulin lispro","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/19\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"1","Submission_Type":"Supplement","License_Number":"1752","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"021017","Proprietary_Name":"Humalog Mix 75\/25","Proper_Name":"insulin lispro protamine and insulin lispro","License_Type":"351(a)","Strength":"750UNITS\/10ML (75UNITS\/ML); 250UNITS\/10ML (25UNITS\/ML)","Dosage_Form":"Injectable Suspension","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/22\/1999","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"021017","Proprietary_Name":"Humalog Mix 75\/25","Proper_Name":"insulin lispro protamine and insulin lispro","License_Type":"351(a)","Strength":"225UNITS\/3ML (75UNITS\/ML); 75UNITS\/3ML (25UNITS\/ML)","Dosage_Form":"Injectable Suspension","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/6\/2007","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"40","Submission_Type":"Supplement","License_Number":"1891","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"021017","Proprietary_Name":"Humalog Mix 75\/25","Proper_Name":"insulin lispro protamine and insulin lispro","License_Type":"351(a)","Strength":"225UNITS\/3ML (75UNITS\/ML); 75UNITS\/3ML (25UNITS\/ML)","Dosage_Form":"Injectable Suspension","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/22\/1999","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"021018","Proprietary_Name":"Humalog Mix 50\/50","Proper_Name":"insulin lispro protamine and insulin lispro","License_Type":"351(a)","Strength":"500UNITS\/10ML (50UNITS\/ML); 500UNITS\/10ML (50UNITS\/ML)","Dosage_Form":"Injectable Suspension","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/22\/1999","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"021018","Proprietary_Name":"Humalog Mix 50\/50","Proper_Name":"insulin lispro protamine and insulin lispro","License_Type":"351(a)","Strength":"150UNITS\/3ML (50UNITS\/ML); 150UNITS\/3ML (50UNITS\/ML)","Dosage_Form":"Injectable Suspension","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/6\/2007","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"34","Submission_Type":"Supplement","License_Number":"1891","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"021018","Proprietary_Name":"Humalog Mix 50\/50","Proper_Name":"insulin lispro protamine and insulin lispro","License_Type":"351(a)","Strength":"150UNITS\/3ML (50UNITS\/ML); 150UNITS\/3ML (50UNITS\/ML)","Dosage_Form":"Injectable Suspension","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/22\/1999","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Iso-Tex Diagnostics, Inc. ","BLA_Number":"017836","Proprietary_Name":"Jeanatope","Proper_Name":"iodinated I-125 albumin","License_Type":"351(a)","Strength":"500uCi\/0.5ML (1,000uCi\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"2\/23\/1976","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2189","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Iso-Tex Diagnostics, Inc. ","BLA_Number":"017836","Proprietary_Name":"Jeanatope","Proper_Name":"iodinated I-125 albumin","License_Type":"351(a)","Strength":"1,000uCi\/ML (1,000uCi\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"2\/23\/1976","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2189","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Iso-Tex Diagnostics, Inc. ","BLA_Number":"017836","Proprietary_Name":"Jeanatope","Proper_Name":"iodinated I-125 albumin","License_Type":"351(a)","Strength":"100uCi\/10ML (10uCi\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/8\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"8","Submission_Type":"Supplement","License_Number":"2189","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Iso-Tex Diagnostics, Inc. ","BLA_Number":"017837","Proprietary_Name":"Megatope","Proper_Name":"iodinated I-131 albumin","License_Type":"351(a)","Strength":"0.5mCi","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"2\/23\/1976","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2189","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Iso-Tex Diagnostics, Inc. ","BLA_Number":"017837","Proprietary_Name":"Megatope","Proper_Name":"iodinated I-131 albumin","License_Type":"351(a)","Strength":"1mCi","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/23\/1976","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2189","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Iso-Tex Diagnostics, Inc. ","BLA_Number":"017837","Proprietary_Name":"Megatope","Proper_Name":"iodinated I-131 albumin","License_Type":"351(a)","Strength":"2mCi","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"2\/23\/1976","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2189","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Iso-Tex Diagnostics, Inc. ","BLA_Number":"017837","Proprietary_Name":"Megatope","Proper_Name":"iodinated I-131 albumin","License_Type":"351(a)","Strength":"5uCi\/AMP","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"2\/23\/1976","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2189","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Iso-Tex Diagnostics, Inc. ","BLA_Number":"017837","Proprietary_Name":"Megatope","Proper_Name":"iodinated I-131 albumin","License_Type":"351(a)","Strength":"20uCi\/AMP","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"2\/23\/1976","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2189","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant DraxImage Inc.","BLA_Number":"017776","Proprietary_Name":"Pulmolite","Proper_Name":"kit for the preparation of technetium Tc-99m albumin aggregated","License_Type":"351(a)","Strength":"1MG\/10MG\/0.24MG\/ 0.7MG\/0.13MG\/10MG","Dosage_Form":"For Injectable Suspension","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"11\/16\/1976","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2186","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bracco Diagnostics Inc.","BLA_Number":"017833","Proprietary_Name":"Macrotec","Proper_Name":"kit for the preparation of technetium Tc-99m albumin aggregated","License_Type":"351(a)","Strength":"1.5MG\/10MG\/0.07MG\/0.19MG\/1.8MG","Dosage_Form":"For Injectable Suspension","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"2\/23\/1976","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2183","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant DraxImage Inc.","BLA_Number":"017881","Proprietary_Name":"Draximage MAA","Proper_Name":"kit for the preparation of technetium Tc-99m albumin aggregated","License_Type":"351(a)","Strength":"2.5MG\/5MG\/0.6MG\/ 1.2MG","Dosage_Form":"For Injectable Suspension","Route_of_Administration":"Intravenous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/30\/1987","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2186","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Cis Bio International","BLA_Number":"210089","Proprietary_Name":"Pulmotech MAA","Proper_Name":"kit for the preparation of technetium Tc-99m albumin aggregated","License_Type":"351(a)","Strength":"2MG","Dosage_Form":"For Injectable Suspension","Route_of_Administration":"Intravenous, Intraperitoneal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/20\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2204","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi-Aventis U.S. LLC","BLA_Number":"208471","Proprietary_Name":"Adlyxin","Proper_Name":"lixisenatide","License_Type":"351(a)","Strength":"150MCG\/3ML (50MCG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"7\/27\/2016","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1752","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi-Aventis U.S. LLC","BLA_Number":"208471","Proprietary_Name":"Adlyxin","Proper_Name":"lixisenatide","License_Type":"351(a)","Strength":"300MCG\/3ML (100MCG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"7\/27\/2016","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1752","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Ipsen Biopharmaceuticals, Inc.","BLA_Number":"021839","Proprietary_Name":"Increlex","Proper_Name":"mecasermin","License_Type":"351(a)","Strength":"40MG\/4ML (10MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/30\/2005","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2194","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"8\/30\/2012"},{"N\/R\/U":null,"Applicant":"Insmed Incorporated","BLA_Number":"021884","Proprietary_Name":"Iplex","Proper_Name":"mecasermin rinfabate","License_Type":"351(a)","Strength":"36MG\/0.6ML (60MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/12\/2005","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2188","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/12\/2012"},{"N\/R\/U":null,"Applicant":"EMD Serono, Inc.","BLA_Number":"017646","Proprietary_Name":"Pergonal","Proper_Name":"menotropins","License_Type":"351(a)","Strength":"75IU","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous, Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"8\/22\/1975","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1773","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"EMD Serono, Inc.","BLA_Number":"017646","Proprietary_Name":"Pergonal","Proper_Name":"menotropins","License_Type":"351(a)","Strength":"150IU","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous, Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"5\/20\/1985","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"22","Submission_Type":"Supplement","License_Number":"1773","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Organon USA Inc., a subsidiary of Merck & Co., Inc.","BLA_Number":"020328","Proprietary_Name":"Humegon","Proper_Name":"menotropins","License_Type":"351(a)","Strength":"75IU","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"9\/1\/1994","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2193","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Organon USA Inc., a subsidiary of Merck & Co., Inc.","BLA_Number":"020328","Proprietary_Name":"Humegon","Proper_Name":"menotropins","License_Type":"351(a)","Strength":"150IU","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"9\/1\/1994","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2193","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Ferring Pharmaceuticals Inc.","BLA_Number":"021047","Proprietary_Name":"Repronex","Proper_Name":"menotropins","License_Type":"351(a)","Strength":"75IU","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous, Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"8\/27\/1999","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2112","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Ferring Pharmaceuticals Inc.","BLA_Number":"021047","Proprietary_Name":"Repronex","Proper_Name":"menotropins","License_Type":"351(a)","Strength":"150IU","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous, Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"8\/27\/1999","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2112","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Ferring Pharmaceuticals Inc.","BLA_Number":"021663","Proprietary_Name":"Menopur","Proper_Name":"menotropins","License_Type":"351(a)","Strength":"75IU","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/29\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2112","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"019959","Proprietary_Name":"Novolin N","Proper_Name":"insulin isophane human","License_Type":"351(a)","Strength":"1,000UNITS\/10ML (100UNITS\/ML)","Dosage_Form":"Injectable Suspension","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"OTC","Licensure":"Licensed","Approval_Date":"7\/1\/1991","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1261","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"019959","Proprietary_Name":"Novolin N","Proper_Name":"insulin isophane human","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injectable Suspension","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"OTC","Licensure":"Licensed","Approval_Date":"7\/1\/1991","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1261","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"019991","Proprietary_Name":"Novolin 70\/30","Proper_Name":"insulin isophane human and insulin human","License_Type":"351(a)","Strength":"300UNITS\/10ML (30UNITS\/ML); 700UNITS\/10ML (70UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"OTC","Licensure":"Licensed","Approval_Date":"6\/25\/1991","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1261","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"019991","Proprietary_Name":"Novolin 70\/30","Proper_Name":"insulin isophane human and insulin human","License_Type":"351(a)","Strength":"90UNITS\/3ML (30UNITS\/ML); 210UNITS\/3ML (70UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"OTC","Licensure":"Licensed","Approval_Date":"6\/1\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"79","Submission_Type":"Supplement","License_Number":"1261","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Organon USA Inc., a subsidiary of Merck & Co., Inc.","BLA_Number":"020580","Proprietary_Name":"Cotazym","Proper_Name":"pancrelipase","License_Type":"351(a)","Strength":"8,000USP UNITS; 30,000USP UNITS; 30,000USP UNITS","Dosage_Form":"Capsule, Delayed Release","Route_of_Administration":"Oral","Product_Presentation":null,"Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"12\/9\/1996","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2193","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"AbbVie Inc.","BLA_Number":"020725","Proprietary_Name":"Creon","Proper_Name":"pancrelipase","License_Type":"351(a)","Strength":"6,000USP UNITS; 19,000USP UNITS; 30,000USP UNITS","Dosage_Form":"Capsule, Delayed Release","Route_of_Administration":"Oral","Product_Presentation":null,"Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/30\/2009","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1889","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"AbbVie Inc.","BLA_Number":"020725","Proprietary_Name":"Creon","Proper_Name":"pancrelipase","License_Type":"351(a)","Strength":"12,000USP UNITS; 38,000USP UNITS; 60,000USP UNITS","Dosage_Form":"Capsule, Delayed Release","Route_of_Administration":"Oral","Product_Presentation":null,"Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/30\/2009","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1889","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"AbbVie Inc.","BLA_Number":"020725","Proprietary_Name":"Creon","Proper_Name":"pancrelipase","License_Type":"351(a)","Strength":"24,000USP UNITS; 76,000USP UNITS; 120,000USP UNITS","Dosage_Form":"Capsule, Delayed Release","Route_of_Administration":"Oral","Product_Presentation":null,"Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/30\/2009","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1889","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"AbbVie Inc.","BLA_Number":"020725","Proprietary_Name":"Creon","Proper_Name":"pancrelipase","License_Type":"351(a)","Strength":"3,000USP UNITS; 9,500USP UNITS; 15,000USP UNITS","Dosage_Form":"Capsule, Delayed Release","Route_of_Administration":"Oral","Product_Presentation":null,"Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/10\/2011","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"11","Submission_Type":"Supplement","License_Number":"1889","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"AbbVie Inc.","BLA_Number":"020725","Proprietary_Name":"Creon","Proper_Name":"pancrelipase","License_Type":"351(a)","Strength":"36,000USP UNITS; 114,000USP UNITS; 180,000USP UNITS","Dosage_Form":"Capsule, Delayed Release","Route_of_Administration":"Oral","Product_Presentation":null,"Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/14\/2013","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"16","Submission_Type":"Supplement","License_Number":"1889","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Digestive Care, Inc.","BLA_Number":"022175","Proprietary_Name":"Pertzye","Proper_Name":"pancrelipase","License_Type":"351(a)","Strength":"8,000USP UNITS; 28,750USP UNITS; 30,250USP UNITS","Dosage_Form":"Capsule, Delayed Release","Route_of_Administration":"Oral","Product_Presentation":null,"Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/17\/2012","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2184","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Digestive Care, Inc.","BLA_Number":"022175","Proprietary_Name":"Pertzye","Proper_Name":"pancrelipase","License_Type":"351(a)","Strength":"16,000USP UNITS; 57,500USP UNITS; 60,500USP UNITS","Dosage_Form":"Capsule, Delayed Release","Route_of_Administration":"Oral","Product_Presentation":null,"Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/17\/2012","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2184","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Digestive Care, Inc.","BLA_Number":"022175","Proprietary_Name":"Pertzye","Proper_Name":"pancrelipase","License_Type":"351(a)","Strength":"4,000USP UNITS; 14,375USP UNITS; 15,125USP UNITS","Dosage_Form":"Capsule, Delayed Release","Route_of_Administration":"Oral","Product_Presentation":null,"Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/6\/2016","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"3","Submission_Type":"Supplement","License_Number":"2184","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Digestive Care, Inc.","BLA_Number":"022175","Proprietary_Name":"Pertzye","Proper_Name":"pancrelipase","License_Type":"351(a)","Strength":"24,000USP UNITS; 86,250USP UNITS; 90,750USP UNITS","Dosage_Form":"Capsule, Delayed Release","Route_of_Administration":"Oral","Product_Presentation":null,"Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/13\/2017","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5","Submission_Type":"Supplement","License_Number":"2184","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Zenpep, LLC","BLA_Number":"022210","Proprietary_Name":"Zenpep","Proper_Name":"pancrelipase","License_Type":"351(a)","Strength":"5,000USP UNITS; 17,000USP UNITS; 24,000USP UNITS","Dosage_Form":"Capsule, Delayed Release","Route_of_Administration":"Oral","Product_Presentation":null,"Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/27\/2009","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2198","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Zenpep, LLC","BLA_Number":"022210","Proprietary_Name":"Zenpep","Proper_Name":"pancrelipase","License_Type":"351(a)","Strength":"10,000USP UNITS; 32,000USP UNITS; 42,000USP UNITS","Dosage_Form":"Capsule, Delayed Release","Route_of_Administration":"Oral","Product_Presentation":null,"Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/27\/2009","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2198","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Zenpep, LLC","BLA_Number":"022210","Proprietary_Name":"Zenpep","Proper_Name":"pancrelipase","License_Type":"351(a)","Strength":"15,000USP UNITS; 47,000USP UNITS; 63,000USP UNITS","Dosage_Form":"Capsule, Delayed Release","Route_of_Administration":"Oral","Product_Presentation":null,"Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/27\/2009","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2198","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Zenpep, LLC","BLA_Number":"022210","Proprietary_Name":"Zenpep","Proper_Name":"pancrelipase","License_Type":"351(a)","Strength":"20,000USP UNITS; 63,000USP UNITS; 84,000USP UNITS","Dosage_Form":"Capsule, Delayed Release","Route_of_Administration":"Oral","Product_Presentation":null,"Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/27\/2009","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2198","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Zenpep, LLC","BLA_Number":"022210","Proprietary_Name":"Zenpep","Proper_Name":"pancrelipase","License_Type":"351(a)","Strength":"3,000USP UNITS; 10,000USP UNITS; 14,000USP UNITS","Dosage_Form":"Capsule, Delayed Release","Route_of_Administration":"Oral","Product_Presentation":null,"Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/15\/2011","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"6","Submission_Type":"Supplement","License_Number":"2198","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Zenpep, LLC","BLA_Number":"022210","Proprietary_Name":"Zenpep","Proper_Name":"pancrelipase","License_Type":"351(a)","Strength":"25,000USP UNITS; 79,000USP UNITS; 105,000USP UNITS","Dosage_Form":"Capsule, Delayed Release","Route_of_Administration":"Oral","Product_Presentation":null,"Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/13\/2011","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5","Submission_Type":"Supplement","License_Number":"2198","Product_Number":"6","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Zenpep, LLC","BLA_Number":"022210","Proprietary_Name":"Zenpep","Proper_Name":"pancrelipase","License_Type":"351(a)","Strength":"40,000USP UNITS; 126,000USP UNITS; 168,000USP UNITS","Dosage_Form":"Capsule, Delayed Release","Route_of_Administration":"Oral","Product_Presentation":null,"Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/25\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"16","Submission_Type":"Supplement","License_Number":"2198","Product_Number":"7","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"VIVUS LLC","BLA_Number":"022523","Proprietary_Name":"Pancreaze","Proper_Name":"pancrelipase","License_Type":"351(a)","Strength":"4,200USP UNITS; 14,200USP UNITS; 24,600USP UNITS","Dosage_Form":"Capsule, Delayed Release","Route_of_Administration":"Oral","Product_Presentation":null,"Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/12\/2010","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2197","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"VIVUS LLC","BLA_Number":"022523","Proprietary_Name":"Pancreaze","Proper_Name":"pancrelipase","License_Type":"351(a)","Strength":"10,500USP UNITS; 35,500USP UNITS; 61,500USP UNITS","Dosage_Form":"Capsule, Delayed Release","Route_of_Administration":"Oral","Product_Presentation":null,"Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/12\/2010","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2197","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"VIVUS LLC","BLA_Number":"022523","Proprietary_Name":"Pancreaze","Proper_Name":"pancrelipase","License_Type":"351(a)","Strength":"16,800USP UNITS; 56,800USP UNITS; 98,400USP UNITS","Dosage_Form":"Capsule, Delayed Release","Route_of_Administration":"Oral","Product_Presentation":null,"Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/12\/2010","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2197","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"VIVUS LLC","BLA_Number":"022523","Proprietary_Name":"Pancreaze","Proper_Name":"pancrelipase","License_Type":"351(a)","Strength":"21,000USP UNITS; 54,700USP UNITS; 83,900USP UNITS","Dosage_Form":"Capsule, Delayed Release","Route_of_Administration":"Oral","Product_Presentation":null,"Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/12\/2010","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2197","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"VIVUS LLC","BLA_Number":"022523","Proprietary_Name":"Pancreaze","Proper_Name":"pancrelipase","License_Type":"351(a)","Strength":"2,600USP UNITS; 8,800USP UNITS; 15,200USP UNITS","Dosage_Form":"Capsule, Delayed Release","Route_of_Administration":"Oral","Product_Presentation":null,"Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/7\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"4","Submission_Type":"Supplement","License_Number":"2197","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"VIVUS LLC","BLA_Number":"022523","Proprietary_Name":"Pancreaze","Proper_Name":"pancrelipase","License_Type":"351(a)","Strength":"37,000USP UNITS; 97,300USP UNITS; 149,900USP UNITS","Dosage_Form":"Capsule, Delayed Release","Route_of_Administration":"Oral","Product_Presentation":null,"Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/26\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"16","Submission_Type":"Supplement","License_Number":"2197","Product_Number":"6","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Viokace, LLC","BLA_Number":"022542","Proprietary_Name":"Viokace","Proper_Name":"pancrelipase","License_Type":"351(a)","Strength":"10,440USP UNITS; 39,150USP UNITS; 39,150USP UNITS","Dosage_Form":"Tablet","Route_of_Administration":"Oral","Product_Presentation":null,"Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/1\/2012","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2196","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Viokace, LLC","BLA_Number":"022542","Proprietary_Name":"Viokace","Proper_Name":"pancrelipase","License_Type":"351(a)","Strength":"20,880USP UNITS; 78,300USP UNITS; 78,300USP UNITS","Dosage_Form":"Tablet","Route_of_Administration":"Oral","Product_Presentation":null,"Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/1\/2012","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2196","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Leadiant Biosciences, Inc","BLA_Number":"019818","Proprietary_Name":"Adagen","Proper_Name":"pegademase bovine","License_Type":"351(a)","Strength":"375UNITS\/1.5ML (250UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"3\/21\/1990","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2073","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/21\/1997"},{"N\/R\/U":null,"Applicant":"Pharmacia & Upjohn Company LLC","BLA_Number":"021106","Proprietary_Name":"Somavert","Proper_Name":"pegvisomant","License_Type":"351(a)","Strength":"10MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/25\/2003","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1216","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/25\/2010"},{"N\/R\/U":null,"Applicant":"Pharmacia & Upjohn Company LLC","BLA_Number":"021106","Proprietary_Name":"Somavert","Proper_Name":"pegvisomant","License_Type":"351(a)","Strength":"15MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/25\/2003","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1216","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/25\/2010"},{"N\/R\/U":null,"Applicant":"Pharmacia & Upjohn Company LLC","BLA_Number":"021106","Proprietary_Name":"Somavert","Proper_Name":"pegvisomant","License_Type":"351(a)","Strength":"20MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/25\/2003","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1216","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/25\/2010"},{"N\/R\/U":null,"Applicant":"Pharmacia & Upjohn Company LLC","BLA_Number":"021106","Proprietary_Name":"Somavert","Proper_Name":"pegvisomant","License_Type":"351(a)","Strength":"25MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/31\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"44","Submission_Type":"Supplement","License_Number":"1216","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/25\/2010"},{"N\/R\/U":null,"Applicant":"Pharmacia & Upjohn Company LLC","BLA_Number":"021106","Proprietary_Name":"Somavert","Proper_Name":"pegvisomant","License_Type":"351(a)","Strength":"30MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/31\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"44","Submission_Type":"Supplement","License_Number":"1216","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/25\/2010"},{"N\/R\/U":null,"Applicant":"Chiesi USA, Inc.","BLA_Number":"020744","Proprietary_Name":"Curosurf","Proper_Name":"poractant alfa","License_Type":"351(a)","Strength":"120MG\/1.5ML (80MG\/ML)","Dosage_Form":"Suspension","Route_of_Administration":"Intratracheal","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/18\/1999","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2150","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Chiesi USA, Inc.","BLA_Number":"020744","Proprietary_Name":"Curosurf","Proper_Name":"poractant alfa","License_Type":"351(a)","Strength":"240MG\/3ML (80MG\/ML)","Dosage_Form":"Suspension","Route_of_Administration":"Intratracheal","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/18\/1999","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2150","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Pharmalucence Inc","BLA_Number":"018263","Proprietary_Name":"Microlite","Proper_Name":"radiolabeled albumin technetium Tc-99m albumin colloid kit","License_Type":"351(a)","Strength":null,"Dosage_Form":null,"Route_of_Administration":null,"Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"3\/25\/1983","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2203","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"019938","Proprietary_Name":"Novolin R","Proper_Name":"insulin human","License_Type":"351(a)","Strength":"1,000UNITS\/10ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"OTC","Licensure":"Licensed","Approval_Date":"6\/25\/1991","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1261","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"019938","Proprietary_Name":"Novolin R","Proper_Name":"insulin human","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"OTC","Licensure":"Licensed","Approval_Date":"6\/1\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"76","Submission_Type":"Supplement","License_Number":"1261","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"QOL Medical, LLC","BLA_Number":"020772","Proprietary_Name":"Sucraid","Proper_Name":"sacrosidase","License_Type":"351(a)","Strength":"1,003,000IU\/118ML (8,500IU\/ML)","Dosage_Form":"Solution For Oral","Route_of_Administration":"Oral","Product_Presentation":"Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/9\/1998","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2195","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"4\/9\/2005"},{"N\/R\/U":null,"Applicant":"QOL Medical, LLC","BLA_Number":"020772","Proprietary_Name":"Sucraid","Proper_Name":"sacrosidase","License_Type":"351(a)","Strength":"17,000IU\/2ML (8,500IU\/ML)","Dosage_Form":"Solution For Oral","Route_of_Administration":"Oral","Product_Presentation":null,"Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/25\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"27","Submission_Type":"Supplement","License_Number":"2195","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"4\/9\/2005"},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"019640","Proprietary_Name":"Humatrope","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"2MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/23\/1987","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"1","Submission_Type":"Supplement","License_Number":"1891","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/1\/2013"},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"019640","Proprietary_Name":"Humatrope","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"5MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"10\/16\/1986","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/1\/2013"},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"019640","Proprietary_Name":"Humatrope","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"6MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/4\/1999","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"22","Submission_Type":"Supplement","License_Number":"1891","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/1\/2013"},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"019640","Proprietary_Name":"Humatrope","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"12MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/4\/1999","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"22","Submission_Type":"Supplement","License_Number":"1891","Product_Number":"6","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/1\/2013"},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"019640","Proprietary_Name":"Humatrope","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"24MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/4\/1999","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"22","Submission_Type":"Supplement","License_Number":"1891","Product_Number":"7","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/1\/2013"},{"N\/R\/U":null,"Applicant":"EMD Serono, Inc.","BLA_Number":"019764","Proprietary_Name":"Saizen","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"6MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"10\/8\/1996","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1773","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"EMD Serono, Inc.","BLA_Number":"019764","Proprietary_Name":"Saizen","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"5MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"10\/8\/1996","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1773","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"EMD Serono, Inc.","BLA_Number":"019764","Proprietary_Name":"Saizen","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"8.8MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"8\/29\/2000","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"3","Submission_Type":"Supplement","License_Number":"1773","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"EMD Serono, Inc.","BLA_Number":"019764","Proprietary_Name":"Saizen","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"4MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"1\/16\/2007","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"30","Submission_Type":"Supplement","License_Number":"1773","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Ferring Pharmaceuticals Inc.","BLA_Number":"019774","Proprietary_Name":"Zomacton","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"4.8MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"5\/25\/1995","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2112","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Ferring Pharmaceuticals Inc.","BLA_Number":"019774","Proprietary_Name":"Zomacton","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"5MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/4\/2002","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"8","Submission_Type":"Supplement","License_Number":"2112","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Ferring Pharmaceuticals Inc.","BLA_Number":"019774","Proprietary_Name":"Zomacton","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"10MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/7\/2012","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"25","Submission_Type":"Supplement","License_Number":"2112","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"020168","Proprietary_Name":"Nutropin","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"5MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"11\/17\/1993","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/30\/2003"},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"020168","Proprietary_Name":"Nutropin","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"10MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"11\/17\/1993","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/30\/2003"},{"N\/R\/U":null,"Applicant":"Pharmacia & Upjohn Company LLC","BLA_Number":"020280","Proprietary_Name":"Genotropin","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"0.2MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/27\/1998","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"9","Submission_Type":"Supplement","License_Number":"1216","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/25\/2008"},{"N\/R\/U":null,"Applicant":"Pharmacia & Upjohn Company LLC","BLA_Number":"020280","Proprietary_Name":"Genotropin","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"0.4MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/27\/1998","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"9","Submission_Type":"Supplement","License_Number":"1216","Product_Number":"6","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/25\/2008"},{"N\/R\/U":null,"Applicant":"Pharmacia & Upjohn Company LLC","BLA_Number":"020280","Proprietary_Name":"Genotropin","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"0.6MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/27\/1998","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"9","Submission_Type":"Supplement","License_Number":"1216","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/25\/2008"},{"N\/R\/U":null,"Applicant":"Pharmacia & Upjohn Company LLC","BLA_Number":"020280","Proprietary_Name":"Genotropin","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"1.5MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"8\/24\/1995","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1216","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/25\/2008"},{"N\/R\/U":null,"Applicant":"Pharmacia & Upjohn Company LLC","BLA_Number":"020280","Proprietary_Name":"Genotropin","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"0.8MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/27\/1998","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"9","Submission_Type":"Supplement","License_Number":"1216","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/25\/2008"},{"N\/R\/U":null,"Applicant":"Pharmacia & Upjohn Company LLC","BLA_Number":"020280","Proprietary_Name":"Genotropin","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"5MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/24\/1995","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1216","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/25\/2008"},{"N\/R\/U":null,"Applicant":"Pharmacia & Upjohn Company LLC","BLA_Number":"020280","Proprietary_Name":"Genotropin","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"12MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/23\/1996","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"7","Submission_Type":"Supplement","License_Number":"1216","Product_Number":"7","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/25\/2008"},{"N\/R\/U":null,"Applicant":"Pharmacia & Upjohn Company LLC","BLA_Number":"020280","Proprietary_Name":"Genotropin","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"1MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/27\/1998","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"9","Submission_Type":"Supplement","License_Number":"1216","Product_Number":"8","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/25\/2008"},{"N\/R\/U":null,"Applicant":"Pharmacia & Upjohn Company LLC","BLA_Number":"020280","Proprietary_Name":"Genotropin","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"1.2MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/27\/1998","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"9","Submission_Type":"Supplement","License_Number":"1216","Product_Number":"9","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/25\/2008"},{"N\/R\/U":null,"Applicant":"Pharmacia & Upjohn Company LLC","BLA_Number":"020280","Proprietary_Name":"Genotropin","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"1.4MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/27\/1998","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"9","Submission_Type":"Supplement","License_Number":"1216","Product_Number":"10","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/25\/2008"},{"N\/R\/U":null,"Applicant":"Pharmacia & Upjohn Company LLC","BLA_Number":"020280","Proprietary_Name":"Genotropin","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"1.6MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/27\/1998","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"9","Submission_Type":"Supplement","License_Number":"1216","Product_Number":"11","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/25\/2008"},{"N\/R\/U":null,"Applicant":"Pharmacia & Upjohn Company LLC","BLA_Number":"020280","Proprietary_Name":"Genotropin","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"1.8MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/27\/1998","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"9","Submission_Type":"Supplement","License_Number":"1216","Product_Number":"12","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/25\/2008"},{"N\/R\/U":null,"Applicant":"Pharmacia & Upjohn Company LLC","BLA_Number":"020280","Proprietary_Name":"Genotropin","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"2MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/27\/1998","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"9","Submission_Type":"Supplement","License_Number":"1216","Product_Number":"13","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/25\/2008"},{"N\/R\/U":null,"Applicant":" Genentech, Inc.","BLA_Number":"020522","Proprietary_Name":"Nutropin AQ","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"10MG\/2ML ","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/29\/1995","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":" Genentech, Inc.","BLA_Number":"020522","Proprietary_Name":"Nutropin AQ","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"10MG\/2ML ","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Cartridge","Status":"Disc","Licensure":"Licensed","Approval_Date":"4\/22\/2002","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"17","Submission_Type":"Supplement","License_Number":"1048","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":" Genentech, Inc.","BLA_Number":"020522","Proprietary_Name":"Nutropin AQ","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"5MG\/2ML ","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/3\/2008","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"37","Submission_Type":"Supplement","License_Number":"1048","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":" Genentech, Inc.","BLA_Number":"020522","Proprietary_Name":"Nutropin AQ","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"20MG\/2ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/3\/2008","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"37","Submission_Type":"Supplement","License_Number":"1048","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":" Genentech, Inc.","BLA_Number":"020522","Proprietary_Name":"Nutropin AQ","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"10MG\/2ML ","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/3\/2008","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"36","Submission_Type":"Supplement","License_Number":"1048","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":" Genentech, Inc.","BLA_Number":"020522","Proprietary_Name":"Nutropin AQ","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"20MG\/2ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Cartridge","Status":"Disc","Licensure":"Licensed","Approval_Date":"1\/3\/2008","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"26","Submission_Type":"Supplement","License_Number":"1048","Product_Number":"6","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"EMD Serono, Inc.","BLA_Number":"020604","Proprietary_Name":"Serostim","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"6MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/23\/1996","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1773","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"8\/23\/2003"},{"N\/R\/U":null,"Applicant":"EMD Serono, Inc.","BLA_Number":"020604","Proprietary_Name":"Serostim","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"5MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/23\/1996","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1773","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"EMD Serono, Inc.","BLA_Number":"020604","Proprietary_Name":"Serostim","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"4MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/25\/1997","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"2","Submission_Type":"Supplement","License_Number":"1773","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"EMD Serono, Inc.","BLA_Number":"020604","Proprietary_Name":"Zorbtive\/Serostim","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"8.8MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"11\/19\/2001","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"19","Submission_Type":"Supplement","License_Number":"1773","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"EMD Serono, Inc.","BLA_Number":"020604","Proprietary_Name":"Serostim","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"6MG\/0.5ML ","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Cartridge","Status":"Disc","Licensure":"Licensed","Approval_Date":"2\/11\/2005","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"29","Submission_Type":"Supplement","License_Number":"1773","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"021148","Proprietary_Name":"Norditropin","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"5MG\/1.5ML ","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Cartridge","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/20\/2000","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1261","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/31\/2014"},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"021148","Proprietary_Name":"Norditropin","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"10MG\/1.5ML ","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Cartridge","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/20\/2000","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1261","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/31\/2014"},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"021148","Proprietary_Name":"Norditropin","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"15MG\/1.5ML ","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Cartridge","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/20\/2000","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1261","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/31\/2014"},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"021148","Proprietary_Name":"Norditropin","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"5MG\/1.5ML ","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"10\/1\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"6","Submission_Type":"Supplement","License_Number":"1261","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/31\/2014"},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"021148","Proprietary_Name":"Norditropin","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"10MG\/1.5ML ","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"10\/1\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"6","Submission_Type":"Supplement","License_Number":"1261","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/31\/2014"},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"021148","Proprietary_Name":"Norditropin","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"15MG\/1.5ML ","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"10\/1\/2004","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"6","Submission_Type":"Supplement","License_Number":"1261","Product_Number":"6","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/31\/2014"},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"021148","Proprietary_Name":"Norditropin","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"30MG\/3ML ","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"3\/10\/2009","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"25","Submission_Type":"Supplement","License_Number":"1261","Product_Number":"7","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/31\/2014"},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"021148","Proprietary_Name":"Norditropin","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"5MG\/1.5ML ","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/1\/2010","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"27","Submission_Type":"Supplement","License_Number":"1261","Product_Number":"8","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/31\/2014"},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"021148","Proprietary_Name":"Norditropin","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"10MG\/1.5ML ","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/1\/2010","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"27","Submission_Type":"Supplement","License_Number":"1261","Product_Number":"9","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/31\/2014"},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"021148","Proprietary_Name":"Norditropin","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"15MG\/1.5ML ","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/1\/2010","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"27","Submission_Type":"Supplement","License_Number":"1261","Product_Number":"10","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/31\/2014"},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"021148","Proprietary_Name":"Norditropin","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"30MG\/3ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/23\/2015","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"42","Submission_Type":"Supplement","License_Number":"1261","Product_Number":"11","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/31\/2014"},{"N\/R\/U":null,"Applicant":"Sandoz Inc.","BLA_Number":"021426","Proprietary_Name":"Omnitrope","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"5.8MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/30\/2006","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2003","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sandoz Inc.","BLA_Number":"021426","Proprietary_Name":"Omnitrope","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"1.5MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"5\/30\/2006","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2003","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sandoz Inc.","BLA_Number":"021426","Proprietary_Name":"Omnitrope","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"5MG\/1.5ML ","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/16\/2008","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"2","Submission_Type":"Supplement","License_Number":"2003","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sandoz Inc.","BLA_Number":"021426","Proprietary_Name":"Omnitrope","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"10MG\/1.5ML ","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/25\/2008","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"4","Submission_Type":"Supplement","License_Number":"2003","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Emergent Biosolutions Canada Inc.","BLA_Number":"021538","Proprietary_Name":"Accretropin","Proper_Name":"somatropin","License_Type":"351(a)","Strength":"5MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"1\/23\/2008","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2084","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Pfizer Inc.","BLA_Number":"022458","Proprietary_Name":"Elelyso","Proper_Name":"taliglucerase alfa","License_Type":"351(a)","Strength":"200UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/1\/2012","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2001","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Theratechnologies Inc.","BLA_Number":"022505","Proprietary_Name":"Egrifta","Proper_Name":"tesamorelin acetate","License_Type":"351(a)","Strength":"1MG ","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"11\/10\/2010","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2091","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Theratechnologies Inc.","BLA_Number":"022505","Proprietary_Name":"Egrifta SV","Proper_Name":"tesamorelin acetate","License_Type":"351(a)","Strength":"2MG ","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/29\/2011","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"1","Submission_Type":"Supplement","License_Number":"2091","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genzyme Corporation","BLA_Number":"020898","Proprietary_Name":"Thyrogen","Proper_Name":"thyrotropin alfa","License_Type":"351(a)","Strength":"0.9MG","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/30\/1998","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1596","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/14\/2014"},{"N\/R\/U":null,"Applicant":"Ferring Pharmaceuticals Inc.","BLA_Number":"021289","Proprietary_Name":"Bravelle","Proper_Name":"urofollitropin","License_Type":"351(a)","Strength":"75IU ","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous, Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"5\/6\/2002","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2112","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Microbix Biosystems Inc.","BLA_Number":"021846","Proprietary_Name":"Kinlytic","Proper_Name":"urokinase","License_Type":"351(a)","Strength":"250,000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"1\/16\/1978","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2191","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Microbix Biosystems Inc.","BLA_Number":"021846","Proprietary_Name":"Kinlytic","Proper_Name":"urokinase","License_Type":"351(a)","Strength":"9,000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"1\/16\/1978","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2191","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Microbix Biosystems Inc.","BLA_Number":"021846","Proprietary_Name":"Kinlytic","Proper_Name":"urokinase","License_Type":"351(a)","Strength":"5,000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"1\/16\/1978","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2191","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"022575","Proprietary_Name":"VPRIV","Proper_Name":"velaglucerase alfa","License_Type":"351(a)","Strength":"400UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/26\/2010","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1898","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"022575","Proprietary_Name":"VPRIV","Proper_Name":"velaglucerase alfa","License_Type":"351(a)","Strength":"200UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"2\/26\/2010","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1898","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"761109","Proprietary_Name":"Lyumjev","Proper_Name":"insulin lispro-aabc","License_Type":"351(a)","Strength":"1,000UNITS\/10ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/15\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"761109","Proprietary_Name":"Lyumjev","Proper_Name":"insulin lispro-aabc","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/15\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"761109","Proprietary_Name":"Lyumjev","Proper_Name":"insulin lispro-aabc","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/15\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"761109","Proprietary_Name":"Lyumjev","Proper_Name":"insulin lispro-aabc","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/15\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"761109","Proprietary_Name":"Lyumjev","Proper_Name":"insulin lispro-aabc","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Multi-Dose Cartridge","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/15\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"761109","Proprietary_Name":"Lyumjev","Proper_Name":"insulin lispro-aabc","License_Type":"351(a)","Strength":"600UNITS\/3ML (200UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/15\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"6","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Hospira Inc., a Pfizer Company","BLA_Number":"761111","Proprietary_Name":"Nyvepria","Proper_Name":"pegfilgrastim-apgf","License_Type":"351(k) Biosimilar","Strength":"6MG\/0.6ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/10\/2020","Ref._Product_Proper_Name":"pegfilgrastim","Ref._Product_Proprietary_Name":"Neulasta","Supplement_Number":null,"Submission_Type":"Original","License_Number":"1974","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Mylan Pharmaceuticals Inc.","BLA_Number":"761154","Proprietary_Name":"Hulio","Proper_Name":"adalimumab-fkjp","License_Type":"351(k) Biosimilar","Strength":"40MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/6\/2020","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2210","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Mylan Pharmaceuticals Inc.","BLA_Number":"761154","Proprietary_Name":"Hulio","Proper_Name":"adalimumab-fkjp","License_Type":"351(k) Biosimilar","Strength":"40MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/6\/2020","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2210","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Mylan Pharmaceuticals Inc.","BLA_Number":"761154","Proprietary_Name":"Hulio","Proper_Name":"adalimumab-fkjp","License_Type":"351(k) Biosimilar","Strength":"20MG\/0.4ML ","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/6\/2020","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2210","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Mylan Pharmaceuticals Inc.","BLA_Number":"210605","Proprietary_Name":"Semglee","Proper_Name":"insulin glargine","License_Type":"351(a)","Strength":"1,000UNITS\/10ML (100 UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/11\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2210","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Mylan Pharmaceuticals Inc.","BLA_Number":"210605","Proprietary_Name":"Semglee","Proper_Name":"insulin glargine","License_Type":"351(a)","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/11\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2210","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Horizon Therapeutics Ireland DAC","BLA_Number":"761142","Proprietary_Name":"Uplizna","Proper_Name":"inebilizumab-cdon","License_Type":"351(a)","Strength":"100MG\/10ML (10MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/11\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2022","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/11\/2027"},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"761170","Proprietary_Name":"Phesgo","Proper_Name":"pertuzumab, trastuzumab, and hyaluronidase-zzxf","License_Type":"351(a)","Strength":"1,200MG, 600MG, 30,000UNITS\/15ML (80MG, 40MG, 2,000UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/29\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"761170","Proprietary_Name":"Phesgo","Proper_Name":"pertuzumab, trastuzumab, and hyaluronidase-zzxf","License_Type":"351(a)","Strength":"600MG, 600MG, 20,000UNITS\/10ML (60MG, 60MG, 2,000UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/29\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Endo Global Aesthetics Limited","BLA_Number":"761146","Proprietary_Name":"Qwo","Proper_Name":"collagenase clostridium histolyticum-aaes","License_Type":"351(a)","Strength":".92MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/6\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2136","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Endo Global Aesthetics Limited","BLA_Number":"761146","Proprietary_Name":"Qwo","Proper_Name":"collagenase clostridium histolyticum-aaes","License_Type":"351(a)","Strength":"1.84MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/6\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2136","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103949","Proprietary_Name":"Sylatron","Proper_Name":"peginterferon alfa-2b","License_Type":"351(a)","Strength":"200MCG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"3\/29\/2011","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5153","Submission_Type":"Supplement","License_Number":"2","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103949","Proprietary_Name":"Sylatron","Proper_Name":"peginterferon alfa-2b","License_Type":"351(a)","Strength":"300MCG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"3\/29\/2011","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5153","Submission_Type":"Supplement","License_Number":"2","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103949","Proprietary_Name":"Sylatron","Proper_Name":"peginterferon alfa-2b","License_Type":"351(a)","Strength":"600MCG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"3\/29\/2011","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5153","Submission_Type":"Supplement","License_Number":"2","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"MorphoSys US Inc.","BLA_Number":"761163","Proprietary_Name":"Monjuvi","Proper_Name":"tafasitamab-cxix","License_Type":"351(a)","Strength":"200MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/31\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2152","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/31\/2027"},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline Intellectual Property Development Ltd. England","BLA_Number":"761158","Proprietary_Name":"Blenrep","Proper_Name":"belantamab mafodotin-blmf","License_Type":"351(a)","Strength":"100MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"8\/5\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2148","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"8\/5\/2027"},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"761149","Proprietary_Name":"Enspryng","Proper_Name":"satralizumab-mwge","License_Type":"351(a)","Strength":"120MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/14\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"8\/14\/2027"},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"761156","Proprietary_Name":"Sogroya","Proper_Name":"somapacitan-beco","License_Type":"351(a)","Strength":"10MG\/1.5ML (6.7MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/28\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1261","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"761156","Proprietary_Name":"Sogroya","Proper_Name":"somapacitan-beco","License_Type":"351(a)","Strength":"5MG\/1.5ML (3.3MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/1\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"1","Submission_Type":"Supplement","License_Number":"1261","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"761156","Proprietary_Name":"Sogroya","Proper_Name":"somapacitan-beco","License_Type":"351(a)","Strength":"15MG\/1.5ML (10MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/28\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5","Submission_Type":"Supplement","License_Number":"1261","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Regeneron Pharmaceuticals, Inc.","BLA_Number":"761169","Proprietary_Name":"Inmazeb","Proper_Name":"atoltivimab, maftivimab, and odesivimab-ebgn","License_Type":"351(a)","Strength":"241.7MG, 241.7MG, 241.7MG\/14.5ML (16.67MG, 16.67MG, 16.67MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/14\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1760","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"10\/14\/2027"},{"N\/R\/U":null,"Applicant":"Regeneron Pharmaceuticals, Inc.","BLA_Number":"761169","Proprietary_Name":"Inmazeb","Proper_Name":"atoltivimab, maftivimab, and odesivimab-ebgn","License_Type":"351(a)","Strength":"483.3MG, 483.3MG, 483.3MG\/14.5ML (33.33MG, 33.33MG, 33.33MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"2","Submission_Type":"Supplement","License_Number":"1760","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"10\/14\/2027"},{"N\/R\/U":null,"Applicant":"Y-mABs Therapeutics, Inc","BLA_Number":"761171","Proprietary_Name":"Danyelza","Proper_Name":"naxitamab-gqgk","License_Type":"351(a)","Strength":"40MG\/10ML (4MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/25\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2209","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/25\/2027"},{"N\/R\/U":null,"Applicant":"MacroGenics Inc.","BLA_Number":"761150","Proprietary_Name":"Margenza","Proper_Name":"margetuximab-cmkb","License_Type":"351(a)","Strength":"250MG\/10ML (25MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/16\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2139","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"761140","Proprietary_Name":"Riabni","Proper_Name":"rituximab-arrx","License_Type":"351(k) Biosimilar","Strength":"100MG\/10ML (10MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/17\/2020","Ref._Product_Proper_Name":"rituximab","Ref._Product_Proprietary_Name":"Rituxan","Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"761140","Proprietary_Name":"Riabni","Proper_Name":"rituximab-arrx","License_Type":"351(k) Biosimilar","Strength":"500MG\/50ML (10MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/17\/2020","Ref._Product_Proper_Name":"rituximab","Ref._Product_Proprietary_Name":"Rituxan","Supplement_Number":null,"Submission_Type":"Original","License_Number":"1080","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Emergent Manufacturing Operations Baltimore LLC","BLA_Number":"761172","Proprietary_Name":"Ebanga","Proper_Name":"ansuvimab-zykl","License_Type":"351(a)","Strength":"400MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/21\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2083","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/21\/2027"},{"N\/R\/U":null,"Applicant":"Regeneron Pharmaceuticals, Inc.","BLA_Number":"761181","Proprietary_Name":"Evkeeza","Proper_Name":"evinacumab-dgnb","License_Type":"351(a)","Strength":"345MG\/2.3ML (150MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/11\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1760","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/21\/2030"},{"N\/R\/U":null,"Applicant":"Regeneron Pharmaceuticals, Inc.","BLA_Number":"761181","Proprietary_Name":"Evkeeza","Proper_Name":"evinacumab-dgnb","License_Type":"351(a)","Strength":"1,200MG\/8ML (150MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/11\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1760","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/21\/2030"},{"N\/R\/U":null,"Applicant":"ADC Therapeutics SA","BLA_Number":"761196","Proprietary_Name":"Zynlonta","Proper_Name":"loncastuximab tesirine-lpyl","License_Type":"351(a)","Strength":"10MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/23\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2166","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"4\/23\/2028"},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline LLC","BLA_Number":"761174","Proprietary_Name":"Jemperli","Proper_Name":"dostarlimab-gxly","License_Type":"351(a)","Strength":"500MG\/10ML (50MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/22\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1727","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Janssen Biotech, Inc.","BLA_Number":"761210","Proprietary_Name":"Rybrevant","Proper_Name":"amivantamab-vmjw","License_Type":"351(a)","Strength":"350MG\/7ML (50MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/21\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1864","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Biogen Inc.","BLA_Number":"761178","Proprietary_Name":"Aduhelm","Proper_Name":"aducanumab-avwa","License_Type":"351(a)","Strength":"170MG\/1.7ML (100MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/7\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1697","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Biogen Inc.","BLA_Number":"761178","Proprietary_Name":"Aduhelm","Proper_Name":"aducanumab-avwa","License_Type":"351(a)","Strength":"300MG\/3ML (100MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/7\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1697","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jazz Pharmaceuticals Ireland Limited","BLA_Number":"761179","Proprietary_Name":"Rylaze","Proper_Name":"asparaginase erwinia chrysanthemi (recombinant)-rywn","License_Type":"351(a)","Strength":"10MG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/30\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2167","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"AstraZeneca AB","BLA_Number":"761123","Proprietary_Name":"Saphnelo","Proper_Name":"anifrolumab-fnia","License_Type":"351(a)","Strength":"300MG\/2ML (150MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/30\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2059","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genzyme Corporation","BLA_Number":"761194","Proprietary_Name":"Nexviazyme","Proper_Name":"avalglucosidase alfa-ngpt","License_Type":"351(a)","Strength":"100MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/6\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1596","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Lundbeck Seattle BioPharmaceuticals, Inc.","BLA_Number":"761119","Proprietary_Name":"Vyepti","Proper_Name":"eptinezumab-jjmr","License_Type":"351(a)","Strength":"100MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/21\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2097","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Ascendis Pharma Endocrinology Division A\/S","BLA_Number":"761177","Proprietary_Name":"Skytrofa","Proper_Name":"lonapegsomatropin-tcgd","License_Type":"351(a)","Strength":"3MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/25\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2165","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Ascendis Pharma Endocrinology Division A\/S","BLA_Number":"761177","Proprietary_Name":"Skytrofa","Proper_Name":"lonapegsomatropin-tcgd","License_Type":"351(a)","Strength":"3.6MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/25\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2165","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Ascendis Pharma Endocrinology Division A\/S","BLA_Number":"761177","Proprietary_Name":"Skytrofa","Proper_Name":"lonapegsomatropin-tcgd","License_Type":"351(a)","Strength":"4.3MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/25\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2165","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Ascendis Pharma Endocrinology Division A\/S","BLA_Number":"761177","Proprietary_Name":"Skytrofa","Proper_Name":"lonapegsomatropin-tcgd","License_Type":"351(a)","Strength":"5.2MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/25\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2165","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Ascendis Pharma Endocrinology Division A\/S","BLA_Number":"761177","Proprietary_Name":"Skytrofa","Proper_Name":"lonapegsomatropin-tcgd","License_Type":"351(a)","Strength":"6.3MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/25\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2165","Product_Number":"5","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Ascendis Pharma Endocrinology Division A\/S","BLA_Number":"761177","Proprietary_Name":"Skytrofa","Proper_Name":"lonapegsomatropin-tcgd","License_Type":"351(a)","Strength":"7.6MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/25\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2165","Product_Number":"6","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Ascendis Pharma Endocrinology Division A\/S","BLA_Number":"761177","Proprietary_Name":"Skytrofa","Proper_Name":"lonapegsomatropin-tcgd","License_Type":"351(a)","Strength":"9.1MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/25\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2165","Product_Number":"7","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Ascendis Pharma Endocrinology Division A\/S","BLA_Number":"761177","Proprietary_Name":"Skytrofa","Proper_Name":"lonapegsomatropin-tcgd","License_Type":"351(a)","Strength":"11MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/25\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2165","Product_Number":"8","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Ascendis Pharma Endocrinology Division A\/S","BLA_Number":"761177","Proprietary_Name":"Skytrofa","Proper_Name":"lonapegsomatropin-tcgd","License_Type":"351(a)","Strength":"13.3MG","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Cartridge","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/25\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2165","Product_Number":"9","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Samsung Bioepis Co., Ltd.","BLA_Number":"761202","Proprietary_Name":"Byooviz","Proper_Name":"ranibizumab-nuna","License_Type":"351(k) Biosimilar","Strength":"10MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravitreal","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/17\/2021","Ref._Product_Proper_Name":"ranibizumab","Ref._Product_Proprietary_Name":"Lucentis","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2046","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Seagen Inc.","BLA_Number":"761208","Proprietary_Name":"Tivdak","Proper_Name":"tisotumab vedotin-tftv","License_Type":"351(a)","Strength":"40MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/20\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2257","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"AllerQuest, LLC","BLA_Number":"050114","Proprietary_Name":"Pre-Pen","Proper_Name":"benzylpenicilloyl polylysine","License_Type":"351(a)","Strength":"0.25ML","Dosage_Form":"Injection ","Route_of_Administration":"Intradermal","Product_Presentation":"Ampule","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/25\/1974","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2265","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"761197","Proprietary_Name":"Susvimo","Proper_Name":"ranibizumab","License_Type":"351(a)","Strength":"100MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravitreal","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/22\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"PharmaEssentia Corporation","BLA_Number":"761166","Proprietary_Name":"Besremi","Proper_Name":"ropeginterferon alfa-2b-njft","License_Type":"351(a)","Strength":"500MCG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/12\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2155","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/12\/2028"},{"N\/R\/U":null,"Applicant":"AstraZeneca AB","BLA_Number":"761224","Proprietary_Name":"Tezspire","Proper_Name":"tezepelumab-ekko","License_Type":"351(a)","Strength":"210MG\/1.91ML (110MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/17\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2059","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"AstraZeneca AB","BLA_Number":"761224","Proprietary_Name":"Tezspire","Proper_Name":"tezepelumab-ekko","License_Type":"351(a)","Strength":"210MG\/1.91ML (110MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/17\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2059","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"AstraZeneca AB","BLA_Number":"761224","Proprietary_Name":"Tezspire","Proper_Name":"tezepelumab-ekko","License_Type":"351(a)","Strength":"210MG\/1.91ML (110MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/1\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"1","Submission_Type":"Supplement","License_Number":"2059","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Argenx BV","BLA_Number":"761195","Proprietary_Name":"Vyvgart","Proper_Name":"efgartigimod alfa-fcab","License_Type":"351(a)","Strength":"400MG\/20ML (20MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/17\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2217","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/17\/2028"},{"N\/R\/U":null,"Applicant":"Eli Lilly and Company","BLA_Number":"761215","Proprietary_Name":"Rezvoglar","Proper_Name":"insulin glargine-aglr","License_Type":"351(k) Interchangeable","Strength":"300UNITS\/3ML (100UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/17\/2021","Ref._Product_Proper_Name":"insulin glargine","Ref._Product_Proprietary_Name":"Lantus","Supplement_Number":null,"Submission_Type":"Original","License_Number":"1891","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Coherus BioSciences, Inc.","BLA_Number":"761216","Proprietary_Name":"Yusimry","Proper_Name":"adalimumab-aqvh","License_Type":"351(k) Biosimilar","Strength":"40MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/17\/2021","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2023","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Coherus BioSciences, Inc.","BLA_Number":"761216","Proprietary_Name":"Yusimry","Proper_Name":"adalimumab-aqvh","License_Type":"351(k) Biosimilar","Strength":"40MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/27\/2023","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":"1","Submission_Type":"Supplement","License_Number":"2023","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"LEO Pharma A\/S","BLA_Number":"761180","Proprietary_Name":"Adbry","Proper_Name":"tralokinumab-ldrm","License_Type":"351(a)","Strength":"150MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/27\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2169","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Immunocore Limited","BLA_Number":"761228","Proprietary_Name":"Kimmtrak","Proper_Name":"tebentafusp-tebn","License_Type":"351(a)","Strength":"100MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/25\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2239","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"1\/25\/2029"},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"761235","Proprietary_Name":"Vabysmo","Proper_Name":"faricimab-svoa","License_Type":"351(a)","Strength":"120MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravitreal","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/28\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bioverativ Therapeutics, Inc.","BLA_Number":"761164","Proprietary_Name":"Enjaymo","Proper_Name":"sutimlimab-jome","License_Type":"351(a)","Strength":"1,100MG\/22ML (50MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/4\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2078","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/4\/2029"},{"N\/R\/U":null,"Applicant":"Kashiv BioSciences, LLC","BLA_Number":"761082","Proprietary_Name":"Releuko","Proper_Name":"filgrastim-ayow","License_Type":"351(k) Biosimilar","Strength":"300MCG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/25\/2022","Ref._Product_Proper_Name":"filgrastim","Ref._Product_Proprietary_Name":"Neupogen","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2131","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Kashiv BioSciences, LLC","BLA_Number":"761082","Proprietary_Name":"Releuko","Proper_Name":"filgrastim-ayow","License_Type":"351(k) Biosimilar","Strength":"480MCG\/1.6ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous ","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/25\/2022","Ref._Product_Proper_Name":"filgrastim","Ref._Product_Proprietary_Name":"Neupogen","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2131","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Kashiv BioSciences, LLC","BLA_Number":"761082","Proprietary_Name":"Releuko","Proper_Name":"filgrastim-ayow","License_Type":"351(k) Biosimilar","Strength":"300MCG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/25\/2022","Ref._Product_Proper_Name":"filgrastim","Ref._Product_Proprietary_Name":"Neupogen","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2131","Product_Number":"3","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Kashiv BioSciences, LLC","BLA_Number":"761082","Proprietary_Name":"Releuko","Proper_Name":"filgrastim-ayow","License_Type":"351(k) Biosimilar","Strength":"480MCG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/25\/2022","Ref._Product_Proper_Name":"filgrastim","Ref._Product_Proprietary_Name":"Neupogen","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2131","Product_Number":"4","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bristol-Myers Squibb Company","BLA_Number":"761234","Proprietary_Name":"Opdualag","Proper_Name":"nivolumab and relatlimab-rmbw","License_Type":"351(a)","Strength":"240MG, 80MG\/20ML (12MG, 4MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/18\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1713","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/18\/2029"},{"N\/R\/U":null,"Applicant":"Amneal Pharmaceuticals LLC","BLA_Number":"761231","Proprietary_Name":"Alymsys","Proper_Name":"bevacizumab-maly","License_Type":"351(k) Biosimilar","Strength":"100MG\/4ML (25MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/13\/2022","Ref._Product_Proper_Name":"bevacizumab","Ref._Product_Proprietary_Name":"Avastin","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2241","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Amneal Pharmaceuticals LLC","BLA_Number":"761231","Proprietary_Name":"Alymsys","Proper_Name":"bevacizumab-maly","License_Type":"351(k) Biosimilar","Strength":"400MG\/16ML (25MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/13\/2022","Ref._Product_Proper_Name":"bevacizumab","Ref._Product_Proprietary_Name":"Avastin","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2241","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Kashiv BioSciences, LLC","BLA_Number":"761084","Proprietary_Name":"Fylnetra","Proper_Name":"pegfilgrastim-pbbk","License_Type":"351(k) Biosimilar","Strength":"6MG\/0.6ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/26\/2022","Ref._Product_Proper_Name":"pegfilgrastim","Ref._Product_Proprietary_Name":"Neulasta","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2131","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Coherus BioSciences, Inc.","BLA_Number":"761165","Proprietary_Name":"Cimerli","Proper_Name":"ranibizumab-eqrn","License_Type":"351(k) Interchangeable","Strength":"10MG\/ML (0.5MG\/0.05ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravitreal","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/2\/2022","Ref._Product_Proper_Name":"ranibizumab","Ref._Product_Proprietary_Name":"Lucentis","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2023","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":"10\/3\/2023","Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Coherus BioSciences, Inc.","BLA_Number":"761165","Proprietary_Name":"Cimerli","Proper_Name":"ranibizumab-eqrn","License_Type":"351(k) Interchangeable","Strength":"6MG\/ML (0.3MG\/0.05ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravitreal","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/2\/2022","Ref._Product_Proper_Name":"ranibizumab","Ref._Product_Proprietary_Name":"Lucentis","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2023","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":"10\/3\/2023","Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genzyme Corporation","BLA_Number":"761261","Proprietary_Name":"Xenpozyme","Proper_Name":"olipudase alfa-rpcp","License_Type":"351(a)","Strength":"20MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/31\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1596","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"8\/31\/2029"},{"N\/R\/U":null,"Applicant":"Genzyme Corporation","BLA_Number":"761261","Proprietary_Name":"Xenpozyme","Proper_Name":"olipudase alfa-rpcp","License_Type":"351(a)","Strength":"4MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/31\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"1","Submission_Type":"Supplement","License_Number":"1596","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"8\/31\/2029"},{"N\/R\/U":null,"Applicant":"Fresenius Kabi USA, LLC","BLA_Number":"761173","Proprietary_Name":"Stimufend","Proper_Name":"pegfilgrastim-fpgk","License_Type":"351(k) Biosimilar","Strength":"6MG\/0.6ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/1\/2022","Ref._Product_Proper_Name":"pegfilgrastim","Ref._Product_Proprietary_Name":"Neulasta","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2146","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Boehringer Ingelheim Pharmaceuticals, Inc.","BLA_Number":"761244","Proprietary_Name":"Spevigo","Proper_Name":"spesolimab-sbzo","License_Type":"351(a)","Strength":"450MG\/7.5ML (60MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/1\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2006","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/1\/2029"},{"N\/R\/U":null,"Applicant":"Revance Therapeutics, Inc.","BLA_Number":"761127","Proprietary_Name":"Daxxify","Proper_Name":"daxibotulinumtoxinA-lanm","License_Type":"351(a)","Strength":"50UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/7\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2101","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Revance Therapeutics, Inc.","BLA_Number":"761127","Proprietary_Name":"Daxxify","Proper_Name":"daxibotulinumtoxinA-lanm","License_Type":"351(a)","Strength":"100UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/7\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2101","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Spectrum Pharmaceuticals, Inc.","BLA_Number":"761148","Proprietary_Name":"Rolvedon","Proper_Name":"eflapegrastim-xnst","License_Type":"351(a)","Strength":"13.2MG\/0.6ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/9\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2312","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CELLTRION, Inc.","BLA_Number":"761268","Proprietary_Name":"Vegzelma","Proper_Name":"bevacizumab-adcd","License_Type":"351(k) Biosimilar","Strength":"100MG\/4ML (25MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/27\/2022","Ref._Product_Proper_Name":"bevacizumab","Ref._Product_Proprietary_Name":"Avastin","Supplement_Number":null,"Submission_Type":"Original","License_Number":"1996","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CELLTRION, Inc.","BLA_Number":"761268","Proprietary_Name":"Vegzelma","Proper_Name":"bevacizumab-adcd","License_Type":"351(k) Biosimilar","Strength":"400MG\/16ML (25MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/27\/2022","Ref._Product_Proper_Name":"bevacizumab","Ref._Product_Proprietary_Name":"Avastin","Supplement_Number":null,"Submission_Type":"Original","License_Number":"1996","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"AstraZeneca AB","BLA_Number":"761289","Proprietary_Name":"Imjudo","Proper_Name":"tremelimumab-actl","License_Type":"351(a)","Strength":"25MG\/1.25ML (20MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/21\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2059","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"10\/21\/2029"},{"N\/R\/U":null,"Applicant":"AstraZeneca AB","BLA_Number":"761289","Proprietary_Name":"Imjudo","Proper_Name":"tremelimumab-actl","License_Type":"351(a)","Strength":"300MG\/15ML (20MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/21\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2059","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"10\/21\/2029"},{"N\/R\/U":null,"Applicant":"Janssen Biotech, Inc.","BLA_Number":"761291","Proprietary_Name":"Tecvayli","Proper_Name":"teclistamab-cqyv","License_Type":"351(a)","Strength":"30MG\/3ML (10MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/25\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1864","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"10\/25\/2029"},{"N\/R\/U":null,"Applicant":"Janssen Biotech, Inc.","BLA_Number":"761291","Proprietary_Name":"Tecvayli","Proper_Name":"teclistamab-cqyv","License_Type":"351(a)","Strength":"153MG\/1.7ML (90MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/25\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1864","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"10\/25\/2029"},{"N\/R\/U":null,"Applicant":"ImmunoGen, Inc.","BLA_Number":"761310","Proprietary_Name":"Elahere","Proper_Name":"mirvetuximab soravtansine-gynx","License_Type":"351(a)","Strength":"100MG\/20ML (5MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/14\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2288","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/14\/2029"},{"N\/R\/U":null,"Applicant":"Provention Bio, Inc.","BLA_Number":"761183","Proprietary_Name":"Tzield","Proper_Name":"teplizumab-mzwv","License_Type":"351(a)","Strength":"2MG\/2ML (1MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/17\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2170","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Fresenius Kabi USA, LLC","BLA_Number":"761255","Proprietary_Name":"Idacio","Proper_Name":"adalimumab-aacf","License_Type":"351(k) Biosimilar","Strength":"40MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/13\/2022","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2146","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Fresenius Kabi USA, LLC","BLA_Number":"761255","Proprietary_Name":"Idacio","Proper_Name":"adalimumab-aacf","License_Type":"351(k) Biosimilar","Strength":"40MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/13\/2022","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":null,"Submission_Type":"Original","License_Number":"2146","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"761263","Proprietary_Name":"Lunsumio","Proper_Name":"mosunetuzumab-axgb","License_Type":"351(a)","Strength":"1MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/22\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/22\/2029"},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"761263","Proprietary_Name":"Lunsumio","Proper_Name":"mosunetuzumab-axgb","License_Type":"351(a)","Strength":"30MG\/30ML (1MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/22\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/22\/2029"},{"N\/R\/U":null,"Applicant":"TG Therapeutics, Inc.","BLA_Number":"761238","Proprietary_Name":"Briumvi","Proper_Name":"ublituximab-xiiy","License_Type":"351(a)","Strength":"150MG\/6ML (25MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/28\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2090","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"MediWound, Ltd.","BLA_Number":"761192","Proprietary_Name":"Nexobrid","Proper_Name":"anacaulase-bcdb","License_Type":"351(a)","Strength":"8.8% (1.94GM)","Dosage_Form":"For Topical Gel","Route_of_Administration":"Topical","Product_Presentation":"Single-Use Jar","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/28\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2215","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/28\/2029"},{"N\/R\/U":null,"Applicant":"MediWound, Ltd.","BLA_Number":"761192","Proprietary_Name":"Nexobrid","Proper_Name":"anacaulase-bcdb","License_Type":"351(a)","Strength":"8.8% (4.85GM)","Dosage_Form":"For Topical Gel","Route_of_Administration":"Topical","Product_Presentation":"Single-Use Jar","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/28\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2215","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/28\/2029"},{"N\/R\/U":null,"Applicant":"Eisai, Incorporated","BLA_Number":"761269","Proprietary_Name":"Leqembi","Proper_Name":"lecanemab-irmb","License_Type":"351(a)","Strength":"200MG\/2ML (100MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/6\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1862","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Eisai, Incorporated","BLA_Number":"761269","Proprietary_Name":"Leqembi","Proper_Name":"lecanemab-irmb","License_Type":"351(a)","Strength":"500MG\/5ML (100MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/6\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1862","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Chiesi Farmaceutici S.p.A.","BLA_Number":"761278","Proprietary_Name":"Lamzede","Proper_Name":"velmanase alfa-tycv","License_Type":"351(a)","Strength":"10MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/16\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2245","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/16\/2030"},{"N\/R\/U":null,"Applicant":"Incyte Corporation","BLA_Number":"761334","Proprietary_Name":"Zynyz","Proper_Name":"retifanlimab-dlwr","License_Type":"351(a)","Strength":"500MG\/20ML (25MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/22\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2228","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/22\/2030"},{"N\/R\/U":null,"Applicant":"Chiesi Farmaceutici S.p.A.","BLA_Number":"761161","Proprietary_Name":"Elfabrio","Proper_Name":"pegunigalsidase alfa-iwxj","License_Type":"351(a)","Strength":"20MG\/10ML (2MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/9\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2245","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genmab US, Inc.","BLA_Number":"761324","Proprietary_Name":"Epkinly","Proper_Name":"epcoritamab-bysp","License_Type":"351(a)","Strength":"4MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/19\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2293","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genmab US, Inc.","BLA_Number":"761324","Proprietary_Name":"Epkinly","Proper_Name":"epcoritamab-bysp","License_Type":"351(a)","Strength":"48MG\/0.8ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/19\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2293","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CELLTRION, Inc.","BLA_Number":"761219","Proprietary_Name":"Yuflyma","Proper_Name":"adalimumab-aaty","License_Type":"351(k) Biosimilar","Strength":"40MG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/23\/2023","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":null,"Submission_Type":"Original","License_Number":"1996","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CELLTRION, Inc.","BLA_Number":"761219","Proprietary_Name":"Yuflyma","Proper_Name":"adalimumab-aaty","License_Type":"351(k) Biosimilar","Strength":"40MG\/0.4ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/23\/2023","Ref._Product_Proper_Name":"adalimumab","Ref._Product_Proprietary_Name":"Humira","Supplement_Number":null,"Submission_Type":"Original","License_Number":"1996","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"761309","Proprietary_Name":"Columvi","Proper_Name":"glofitamab-gxbm","License_Type":"351(a)","Strength":"2.5MG\/2.5ML (1MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/15\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genentech, Inc.","BLA_Number":"761309","Proprietary_Name":"Columvi","Proper_Name":"glofitamab-gxbm","License_Type":"351(a)","Strength":"10MG\/10ML (1MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/15\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1048","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Argenx BV","BLA_Number":"761304","Proprietary_Name":"Vyvgart Hytrulo","Proper_Name":"efgartigimod alfa and hyaluronidase-qvfc","License_Type":"351(a)","Strength":"1,008MG\/5.6ML; 11,200UNITS\/5.6ML (180MG\/2,000UNITS\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/20\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2217","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"UCB, Inc.","BLA_Number":"761286","Proprietary_Name":"Rystiggo","Proper_Name":"rozanolixizumab-noli","License_Type":"351(a)","Strength":"280MG\/2ML (140MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/26\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1736","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Pfizer Ireland Pharmaceuticals","BLA_Number":"761184","Proprietary_Name":"Ngenla","Proper_Name":"somatrogon-ghla","License_Type":"351(a)","Strength":"24MG\/1.2ML (20MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/27\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2060","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Pfizer Ireland Pharmaceuticals","BLA_Number":"761184","Proprietary_Name":"Ngenla","Proper_Name":"somatrogon-ghla","License_Type":"351(a)","Strength":"60MG\/1.2ML (50MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Autoinjector","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/27\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2060","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"AstraZeneca AB","BLA_Number":"761328","Proprietary_Name":"Beyfortus","Proper_Name":"nirsevimab-alip","License_Type":"351(a)","Strength":"50MG\/0.5ML","Dosage_Form":"Injection ","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/17\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2059","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"N","Applicant":"Janssen Biotech, Inc.","BLA_Number":"761342","Proprietary_Name":"Talvey","Proper_Name":"talquetamab-tgvs","License_Type":"351(a)","Strength":"3MG\/1.5ML (2MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/9\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1864","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"N","Applicant":"Janssen Biotech, Inc.","BLA_Number":"761342","Proprietary_Name":"Talvey","Proper_Name":"talquetamab-tgvs","License_Type":"351(a)","Strength":"40MG\/ML","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/9\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1864","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"N","Applicant":"Pfizer Inc.","BLA_Number":"761345","Proprietary_Name":"Elrexfio","Proper_Name":"elranatamab-bcmm","License_Type":"351(a)","Strength":"76MG\/1.9ML (40MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/14\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2001","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"N","Applicant":"Pfizer Inc.","BLA_Number":"761345","Proprietary_Name":"Elrexfio","Proper_Name":"elranatamab-bcmm","License_Type":"351(a)","Strength":"44MG\/1.1ML (40MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/14\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"2001","Product_Number":"2","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"N","Applicant":"Regeneron Pharmaceuticals, Inc.","BLA_Number":"761339","Proprietary_Name":"Veopoz","Proper_Name":"pozelimab-bbfg","License_Type":"351(a)","Strength":"400MG\/2ML (200MG\/ML)","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous, Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/18\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1760","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"N","Applicant":"Regeneron Pharmaceuticals, Inc.","BLA_Number":"761355","Proprietary_Name":"Eylea HD","Proper_Name":"aflibercept","License_Type":"351(a)","Strength":"8MG\/0.07ML","Dosage_Form":"Injection ","Route_of_Administration":"Intravitreal","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/18\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":null,"Submission_Type":"Original","License_Number":"1760","Product_Number":"1","Center":"CDER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"101062","Proprietary_Name":null,"Proper_Name":"Antivenin (Latrodectus mactans)","License_Type":"351(a)","Strength":"NLT6000U","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/13\/1936","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"101062","Proprietary_Name":null,"Proper_Name":"Antivenin (Latrodectus mactans)","License_Type":"351(a)","Strength":"NLT6000U","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/13\/1936","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"101066","Proprietary_Name":"Recombivax, Recombivax Hb","Proper_Name":"Hepatitis B Vaccine (Recombinant)","License_Type":"351(a)","Strength":"10UG\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/23\/1986","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"101066","Proprietary_Name":"Recombivax, Recombivax Hb","Proper_Name":"Hepatitis B Vaccine (Recombinant)","License_Type":"351(a)","Strength":"40UG\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/23\/1986","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"101066","Proprietary_Name":"Recombivax, Recombivax Hb","Proper_Name":"Hepatitis B Vaccine (Recombinant)","License_Type":"351(a)","Strength":"5UG\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/23\/1986","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"101068","Proprietary_Name":"ATTENUVAX","Proper_Name":"Measles Virus Vaccine Live","License_Type":"351(a)","Strength":"NLT1000U\/.5ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"3\/21\/1963","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"2","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"101069","Proprietary_Name":"M-M-R Ii","Proper_Name":"Measles, Mumps and Rubella Virus Vaccine Live","License_Type":"351(a)","Strength":"0.5ML","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/27\/2023","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5846","Submission_Type":"Supplement","License_Number":"2","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"101069","Proprietary_Name":"M-M-R Ii","Proper_Name":"Measles, Mumps and Rubella Virus Vaccine Live","License_Type":"351(a)","Strength":"0.5ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/22\/1971","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"101072","Proprietary_Name":"MumpsVax","Proper_Name":"Mumps Virus Vaccine Live","License_Type":"351(a)","Strength":"0.5ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"12\/28\/1967","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"2","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"101075","Proprietary_Name":"MERUVAX II","Proper_Name":"Rubella Virus Vaccine Live","License_Type":"351(a)","Strength":"NLT1000U\/.5ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/9\/1969","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"2","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"101094","Proprietary_Name":"Pneumovax 23","Proper_Name":"Pneumococcal Vaccine, Polyvalent","License_Type":"351(a)","Strength":"25UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/21\/1977","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"101094","Proprietary_Name":"Pneumovax 23","Proper_Name":"Pneumococcal Vaccine, Polyvalent","License_Type":"351(a)","Strength":"25UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/21\/1977","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Wyeth Pharmaceuticals LLC","BLA_Number":"101098","Proprietary_Name":null,"Proper_Name":"Antivenin (Crotalidae) Polyvalent","License_Type":"351(a)","Strength":"10ML","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"2\/8\/1954","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"3","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Wyeth Pharmaceuticals LLC","BLA_Number":"101099","Proprietary_Name":null,"Proper_Name":"Antivenin (Micrurus fulvius)","License_Type":"351(a)","Strength":"10ML","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"8\/28\/1967","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"3","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"101130","Proprietary_Name":"Koate, Koate-Dvi","Proper_Name":"Antihemophilic Factor (Human)","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/24\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"101130","Proprietary_Name":"Koate, Koate-Dvi","Proper_Name":"Antihemophilic Factor (Human)","License_Type":"351(a)","Strength":"250IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/24\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"101130","Proprietary_Name":"Koate, Koate-Dvi","Proper_Name":"Antihemophilic Factor (Human)","License_Type":"351(a)","Strength":"1,000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/24\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"101134","Proprietary_Name":"Baygam, Gamastan S\/D","Proper_Name":"Immune Globulin (Human)","License_Type":"351(a)","Strength":"16.50%","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/11\/1944","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"101138","Proprietary_Name":"Albuked, Plasbumin-20, Plasbumin-25, Plasbumin-5","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"12.5G\/250ML","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/21\/1942","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"8","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"101138","Proprietary_Name":"Albuked, Plasbumin-20, Plasbumin-25, Plasbumin-5","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"25G\/500ML","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/21\/1942","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"7","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"101138","Proprietary_Name":"Albuked, Plasbumin-20, Plasbumin-25, Plasbumin-5","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"5G\/20ML","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/21\/1942","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"101138","Proprietary_Name":"Albuked, Plasbumin-20, Plasbumin-25, Plasbumin-5","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"12.5G\/50ML","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/21\/1942","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"101138","Proprietary_Name":"Albuked, Plasbumin-20, Plasbumin-25, Plasbumin-5","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"10G\/50ML","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/21\/1942","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"101138","Proprietary_Name":"Albuked, Plasbumin-20, Plasbumin-25, Plasbumin-5","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"20G\/100ML","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/21\/1942","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"101138","Proprietary_Name":"Albuked, Plasbumin-20, Plasbumin-25, Plasbumin-5","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"25G\/100ML","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/21\/1942","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"101138","Proprietary_Name":"Albuked, Plasbumin-20, Plasbumin-25, Plasbumin-5","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"2.5G\/50ML","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/21\/1942","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"101140","Proprietary_Name":"Plasmanate","Proper_Name":"Plasma Protein Fraction (Human)","License_Type":"351(a)","Strength":"12.5G\/250ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/2\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"101140","Proprietary_Name":"Plasmanate","Proper_Name":"Plasma Protein Fraction (Human)","License_Type":"351(a)","Strength":"2.5G\/50ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/2\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"101140","Proprietary_Name":"Plasmanate","Proper_Name":"Plasma Protein Fraction (Human)","License_Type":"351(a)","Strength":"25G\/500ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/2\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"101141","Proprietary_Name":"Bayrho-D, Hyprho-D, Hyperrho S\/D Full Dose, Hyperrho S\/D Mini-Dose","Proper_Name":"Rho(D) Immune Globulin (Human)","License_Type":"351(a)","Strength":"250IU","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/11\/1971","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"101141","Proprietary_Name":"Bayrho-D, Hyprho-D, Hyperrho S\/D Full Dose, Hyperrho S\/D Mini-Dose","Proper_Name":"Rho(D) Immune Globulin (Human)","License_Type":"351(a)","Strength":"1500IU","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/11\/1971","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"101142","Proprietary_Name":"Baytet, Hypertet","Proper_Name":"Tetanus Immune Globulin (Human)","License_Type":"351(a)","Strength":"250U","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/17\/1957","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"101144","Proprietary_Name":"Bayrab,Hyperrab","Proper_Name":"Rabies Immune Globulin (Human)","License_Type":"351(a)","Strength":"900 IU\/ 3ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/6\/2019","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5817","Submission_Type":"Supplement","License_Number":"1871","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"101144","Proprietary_Name":"Bayrab, Hyperrab","Proper_Name":"Rabies Immune Globulin (Human)","License_Type":"351(a)","Strength":"1500IU\/5 ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"101144","Proprietary_Name":"Bayrab, Hyperrab","Proper_Name":"Rabies Immune Globulin (Human)","License_Type":"351(a)","Strength":"300IU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"101146","Proprietary_Name":"Bayhep B, Hyperhep B S\/D","Proper_Name":"Hepatitis B Immune Globulin (Human)","License_Type":"351(a)","Strength":"220IU\/5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/23\/1977","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"101146","Proprietary_Name":"Bayhep B, Hyperhep B S\/D","Proper_Name":"Hepatitis B Immune Globulin (Human)","License_Type":"351(a)","Strength":"220U\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/23\/1977","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"101146","Proprietary_Name":"Bayhep B, Hyperhep B S\/D","Proper_Name":"Hepatitis B Immune Globulin (Human)","License_Type":"351(a)","Strength":"220U\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/23\/1977","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"101146","Proprietary_Name":"Bayhep B, Hyperhep B S\/D","Proper_Name":"Hepatitis B Immune Globulin (Human)","License_Type":"351(a)","Strength":"220U\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/23\/1977","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"101147","Proprietary_Name":"Gamimune","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"10PCT","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"9\/11\/1981","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"101147","Proprietary_Name":"Gamimune","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"5PCT","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"9\/11\/1981","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Recordati Rare Diseases, Inc.","BLA_Number":"101246","Proprietary_Name":"Panhematin","Proper_Name":"Hemin for Injection","License_Type":"351(a)","Strength":"350MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/20\/1983","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5350","Submission_Type":"Supplement","License_Number":"1899","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/20\/1990"},{"N\/R\/U":null,"Applicant":"MassBiologics","BLA_Number":"101322","Proprietary_Name":"Tdvax","Proper_Name":"Tetanus and Diphtheria Toxoids Adsorbed","License_Type":"351(a)","Strength":"0.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/27\/1970","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1779","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101377","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides farinae","License_Type":"351(a)","Strength":"10,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"7\/11\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101377","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides farinae","License_Type":"351(a)","Strength":"10,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"7\/11\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101378","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides pteronyssinus","License_Type":"351(a)","Strength":"10,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"7\/11\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101378","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides pteronyssinus","License_Type":"351(a)","Strength":"10,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"7\/11\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101379","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bermuda Grass Cynodon dactylon","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101379","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bermuda Grass Cynodon dactylon","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101380","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bluegrass, Kentucky (June) Poa pratensis","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101380","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bluegrass, Kentucky (June) Poa pratensis","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101380","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bluegrass, Kentucky (June) Poa pratensis","License_Type":"351(a)","Strength":"10,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101380","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bluegrass, Kentucky (June) Poa pratensis","License_Type":"351(a)","Strength":"10,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101381","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Fescue, Meadow Festuca elatior","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101381","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Fescue, Meadow Festuca elatior","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101381","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Fescue, Meadow Festuca elatior","License_Type":"351(a)","Strength":"10,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101381","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Fescue, Meadow Festuca elatior","License_Type":"351(a)","Strength":"10,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101382","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Orchard Grass Dactylis glomerata","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"5\/29\/1997","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101382","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Orchard Grass Dactylis glomerata","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101382","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Orchard Grass Dactylis glomerata","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101382","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Orchard Grass Dactylis glomerata","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101383","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Redtop Agrostis alba","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101383","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Redtop Agrostis alba","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101383","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Redtop Agrostis alba","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101383","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Redtop Agrostis alba","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101384","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Ryegrass, Perennial Lolium perenne","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/25\/1997","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101384","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Ryegrass, Perennial Lolium perenne","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101384","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Ryegrass, Perennial Lolium perenne","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101384","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Ryegrass, Perennial Lolium perenne","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101385","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Sweet Vernal Grass Anthoxanthum odoratum","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101385","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Sweet Vernal Grass Anthoxanthum odoratum","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101385","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Sweet Vernal Grass Anthoxanthum odoratum","License_Type":"351(a)","Strength":"10,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101385","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Sweet Vernal Grass Anthoxanthum odoratum","License_Type":"351(a)","Strength":"10,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101386","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Timothy Phleum pratense","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101386","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Timothy Phleum pratense","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101386","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Timothy Phleum pratense","License_Type":"351(a)","Strength":"10,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101386","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Timothy Phleum pratense","License_Type":"351(a)","Strength":"10,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101387","Proprietary_Name":null,"Proper_Name":"Pollens - Weeds and Garden Plants, Ragweed, Short Ambrosia artemisiifolia","License_Type":"351(a)","Strength":"1:10W\/V","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101387","Proprietary_Name":null,"Proper_Name":"Pollens - Weeds and Garden Plants, Ragweed, Short Ambrosia artemisiifolia","License_Type":"351(a)","Strength":"1:10W\/V","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"101387","Proprietary_Name":null,"Proper_Name":"Pollens - Weeds and Garden Plants, Ragweed, Short Ambrosia artemisiifolia","License_Type":"351(a)","Strength":"1:10W\/V","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"101447","Proprietary_Name":"Autoplex, Feiba Nf, Feiba Vh","Proper_Name":"Anti-Inhibitor Coagulant Complex","License_Type":"351(a)","Strength":"2500U","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/11\/2005","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5126","Submission_Type":"Supplement","License_Number":"1898","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/16\/2020"},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"101447","Proprietary_Name":"Autoplex, Feiba Nf, Feiba Vh","Proper_Name":"Anti-Inhibitor Coagulant Complex","License_Type":"351(a)","Strength":"500U","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/31\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"1029","Submission_Type":"Supplement","License_Number":"1898","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/16\/2020"},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"101447","Proprietary_Name":"Autoplex, Feiba Nf, Feiba Vh","Proper_Name":"Anti-Inhibitor Coagulant Complex","License_Type":"351(a)","Strength":"1000U","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/31\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"1029","Submission_Type":"Supplement","License_Number":"1898","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/16\/2020"},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"101447","Proprietary_Name":"Autoplex, Feiba Nf, Feiba Vh","Proper_Name":"Anti-Inhibitor Coagulant Complex","License_Type":"351(a)","Strength":"500IU ","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Bottle","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/21\/1979","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/16\/2020"},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"101447","Proprietary_Name":"Autoplex, Feiba Nf, Feiba Vh","Proper_Name":"Anti-Inhibitor Coagulant Complex","License_Type":"351(a)","Strength":"1000IU ","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Bottle","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/21\/1979","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/16\/2020"},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"101448","Proprietary_Name":"Hemofil M","Proper_Name":"Antihemophilic Factor (Human)","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/14\/2001","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"1062","Submission_Type":"Supplement","License_Number":"1898","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"101448","Proprietary_Name":"Hemofil M","Proper_Name":"Antihemophilic Factor (Human)","License_Type":"351(a)","Strength":"1700IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/14\/2001","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"1062","Submission_Type":"Supplement","License_Number":"1898","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"101448","Proprietary_Name":"Hemofil M","Proper_Name":"Antihemophilic Factor (Human)","License_Type":"351(a)","Strength":"1000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/14\/2001","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"1062","Submission_Type":"Supplement","License_Number":"1898","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"101448","Proprietary_Name":"Hemofil M","Proper_Name":"Antihemophilic Factor (Human)","License_Type":"351(a)","Strength":"250IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/14\/2001","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"1062","Submission_Type":"Supplement","License_Number":"1898","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"101452","Proprietary_Name":"Buminate, Flexbumin","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"12.5G\/250ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/3\/1954","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"101452","Proprietary_Name":"Buminate, Flexbumin","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"10G\/50ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/3\/1954","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"101452","Proprietary_Name":"Buminate, Flexbumin","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"12.5G\/50ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/3\/1954","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"101452","Proprietary_Name":"Buminate, Flexbumin","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"25G\/100ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/3\/1954","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"101452","Proprietary_Name":"Buminate, Flexbumin","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"20G\/100ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/3\/1954","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101834","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides farinae","License_Type":"351(a)","Strength":"30,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/15\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"7","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101834","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides farinae","License_Type":"351(a)","Strength":"30,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/15\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101834","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides farinae","License_Type":"351(a)","Strength":"10,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/15\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101834","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides farinae","License_Type":"351(a)","Strength":"10,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/15\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101834","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides farinae","License_Type":"351(a)","Strength":"5,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/15\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101834","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides farinae","License_Type":"351(a)","Strength":"5,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/15\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101834","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides farinae","License_Type":"351(a)","Strength":"10,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/15\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101835","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides pteronyssinus","License_Type":"351(a)","Strength":"30,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/15\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"7","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101835","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides pteronyssinus","License_Type":"351(a)","Strength":"30,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/15\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101835","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides pteronyssinus","License_Type":"351(a)","Strength":"10,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/15\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101835","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides pteronyssinus","License_Type":"351(a)","Strength":"10,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/15\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101835","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides pteronyssinus","License_Type":"351(a)","Strength":"5,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/15\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101835","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides pteronyssinus","License_Type":"351(a)","Strength":"5,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/15\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101835","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides pteronyssinus","License_Type":"351(a)","Strength":"10,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/15\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101836","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bermuda Grass Cynodon dactylon","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101836","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bermuda Grass Cynodon dactylon","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101836","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bermuda Grass Cynodon dactylon","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101836","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bermuda Grass Cynodon dactylon","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101836","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bermuda Grass Cynodon dactylon","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101836","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bermuda Grass Cynodon dactylon","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101837","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bluegrass, Kentucky (June) Poa pratensis","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101837","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bluegrass, Kentucky (June) Poa pratensis","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101837","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bluegrass, Kentucky (June) Poa pratensis","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101838","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Fescue, Meadow Festuca elatior","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101838","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Fescue, Meadow Festuca elatior","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101838","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Fescue, Meadow Festuca elatior","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101838","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Fescue, Meadow Festuca elatior","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101838","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Fescue, Meadow Festuca elatior","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101838","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Fescue, Meadow Festuca elatior","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101839","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Orchard Grass Dactylis glomerata","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101839","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Orchard Grass Dactylis glomerata","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101839","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Orchard Grass Dactylis glomerata","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101839","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Orchard Grass Dactylis glomerata","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101839","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Orchard Grass Dactylis glomerata","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101839","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Orchard Grass Dactylis glomerata","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101840","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Redtop Agrostis alba","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101840","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Redtop Agrostis alba","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101840","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Redtop Agrostis alba","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101840","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Redtop Agrostis alba","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101840","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Redtop Agrostis alba","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101840","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Redtop Agrostis alba","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101841","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Ryegrass, Perennial Lolium perenne","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101841","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Ryegrass, Perennial Lolium perenne","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101841","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Ryegrass, Perennial Lolium perenne","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101841","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Ryegrass, Perennial Lolium perenne","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101841","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Ryegrass, Perennial Lolium perenne","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101841","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Ryegrass, Perennial Lolium perenne","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101842","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Sweet Vernal Grass Anthoxanthum odoratum","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101842","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Sweet Vernal Grass Anthoxanthum odoratum","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101842","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Sweet Vernal Grass Anthoxanthum odoratum","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101842","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Sweet Vernal Grass Anthoxanthum odoratum","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101842","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Sweet Vernal Grass Anthoxanthum odoratum","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101842","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Sweet Vernal Grass Anthoxanthum odoratum","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101843","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Timothy Phleum pratense","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101843","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Timothy Phleum pratense","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101843","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Timothy Phleum pratense","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101843","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Timothy Phleum pratense","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101843","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Timothy Phleum pratense","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101843","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Timothy Phleum pratense","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101844","Proprietary_Name":null,"Proper_Name":"Pollens - Weeds and Garden Plants, Ragweed, Short Ambrosia artemisiifolia","License_Type":"351(a)","Strength":"1:20W\/V","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101844","Proprietary_Name":null,"Proper_Name":"Pollens - Weeds and Garden Plants, Ragweed, Short Ambrosia artemisiifolia","License_Type":"351(a)","Strength":"1:20W\/V","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101844","Proprietary_Name":null,"Proper_Name":"Pollens - Weeds and Garden Plants, Ragweed, Short Ambrosia artemisiifolia","License_Type":"351(a)","Strength":"1:20W\/V","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101845","Proprietary_Name":null,"Proper_Name":"Pollens - Weeds and Garden Plants, Ragweed, Short Ambrosia elatior","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/15\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101845","Proprietary_Name":null,"Proper_Name":"Pollens - Weeds and Garden Plants, Ragweed, Short Ambrosia elatior","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/15\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101845","Proprietary_Name":null,"Proper_Name":"Pollens - Weeds and Garden Plants, Ragweed, Short Ambrosia elatior","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/15\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101845","Proprietary_Name":null,"Proper_Name":"Pollens - Weeds and Garden Plants, Ragweed, Short Ambrosia elatior","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/15\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101845","Proprietary_Name":null,"Proper_Name":"Pollens - Weeds and Garden Plants, Ragweed, Short Ambrosia elatior","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/15\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"101845","Proprietary_Name":null,"Proper_Name":"Pollens - Weeds and Garden Plants, Ragweed, Short Ambrosia elatior","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/15\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Central Laboratory of the Netherlands Red Cross Blood Transfusion Service","BLA_Number":"101993","Proprietary_Name":null,"Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"25%","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/7\/1979","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"379","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102212","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides farinae","License_Type":"351(a)","Strength":"10,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"8","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102212","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides farinae","License_Type":"351(a)","Strength":"10,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"7","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102212","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides farinae","License_Type":"351(a)","Strength":"10,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102212","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides farinae","License_Type":"351(a)","Strength":"10,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102212","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides farinae","License_Type":"351(a)","Strength":"5,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102212","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides farinae","License_Type":"351(a)","Strength":"5,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102212","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides farinae","License_Type":"351(a)","Strength":"5,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102212","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides farinae","License_Type":"351(a)","Strength":"5,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102213","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides pteronyssinus","License_Type":"351(a)","Strength":"10,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"8","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102213","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides pteronyssinus","License_Type":"351(a)","Strength":"10,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"7","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102213","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides pteronyssinus","License_Type":"351(a)","Strength":"10,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102213","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides pteronyssinus","License_Type":"351(a)","Strength":"10,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102213","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides pteronyssinus","License_Type":"351(a)","Strength":"5,000AU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102213","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides pteronyssinus","License_Type":"351(a)","Strength":"5,000AU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102213","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides pteronyssinus","License_Type":"351(a)","Strength":"5,000AU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102213","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides pteronyssinus","License_Type":"351(a)","Strength":"5,000AU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102214","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bermuda Grass Cynodon dactylon","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102214","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bermuda Grass Cynodon dactylon","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102214","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bermuda Grass Cynodon dactylon","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102214","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bermuda Grass Cynodon dactylon","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102215","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bluegrass, Kentucky (June) Poa pratensis","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"8","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102215","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bluegrass, Kentucky (June) Poa pratensis","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"7","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102215","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bluegrass, Kentucky (June) Poa pratensis","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102215","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bluegrass, Kentucky (June) Poa pratensis","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102215","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bluegrass, Kentucky (June) Poa pratensis","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102215","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bluegrass, Kentucky (June) Poa pratensis","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102215","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bluegrass, Kentucky (June) Poa pratensis","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102215","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bluegrass, Kentucky (June) Poa pratensis","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102216","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Fescue, Meadow Festuca elatior","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"8","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102216","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Fescue, Meadow Festuca elatior","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"7","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102216","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Fescue, Meadow Festuca elatior","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102216","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Fescue, Meadow Festuca elatior","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102216","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Fescue, Meadow Festuca elatior","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102216","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Fescue, Meadow Festuca elatior","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102216","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Fescue, Meadow Festuca elatior","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102216","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Fescue, Meadow Festuca elatior","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102217","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Orchard Grass Dactylis glomerata","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"8","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102217","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Orchard Grass Dactylis glomerata","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"7","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102217","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Orchard Grass Dactylis glomerata","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102217","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Orchard Grass Dactylis glomerata","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102217","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Orchard Grass Dactylis glomerata","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102217","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Orchard Grass Dactylis glomerata","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102217","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Orchard Grass Dactylis glomerata","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102217","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Orchard Grass Dactylis glomerata","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102218","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Redtop Agrostis alba","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"8","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102218","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Redtop Agrostis alba","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"7","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102218","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Redtop Agrostis alba","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102218","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Redtop Agrostis alba","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102218","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Redtop Agrostis alba","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102218","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Redtop Agrostis alba","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102218","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Redtop Agrostis alba","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102218","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Redtop Agrostis alba","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102219","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Ryegrass, Perennial Lolium perenne","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"8","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102219","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Ryegrass, Perennial Lolium perenne","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"7","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102219","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Ryegrass, Perennial Lolium perenne","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102219","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Ryegrass, Perennial Lolium perenne","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102219","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Ryegrass, Perennial Lolium perenne","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102219","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Ryegrass, Perennial Lolium perenne","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102219","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Ryegrass, Perennial Lolium perenne","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102219","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Ryegrass, Perennial Lolium perenne","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102220","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Sweet Vernal Grass Anthoxanthum odoratum","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"8","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102220","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Sweet Vernal Grass Anthoxanthum odoratum","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"7","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102220","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Sweet Vernal Grass Anthoxanthum odoratum","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102220","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Sweet Vernal Grass Anthoxanthum odoratum","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102220","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Sweet Vernal Grass Anthoxanthum odoratum","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102220","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Sweet Vernal Grass Anthoxanthum odoratum","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102220","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Sweet Vernal Grass Anthoxanthum odoratum","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102220","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Sweet Vernal Grass Anthoxanthum odoratum","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102221","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Timothy Phleum pratense","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102221","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Timothy Phleum pratense","License_Type":"351(a)","Strength":"100,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102221","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Timothy Phleum pratense","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"102221","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Timothy Phleum pratense","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/14\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring AG","BLA_Number":"102366","Proprietary_Name":"Alburx","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"12.5G\/250ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/23\/1976","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1766","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring AG","BLA_Number":"102366","Proprietary_Name":"Alburx","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"12.5G\/50ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/23\/1976","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1766","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring AG","BLA_Number":"102366","Proprietary_Name":"Alburx","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"25G\/500ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/23\/1976","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1766","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring AG","BLA_Number":"102366","Proprietary_Name":"Alburx","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"25G\/100mL","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/23\/1976","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1766","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring AG","BLA_Number":"102367","Proprietary_Name":"Carimune, Carimune Nf, Panglobulin, Sandoglobulin","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"3G","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"7\/27\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"1055","Submission_Type":"Supplement","License_Number":"1766","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring AG","BLA_Number":"102367","Proprietary_Name":"Carimune, Carimune Nf, Panglobulin, Sandoglobulin","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"12G","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"7\/27\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"1055","Submission_Type":"Supplement","License_Number":"1766","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring AG","BLA_Number":"102367","Proprietary_Name":"Carimune, Carimune Nf, Panglobulin, Sandoglobulin","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"6G","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"7\/27\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"1055","Submission_Type":"Supplement","License_Number":"1766","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Biologicals LLC","BLA_Number":"102475","Proprietary_Name":"Alphanate","Proper_Name":"Antihemophilic Factor\/von Willebrand Factor Complex (Human)","License_Type":"351(a)","Strength":"2000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/26\/2014","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5400","Submission_Type":"Supplement","License_Number":"1694","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"1\/31\/2014"},{"N\/R\/U":null,"Applicant":"Grifols Biologicals LLC","BLA_Number":"102475","Proprietary_Name":"Alphanate","Proper_Name":"Antihemophilic Factor\/von Willebrand Factor Complex (Human)","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/15\/1978","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1694","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"1\/31\/2014"},{"N\/R\/U":null,"Applicant":"Grifols Biologicals LLC","BLA_Number":"102475","Proprietary_Name":"Alphanate","Proper_Name":"Antihemophilic Factor\/von Willebrand Factor Complex (Human)","License_Type":"351(a)","Strength":"1500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/15\/1978","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1694","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"1\/31\/2014"},{"N\/R\/U":null,"Applicant":"Grifols Biologicals LLC","BLA_Number":"102475","Proprietary_Name":"Alphanate","Proper_Name":"Antihemophilic Factor\/von Willebrand Factor Complex (Human)","License_Type":"351(a)","Strength":"1000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/15\/1978","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1694","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"1\/31\/2014"},{"N\/R\/U":null,"Applicant":"Grifols Biologicals LLC","BLA_Number":"102475","Proprietary_Name":"Alphanate","Proper_Name":"Antihemophilic Factor\/von Willebrand Factor Complex (Human)","License_Type":"351(a)","Strength":"250IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/15\/1978","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1694","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"1\/31\/2014"},{"N\/R\/U":null,"Applicant":"Grifols Biologicals LLC","BLA_Number":"102476","Proprietary_Name":"Profilnine, Profilnine Hp, Profilnine Ht, Profilnine Sd","Proper_Name":"Factor IX Complex","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/20\/1981","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1694","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Biologicals LLC","BLA_Number":"102476","Proprietary_Name":"Profilnine, Profilnine Hp, Profilnine Ht, Profilnine Sd","Proper_Name":"Factor IX Complex","License_Type":"351(a)","Strength":"1500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/20\/1981","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1694","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Biologicals LLC","BLA_Number":"102476","Proprietary_Name":"Profilnine, Profilnine Hp, Profilnine Ht, Profilnine Sd","Proper_Name":"Factor IX Complex","License_Type":"351(a)","Strength":"1000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/20\/1981","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1694","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Biologicals LLC","BLA_Number":"102478","Proprietary_Name":"Albutein","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"5G\/100ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Bag","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/29\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"5570","Submission_Type":"Supplement","License_Number":"1694","Product_Number":"9","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Biologicals LLC","BLA_Number":"102478","Proprietary_Name":"Albutein","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"25G\/500ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/15\/1978","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1694","Product_Number":"8","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Biologicals LLC","BLA_Number":"102478","Proprietary_Name":"Albutein","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"12.5ML\/250ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/15\/1978","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1694","Product_Number":"7","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Biologicals LLC","BLA_Number":"102478","Proprietary_Name":"Albutein","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"5G\/20ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/15\/1978","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1694","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Biologicals LLC","BLA_Number":"102478","Proprietary_Name":"Albutein","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"12.5G\/50ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/15\/1978","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1694","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Biologicals LLC","BLA_Number":"102478","Proprietary_Name":"Albutein","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"2.5G\/50ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/15\/1978","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1694","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Biologicals LLC","BLA_Number":"102478","Proprietary_Name":"Albutein","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"25G\/100ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/15\/1978","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1694","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Biologicals LLC","BLA_Number":"102478","Proprietary_Name":"Albutein","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"20G\/100ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/15\/1978","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1694","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Biologicals LLC","BLA_Number":"102478","Proprietary_Name":"Albutein","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"10G\/50ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/15\/1978","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1694","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Teknika LLC","BLA_Number":"102821","Proprietary_Name":"Tice Bcg","Proper_Name":"BCG Live","License_Type":"351(a)","Strength":"100-800 MIL CFU","Dosage_Form":"For Injection","Route_of_Administration":"Intravesical","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/21\/1989","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1747","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GenTrac, Inc.","BLA_Number":"102865","Proprietary_Name":"Thrombin-Jmi, Thrombocoll","Proper_Name":"Thrombin, Topical (Bovine)","License_Type":"351(a)","Strength":"5,000IU","Dosage_Form":"Powder","Route_of_Administration":"Topical","Product_Presentation":"Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/10\/2011","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5387","Submission_Type":"Supplement","License_Number":"977","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GenTrac, Inc.","BLA_Number":"102865","Proprietary_Name":"Thrombin-Jmi, Thrombocoll","Proper_Name":"Thrombin, Topical (Bovine)","License_Type":"351(a)","Strength":"20,000IU","Dosage_Form":"Powder","Route_of_Administration":"Topical","Product_Presentation":"Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/3\/1986","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"977","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Teknika LLC","BLA_Number":"103050","Proprietary_Name":null,"Proper_Name":"BCG Vaccine","License_Type":"351(a)","Strength":"100-800 MIL CFU","Dosage_Form":"For Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/21\/1989","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1747","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103051","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bermuda Grass Cynodon dactylon","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103051","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bermuda Grass Cynodon dactylon","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103052","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bluegrass, Kentucky (June) Poa pratensis","License_Type":"351(a)","Strength":"100,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103052","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bluegrass, Kentucky (June) Poa pratensis","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103052","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bluegrass, Kentucky (June) Poa pratensis","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103052","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bluegrass, Kentucky (June) Poa pratensis","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103053","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Fescue, Meadow Festuca elatior","License_Type":"351(a)","Strength":"100,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103053","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Fescue, Meadow Festuca elatior","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103053","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Fescue, Meadow Festuca elatior","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103053","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Fescue, Meadow Festuca elatior","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103054","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Orchard Grass Dactylis glomerata","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103054","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Orchard Grass Dactylis glomerata","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103054","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Orchard Grass Dactylis glomerata","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103054","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Orchard Grass Dactylis glomerata","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103055","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Redtop Agrostis alba","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103055","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Redtop Agrostis alba","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103055","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Redtop Agrostis alba","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103055","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Redtop Agrostis alba","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103056","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Ryegrass, Perennial Lolium perenne","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103056","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Ryegrass, Perennial Lolium perenne","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103057","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Sweet Vernal Grass Anthoxanthum odoratum","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103057","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Sweet Vernal Grass Anthoxanthum odoratum","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103058","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Timothy Phleum pratense","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103058","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Timothy Phleum pratense","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"ALK-Abello, Inc.","BLA_Number":"103059","Proprietary_Name":null,"Proper_Name":"Pollens - Weeds and Garden Plants, Ragweed, Short Ambrosia artemisiifolia","License_Type":"351(a)","Strength":"1:20W\/V","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"ALK-Abello, Inc.","BLA_Number":"103059","Proprietary_Name":null,"Proper_Name":"Pollens - Weeds and Garden Plants, Ragweed, Short Ambrosia artemisiifolia","License_Type":"351(a)","Strength":"1:20W\/V","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103060","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides farinae","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103060","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides farinae","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103061","Proprietary_Name":null,"Proper_Name":"Animal Allergens, Standardized Cat Pelt","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103061","Proprietary_Name":null,"Proper_Name":"Animal Allergens, Standardized Cat Pelt","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Baxalta US Inc.","BLA_Number":"103112","Proprietary_Name":"Proplex-T; Bebulin","Proper_Name":"Factor IX Complex","License_Type":"351(a)","Strength":"200-1200U\/20ML","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Rx","Licensure":"Voluntarily Revoked","Approval_Date":"8\/21\/1970","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"2020","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"103113","Proprietary_Name":null,"Proper_Name":"Pollens - Weeds and Garden Plants, Ragweed, Short Ambrosia artemisiifolia","License_Type":"351(a)","Strength":"1:10W\/V","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"103113","Proprietary_Name":null,"Proper_Name":"Pollens - Weeds and Garden Plants, Ragweed, Short Ambrosia artemisiifolia","License_Type":"351(a)","Strength":"1:10W\/V","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Emergent Travel Health, Inc.","BLA_Number":"103123","Proprietary_Name":"Vivotif","Proper_Name":"Typhoid Vaccine Live Oral Ty21a","License_Type":"351(a)","Strength":"2-6.8 BIL. CFU","Dosage_Form":"Capsule","Route_of_Administration":"Oral","Product_Presentation":"Blister Pack","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/15\/1989","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2015","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"103133","Proprietary_Name":"Gammagard, Gammagard S\/D, Iveegam","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"5.0G","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/27\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"1064","Submission_Type":"Supplement","License_Number":"1898","Product_Number":"8","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"103133","Proprietary_Name":"Gammagard, Gammagard S\/D, Iveegam","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"2.5G","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Disc","Licensure":"Licensed","Approval_Date":"7\/27\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"1064","Submission_Type":"Supplement","License_Number":"1898","Product_Number":"7","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"103133","Proprietary_Name":"Gammagard, Gammagard S\/D, Iveegam","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"10G","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/27\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"1064","Submission_Type":"Supplement","License_Number":"1898","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"103133","Proprietary_Name":"Gammagard, Gammagard S\/D, Iveegam","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"5000MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Disc","Licensure":"Licensed","Approval_Date":"2\/18\/1986","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"103133","Proprietary_Name":"Gammagard, Gammagard S\/D, Iveegam","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"500MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Disc","Licensure":"Licensed","Approval_Date":"2\/18\/1986","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"103133","Proprietary_Name":"Gammagard, Gammagard S\/D, Iveegam","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"2500MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Disc","Licensure":"Licensed","Approval_Date":"2\/18\/1986","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"103133","Proprietary_Name":"Gammagard, Gammagard S\/D, Iveegam","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"1000MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Disc","Licensure":"Licensed","Approval_Date":"2\/18\/1986","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"103133","Proprietary_Name":"Gammagard, Gammagard S\/D, Iveegam","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"0.5G","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Disc","Licensure":"Licensed","Approval_Date":"2\/18\/1986","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Wellcome Foundation Limited Wellcome Research Laboratories","BLA_Number":"103141","Proprietary_Name":"Digibind","Proper_Name":"Digoxin Immune Fab (Ovine)","License_Type":"351(a)","Strength":"38MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"4\/22\/1986","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"129","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"4\/22\/1993"},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Limited","BLA_Number":"103171","Proprietary_Name":"Tenivac","Proper_Name":"Tetanus and Diphtheria Toxoids Adsorbed","License_Type":"351(a)","Strength":"5LF,2LF\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/3\/2003","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1726","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Limited","BLA_Number":"103171","Proprietary_Name":"Tenivac","Proper_Name":"Tetanus and Diphtheria Toxoids Adsorbed","License_Type":"351(a)","Strength":"5LF,2LF\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/3\/2003","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1726","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"103174","Proprietary_Name":"Prolastin, Prolastin-C","Proper_Name":"Alpha-1-Proteinase Inhibitor (Human)","License_Type":"351(a)","Strength":"500MG\/10ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/5\/2020","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"6314","Submission_Type":"Supplement","License_Number":"1871","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/2\/1994"},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"103174","Proprietary_Name":"Prolastin, Prolastin-C","Proper_Name":"Alpha-1-Proteinase Inhibitor (Human)","License_Type":"351(a)","Strength":"4000MG\/80ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/5\/2020","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"6314","Submission_Type":"Supplement","License_Number":"1871","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/2\/1994"},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"103174","Proprietary_Name":"Prolastin, Prolastin-C","Proper_Name":"Alpha-1-Proteinase Inhibitor (Human)","License_Type":"351(a)","Strength":"1000MG\/20ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/8\/2017","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"6160","Submission_Type":"Supplement","License_Number":"1871","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/2\/1994"},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"103174","Proprietary_Name":"Prolastin, Prolastin-C","Proper_Name":"Alpha-1-Proteinase Inhibitor (Human)","License_Type":"351(a)","Strength":"500MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/2\/1987","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/2\/1994"},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"103174","Proprietary_Name":"Prolastin, Prolastin-C","Proper_Name":"Alpha-1-Proteinase Inhibitor (Human)","License_Type":"351(a)","Strength":"1000MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/2\/1987","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/2\/1994"},{"N\/R\/U":null,"Applicant":"Kamada Ltd.","BLA_Number":"103189","Proprietary_Name":"Cytogam","Proper_Name":"Cytomegalovirus Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"2.5G\/50ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/17\/1990","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1826","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"10\/4\/2005"},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"103196","Proprietary_Name":"Thrombate Iii","Proper_Name":"Antithrombin III (Human)","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/30\/1991","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/30\/1998"},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103237","Proprietary_Name":"Pedvaxhib","Proper_Name":"Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate)","License_Type":"351(a)","Strength":"7.5UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/20\/1989","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline Biologicals","BLA_Number":"103239","Proprietary_Name":"Engerix-B","Proper_Name":"Hepatitis B Vaccine (Recombinant)","License_Type":"351(a)","Strength":"10UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/28\/1989","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1617","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline Biologicals","BLA_Number":"103239","Proprietary_Name":"Engerix-B","Proper_Name":"Hepatitis B Vaccine (Recombinant)","License_Type":"351(a)","Strength":"10UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/28\/1989","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1617","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline Biologicals","BLA_Number":"103239","Proprietary_Name":"Engerix-B","Proper_Name":"Hepatitis B Vaccine (Recombinant)","License_Type":"351(a)","Strength":"20UG\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/28\/1989","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1617","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline Biologicals","BLA_Number":"103239","Proprietary_Name":"Engerix-B","Proper_Name":"Hepatitis B Vaccine (Recombinant)","License_Type":"351(a)","Strength":"20UG\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/28\/1989","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1617","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Biologicals LLC","BLA_Number":"103249","Proprietary_Name":"Alphanine, Alphanine Hp, Alphanine Sd","Proper_Name":"Coagulation Factor IX (Human)","License_Type":"351(a)","Strength":"1500IU","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/31\/1990","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1694","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/31\/1997"},{"N\/R\/U":null,"Applicant":"Grifols Biologicals LLC","BLA_Number":"103249","Proprietary_Name":"Alphanine, Alphanine Hp, Alphanine Sd","Proper_Name":"Coagulation Factor IX (Human)","License_Type":"351(a)","Strength":"250IU","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/31\/1990","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1694","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/31\/1997"},{"N\/R\/U":null,"Applicant":"Grifols Biologicals LLC","BLA_Number":"103249","Proprietary_Name":"Alphanine, Alphanine Hp, Alphanine Sd","Proper_Name":"Coagulation Factor IX (Human)","License_Type":"351(a)","Strength":"1000IU","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/31\/1990","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1694","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/31\/1997"},{"N\/R\/U":null,"Applicant":"Grifols Biologicals LLC","BLA_Number":"103249","Proprietary_Name":"Alphanine, Alphanine Hp, Alphanine Sd","Proper_Name":"Coagulation Factor IX (Human)","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/31\/1990","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1694","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/31\/1997"},{"N\/R\/U":null,"Applicant":"Nielsen Bioscience, Inc","BLA_Number":"103257","Proprietary_Name":"Candin","Proper_Name":"Candida albicans Skin Test Antigen for Cellular Hypersensitivity","License_Type":"351(a)","Strength":"1U\/.1ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/27\/1995","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1903","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Nielsen Bioscience, Inc","BLA_Number":"103317","Proprietary_Name":null,"Proper_Name":"Positive Skin Test Control-Histamine","License_Type":"351(a)","Strength":"1.8MG\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"2\/14\/1992","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1903","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"103324","Proprietary_Name":null,"Proper_Name":"Animal Allergens, Standardized Cat Hair","License_Type":"351(a)","Strength":"10,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"7\/11\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allergy Laboratories, Inc.","BLA_Number":"103324","Proprietary_Name":null,"Proper_Name":"Animal Allergens, Standardized Cat Hair","License_Type":"351(a)","Strength":"10,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"7\/11\/1930","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"103","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bayer HealthCare LLC","BLA_Number":"103332","Proprietary_Name":"Helixate Fs, Kogenate, Kogenate Fs","Proper_Name":"Antihemophilic Factor (Recombinant)","License_Type":"351(a)","Strength":"3000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/31\/2009","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5987","Submission_Type":"Supplement","License_Number":"8","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/25\/2000"},{"N\/R\/U":null,"Applicant":"Bayer HealthCare LLC","BLA_Number":"103332","Proprietary_Name":"Helixate Fs, Kogenate, Kogenate Fs","Proper_Name":"Antihemophilic Factor (Recombinant)","License_Type":"351(a)","Strength":"2000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/7\/2007","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5672","Submission_Type":"Supplement","License_Number":"8","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/25\/2000"},{"N\/R\/U":null,"Applicant":"Bayer HealthCare LLC","BLA_Number":"103332","Proprietary_Name":"Helixate Fs, Kogenate, Kogenate Fs","Proper_Name":"Antihemophilic Factor (Recombinant)","License_Type":"351(a)","Strength":"1000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/20\/2002","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5000","Submission_Type":"Supplement","License_Number":"8","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/25\/2000"},{"N\/R\/U":null,"Applicant":"Bayer HealthCare LLC","BLA_Number":"103332","Proprietary_Name":"Helixate Fs, Kogenate, Kogenate Fs","Proper_Name":"Antihemophilic Factor (Recombinant)","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/20\/2002","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5000","Submission_Type":"Supplement","License_Number":"8","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/25\/2000"},{"N\/R\/U":null,"Applicant":"Bayer HealthCare LLC","BLA_Number":"103332","Proprietary_Name":"Helixate Fs, Kogenate, Kogenate Fs","Proper_Name":"Antihemophilic Factor (Recombinant)","License_Type":"351(a)","Strength":"250IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/20\/2002","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5000","Submission_Type":"Supplement","License_Number":"8","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/25\/2000"},{"N\/R\/U":null,"Applicant":"Bavarian Nordic A\/S","BLA_Number":"103334","Proprietary_Name":"Rabavert","Proper_Name":"Rabies Vaccine","License_Type":"351(a)","Strength":"2.5IU","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/20\/1997","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2096","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Instituto Grifols, S.A.","BLA_Number":"103352","Proprietary_Name":"Human Albumin Grifols","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"25G\/100ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/11\/2003","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1181","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Instituto Grifols, S.A.","BLA_Number":"103352","Proprietary_Name":"Human Albumin Grifols","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"10G\/50ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/17\/1995","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5024","Submission_Type":"Supplement","License_Number":"1181","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Instituto Grifols, S.A.","BLA_Number":"103352","Proprietary_Name":"Human Albumin Grifols","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"20G\/100ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/11\/2003","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1181","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Instituto Grifols, S.A.","BLA_Number":"103352","Proprietary_Name":"Human Albumin Grifols","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"12.5G\/50ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/17\/1995","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5024","Submission_Type":"Supplement","License_Number":"1181","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"103375","Proprietary_Name":"Bioclate (Armour), Recombinate","Proper_Name":"Antihemophilic Factor (Recombinant)","License_Type":"351(a)","Strength":"2000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/10\/2010","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5313","Submission_Type":"Supplement","License_Number":"1898","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"103375","Proprietary_Name":"Bioclate (Armour), Recombinate","Proper_Name":"Antihemophilic Factor (Recombinant)","License_Type":"351(a)","Strength":"1500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/10\/2010","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5313","Submission_Type":"Supplement","License_Number":"1898","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"103375","Proprietary_Name":"Bioclate (Armour), Recombinate","Proper_Name":"Antihemophilic Factor (Recombinant)","License_Type":"351(a)","Strength":"250IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/10\/1992","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"103375","Proprietary_Name":"Bioclate (Armour), Recombinate","Proper_Name":"Antihemophilic Factor (Recombinant)","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/10\/1992","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"103375","Proprietary_Name":"Bioclate (Armour), Recombinate","Proper_Name":"Antihemophilic Factor (Recombinant)","License_Type":"351(a)","Strength":"1000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/10\/1992","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"103397","Proprietary_Name":null,"Proper_Name":"Animal Allergens, Standardized Cat Hair","License_Type":"351(a)","Strength":"5,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/15\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"7","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"103397","Proprietary_Name":null,"Proper_Name":"Animal Allergens, Standardized Cat Hair","License_Type":"351(a)","Strength":"5,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/15\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"103397","Proprietary_Name":null,"Proper_Name":"Animal Allergens, Standardized Cat Hair","License_Type":"351(a)","Strength":"5,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/15\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"103397","Proprietary_Name":null,"Proper_Name":"Animal Allergens, Standardized Cat Hair","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/15\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"103397","Proprietary_Name":null,"Proper_Name":"Animal Allergens, Standardized Cat Hair","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/15\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"103397","Proprietary_Name":null,"Proper_Name":"Animal Allergens, Standardized Cat Hair","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/15\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"103397","Proprietary_Name":null,"Proper_Name":"Animal Allergens, Standardized Cat Hair","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/15\/1958","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"103473","Proprietary_Name":null,"Proper_Name":"Animal Allergens, Standardized Cat Hair","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Allermed Laboratories, Inc.","BLA_Number":"103473","Proprietary_Name":null,"Proper_Name":"Animal Allergens, Standardized Cat Hair","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/12\/1974","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"467","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline Biologicals","BLA_Number":"103475","Proprietary_Name":"Havrix","Proper_Name":"Hepatitis A Vaccine","License_Type":"351(a)","Strength":"1440 EL.U.\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/22\/1995","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1617","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline Biologicals","BLA_Number":"103475","Proprietary_Name":"Havrix","Proper_Name":"Hepatitis A Vaccine","License_Type":"351(a)","Strength":"1440 EL.U.\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/22\/1995","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1617","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline Biologicals","BLA_Number":"103475","Proprietary_Name":"Havrix","Proper_Name":"Hepatitis A Vaccine","License_Type":"351(a)","Strength":"720EL.U\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/22\/1995","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1617","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline Biologicals","BLA_Number":"103475","Proprietary_Name":"Havrix","Proper_Name":"Hepatitis A Vaccine","License_Type":"351(a)","Strength":"720EL.U\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/22\/1995","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1617","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103552","Proprietary_Name":"Varivax","Proper_Name":"Varicella Virus Vaccine Live","License_Type":"351(a)","Strength":"NLT  1350PFU\/.5ML","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/27\/2023","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"6277","Submission_Type":"Supplement","License_Number":"2","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103552","Proprietary_Name":"Varivax","Proper_Name":"Varicella Virus Vaccine Live","License_Type":"351(a)","Strength":"NLT  1350PFU\/.5ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/17\/1995","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Greer Laboratories, Inc.","BLA_Number":"103569","Proprietary_Name":null,"Proper_Name":"Plague Vaccine","License_Type":"351(a)","Strength":"2BIL. CELL\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"10\/5\/1994","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"308","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103606","Proprietary_Name":"Vaqta","Proper_Name":"Hepatitis A Vaccine Inactivated","License_Type":"351(a)","Strength":"25U\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/29\/1996","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103606","Proprietary_Name":"Vaqta","Proper_Name":"Hepatitis A Vaccine Inactivated","License_Type":"351(a)","Strength":"50U\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/29\/1996","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103606","Proprietary_Name":"Vaqta","Proper_Name":"Hepatitis A Vaccine Inactivated","License_Type":"351(a)","Strength":"25U\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/29\/1996","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103606","Proprietary_Name":"Vaqta","Proper_Name":"Hepatitis A Vaccine Inactivated","License_Type":"351(a)","Strength":"50U\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/29\/1996","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"103623","Proprietary_Name":"COMVAX ","Proper_Name":"Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine","License_Type":"351(a)","Strength":"7.5UG PRP\/125UG OMPC\/5UG HBsAg","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"10\/2\/1996","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"2","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline Biologicals","BLA_Number":"103647","Proprietary_Name":"Infanrix","Proper_Name":"Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed","License_Type":"351(a)","Strength":"25LF\/10LF\/25UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/29\/1997","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1617","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline Biologicals","BLA_Number":"103647","Proprietary_Name":"Infanrix","Proper_Name":"Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed","License_Type":"351(a)","Strength":"25LF\/10LF\/25UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/29\/1997","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1617","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Kamada Ltd.","BLA_Number":"103649","Proprietary_Name":"Winrho Sd, Winrho Sdf Liquid, Winrho Sdf Lyophilized","Proper_Name":"Rho(D) Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"3000IU","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/18\/2015","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5690","Submission_Type":"Supplement","License_Number":"2098","Product_Number":"18","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/24\/2002"},{"N\/R\/U":null,"Applicant":"Kamada Ltd.","BLA_Number":"103649","Proprietary_Name":"Winrho Sd, Winrho Sdf Liquid, Winrho Sdf Lyophilized","Proper_Name":"Rho(D) Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"15000IU","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"3\/31\/2005","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5107","Submission_Type":"Supplement","License_Number":"2098","Product_Number":"17","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/24\/2002"},{"N\/R\/U":null,"Applicant":"Kamada Ltd.","BLA_Number":"103649","Proprietary_Name":"Winrho Sd, Winrho Sdf Liquid, Winrho Sdf Lyophilized","Proper_Name":"Rho(D) Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"5000IU","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/31\/2005","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5107","Submission_Type":"Supplement","License_Number":"2098","Product_Number":"16","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/24\/2002"},{"N\/R\/U":null,"Applicant":"Kamada Ltd.","BLA_Number":"103649","Proprietary_Name":"Winrho Sd, Winrho Sdf Liquid, Winrho Sdf Lyophilized","Proper_Name":"Rho(D) Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"2500IU","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"3\/31\/2005","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5107","Submission_Type":"Supplement","License_Number":"2098","Product_Number":"15","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/24\/2002"},{"N\/R\/U":null,"Applicant":"Kamada Ltd.","BLA_Number":"103649","Proprietary_Name":"Winrho Sd, Winrho Sdf Liquid, Winrho Sdf Lyophilized","Proper_Name":"Rho(D) Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"1500IU","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/31\/2005","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5107","Submission_Type":"Supplement","License_Number":"2098","Product_Number":"14","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/24\/2002"},{"N\/R\/U":null,"Applicant":"Kamada Ltd.","BLA_Number":"103649","Proprietary_Name":"Winrho Sd, Winrho Sdf Liquid, Winrho Sdf Lyophilized","Proper_Name":"Rho(D) Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"600IU","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/31\/2005","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5107","Submission_Type":"Supplement","License_Number":"2098","Product_Number":"13","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/24\/2002"},{"N\/R\/U":null,"Applicant":"Kamada Ltd.","BLA_Number":"103649","Proprietary_Name":"Winrho Sd, Winrho Sdf Liquid, Winrho Sdf Lyophilized","Proper_Name":"Rho(D) Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"5,000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"4\/2\/1996","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2098","Product_Number":"12","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/24\/2002"},{"N\/R\/U":null,"Applicant":"Kamada Ltd.","BLA_Number":"103649","Proprietary_Name":"Winrho Sd, Winrho Sdf Liquid, Winrho Sdf Lyophilized","Proper_Name":"Rho(D) Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"1500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"4\/2\/1996","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2098","Product_Number":"11","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/24\/2002"},{"N\/R\/U":null,"Applicant":"Kamada Ltd.","BLA_Number":"103649","Proprietary_Name":"Winrho Sd, Winrho Sdf Liquid, Winrho Sdf Lyophilized","Proper_Name":"Rho(D) Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"600IU","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"4\/2\/1996","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2098","Product_Number":"10","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/24\/2002"},{"N\/R\/U":null,"Applicant":"Kamada Ltd.","BLA_Number":"103649","Proprietary_Name":"Winrho Sd, Winrho Sdf Liquid, Winrho Sdf Lyophilized","Proper_Name":"Rho(D) Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"3000IU","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/18\/2015","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5690","Submission_Type":"Supplement","License_Number":"2098","Product_Number":"9","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/24\/2002"},{"N\/R\/U":null,"Applicant":"Kamada Ltd.","BLA_Number":"103649","Proprietary_Name":"Winrho Sd, Winrho Sdf Liquid, Winrho Sdf Lyophilized","Proper_Name":"Rho(D) Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"15000IU","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"3\/31\/2005","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5107","Submission_Type":"Supplement","License_Number":"2098","Product_Number":"8","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/24\/2002"},{"N\/R\/U":null,"Applicant":"Kamada Ltd.","BLA_Number":"103649","Proprietary_Name":"Winrho Sd, Winrho Sdf Liquid, Winrho Sdf Lyophilized","Proper_Name":"Rho(D) Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"5000IU","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/31\/2005","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5107","Submission_Type":"Supplement","License_Number":"2098","Product_Number":"7","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/24\/2002"},{"N\/R\/U":null,"Applicant":"Kamada Ltd.","BLA_Number":"103649","Proprietary_Name":"Winrho Sd, Winrho Sdf Liquid, Winrho Sdf Lyophilized","Proper_Name":"Rho(D) Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"2500IU","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"3\/31\/2005","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5107","Submission_Type":"Supplement","License_Number":"2098","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/24\/2002"},{"N\/R\/U":null,"Applicant":"Kamada Ltd.","BLA_Number":"103649","Proprietary_Name":"Winrho Sd, Winrho Sdf Liquid, Winrho Sdf Lyophilized","Proper_Name":"Rho(D) Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"1500IU","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/31\/2005","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5107","Submission_Type":"Supplement","License_Number":"2098","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/24\/2002"},{"N\/R\/U":null,"Applicant":"Kamada Ltd.","BLA_Number":"103649","Proprietary_Name":"Winrho Sd, Winrho Sdf Liquid, Winrho Sdf Lyophilized","Proper_Name":"Rho(D) Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"600IU","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/31\/2005","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5107","Submission_Type":"Supplement","License_Number":"2098","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/24\/2002"},{"N\/R\/U":null,"Applicant":"Kamada Ltd.","BLA_Number":"103649","Proprietary_Name":"Winrho Sd, Winrho Sdf Liquid, Winrho Sdf Lyophilized","Proper_Name":"Rho(D) Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"5,000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"4\/2\/1996","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2098","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/24\/2002"},{"N\/R\/U":null,"Applicant":"Kamada Ltd.","BLA_Number":"103649","Proprietary_Name":"Winrho Sd, Winrho Sdf Liquid, Winrho Sdf Lyophilized","Proper_Name":"Rho(D) Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"1500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"4\/2\/1996","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2098","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/24\/2002"},{"N\/R\/U":null,"Applicant":"Kamada Ltd.","BLA_Number":"103649","Proprietary_Name":"Winrho Sd, Winrho Sdf Liquid, Winrho Sdf Lyophilized","Proper_Name":"Rho(D) Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"600IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"4\/2\/1996","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2098","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/24\/2002"},{"N\/R\/U":null,"Applicant":"Vericel Corporation","BLA_Number":"103661","Proprietary_Name":"Carticel Sm Service","Proper_Name":"Autologous Cultured Chondrocytes","License_Type":"351(a)","Strength":"12MIU\/VL","Dosage_Form":"Injection","Route_of_Administration":"Implantation","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"8\/22\/1997","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2010","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"103665","Proprietary_Name":"Novoseven, Novoseven Rt","Proper_Name":"Coagulation Factor VIIa (Recombinant)","License_Type":"351(a)","Strength":"8.0MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/6\/2010","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5605","Submission_Type":"Supplement","License_Number":"1261","Product_Number":"7","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/2\/2021"},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"103665","Proprietary_Name":"Novoseven, Novoseven Rt","Proper_Name":"Coagulation Factor VIIa (Recombinant)","License_Type":"351(a)","Strength":"2.0MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/9\/2008","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5231","Submission_Type":"Supplement","License_Number":"1261","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/2\/2021"},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"103665","Proprietary_Name":"Novoseven, Novoseven Rt","Proper_Name":"Coagulation Factor VIIa (Recombinant)","License_Type":"351(a)","Strength":"1.0MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/9\/2008","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5231","Submission_Type":"Supplement","License_Number":"1261","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/2\/2021"},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"103665","Proprietary_Name":"Novoseven, Novoseven Rt","Proper_Name":"Coagulation Factor VIIa (Recombinant)","License_Type":"351(a)","Strength":"5.0MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/9\/2008","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5231","Submission_Type":"Supplement","License_Number":"1261","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/2\/2021"},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"103665","Proprietary_Name":"Novoseven, Novoseven Rt","Proper_Name":"Coagulation Factor VIIa (Recombinant)","License_Type":"351(a)","Strength":"4.8MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"11\/15\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5000","Submission_Type":"Supplement","License_Number":"1261","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/2\/2021"},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"103665","Proprietary_Name":"Novoseven, Novoseven Rt","Proper_Name":"Coagulation Factor VIIa (Recombinant)","License_Type":"351(a)","Strength":"1.2MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"11\/15\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5000","Submission_Type":"Supplement","License_Number":"1261","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/2\/2021"},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"103665","Proprietary_Name":"Novoseven, Novoseven Rt","Proper_Name":"Coagulation Factor VIIa (Recombinant)","License_Type":"351(a)","Strength":"2.4MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"3\/25\/1999","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1261","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/2\/2021"},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Limited","BLA_Number":"103666","Proprietary_Name":"Daptacel","Proper_Name":"Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed","License_Type":"351(a)","Strength":"0.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/14\/2002","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1726","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Pharmacia & Upjohn Company LLC","BLA_Number":"103676","Proprietary_Name":"Atgam","Proper_Name":"Lymphocyte Immune Globulin, Anti-thymocyte Globulin (Equine)","License_Type":"351(a)","Strength":"50MG\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Ampule","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/4\/1996","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1216","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Wyeth Pharmaceuticals LLC","BLA_Number":"103677","Proprietary_Name":"Benefix","Proper_Name":"Coagulation Factor IX (Recombinant)","License_Type":"351(a)","Strength":"3000IU\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/23\/2011","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"6051","Submission_Type":"Supplement","License_Number":"3","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/11\/2004"},{"N\/R\/U":null,"Applicant":"Wyeth Pharmaceuticals LLC","BLA_Number":"103677","Proprietary_Name":"Benefix","Proper_Name":"Coagulation Factor IX (Recombinant)","License_Type":"351(a)","Strength":"2000IU\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/21\/2007","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5245","Submission_Type":"Supplement","License_Number":"3","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/11\/2004"},{"N\/R\/U":null,"Applicant":"Wyeth Pharmaceuticals LLC","BLA_Number":"103677","Proprietary_Name":"Benefix","Proper_Name":"Coagulation Factor IX (Recombinant)","License_Type":"351(a)","Strength":"250IU\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/11\/1997","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"3","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/11\/2004"},{"N\/R\/U":null,"Applicant":"Wyeth Pharmaceuticals LLC","BLA_Number":"103677","Proprietary_Name":"Benefix","Proper_Name":"Coagulation Factor IX (Recombinant)","License_Type":"351(a)","Strength":"500IU\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/11\/1997","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"3","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/11\/2004"},{"N\/R\/U":null,"Applicant":"Wyeth Pharmaceuticals LLC","BLA_Number":"103677","Proprietary_Name":"Benefix","Proper_Name":"Coagulation Factor IX (Recombinant)","License_Type":"351(a)","Strength":"1000IU\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/11\/1997","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"3","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/11\/2004"},{"N\/R\/U":null,"Applicant":"SmartPractice Denmark ApS","BLA_Number":"103738","Proprietary_Name":"T.R.U.E. Test","Proper_Name":"Thin-Layer Rapid Use Epicutaneous Patch Test","License_Type":"351(a)","Strength":"36 MCG NICKEL\/PATCH, 810 MCG WOOL ALCOHOL\/PATCH, 486 MCG NEOMYCIN SULFATE\/PATCH, 15.7 MCG CHROMIUM\/PATCH, 510 MCG CAINE MIX\/PATCH, 405 MCG FRAGRANCE MIX\/PATCH, 972 MCG COLOPHONY\/PATCH, 810 MCG PARABEN\/PATCH, 648 MCG OF BALSAM OF PERU RESIN\/PATCH, 18 MCG E","Dosage_Form":"Patch","Route_of_Administration":"Topical","Product_Presentation":"Pouch","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/15\/1997","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1888","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103752","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides pteronyssinus","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103752","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides pteronyssinus","License_Type":"351(a)","Strength":"10,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103754","Proprietary_Name":"Histatrol","Proper_Name":"Positive Skin Test Control-Histamine","License_Type":"351(a)","Strength":"1MG\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103754","Proprietary_Name":"Histatrol","Proper_Name":"Positive Skin Test Control-Histamine","License_Type":"351(a)","Strength":"0.1MG\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/1950","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Kedrion Biopharma Inc.","BLA_Number":"103777","Proprietary_Name":"Micrhogam, Rhogam","Proper_Name":"Rho(D) Immune Globulin (Human)","License_Type":"351(a)","Strength":"300UG","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/23\/1998","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1906","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Kedrion Biopharma Inc.","BLA_Number":"103777","Proprietary_Name":"Micrhogam, Rhogam","Proper_Name":"Rho(D) Immune Globulin (Human)","License_Type":"351(a)","Strength":"50UG","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/23\/1998","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1906","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Wyeth Pharmaceuticals LLC","BLA_Number":"103779","Proprietary_Name":"Refacto","Proper_Name":"Antihemophilic Factor (Recombinant)","License_Type":"351(a)","Strength":"1000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"7\/6\/2001","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5000","Submission_Type":"Supplement","License_Number":"3","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Wyeth Pharmaceuticals LLC","BLA_Number":"103779","Proprietary_Name":"Refacto","Proper_Name":"Antihemophilic Factor (Recombinant)","License_Type":"351(a)","Strength":"250IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"7\/6\/2001","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5000","Submission_Type":"Supplement","License_Number":"3","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Wyeth Pharmaceuticals LLC","BLA_Number":"103779","Proprietary_Name":"Refacto","Proper_Name":"Antihemophilic Factor (Recombinant)","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"7\/6\/2001","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5000","Submission_Type":"Supplement","License_Number":"3","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Wyeth Pharmaceuticals LLC","BLA_Number":"103779","Proprietary_Name":"Refacto","Proper_Name":"Antihemophilic Factor (Recombinant)","License_Type":"351(a)","Strength":"2000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/27\/2001","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5006","Submission_Type":"Supplement","License_Number":"3","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Par Pharmaceutical Companies, Inc.","BLA_Number":"103782","Proprietary_Name":"Aplisol","Proper_Name":"Tuberculin, Purified Protein Derivative","License_Type":"351(a)","Strength":"5TU\/.1ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/20\/1998","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1997","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"BTG International Inc.","BLA_Number":"103788","Proprietary_Name":"Crofab","Proper_Name":"Crotalidae Polyvalent Immune Fab (Ovine)","License_Type":"351(a)","Strength":"1G","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/2\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1861","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"10\/2\/2007"},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103810","Proprietary_Name":null,"Proper_Name":"Animal Allergens, Standardized Cat Hair","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/16\/1971","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK-Abello, Inc.","BLA_Number":"103810","Proprietary_Name":null,"Proper_Name":"Animal Allergens, Standardized Cat Hair","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/16\/1971","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1256","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Emergent BioDefense Operations Lansing LLC","BLA_Number":"103820","Proprietary_Name":"Biorab","Proper_Name":"Rabies Vaccine Adsorbed","License_Type":"351(a)","Strength":"1.0ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"11\/12\/1998","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1755","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Emergent BioDefense Operations Lansing LLC","BLA_Number":"103821","Proprietary_Name":"Biothrax","Proper_Name":"Anthrax Vaccine Adsorbed","License_Type":"351(a)","Strength":"0.5ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/12\/1998","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1755","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/23\/2022"},{"N\/R\/U":null,"Applicant":"Emergent BioDefense Operations Lansing LLC","BLA_Number":"103821","Proprietary_Name":"Biothrax","Proper_Name":"Anthrax Vaccine Adsorbed","License_Type":"351(a)","Strength":"0.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/12\/1998","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1755","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"11\/23\/2022"},{"N\/R\/U":null,"Applicant":"Seqirus Vaccines Limited","BLA_Number":"103837","Proprietary_Name":"Fluvirin","Proper_Name":"Influenza Virus Vaccine","License_Type":"351(a)","Strength":"15UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"11\/3\/1998","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2055","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline Biologicals","BLA_Number":"103850","Proprietary_Name":"Twinrix","Proper_Name":"Hepatitis A & Hepatitis B (Recombinant) Vaccine","License_Type":"351(a)","Strength":"1ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/11\/2001","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1617","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Genzyme Corporation","BLA_Number":"103869","Proprietary_Name":"Thymoglobulin","Proper_Name":"Anti-thymocyte Globulin (Rabbit)","License_Type":"351(a)","Strength":"25MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/19\/1999","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1596","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103870","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides farinae","License_Type":"351(a)","Strength":"30,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103870","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides farinae","License_Type":"351(a)","Strength":"300AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103870","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides farinae","License_Type":"351(a)","Strength":"30,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103870","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides farinae","License_Type":"351(a)","Strength":"30AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103870","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides farinae","License_Type":"351(a)","Strength":"10,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103871","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides pteronyssinus","License_Type":"351(a)","Strength":"30,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103871","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides pteronyssinus","License_Type":"351(a)","Strength":"300AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103871","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides pteronyssinus","License_Type":"351(a)","Strength":"30,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103871","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides pteronyssinus","License_Type":"351(a)","Strength":"30AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103871","Proprietary_Name":null,"Proper_Name":"Insects (Whole Body), Mite Dermatophagoides pteronyssinus","License_Type":"351(a)","Strength":"10,000AU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103872","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bermuda Grass Cynodon dactylon","License_Type":"351(a)","Strength":"10,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103872","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bermuda Grass Cynodon dactylon","License_Type":"351(a)","Strength":"1,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103872","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bermuda Grass Cynodon dactylon","License_Type":"351(a)","Strength":"100BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103872","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bermuda Grass Cynodon dactylon","License_Type":"351(a)","Strength":"10,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103873","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bluegrass, Kentucky (June) Poa pratensis","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103873","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bluegrass, Kentucky (June) Poa pratensis","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103873","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bluegrass, Kentucky (June) Poa pratensis","License_Type":"351(a)","Strength":"1,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103873","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bluegrass, Kentucky (June) Poa pratensis","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103873","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bluegrass, Kentucky (June) Poa pratensis","License_Type":"351(a)","Strength":"100BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103873","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Bluegrass, Kentucky (June) Poa pratensis","License_Type":"351(a)","Strength":"10,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103874","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Fescue, Meadow Festuca elatior","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103874","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Fescue, Meadow Festuca elatior","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103874","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Fescue, Meadow Festuca elatior","License_Type":"351(a)","Strength":"1,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103874","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Fescue, Meadow Festuca elatior","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103874","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Fescue, Meadow Festuca elatior","License_Type":"351(a)","Strength":"100BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103874","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Fescue, Meadow Festuca elatior","License_Type":"351(a)","Strength":"10,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103875","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Orchard Grass Dactylis glomerata","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103875","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Orchard Grass Dactylis glomerata","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103875","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Orchard Grass Dactylis glomerata","License_Type":"351(a)","Strength":"1,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103875","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Orchard Grass Dactylis glomerata","License_Type":"351(a)","Strength":"100,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103875","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Orchard Grass Dactylis glomerata","License_Type":"351(a)","Strength":"100BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103875","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Orchard Grass Dactylis glomerata","License_Type":"351(a)","Strength":"10,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103876","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Redtop Agrostis alba","License_Type":"351(a)","Strength":"100,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103876","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Redtop Agrostis alba","License_Type":"351(a)","Strength":"10,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103876","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Redtop Agrostis alba","License_Type":"351(a)","Strength":"1,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103876","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Redtop Agrostis alba","License_Type":"351(a)","Strength":"100,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103876","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Redtop Agrostis alba","License_Type":"351(a)","Strength":"100BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103876","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Redtop Agrostis alba","License_Type":"351(a)","Strength":"10,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103877","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Ryegrass, Perennial Lolium perenne","License_Type":"351(a)","Strength":"100,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103877","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Ryegrass, Perennial Lolium perenne","License_Type":"351(a)","Strength":"10,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103877","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Ryegrass, Perennial Lolium perenne","License_Type":"351(a)","Strength":"1,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103877","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Ryegrass, Perennial Lolium perenne","License_Type":"351(a)","Strength":"100,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103877","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Ryegrass, Perennial Lolium perenne","License_Type":"351(a)","Strength":"100BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103877","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Ryegrass, Perennial Lolium perenne","License_Type":"351(a)","Strength":"10,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103878","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Sweet Vernal Grass Anthoxanthum odoratum","License_Type":"351(a)","Strength":"100,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103878","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Sweet Vernal Grass Anthoxanthum odoratum","License_Type":"351(a)","Strength":"10,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103878","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Sweet Vernal Grass Anthoxanthum odoratum","License_Type":"351(a)","Strength":"1,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103878","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Sweet Vernal Grass Anthoxanthum odoratum","License_Type":"351(a)","Strength":"100,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103878","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Sweet Vernal Grass Anthoxanthum odoratum","License_Type":"351(a)","Strength":"100BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103878","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Sweet Vernal Grass Anthoxanthum odoratum","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103879","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Timothy Phleum pratense","License_Type":"351(a)","Strength":"100,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103879","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Timothy Phleum pratense","License_Type":"351(a)","Strength":"10,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103879","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Timothy Phleum pratense","License_Type":"351(a)","Strength":"1,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103879","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Timothy Phleum pratense","License_Type":"351(a)","Strength":"100,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103879","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Timothy Phleum pratense","License_Type":"351(a)","Strength":"100BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103879","Proprietary_Name":null,"Proper_Name":"Pollens - Grasses, Timothy Phleum pratense","License_Type":"351(a)","Strength":"10,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103880","Proprietary_Name":null,"Proper_Name":"Pollens - Weeds and Garden Plants, Ragweed, Short Ambrosia artemisiifolia","License_Type":"351(a)","Strength":"1:20W\/V","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103880","Proprietary_Name":null,"Proper_Name":"Pollens - Weeds and Garden Plants, Ragweed, Short Ambrosia artemisiifolia","License_Type":"351(a)","Strength":"1:20W\/V","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103880","Proprietary_Name":null,"Proper_Name":"Pollens - Weeds and Garden Plants, Ragweed, Short Ambrosia artemisiifolia","License_Type":"351(a)","Strength":"1:20W\/V","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103882","Proprietary_Name":null,"Proper_Name":"Venoms, Honey Bee Venom","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103882","Proprietary_Name":null,"Proper_Name":"Venoms, Honey Bee Venom","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103882","Proprietary_Name":null,"Proper_Name":"Venoms, Honey Bee Venom","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103882","Proprietary_Name":null,"Proper_Name":"Venoms, Honey Bee Venom","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103883","Proprietary_Name":null,"Proper_Name":"Venoms, Mixed Vespid Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103883","Proprietary_Name":null,"Proper_Name":"Venoms, Mixed Vespid Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103884","Proprietary_Name":null,"Proper_Name":"Venoms, Wasp Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103884","Proprietary_Name":null,"Proper_Name":"Venoms, Wasp Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103884","Proprietary_Name":null,"Proper_Name":"Venoms, Wasp Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103884","Proprietary_Name":null,"Proper_Name":"Venoms, Wasp Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103885","Proprietary_Name":null,"Proper_Name":"Venoms, White Faced Hornet Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103885","Proprietary_Name":null,"Proper_Name":"Venoms, White Faced Hornet Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103885","Proprietary_Name":null,"Proper_Name":"Venoms, White Faced Hornet Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103885","Proprietary_Name":null,"Proper_Name":"Venoms, White Faced Hornet Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103886","Proprietary_Name":null,"Proper_Name":"Venoms, Yellow Hornet Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103886","Proprietary_Name":null,"Proper_Name":"Venoms, Yellow Hornet Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103886","Proprietary_Name":null,"Proper_Name":"Venoms, Yellow Hornet Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103886","Proprietary_Name":null,"Proper_Name":"Venoms, Yellow Hornet Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103887","Proprietary_Name":null,"Proper_Name":"Venoms, Yellow Jacket Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103887","Proprietary_Name":null,"Proper_Name":"Venoms, Yellow Jacket Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103887","Proprietary_Name":null,"Proper_Name":"Venoms, Yellow Jacket Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103887","Proprietary_Name":null,"Proper_Name":"Venoms, Yellow Jacket Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103889","Proprietary_Name":null,"Proper_Name":"Animal Allergens, Standardized Cat Hair","License_Type":"351(a)","Strength":"10,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103889","Proprietary_Name":null,"Proper_Name":"Animal Allergens, Standardized Cat Hair","License_Type":"351(a)","Strength":"10,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103889","Proprietary_Name":null,"Proper_Name":"Animal Allergens, Standardized Cat Hair","License_Type":"351(a)","Strength":"10,000BAU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103890","Proprietary_Name":null,"Proper_Name":"Animal Allergens, Standardized Cat Pelt","License_Type":"351(a)","Strength":"10,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103890","Proprietary_Name":null,"Proper_Name":"Animal Allergens, Standardized Cat Pelt","License_Type":"351(a)","Strength":"10,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103890","Proprietary_Name":null,"Proper_Name":"Animal Allergens, Standardized Cat Pelt","License_Type":"351(a)","Strength":"10,000BAU\/ML ","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Jubilant HollisterStier LLC","BLA_Number":"103891","Proprietary_Name":null,"Proper_Name":"Positive Skin Test Control-Histamine","License_Type":"351(a)","Strength":"6MG\/ML","Dosage_Form":"Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Dropper Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/1924","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1272","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Wyeth Pharmaceuticals LLC","BLA_Number":"103905","Proprietary_Name":"prevnar","Proper_Name":"Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein)","License_Type":"351(a)","Strength":"0.5ML\/VIAL","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Voluntarily Revoked","Approval_Date":"2\/17\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"3","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline Biologicals","BLA_Number":"103907","Proprietary_Name":"Pediarix","Proper_Name":"DTaP & Hepatitis B (Recombinant) & Inactivated Polio Virus Vaccine","License_Type":"351(a)","Strength":"0.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/13\/2002","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1617","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"BTG International Inc.","BLA_Number":"103910","Proprietary_Name":"Digifab","Proper_Name":"Digoxin Immune Fab (Ovine)","License_Type":"351(a)","Strength":"40MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/31\/2001","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1861","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Inc.","BLA_Number":"103913","Proprietary_Name":null,"Proper_Name":"Tetanus Toxoid Adsorbed","License_Type":"351(a)","Strength":"5LF\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Vial","Status":"Rx","Licensure":"Voluntarily Revoked","Approval_Date":"12\/9\/1999","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"1725","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Inc.","BLA_Number":"103914","Proprietary_Name":"Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent","Proper_Name":"Influenza Virus Vaccine","License_Type":"351(a)","Strength":"240UG\/.7ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/4\/2019","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":" ","Supplement_Number":"6290","Submission_Type":"Supplement","License_Number":"1725","Product_Number":"9","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Inc.","BLA_Number":"103914","Proprietary_Name":"Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent","Proper_Name":"Influenza Virus Vaccine","License_Type":"351(a)","Strength":"36UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/11\/2014","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5733","Submission_Type":"Supplement","License_Number":"1725","Product_Number":"8","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Inc.","BLA_Number":"103914","Proprietary_Name":"Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent","Proper_Name":"Influenza Virus Vaccine","License_Type":"351(a)","Strength":"60UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/7\/2013","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5574","Submission_Type":"Supplement","License_Number":"1725","Product_Number":"7","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Inc.","BLA_Number":"103914","Proprietary_Name":"Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent","Proper_Name":"Influenza Virus Vaccine","License_Type":"351(a)","Strength":"60UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/7\/2013","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5574","Submission_Type":"Supplement","License_Number":"1725","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Inc.","BLA_Number":"103914","Proprietary_Name":"Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent","Proper_Name":"Influenza Virus Vaccine","License_Type":"351(a)","Strength":"60UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/7\/2013","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5574","Submission_Type":"Supplement","License_Number":"1725","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Inc.","BLA_Number":"103914","Proprietary_Name":"Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent","Proper_Name":"Influenza Virus Vaccine","License_Type":"351(a)","Strength":"27UG\/0.1","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"5\/9\/2011","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5369","Submission_Type":"Supplement","License_Number":"1725","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Inc.","BLA_Number":"103914","Proprietary_Name":"Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent","Proper_Name":"Influenza Virus Vaccine","License_Type":"351(a)","Strength":"180 UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/23\/2009","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5240","Submission_Type":"Supplement","License_Number":"1725","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Inc.","BLA_Number":"103914","Proprietary_Name":"Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent","Proper_Name":"Influenza Virus Vaccine","License_Type":"351(a)","Strength":"45UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/9\/1999","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1725","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Inc.","BLA_Number":"103914","Proprietary_Name":"Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent","Proper_Name":"Influenza Virus Vaccine","License_Type":"351(a)","Strength":"45UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/9\/1999","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1725","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Inc.","BLA_Number":"103915","Proprietary_Name":"Yf-Vax","Proper_Name":"Yellow Fever Vaccine","License_Type":"351(a)","Strength":"4.74PFU\/.5ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/9\/1999","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1725","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Inc.","BLA_Number":"103915","Proprietary_Name":"Yf-Vax","Proper_Name":"Yellow Fever Vaccine","License_Type":"351(a)","Strength":"23.7PFU\/.5ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/9\/1999","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1725","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Inc.","BLA_Number":"103919","Proprietary_Name":null,"Proper_Name":"Diphtheria & Tetanus Toxoids Adsorbed","License_Type":"351(a)","Strength":"6.6; 5 UNITS","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Vial","Status":"Rx","Licensure":"Voluntarily Revoked","Approval_Date":"12\/9\/1999","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"1725","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Inc.","BLA_Number":"103921","Proprietary_Name":null,"Proper_Name":"Tetanus and Diphtheria Toxoids Adsorbed","License_Type":"351(a)","Strength":"2.5LF, 5LF, 2.5UG, 8UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Voluntarily Revoked","Approval_Date":"12\/9\/1999","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"1725","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Inc.","BLA_Number":"103921","Proprietary_Name":null,"Proper_Name":"Tetanus and Diphtheria Toxoids Adsorbed","License_Type":"351(a)","Strength":"2.5LF, 5LF, 2.5UG, 8UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Voluntarily Revoked","Approval_Date":"12\/9\/1999","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"1725","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Inc.","BLA_Number":"103922","Proprietary_Name":"Tripedia","Proper_Name":"Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed","License_Type":"351(a)","Strength":"6.7LF, 5LF, 46.8UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Vial","Status":"Rx","Licensure":"Voluntarily Revoked","Approval_Date":"12\/9\/1999","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"1725","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Inc.","BLA_Number":"103923","Proprietary_Name":"Menomune-C","Proper_Name":"Meningococcal Polysaccharide Vaccine, Group C","License_Type":"351(a)","Strength":"0.5ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"12\/9\/1999","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1725","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Inc.","BLA_Number":"103924","Proprietary_Name":"Menomune-A","Proper_Name":"Meningococcal Polysaccharide Vaccine, Group A","License_Type":"351(a)","Strength":"0.5ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"12\/9\/1999","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1725","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Inc.","BLA_Number":"103925","Proprietary_Name":"Menomune-A\/C","Proper_Name":"Meningococcal Polysaccharide Vaccine, Groups A and C Combined","License_Type":"351(a)","Strength":"50UG\/.5ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"12\/9\/1999","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1725","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Inc.","BLA_Number":"103925","Proprietary_Name":"Menomune-A\/C","Proper_Name":"Meningococcal Polysaccharide Vaccine, Groups A and C Combined","License_Type":"351(a)","Strength":"50UG\/.5ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"12\/9\/1999","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1725","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Inc.","BLA_Number":"103926","Proprietary_Name":"Menomune","Proper_Name":"Meningococcal Polysaccharide Vaccine, Groups A, C, Y, and W-135 Combined","License_Type":"351(a)","Strength":"50UG\/.5ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"12\/9\/1999","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1725","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur SA","BLA_Number":"103930","Proprietary_Name":"Ipol","Proper_Name":"Poliovirus Vaccine Inactivated","License_Type":"351(a)","Strength":"32\/40\/8 DAU\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/4\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1724","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur SA","BLA_Number":"103930","Proprietary_Name":"Ipol","Proper_Name":"Poliovirus Vaccine Inactivated","License_Type":"351(a)","Strength":"32\/40\/8 DAU\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/4\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1724","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur SA","BLA_Number":"103931","Proprietary_Name":"Imovax Rabies","Proper_Name":"Rabies Vaccine","License_Type":"351(a)","Strength":"(IM) 2.5IU\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/4\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1724","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"Sanofi Pasteur SA","BLA_Number":"103932","Proprietary_Name":"Imogam","Proper_Name":"Rabies Immune Globulin (Human)","License_Type":"351(a)","Strength":"150IU\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"3\/6\/2001","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5000","Submission_Type":"Supplement","License_Number":"1724","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur SA","BLA_Number":"103935","Proprietary_Name":"Acthib,Omnihib","Proper_Name":"Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)","License_Type":"351(a)","Strength":"24UG","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/4\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1724","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur SA","BLA_Number":"103936","Proprietary_Name":"Typhim Vi","Proper_Name":"Typhoid Vi Polysaccharide Vaccine","License_Type":"351(a)","Strength":"25UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/4\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1724","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur SA","BLA_Number":"103936","Proprietary_Name":"Typhim Vi","Proper_Name":"Typhoid Vi Polysaccharide Vaccine","License_Type":"351(a)","Strength":"50UG\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/4\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1724","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Limited","BLA_Number":"103937","Proprietary_Name":null,"Proper_Name":"Botulism Antitoxin Bivalent (Equine) Types A and B.","License_Type":"351(a)","Strength":"5000IU","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Rx","Licensure":"Voluntarily Revoked","Approval_Date":"2\/24\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"1726","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Limited","BLA_Number":"103940","Proprietary_Name":"Poliovax","Proper_Name":"Poliovirus Vaccine Inactivated (Human Diploid Cell)","License_Type":"351(a)","Strength":"0.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"2\/24\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1726","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Limited","BLA_Number":"103940","Proprietary_Name":"Poliovax","Proper_Name":"Poliovirus Vaccine Inactivated (Human Diploid Cell)","License_Type":"351(a)","Strength":"0.5ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"2\/24\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1726","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Limited","BLA_Number":"103941","Proprietary_Name":"Tubersol","Proper_Name":"Tuberculin, Purified Protein Derivative","License_Type":"351(a)","Strength":"5TU\/.1ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/24\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1726","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Limited","BLA_Number":"103942","Proprietary_Name":"Mycobax","Proper_Name":"BCG Vaccine","License_Type":"351(a)","Strength":"1.5MG","Dosage_Form":"For Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Voluntarily Revoked","Approval_Date":"2\/24\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"1726","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Limited","BLA_Number":"103943","Proprietary_Name":"TheraCys","Proper_Name":"BCG Live","License_Type":"351(a)","Strength":"81MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravesical","Product_Presentation":"Vial","Status":"Rx","Licensure":"Voluntarily Revoked","Approval_Date":"2\/24\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"1726","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Limited","BLA_Number":"103944","Proprietary_Name":null,"Proper_Name":"Diphtheria & Tetanus Toxoids Adsorbed","License_Type":"351(a)","Strength":"25\/LF\/5LF\/0.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"2\/24\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1726","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ADMA Biologics, Inc.","BLA_Number":"103945","Proprietary_Name":"Nabi-HB","Proper_Name":"Hepatitis B Immune Globulin (Human)","License_Type":"351(a)","Strength":"1560IU\/5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/23\/2001","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2019","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ADMA Biologics, Inc.","BLA_Number":"103945","Proprietary_Name":"Nabi-HB","Proper_Name":"Hepatitis B Immune Globulin (Human)","License_Type":"351(a)","Strength":"312IU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/23\/2001","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2019","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring LLC","BLA_Number":"103953","Proprietary_Name":"Monoclate, Monoclate-P","Proper_Name":"Antihemophilic Factor (Human)","License_Type":"351(a)","Strength":"1500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"3\/4\/2004","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"5074","Submission_Type":"Supplement","License_Number":"1767","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring LLC","BLA_Number":"103953","Proprietary_Name":"Monoclate, Monoclate-P","Proper_Name":"Antihemophilic Factor (Human)","License_Type":"351(a)","Strength":"250IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"5\/14\/2003","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"1000","Submission_Type":"Supplement","License_Number":"1767","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring LLC","BLA_Number":"103953","Proprietary_Name":"Monoclate, Monoclate-P","Proper_Name":"Antihemophilic Factor (Human)","License_Type":"351(a)","Strength":"1000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"5\/14\/2003","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"1000","Submission_Type":"Supplement","License_Number":"1767","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring LLC","BLA_Number":"103953","Proprietary_Name":"Monoclate, Monoclate-P","Proper_Name":"Antihemophilic Factor (Human)","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"5\/14\/2003","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"1000","Submission_Type":"Supplement","License_Number":"1767","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring LLC","BLA_Number":"103955","Proprietary_Name":"Albuminar, Albuminar-20, Albuminar-25, Albuminar-5","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"25G\/500ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"7\/17\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1767","Product_Number":"8","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring LLC","BLA_Number":"103955","Proprietary_Name":"Albuminar, Albuminar-20, Albuminar-25, Albuminar-5","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"12.5G\/250ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"7\/17\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1767","Product_Number":"7","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring LLC","BLA_Number":"103955","Proprietary_Name":"Albuminar, Albuminar-20, Albuminar-25, Albuminar-5","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"12.5G\/50ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"7\/17\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1767","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring LLC","BLA_Number":"103955","Proprietary_Name":"Albuminar, Albuminar-20, Albuminar-25, Albuminar-5","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"2.5G\/50ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"3\/17\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1767","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring LLC","BLA_Number":"103955","Proprietary_Name":"Albuminar, Albuminar-20, Albuminar-25, Albuminar-5","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"5G\/20ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"3\/17\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1767","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring LLC","BLA_Number":"103955","Proprietary_Name":"Albuminar, Albuminar-20, Albuminar-25, Albuminar-5","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"25G\/100ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"7\/17\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1767","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring LLC","BLA_Number":"103955","Proprietary_Name":"Albuminar, Albuminar-20, Albuminar-25, Albuminar-5","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"20G\/100ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"3\/17\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1767","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring LLC","BLA_Number":"103955","Proprietary_Name":"Albuminar, Albuminar-20, Albuminar-25, Albuminar-5","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"10G\/50ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"3\/17\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1767","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring LLC","BLA_Number":"103956","Proprietary_Name":"gammar i.v.,gammar-p i.v.","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"1G","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"3\/17\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"1767","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring LLC","BLA_Number":"103956","Proprietary_Name":"gammar i.v.,gammar-p i.v.","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"2.5G","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"3\/17\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"1767","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring LLC","BLA_Number":"103956","Proprietary_Name":"gammar i.v.,gammar-p i.v.","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"5G","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"3\/17\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"1767","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring LLC","BLA_Number":"103956","Proprietary_Name":"gammar i.v.,gammar-p i.v.","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"10G","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"3\/17\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"1767","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring LLC","BLA_Number":"103957","Proprietary_Name":"Mononine","Proper_Name":"Coagulation Factor IX (Human)","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"3\/17\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1767","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"8\/20\/1999"},{"N\/R\/U":null,"Applicant":"CSL Behring LLC","BLA_Number":"103957","Proprietary_Name":"Mononine","Proper_Name":"Coagulation Factor IX (Human)","License_Type":"351(a)","Strength":"1000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"3\/17\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1767","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"8\/20\/1999"},{"N\/R\/U":null,"Applicant":"CSL Behring GmbH","BLA_Number":"103960","Proprietary_Name":"Humate-P","Proper_Name":"Antihemophilic Factor\/von Willebrand Factor Complex (Human)","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/11\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1765","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"4\/1\/2006"},{"N\/R\/U":null,"Applicant":"CSL Behring GmbH","BLA_Number":"103960","Proprietary_Name":"Humate-P","Proper_Name":"Antihemophilic Factor\/von Willebrand Factor Complex (Human)","License_Type":"351(a)","Strength":"250IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/11\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1765","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"4\/1\/2006"},{"N\/R\/U":null,"Applicant":"CSL Behring GmbH","BLA_Number":"103960","Proprietary_Name":"Humate-P","Proper_Name":"Antihemophilic Factor\/von Willebrand Factor Complex (Human)","License_Type":"351(a)","Strength":"1000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/11\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1765","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"4\/1\/2006"},{"N\/R\/U":"U","Applicant":"ALK - Abello A\/S","BLA_Number":"103969","Proprietary_Name":"Pharmalgen","Proper_Name":"Venoms, Honey Bee Venom","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"10\/8\/1991","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1292","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"ALK - Abello A\/S","BLA_Number":"103969","Proprietary_Name":"Pharmalgen","Proper_Name":"Venoms, Honey Bee Venom","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"10\/8\/1991","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1292","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"ALK - Abello A\/S","BLA_Number":"103970","Proprietary_Name":"Pharmalgen","Proper_Name":"Venoms, Mixed Vespid Venom Protein","License_Type":"351(a)","Strength":"300UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"10\/8\/1991","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1292","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"ALK - Abello A\/S","BLA_Number":"103970","Proprietary_Name":"Pharmalgen","Proper_Name":"Venoms, Mixed Vespid Venom Protein","License_Type":"351(a)","Strength":"300UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"10\/8\/1991","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1292","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"ALK - Abello A\/S","BLA_Number":"103971","Proprietary_Name":"Pharmalgen","Proper_Name":"Venoms, Wasp Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"10\/8\/1991","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1292","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"ALK - Abello A\/S","BLA_Number":"103971","Proprietary_Name":"Pharmalgen","Proper_Name":"Venoms, Wasp Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"10\/8\/1991","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1292","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"ALK - Abello A\/S","BLA_Number":"103972","Proprietary_Name":"Pharmalgen","Proper_Name":"Venoms, White Faced Hornet Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"10\/8\/1991","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1292","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"ALK - Abello A\/S","BLA_Number":"103972","Proprietary_Name":"Pharmalgen","Proper_Name":"Venoms, White Faced Hornet Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"10\/8\/1991","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1292","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"ALK - Abello A\/S","BLA_Number":"103973","Proprietary_Name":"Pharmalgen","Proper_Name":"Venoms, Yellow Hornet Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"10\/8\/1991","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1292","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"ALK - Abello A\/S","BLA_Number":"103973","Proprietary_Name":"Pharmalgen","Proper_Name":"Venoms, Yellow Hornet Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"10\/8\/1991","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1292","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"ALK - Abello A\/S","BLA_Number":"103974","Proprietary_Name":"Pharmalgen","Proper_Name":"Venoms, Yellow Jacket Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"10\/8\/1991","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1292","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"ALK - Abello A\/S","BLA_Number":"103974","Proprietary_Name":"Pharmalgen","Proper_Name":"Venoms, Yellow Jacket Venom Protein","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"10\/8\/1991","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1292","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Baxter Healthcare Corporation","BLA_Number":"103980","Proprietary_Name":"Tisseel","Proper_Name":"Fibrin Sealant (Tisseel)","License_Type":"351(a)","Strength":"4ML","Dosage_Form":"For Injection","Route_of_Administration":"Topical","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/7\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"140","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Baxter Healthcare Corporation","BLA_Number":"103980","Proprietary_Name":"Tisseel","Proper_Name":"Fibrin Sealant (Tisseel)","License_Type":"351(a)","Strength":"4ML","Dosage_Form":"For Injection","Route_of_Administration":"Topical","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/7\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"140","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Baxter Healthcare Corporation","BLA_Number":"103980","Proprietary_Name":"Tisseel","Proper_Name":"Fibrin Sealant (Tisseel)","License_Type":"351(a)","Strength":"2ML","Dosage_Form":"For Injection","Route_of_Administration":"Topical","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/7\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"140","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Baxter Healthcare Corporation","BLA_Number":"103980","Proprietary_Name":"Tisseel","Proper_Name":"Fibrin Sealant (Tisseel)","License_Type":"351(a)","Strength":"2ML","Dosage_Form":"For Injection","Route_of_Administration":"Topical","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/7\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"140","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Baxter Healthcare Corporation","BLA_Number":"103980","Proprietary_Name":"Tisseel","Proper_Name":"Fibrin Sealant (Tisseel)","License_Type":"351(a)","Strength":"10ML","Dosage_Form":"For Injection","Route_of_Administration":"Topical","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/7\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"140","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Baxter Healthcare Corporation","BLA_Number":"103980","Proprietary_Name":"Tisseel","Proper_Name":"Fibrin Sealant (Tisseel)","License_Type":"351(a)","Strength":"10ML","Dosage_Form":"For Injection","Route_of_Administration":"Topical","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/7\/2000","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"140","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Omrix Biopharmaceuticals Ltd","BLA_Number":"125010","Proprietary_Name":"Crosseal, Evicel","Proper_Name":"Fibrin Sealant (Human)","License_Type":"351(a)","Strength":"2ML","Dosage_Form":"Spray","Route_of_Administration":"Topical","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"3\/21\/2003","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1603","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Omrix Biopharmaceuticals Ltd","BLA_Number":"125010","Proprietary_Name":"Crosseal, Evicel","Proper_Name":"Fibrin Sealant (Human)","License_Type":"351(a)","Strength":"1ML","Dosage_Form":"Spray","Route_of_Administration":"Topical","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"3\/21\/2003","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1603","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Omrix Biopharmaceuticals Ltd","BLA_Number":"125010","Proprietary_Name":"Crosseal, Evicel","Proper_Name":"Fibrin Sealant (Human)","License_Type":"351(a)","Strength":"5ML","Dosage_Form":"Spray","Route_of_Administration":"Topical","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"3\/21\/2003","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1603","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"MedImmune, LLC","BLA_Number":"125020","Proprietary_Name":"Flumist, Flumist Quad","Proper_Name":"Influenza Vaccine Live, Intranasal","License_Type":"351(a)","Strength":"0.2ML","Dosage_Form":"Suspension","Route_of_Administration":"Nasal","Product_Presentation":"Pump Spray","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/29\/2012","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"1668","Submission_Type":"Supplement","License_Number":"1799","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"MedImmune, LLC","BLA_Number":"125020","Proprietary_Name":"Flumist, Flumist Quad","Proper_Name":"Influenza Vaccine Live, Intranasal","License_Type":"351(a)","Strength":"10X6.5-7.5 TCID","Dosage_Form":"Suspension","Route_of_Administration":"Nasal","Product_Presentation":"Pump Spray","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/17\/2003","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1799","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"California Department of Public Health (CDPH)","BLA_Number":"125034","Proprietary_Name":"BabyBig","Proper_Name":"Botulism Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"100MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/23\/2003","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1797","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"10\/23\/2010"},{"N\/R\/U":null,"Applicant":"Kamada Ltd.","BLA_Number":"125035","Proprietary_Name":"Hepagam B","Proper_Name":"Hepatitis B Immune Globulin (Human)","License_Type":"351(a)","Strength":">312IU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/27\/2006","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1826","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"4\/6\/2014"},{"N\/R\/U":null,"Applicant":"Kamada Ltd.","BLA_Number":"125035","Proprietary_Name":"Hepagam B","Proper_Name":"Hepatitis B Immune Globulin (Human)","License_Type":"351(a)","Strength":">1560IU\/5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/27\/2006","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1826","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"4\/6\/2014"},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125039","Proprietary_Name":"Aralast, Aralast Np","Proper_Name":"Alpha-1-Proteinase Inhibitor (Human)","License_Type":"351(a)","Strength":"1.0G","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/23\/2002","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125039","Proprietary_Name":"Aralast, Aralast Np","Proper_Name":"Alpha-1-Proteinase Inhibitor (Human)","License_Type":"351(a)","Strength":"0.5G","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/23\/2002","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"125046","Proprietary_Name":"Gammaked, Gamunex-C","Proper_Name":"Immune Globulin Injection (Human) 10% Caprylate\/Chromatography Purified","License_Type":"351(a)","Strength":"40G","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/27\/2003","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"11","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/12\/2015"},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"125046","Proprietary_Name":"Gammaked, Gamunex-C","Proper_Name":"Immune Globulin Injection (Human) 10% Caprylate\/Chromatography Purified","License_Type":"351(a)","Strength":"20G","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/27\/2003","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"10","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/12\/2015"},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"125046","Proprietary_Name":"Gammaked, Gamunex-C","Proper_Name":"Immune Globulin Injection (Human) 10% Caprylate\/Chromatography Purified","License_Type":"351(a)","Strength":"10G","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/27\/2003","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"9","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/12\/2015"},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"125046","Proprietary_Name":"Gammaked, Gamunex-C","Proper_Name":"Immune Globulin Injection (Human) 10% Caprylate\/Chromatography Purified","License_Type":"351(a)","Strength":"5G","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/27\/2003","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"8","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/12\/2015"},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"125046","Proprietary_Name":"Gammaked, Gamunex-C","Proper_Name":"Immune Globulin Injection (Human) 10% Caprylate\/Chromatography Purified","License_Type":"351(a)","Strength":"2.5G","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/27\/2003","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"7","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/12\/2015"},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"125046","Proprietary_Name":"Gammaked, Gamunex-C","Proper_Name":"Immune Globulin Injection (Human) 10% Caprylate\/Chromatography Purified","License_Type":"351(a)","Strength":"40G","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/27\/2003","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/12\/2015"},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"125046","Proprietary_Name":"Gammaked, Gamunex-C","Proper_Name":"Immune Globulin Injection (Human) 10% Caprylate\/Chromatography Purified","License_Type":"351(a)","Strength":"20G","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/27\/2003","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/12\/2015"},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"125046","Proprietary_Name":"Gammaked, Gamunex-C","Proper_Name":"Immune Globulin Injection (Human) 10% Caprylate\/Chromatography Purified","License_Type":"351(a)","Strength":"1G","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/27\/2003","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/12\/2015"},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"125046","Proprietary_Name":"Gammaked, Gamunex-C","Proper_Name":"Immune Globulin Injection (Human) 10% Caprylate\/Chromatography Purified","License_Type":"351(a)","Strength":"10G","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/27\/2003","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/12\/2015"},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"125046","Proprietary_Name":"Gammaked, Gamunex-C","Proper_Name":"Immune Globulin Injection (Human) 10% Caprylate\/Chromatography Purified","License_Type":"351(a)","Strength":"5G","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/27\/2003","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/12\/2015"},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"125046","Proprietary_Name":"Gammaked, Gamunex-C","Proper_Name":"Immune Globulin Injection (Human) 10% Caprylate\/Chromatography Purified","License_Type":"351(a)","Strength":"2.5G","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/27\/2003","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/12\/2015"},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125062","Proprietary_Name":"Octagam","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"10% 10G","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/11\/2014","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"234","Submission_Type":"Supplement","License_Number":"1646","Product_Number":"9","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/15\/2028"},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125062","Proprietary_Name":"Octagam","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"10% 2G","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/11\/2014","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"234","Submission_Type":"Supplement","License_Number":"1646","Product_Number":"8","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/15\/2028"},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125062","Proprietary_Name":"Octagam","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"10% 5G","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/11\/2014","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"234","Submission_Type":"Supplement","License_Number":"1646","Product_Number":"7","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/15\/2028"},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125062","Proprietary_Name":"Octagam","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"10% 20G","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/11\/2014","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"234","Submission_Type":"Supplement","License_Number":"1646","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/15\/2028"},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125062","Proprietary_Name":"Octagam","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"5%  25G","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/26\/2007","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"124","Submission_Type":"Supplement","License_Number":"1646","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/15\/2028"},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125062","Proprietary_Name":"Octagam","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"5%  2.5G","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/21\/2004","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1646","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/15\/2028"},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125062","Proprietary_Name":"Octagam","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"5%  10G","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/21\/2004","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1646","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/15\/2028"},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125062","Proprietary_Name":"Octagam","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"5% 1.0G","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/21\/2004","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1646","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/15\/2028"},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125062","Proprietary_Name":"Octagam","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"5% 5.0G","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/21\/2004","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1646","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"7\/15\/2028"},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125063","Proprietary_Name":"Advate","Proper_Name":"Antihemophilic Factor (Recombinant), Plasma\/Albumin Free Method","License_Type":"351(a)","Strength":"4,000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/12\/2012","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"948","Submission_Type":"Supplement","License_Number":"1898","Product_Number":"7","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125063","Proprietary_Name":"Advate","Proper_Name":"Antihemophilic Factor (Recombinant), Plasma\/Albumin Free Method","License_Type":"351(a)","Strength":"3000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/3\/2007","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"279","Submission_Type":"Supplement","License_Number":"1898","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125063","Proprietary_Name":"Advate","Proper_Name":"Antihemophilic Factor (Recombinant), Plasma\/Albumin Free Method","License_Type":"351(a)","Strength":"2000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/12\/2006","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"135","Submission_Type":"Supplement","License_Number":"1898","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125063","Proprietary_Name":"Advate","Proper_Name":"Antihemophilic Factor (Recombinant), Plasma\/Albumin Free Method","License_Type":"351(a)","Strength":"1000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/25\/2003","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125063","Proprietary_Name":"Advate","Proper_Name":"Antihemophilic Factor (Recombinant), Plasma\/Albumin Free Method","License_Type":"351(a)","Strength":"250IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/25\/2003","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125063","Proprietary_Name":"Advate","Proper_Name":"Antihemophilic Factor (Recombinant), Plasma\/Albumin Free Method","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/25\/2003","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125063","Proprietary_Name":"Advate","Proper_Name":"Antihemophilic Factor (Recombinant), Plasma\/Albumin Free Method","License_Type":"351(a)","Strength":"1500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/25\/2003","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring AG","BLA_Number":"125070","Proprietary_Name":"Rhophylac","Proper_Name":"Rho(D) Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"1500IU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/12\/2004","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1766","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring AG","BLA_Number":"125070","Proprietary_Name":"Rhophylac","Proper_Name":"Rho(D) Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"1500IU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/12\/2004","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1766","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Instituto Grifols, S.A.","BLA_Number":"125077","Proprietary_Name":"Flebogamma 5%, Flebogamma 5% Dif","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"5% 20G","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/21\/2006","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"47","Submission_Type":"Supplement","License_Number":"1181","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Instituto Grifols, S.A.","BLA_Number":"125077","Proprietary_Name":"Flebogamma 5%, Flebogamma 5% Dif","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"10%  5,10,20G","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/27\/2010","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"146","Submission_Type":"Supplement","License_Number":"1181","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Instituto Grifols, S.A.","BLA_Number":"125077","Proprietary_Name":"Flebogamma 5%, Flebogamma 5% Dif","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"5% .5,2.5, 5,10G","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/15\/2003","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1181","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring LLC","BLA_Number":"125078","Proprietary_Name":"Zemaira","Proper_Name":"Alpha-1-Proteinase Inhibitor (Human)","License_Type":"351(a)","Strength":"5000MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/16\/2019","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"818","Submission_Type":"Supplement","License_Number":"1767","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring LLC","BLA_Number":"125078","Proprietary_Name":"Zemaira","Proper_Name":"Alpha-1-Proteinase Inhibitor (Human)","License_Type":"351(a)","Strength":"4000MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/16\/2019","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"818","Submission_Type":"Supplement","License_Number":"1767","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring LLC","BLA_Number":"125078","Proprietary_Name":"Zemaira","Proper_Name":"Alpha-1-Proteinase Inhibitor (Human)","License_Type":"351(a)","Strength":"1000MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/8\/2003","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1767","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Inc.","BLA_Number":"125089","Proprietary_Name":"Menactra","Proper_Name":"Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine","License_Type":"351(a)","Strength":"48UG\/.5ML","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/14\/2005","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1725","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125105","Proprietary_Name":"Gammagard Liquid","Proper_Name":"Immune Globulin Infusion (Human)","License_Type":"351(a)","Strength":"10% MG\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous, Subcutaneous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/27\/2005","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/22\/2019"},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline Biologicals","BLA_Number":"125106","Proprietary_Name":"Boostrix","Proper_Name":"Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed","License_Type":"351(a)","Strength":"2.5LF, 5LF, 2.5UG, 8UG UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/3\/2005","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1617","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline Biologicals","BLA_Number":"125106","Proprietary_Name":"Boostrix","Proper_Name":"Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed","License_Type":"351(a)","Strength":"2.5LF, 5LF, 2.5UG, 8UG UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/3\/2005","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1617","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"125108","Proprietary_Name":"Proquad","Proper_Name":"Measles, Mumps, Rubella and Varicella Virus Vaccine Live","License_Type":"351(a)","Strength":"0.5ML","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/27\/2023","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"1128","Submission_Type":"Supplement","License_Number":"2","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"125108","Proprietary_Name":"Proquad","Proper_Name":"Measles, Mumps, Rubella and Varicella Virus Vaccine Live","License_Type":"351(a)","Strength":"0.5ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/6\/2005","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Emergent BioSolutions Canada Inc.","BLA_Number":"125109","Proprietary_Name":"Cnj-016","Proper_Name":"Vaccinia Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":">=50,000U","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/2\/2005","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2084","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Limited","BLA_Number":"125111","Proprietary_Name":"Adacel","Proper_Name":"Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed","License_Type":"351(a)","Strength":"0.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/10\/2005","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1726","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring GmbH","BLA_Number":"125115","Proprietary_Name":"Vivaglobin","Proper_Name":"Immune Globulin Subcutaneous (Human)","License_Type":"351(a)","Strength":"160MG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"1\/9\/2006","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"1765","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"125122","Proprietary_Name":"Rotateq","Proper_Name":"Rotavirus Vaccine, Live, Oral, Pentavalent","License_Type":"351(a)","Strength":"2.2X10E6 IU","Dosage_Form":"Suspension","Route_of_Administration":"Oral","Product_Presentation":"Tube","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/3\/2006","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"125123","Proprietary_Name":"Zostavax","Proper_Name":"Zoster Vaccine Live","License_Type":"351(a)","Strength":"0.65ML ","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"5\/25\/2006","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"125126","Proprietary_Name":"Gardasil","Proper_Name":"Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant","License_Type":"351(a)","Strength":"120MCG L1 PROTEIN FROM HPV 6, 11, 16 AND 18 UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/8\/2006","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline Biologicals","BLA_Number":"125127","Proprietary_Name":"Fluarix, Fluarix Quadrivalent","Proper_Name":"Influenza Virus Vaccine","License_Type":"351(a)","Strength":"60UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/14\/2012","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"513","Submission_Type":"Supplement","License_Number":"1617","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline Biologicals","BLA_Number":"125127","Proprietary_Name":"Fluarix, Fluarix Quadrivalent","Proper_Name":"Influenza Virus Vaccine","License_Type":"351(a)","Strength":"45UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"8\/31\/2005","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1617","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Limited","BLA_Number":"125145","Proprietary_Name":"Pentacel","Proper_Name":"Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine","License_Type":"351(a)","Strength":"0.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/20\/2008","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1726","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125154","Proprietary_Name":null,"Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"12.5G\/50ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/17\/2006","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1646","Product_Number":"7","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125154","Proprietary_Name":null,"Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"20G\/100ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/27\/2007","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"17","Submission_Type":"Supplement","License_Number":"1646","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125154","Proprietary_Name":null,"Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"25G\/500ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/17\/2006","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1646","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125154","Proprietary_Name":null,"Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"25G\/100ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/17\/2006","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1646","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125154","Proprietary_Name":null,"Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"10G\/50ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/27\/2007","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"17","Submission_Type":"Supplement","License_Number":"1646","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125154","Proprietary_Name":null,"Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"5G\/100ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/17\/2006","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1646","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125154","Proprietary_Name":null,"Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"12.5G\/250ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/17\/2006","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1646","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Emergent Product Development Gaithersburg, Inc.","BLA_Number":"125158","Proprietary_Name":"Acam2000","Proper_Name":"Smallpox (Vaccinia) Vaccine, Live","License_Type":"351(a)","Strength":"1 - 5 X 10-8TH PFU\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Percutaneous","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/31\/2007","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2089","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ID Biomedical Corporation of Quebec","BLA_Number":"125163","Proprietary_Name":"Flulaval, Flulaval Quadrivalent","Proper_Name":"Influenza Vaccine","License_Type":"351(a)","Strength":"60UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/27\/2013","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"279","Submission_Type":"Supplement","License_Number":"1739","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ID Biomedical Corporation of Quebec","BLA_Number":"125163","Proprietary_Name":"Flulaval, Flulaval Quadrivalent","Proper_Name":"Influenza Vaccine","License_Type":"351(a)","Strength":"45UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"9\/27\/2013","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"279","Submission_Type":"Supplement","License_Number":"1739","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ID Biomedical Corporation of Quebec","BLA_Number":"125163","Proprietary_Name":"Flulaval, Flulaval Quadrivalent","Proper_Name":"Influenza Vaccine","License_Type":"351(a)","Strength":"60UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/15\/2013","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"253","Submission_Type":"Supplement","License_Number":"1739","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ID Biomedical Corporation of Quebec","BLA_Number":"125163","Proprietary_Name":"Flulaval, Flulaval Quadrivalent","Proper_Name":"Influenza Vaccine","License_Type":"351(a)","Strength":"15UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"11\/10\/2009","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"135","Submission_Type":"Supplement","License_Number":"1739","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ID Biomedical Corporation of Quebec","BLA_Number":"125163","Proprietary_Name":"Flulaval, Flulaval Quadrivalent","Proper_Name":"Influenza Vaccine","License_Type":"351(a)","Strength":"45UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"10\/5\/2006","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1739","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Dendreon Pharmaceuticals LLC","BLA_Number":"125197","Proprietary_Name":"Provenge","Proper_Name":"sipuleucel-T","License_Type":"351(a)","Strength":"50 M CD54 + ACTIVATED CELLS\/250 ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Bag","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/29\/2010","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1749","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring AG","BLA_Number":"125201","Proprietary_Name":"Privigen","Proper_Name":"Immune Globulin Intravenous (Human), 10% Liquid","License_Type":"351(a)","Strength":"40G","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/7\/2013","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"443","Submission_Type":"Supplement","License_Number":"1766","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring AG","BLA_Number":"125201","Proprietary_Name":"Privigen","Proper_Name":"Immune Globulin Intravenous (Human), 10% Liquid","License_Type":"351(a)","Strength":"2.5G","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/2\/2009","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"145","Submission_Type":"Supplement","License_Number":"1766","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring AG","BLA_Number":"125201","Proprietary_Name":"Privigen","Proper_Name":"Immune Globulin Intravenous (Human), 10% Liquid","License_Type":"351(a)","Strength":"5G","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/26\/2007","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1766","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring AG","BLA_Number":"125201","Proprietary_Name":"Privigen","Proper_Name":"Immune Globulin Intravenous (Human), 10% Liquid","License_Type":"351(a)","Strength":"10G","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/26\/2007","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1766","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring AG","BLA_Number":"125201","Proprietary_Name":"Privigen","Proper_Name":"Immune Globulin Intravenous (Human), 10% Liquid","License_Type":"351(a)","Strength":"20G","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/26\/2007","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1766","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125234","Proprietary_Name":"Ceprotin","Proper_Name":"Protein C Concentrate (Human)","License_Type":"351(a)","Strength":"1000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/30\/2007","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/30\/2014"},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125234","Proprietary_Name":"Ceprotin","Proper_Name":"Protein C Concentrate (Human)","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/30\/2007","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/30\/2014"},{"N\/R\/U":null,"Applicant":"Kamada Ltd.","BLA_Number":"125237","Proprietary_Name":"Hepagam B","Proper_Name":"Hepatitis B Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":">1560IU\/5ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/6\/2007","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1826","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Kamada Ltd.","BLA_Number":"125237","Proprietary_Name":"Hepagam B","Proper_Name":"Hepatitis B Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":">312IU\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/6\/2007","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1826","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Inc.","BLA_Number":"125244","Proprietary_Name":null,"Proper_Name":"Influenza Virus Vaccine, H5N1","License_Type":"351(a)","Strength":"90 MG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"4\/17\/2007","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1725","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Omrix Biopharmaceuticals Ltd","BLA_Number":"125247","Proprietary_Name":"Evithrom","Proper_Name":"Thrombin, Topical (Human)","License_Type":"351(a)","Strength":"1600-2400IU\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Topical","Product_Presentation":"Single-dose vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/17\/2009","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"89","Submission_Type":"Supplement","License_Number":"1603","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Omrix Biopharmaceuticals Ltd","BLA_Number":"125247","Proprietary_Name":"Evithrom","Proper_Name":"Thrombin, Topical (Human)","License_Type":"351(a)","Strength":"5ML IU\/ML","Dosage_Form":"Solution","Route_of_Administration":"Topical","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"8\/27\/2007","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1603","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Omrix Biopharmaceuticals Ltd","BLA_Number":"125247","Proprietary_Name":"Evithrom","Proper_Name":"Thrombin, Topical (Human)","License_Type":"351(a)","Strength":"20ML IU\/ML","Dosage_Form":"Solution","Route_of_Administration":"Topical","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"8\/27\/2007","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1603","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Omrix Biopharmaceuticals Ltd","BLA_Number":"125247","Proprietary_Name":"Evithrom","Proper_Name":"Thrombin, Topical (Human)","License_Type":"351(a)","Strength":"2ML IU\/ML","Dosage_Form":"Solution","Route_of_Administration":"Topical","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"8\/27\/2007","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1603","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Baxter Healthcare Corporation","BLA_Number":"125248","Proprietary_Name":"Recothrom","Proper_Name":"Thrombin topical (Recombinant)","License_Type":"351(a)","Strength":"20000IU","Dosage_Form":"For Suspension","Route_of_Administration":"Topical","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/23\/2008","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"7","Submission_Type":"Supplement","License_Number":"140","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Baxter Healthcare Corporation","BLA_Number":"125248","Proprietary_Name":"Recothrom","Proper_Name":"Thrombin topical (Recombinant)","License_Type":"351(a)","Strength":"5000IU","Dosage_Form":"For Suspension","Route_of_Administration":"Topical","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/17\/2008","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"140","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125251","Proprietary_Name":"Wilate","Proper_Name":"von Willebrand Factor\/Coagulation Factor VIII Complex (Human)","License_Type":"351(a)","Strength":"1000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/20\/2010","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"22","Submission_Type":"Supplement","License_Number":"1646","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125251","Proprietary_Name":"Wilate","Proper_Name":"von Willebrand Factor\/Coagulation Factor VIII Complex (Human)","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/20\/2010","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"22","Submission_Type":"Supplement","License_Number":"1646","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Seqirus Pty Ltd.","BLA_Number":"125254","Proprietary_Name":"Afluria, Afluria Quadrivalent","Proper_Name":"Influenza Vaccine","License_Type":"351(a)","Strength":"30UG\/.25ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"10\/4\/2018","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"692","Submission_Type":"Supplement","License_Number":"2044","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Seqirus Pty Ltd.","BLA_Number":"125254","Proprietary_Name":"Afluria, Afluria Quadrivalent","Proper_Name":"Influenza Vaccine","License_Type":"351(a)","Strength":"60UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/26\/2016","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"565","Submission_Type":"Supplement","License_Number":"2044","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Seqirus Pty Ltd.","BLA_Number":"125254","Proprietary_Name":"Afluria, Afluria Quadrivalent","Proper_Name":"Influenza Vaccine","License_Type":"351(a)","Strength":"60UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/26\/2016","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"565","Submission_Type":"Supplement","License_Number":"2044","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Seqirus Pty Ltd.","BLA_Number":"125254","Proprietary_Name":"Afluria, Afluria Quadrivalent","Proper_Name":"Influenza Vaccine","License_Type":"351(a)","Strength":"45UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"9\/28\/2007","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2044","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Seqirus Pty Ltd.","BLA_Number":"125254","Proprietary_Name":"Afluria, Afluria Quadrivalent","Proper_Name":"Influenza Vaccine","License_Type":"351(a)","Strength":"225UG","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"9\/28\/2007","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2044","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline Biologicals","BLA_Number":"125259","Proprietary_Name":"Cervarix","Proper_Name":"Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant","License_Type":"351(a)","Strength":"0.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"10\/16\/2009","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1617","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline Biologicals","BLA_Number":"125260","Proprietary_Name":"Kinrix","Proper_Name":"Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine","License_Type":"351(a)","Strength":"0.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/24\/2008","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1617","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Wyeth Pharmaceuticals LLC","BLA_Number":"125264","Proprietary_Name":"Xyntha, Xyntha Solofuse","Proper_Name":"Antihemophilic Factor (Recombinant), Plasma\/Albumin Free","License_Type":"351(a)","Strength":"3000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/6\/2010","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"492","Submission_Type":"Supplement","License_Number":"3","Product_Number":"9","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Wyeth Pharmaceuticals LLC","BLA_Number":"125264","Proprietary_Name":"Xyntha, Xyntha Solofuse","Proper_Name":"Antihemophilic Factor (Recombinant), Plasma\/Albumin Free","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/21\/2008","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"3","Product_Number":"8","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Wyeth Pharmaceuticals LLC","BLA_Number":"125264","Proprietary_Name":"Xyntha, Xyntha Solofuse","Proper_Name":"Antihemophilic Factor (Recombinant), Plasma\/Albumin Free","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/21\/2008","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"3","Product_Number":"7","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Wyeth Pharmaceuticals LLC","BLA_Number":"125264","Proprietary_Name":"Xyntha, Xyntha Solofuse","Proper_Name":"Antihemophilic Factor (Recombinant), Plasma\/Albumin Free","License_Type":"351(a)","Strength":"250IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/21\/2008","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"3","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Wyeth Pharmaceuticals LLC","BLA_Number":"125264","Proprietary_Name":"Xyntha, Xyntha Solofuse","Proper_Name":"Antihemophilic Factor (Recombinant), Plasma\/Albumin Free","License_Type":"351(a)","Strength":"250IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/21\/2008","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"3","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Wyeth Pharmaceuticals LLC","BLA_Number":"125264","Proprietary_Name":"Xyntha, Xyntha Solofuse","Proper_Name":"Antihemophilic Factor (Recombinant), Plasma\/Albumin Free","License_Type":"351(a)","Strength":"1000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/21\/2008","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"3","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Wyeth Pharmaceuticals LLC","BLA_Number":"125264","Proprietary_Name":"Xyntha, Xyntha Solofuse","Proper_Name":"Antihemophilic Factor (Recombinant), Plasma\/Albumin Free","License_Type":"351(a)","Strength":"1000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/21\/2008","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"3","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Wyeth Pharmaceuticals LLC","BLA_Number":"125264","Proprietary_Name":"Xyntha, Xyntha Solofuse","Proper_Name":"Antihemophilic Factor (Recombinant), Plasma\/Albumin Free","License_Type":"351(a)","Strength":"2000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/21\/2008","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"3","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Wyeth Pharmaceuticals LLC","BLA_Number":"125264","Proprietary_Name":"Xyntha, Xyntha Solofuse","Proper_Name":"Antihemophilic Factor (Recombinant), Plasma\/Albumin Free","License_Type":"351(a)","Strength":"2000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/21\/2008","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"3","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline Biologicals","BLA_Number":"125265","Proprietary_Name":"Rotarix","Proper_Name":"Rotavirus Vaccine, Live, Oral","License_Type":"351(a)","Strength":"106.0CCID50","Dosage_Form":"Suspension","Route_of_Administration":"Oral","Product_Presentation":"Oral Applicator","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/4\/2022","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"645","Submission_Type":"Supplement","License_Number":"1617","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline Biologicals","BLA_Number":"125265","Proprietary_Name":"Rotarix","Proper_Name":"Rotavirus Vaccine, Live, Oral","License_Type":"351(a)","Strength":"106.0CCID50","Dosage_Form":"Suspension","Route_of_Administration":"Oral","Product_Presentation":"Tube","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/4\/2022","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"645","Submission_Type":"Supplement","License_Number":"1617","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline Biologicals","BLA_Number":"125265","Proprietary_Name":"Rotarix","Proper_Name":"Rotavirus Vaccine, Live, Oral","License_Type":"351(a)","Strength":"1ML","Dosage_Form":"For Suspension","Route_of_Administration":"Oral","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/3\/2008","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1617","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Baxter Healthcare Corporation","BLA_Number":"125266","Proprietary_Name":"Artiss","Proper_Name":"Fibrin Sealant (Human)","License_Type":"351(a)","Strength":"2ML","Dosage_Form":"For Suspension","Route_of_Administration":"Topical","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"3\/19\/2008","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"140","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Baxter Healthcare Corporation","BLA_Number":"125266","Proprietary_Name":"Artiss","Proper_Name":"Fibrin Sealant (Human)","License_Type":"351(a)","Strength":"10ML","Dosage_Form":"For Suspension","Route_of_Administration":"Topical","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"3\/19\/2008","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"140","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Baxter Healthcare Corporation","BLA_Number":"125266","Proprietary_Name":"Artiss","Proper_Name":"Fibrin Sealant (Human)","License_Type":"351(a)","Strength":"4ML","Dosage_Form":"For Suspension","Route_of_Administration":"Topical","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"3\/19\/2008","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"140","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Baxter Healthcare Corporation","BLA_Number":"125266","Proprietary_Name":"Artiss","Proper_Name":"Fibrin Sealant (Human)","License_Type":"351(a)","Strength":"3000KIU\/4IU\/ML","Dosage_Form":"Frozen","Route_of_Administration":"Topical","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/19\/2008","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"140","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125267","Proprietary_Name":"Cinryze","Proper_Name":"C1 Esterase Inhibitor (Human)","License_Type":"351(a)","Strength":"500U","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/10\/2008","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/20\/2025"},{"N\/R\/U":null,"Applicant":"Valneva Austria GmbH","BLA_Number":"125280","Proprietary_Name":"Ixiaro","Proper_Name":"Japanese Encephalitis Vaccine, Inactivated, Adsorbed","License_Type":"351(a)","Strength":"0.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/30\/2009","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1909","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/17\/2020"},{"N\/R\/U":null,"Applicant":"rEVO Biologics, Inc.","BLA_Number":"125284","Proprietary_Name":"Atryn","Proper_Name":"Antithrombin (Recombinant)","License_Type":"351(a)","Strength":"525IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"4\/11\/2014","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"134","Submission_Type":"Supplement","License_Number":"1904","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/6\/2016"},{"N\/R\/U":null,"Applicant":"rEVO Biologics, Inc.","BLA_Number":"125284","Proprietary_Name":"Atryn","Proper_Name":"Antithrombin (Recombinant)","License_Type":"351(a)","Strength":"1750IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"2\/6\/2009","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1904","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/6\/2016"},{"N\/R\/U":null,"Applicant":"Protein Sciences Corporation","BLA_Number":"125285","Proprietary_Name":"Flublok","Proper_Name":"Influenza Vaccine","License_Type":"351(a)","Strength":"180UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/7\/2016","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"194","Submission_Type":"Supplement","License_Number":"1795","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":"1\/16\/2013","Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":"1\/16\/2025","Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Protein Sciences Corporation","BLA_Number":"125285","Proprietary_Name":"Flublok","Proper_Name":"Influenza Vaccine","License_Type":"351(a)","Strength":"135UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"1\/16\/2013","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1795","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":"1\/16\/2013","Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":"1\/16\/2025","Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring GmbH","BLA_Number":"125287","Proprietary_Name":"Berinert","Proper_Name":"C1 Esterase Inhibitor (Human)","License_Type":"351(a)","Strength":"500U","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/9\/2009","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1765","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"10\/8\/2016"},{"N\/R\/U":null,"Applicant":"Teva Women's Health, Inc.","BLA_Number":"125296","Proprietary_Name":null,"Proper_Name":"Adenovirus Type 4 and Type 7 Vaccine, Live, Oral","License_Type":"351(a)","Strength":"4.5LOG 10TCID","Dosage_Form":"Tablet","Route_of_Administration":"Oral","Product_Presentation":"Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/16\/2011","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1804","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Seqirus Inc.","BLA_Number":"125297","Proprietary_Name":"Agriflu","Proper_Name":"Influenza Virus Vaccine","License_Type":"351(a)","Strength":".05ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"11\/27\/2009","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2049","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline Biologicals","BLA_Number":"125300","Proprietary_Name":"Menveo","Proper_Name":"Meningococcal (Groups A, C, Y, and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine","License_Type":"351(a)","Strength":"0.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/14\/2022","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"778","Submission_Type":"Supplement","License_Number":"1617","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline Biologicals","BLA_Number":"125300","Proprietary_Name":"Menveo","Proper_Name":"Meningococcal (Groups A, C, Y, and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine","License_Type":"351(a)","Strength":"0.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/19\/2010","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1617","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring GmbH","BLA_Number":"125317","Proprietary_Name":"Riastap","Proper_Name":"Fibrinogen Concentrate (Human)","License_Type":"351(a)","Strength":"900-1300MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/16\/2009","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1765","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"1\/16\/2016"},{"N\/R\/U":null,"Applicant":"Wyeth Pharmaceuticals LLC","BLA_Number":"125324","Proprietary_Name":"Prevnar 13","Proper_Name":"Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein)","License_Type":"351(a)","Strength":"0.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/24\/2010","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"3","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125325","Proprietary_Name":"Glassia","Proper_Name":"Alpha-1-Proteinase Inhibitor (Human)","License_Type":"351(a)","Strength":"1G","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/1\/2010","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bio Products Laboratory","BLA_Number":"125329","Proprietary_Name":"Gammaplex","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"20G\/200ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/6\/2017","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"151","Submission_Type":"Supplement","License_Number":"1811","Product_Number":"7","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bio Products Laboratory","BLA_Number":"125329","Proprietary_Name":"Gammaplex","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"10G\/100ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/6\/2017","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"151","Submission_Type":"Supplement","License_Number":"1811","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bio Products Laboratory","BLA_Number":"125329","Proprietary_Name":"Gammaplex","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"5G\/50ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/6\/2017","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"151","Submission_Type":"Supplement","License_Number":"1811","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bio Products Laboratory","BLA_Number":"125329","Proprietary_Name":"Gammaplex","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"20G\/400ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/7\/2014","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"85","Submission_Type":"Supplement","License_Number":"1811","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bio Products Laboratory","BLA_Number":"125329","Proprietary_Name":"Gammaplex","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"5G\/100ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/17\/2009","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1811","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bio Products Laboratory","BLA_Number":"125329","Proprietary_Name":"Gammaplex","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"2.5G\/50ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"9\/17\/2009","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1811","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bio Products Laboratory","BLA_Number":"125329","Proprietary_Name":"Gammaplex","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"10G\/200ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/17\/2009","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1811","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Rare Disease Therapeutics, Inc. (RDT)","BLA_Number":"125335","Proprietary_Name":"Anascorp","Proper_Name":"Centruroides (Scorpion) Immune F(ab')2 (Equine) Injection","License_Type":"351(a)","Strength":">\/=150 LD50 NEUTRALIZING UNITS","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/3\/2011","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1860","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"8\/4\/2018"},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline Biologicals","BLA_Number":"125347","Proprietary_Name":"Hiberix","Proper_Name":"Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)","License_Type":"351(a)","Strength":"25UG","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/19\/2009","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1617","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Fibrocell Technologies, Inc.","BLA_Number":"125348","Proprietary_Name":"Laviv","Proper_Name":"Azficel-T","License_Type":"351(a)","Strength":"18MU CELL\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"6\/21\/2011","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1818","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring AG","BLA_Number":"125350","Proprietary_Name":"Hizentra","Proper_Name":"Immune Globulin Subcutaneous (Human), 20% Liquid","License_Type":"351(a)","Strength":"4G","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/4\/2010","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1766","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/15\/2025"},{"N\/R\/U":null,"Applicant":"CSL Behring AG","BLA_Number":"125350","Proprietary_Name":"Hizentra","Proper_Name":"Immune Globulin Subcutaneous (Human), 20% Liquid","License_Type":"351(a)","Strength":"10G","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/4\/2010","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1766","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/15\/2025"},{"N\/R\/U":null,"Applicant":"CSL Behring AG","BLA_Number":"125350","Proprietary_Name":"Hizentra","Proper_Name":"Immune Globulin Subcutaneous (Human), 20% Liquid","License_Type":"351(a)","Strength":"1G","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/4\/2010","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1766","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/15\/2025"},{"N\/R\/U":null,"Applicant":"CSL Behring AG","BLA_Number":"125350","Proprietary_Name":"Hizentra","Proper_Name":"Immune Globulin Subcutaneous (Human), 20% Liquid","License_Type":"351(a)","Strength":"2G","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/4\/2010","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1766","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/15\/2025"},{"N\/R\/U":null,"Applicant":"Corza Medical GmbH","BLA_Number":"125351","Proprietary_Name":"Tachosil","Proper_Name":"Fibrin Sealant Patch","License_Type":"351(a)","Strength":"3.0 CM X 2.5 CM MG PER CM2 FOR FIBRINOGEN; IU PER CM2 FOR THROMBIN","Dosage_Form":"Patch","Route_of_Administration":"Topical","Product_Presentation":"Tray & Lid","Status":"Disc","Licensure":"Licensed","Approval_Date":"4\/5\/2010","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2294","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Corza Medical GmbH","BLA_Number":"125351","Proprietary_Name":"Tachosil","Proper_Name":"Fibrin Sealant Patch","License_Type":"351(a)","Strength":"9.5 CM X 4.8 CM MG PER CM2 FOR FIBRINOGEN; IU PER CM2 FOR THROMBIN","Dosage_Form":"Patch","Route_of_Administration":"Topical","Product_Presentation":"Tray & Lid","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/5\/2010","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2294","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Corza Medical GmbH","BLA_Number":"125351","Proprietary_Name":"Tachosil","Proper_Name":"Fibrin Sealant Patch","License_Type":"351(a)","Strength":"4.8 CM X 4.8 CM MG PER CM2 FOR FIBRINOGEN; IU PER CM2 FOR THROMBIN","Dosage_Form":"Patch","Route_of_Administration":"Topical","Product_Presentation":"Tray & Lid","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/5\/2010","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2294","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Nielsen Bioscience, Inc","BLA_Number":"125354","Proprietary_Name":"Spherusol","Proper_Name":"Coccidioides immitis Spherule-Derived Skin Test Antigen","License_Type":"351(a)","Strength":"1.0ML","Dosage_Form":"Injection","Route_of_Administration":"Intradermal","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/29\/2011","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1903","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline Biologicals","BLA_Number":"125363","Proprietary_Name":"MENHIBRIX","Proper_Name":"Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine","License_Type":"351(a)","Strength":" 0.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"6\/14\/2012","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"1617","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Kedrion, S.p.A.","BLA_Number":"125384","Proprietary_Name":"Kedbumin","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"25G\/100ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/5\/2013","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"35","Submission_Type":"Supplement","License_Number":"1851","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Kedrion, S.p.A.","BLA_Number":"125384","Proprietary_Name":"Kedbumin","Proper_Name":"Albumin (Human)","License_Type":"351(a)","Strength":"12.5G\/50ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/3\/2011","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1851","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring GmbH","BLA_Number":"125385","Proprietary_Name":"Corifact","Proper_Name":"Factor XIII Concentrate (Human)","License_Type":"351(a)","Strength":"1000-1600IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/17\/2011","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1765","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"1\/24\/2020"},{"N\/R\/U":null,"Applicant":"ADMA Biologics, Inc.","BLA_Number":"125389","Proprietary_Name":"Bivigam","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"10GM\/100ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/19\/2012","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2019","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ADMA Biologics, Inc.","BLA_Number":"125389","Proprietary_Name":"Bivigam","Proper_Name":"Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":"5GM\/50ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/19\/2012","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2019","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Clinimmune Labs","BLA_Number":"125391","Proprietary_Name":null,"Proper_Name":"HPC, Cord Blood","License_Type":"351(a)","Strength":"5X10^8 TOTAL NUCLEATED CELLS WITH AT LEAST 1.25X10^6 VIABLE CD34+ CELLS","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Bag","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/24\/2012","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1855","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Ethicon, Inc.","BLA_Number":"125392","Proprietary_Name":"Evarrest","Proper_Name":"Fibrin Sealant Patch","License_Type":"351(a)","Strength":"50.3 X 203.2 MG PER SQUARE INCH FOR HUMAN FIBRINOGEN;IU PER SQUARE INCH FOR HUMAN THROMBIN","Dosage_Form":"Patch","Route_of_Administration":"Topical","Product_Presentation":"Pouch","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/5\/2012","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1879","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Ethicon, Inc.","BLA_Number":"125392","Proprietary_Name":"Evarrest","Proper_Name":"Fibrin Sealant Patch","License_Type":"351(a)","Strength":"130  MG PER SQUARE INCH","Dosage_Form":"Patch","Route_of_Administration":"Topical","Product_Presentation":"Pouch","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/5\/2012","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1879","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"New York Blood Center, Inc.","BLA_Number":"125397","Proprietary_Name":"Hemacord","Proper_Name":"Hematopoietic Progenitor Cells, Cord (HPC-C)","License_Type":"351(a)","Strength":"5 X 10E8 TOTAL NUCLEATED CELLS WITH AT LEAST 1.25 X 10E6 VIABLE CD34+ CELLS U","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Bag","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/10\/2011","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"465","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"125398","Proprietary_Name":"Tretten","Proper_Name":"Coagulation Factor XIII A-Subunit (Recombinant)","License_Type":"351(a)","Strength":"2000 - 3125IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/23\/2013","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1261","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/23\/2020"},{"N\/R\/U":null,"Applicant":"Organogenesis, Inc.","BLA_Number":"125400","Proprietary_Name":"Gintuit","Proper_Name":"Allogeneic Cultured Keratinocytes and Fibroblasts in Bovine Collagen","License_Type":"351(a)","Strength":">0.000001UG\/ML","Dosage_Form":"Cellular Sheet","Route_of_Administration":"Topical","Product_Presentation":"Bag","Status":"Disc","Licensure":"Licensed","Approval_Date":"3\/9\/2012","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1863","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125402","Proprietary_Name":"Hyqvia","Proper_Name":"Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase","License_Type":"351(a)","Strength":"10%MG\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/12\/2014","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Duke University School of Medicine","BLA_Number":"125407","Proprietary_Name":"Ducord","Proper_Name":"HPC, Cord Blood","License_Type":"351(a)","Strength":"GREATER THAN OR EQUAL TO 2.5 X 10E7 PER KG CELLS PER KILOGRAM","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Bag","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/4\/2012","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1870","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Seqirus Inc.","BLA_Number":"125408","Proprietary_Name":"Flucelvax, Flucelvax Quadrivalent","Proper_Name":"Influenza Vaccine","License_Type":"351(a)","Strength":"60UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/26\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"329","Submission_Type":"Supplement","License_Number":"2049","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Seqirus Inc.","BLA_Number":"125408","Proprietary_Name":"Flucelvax, Flucelvax Quadrivalent","Proper_Name":"Influenza Vaccine","License_Type":"351(a)","Strength":"60UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/3\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"329","Submission_Type":"Supplement","License_Number":"2049","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Seqirus Inc.","BLA_Number":"125408","Proprietary_Name":"Flucelvax, Flucelvax Quadrivalent","Proper_Name":"Influenza Vaccine","License_Type":"351(a)","Strength":"600UG","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"11\/20\/2012","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2049","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Seqirus Inc.","BLA_Number":"125408","Proprietary_Name":"Flucelvax, Flucelvax Quadrivalent","Proper_Name":"Influenza Vaccine","License_Type":"351(a)","Strength":"60UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"11\/20\/2012","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2049","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"SSM Cardinal Glennon Children's Medical Center","BLA_Number":"125413","Proprietary_Name":"Allocord","Proper_Name":"HPC, Cord Blood","License_Type":"351(a)","Strength":"TOTAL NUCLEATED CELLS CELL\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Bag","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/30\/2013","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1873","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125416","Proprietary_Name":"Octaplas","Proper_Name":"Pooled Plasma (Human), Solvent\/Detergent Treated","License_Type":"351(a)","Strength":"45-70MG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Bag","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/17\/2013","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1646","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ID Biomedical Corporation of Quebec","BLA_Number":"125419","Proprietary_Name":null,"Proper_Name":"Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted","License_Type":"351(a)","Strength":"0.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"11\/22\/2013","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1739","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring GmbH","BLA_Number":"125421","Proprietary_Name":"Kcentra","Proper_Name":"Prothrombin Complex Concentrate (Human)","License_Type":"351(a)","Strength":"1000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/26\/2013","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"26","Submission_Type":"Supplement","License_Number":"1765","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/13\/2020"},{"N\/R\/U":null,"Applicant":"CSL Behring GmbH","BLA_Number":"125421","Proprietary_Name":"Kcentra","Proper_Name":"Prothrombin Complex Concentrate (Human)","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/29\/2013","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1765","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/13\/2020"},{"N\/R\/U":null,"Applicant":"Medexus Pharma, Inc.","BLA_Number":"125426","Proprietary_Name":"Ixinity","Proper_Name":"Coagulation Factor IX (Recombinant)","License_Type":"351(a)","Strength":"2000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/21\/2015","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"19","Submission_Type":"Supplement","License_Number":"2220","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Medexus Pharma, Inc.","BLA_Number":"125426","Proprietary_Name":"Ixinity","Proper_Name":"Coagulation Factor IX (Recombinant)","License_Type":"351(a)","Strength":"3000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/21\/2015","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"19","Submission_Type":"Supplement","License_Number":"2220","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Medexus Pharma, Inc.","BLA_Number":"125426","Proprietary_Name":"Ixinity","Proper_Name":"Coagulation Factor IX (Recombinant)","License_Type":"351(a)","Strength":"250IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/21\/2015","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"19","Submission_Type":"Supplement","License_Number":"2220","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Medexus Pharma, Inc.","BLA_Number":"125426","Proprietary_Name":"Ixinity","Proper_Name":"Coagulation Factor IX (Recombinant)","License_Type":"351(a)","Strength":"1000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/29\/2015","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2220","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Medexus Pharma, Inc.","BLA_Number":"125426","Proprietary_Name":"Ixinity","Proper_Name":"Coagulation Factor IX (Recombinant)","License_Type":"351(a)","Strength":"1500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/29\/2015","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2220","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Medexus Pharma, Inc.","BLA_Number":"125426","Proprietary_Name":"Ixinity","Proper_Name":"Coagulation Factor IX (Recombinant)","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/29\/2015","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2220","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Dynavax Technologies Corporation","BLA_Number":"125428","Proprietary_Name":"Heplisav-B","Proper_Name":"Hepatitis B Vaccine (Recombinant), Adjuvanted","License_Type":"351(a)","Strength":"20UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/9\/2017","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1883","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Kamada Ltd.","BLA_Number":"125430","Proprietary_Name":"Varizig","Proper_Name":"Varicella Zoster Immune Globulin (Human)","License_Type":"351(a)","Strength":"125IU","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/29\/2014","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"27","Submission_Type":"Supplement","License_Number":"2098","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/20\/2019"},{"N\/R\/U":null,"Applicant":"Kamada Ltd.","BLA_Number":"125430","Proprietary_Name":"Varizig","Proper_Name":"Varicella Zoster Immune Globulin (Human)","License_Type":"351(a)","Strength":"125IU","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"12\/20\/2012","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2098","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/20\/2019"},{"N\/R\/U":null,"Applicant":"LifeSouth Community Blood Centers, Inc.","BLA_Number":"125432","Proprietary_Name":"Cordcyte","Proper_Name":"HPC, Cord Blood","License_Type":"351(a)","Strength":"TOTAL NUCLEATED CELLS  CELL\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Bag","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/13\/2013","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1647","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bioverativ Therapeutics, Inc.","BLA_Number":"125444","Proprietary_Name":"Alprolix","Proper_Name":"Coagulation Factor IX (Recombinant), Fc Fusion Protein","License_Type":"351(a)","Strength":"4000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/14\/2016","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"286","Submission_Type":"Supplement","License_Number":"2078","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/28\/2021"},{"N\/R\/U":null,"Applicant":"Bioverativ Therapeutics, Inc.","BLA_Number":"125444","Proprietary_Name":"Alprolix","Proper_Name":"Coagulation Factor IX (Recombinant), Fc Fusion Protein","License_Type":"351(a)","Strength":"250IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/18\/2016","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"175","Submission_Type":"Supplement","License_Number":"2078","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/28\/2021"},{"N\/R\/U":null,"Applicant":"Bioverativ Therapeutics, Inc.","BLA_Number":"125444","Proprietary_Name":"Alprolix","Proper_Name":"Coagulation Factor IX (Recombinant), Fc Fusion Protein","License_Type":"351(a)","Strength":"3000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/28\/2014","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2078","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/28\/2021"},{"N\/R\/U":null,"Applicant":"Bioverativ Therapeutics, Inc.","BLA_Number":"125444","Proprietary_Name":"Alprolix","Proper_Name":"Coagulation Factor IX (Recombinant), Fc Fusion Protein","License_Type":"351(a)","Strength":"1000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/28\/2014","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2078","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/28\/2021"},{"N\/R\/U":null,"Applicant":"Bioverativ Therapeutics, Inc.","BLA_Number":"125444","Proprietary_Name":"Alprolix","Proper_Name":"Coagulation Factor IX (Recombinant), Fc Fusion Protein","License_Type":"351(a)","Strength":"2000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/28\/2014","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2078","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/28\/2021"},{"N\/R\/U":null,"Applicant":"Bioverativ Therapeutics, Inc.","BLA_Number":"125444","Proprietary_Name":"Alprolix","Proper_Name":"Coagulation Factor IX (Recombinant), Fc Fusion Protein","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/28\/2014","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2078","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/28\/2021"},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125446","Proprietary_Name":"Rixubis","Proper_Name":"Coagulation Factor IX (Recombinant)","License_Type":"351(a)","Strength":"2000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/26\/2013","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/12\/2021"},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125446","Proprietary_Name":"Rixubis","Proper_Name":"Coagulation Factor IX (Recombinant)","License_Type":"351(a)","Strength":"3000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/26\/2013","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/12\/2021"},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125446","Proprietary_Name":"Rixubis","Proper_Name":"Coagulation Factor IX (Recombinant)","License_Type":"351(a)","Strength":"250IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/26\/2013","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/12\/2021"},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125446","Proprietary_Name":"Rixubis","Proper_Name":"Coagulation Factor IX (Recombinant)","License_Type":"351(a)","Strength":"1000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/26\/2013","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/12\/2021"},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125446","Proprietary_Name":"Rixubis","Proper_Name":"Coagulation Factor IX (Recombinant)","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/26\/2013","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"9\/12\/2021"},{"N\/R\/U":null,"Applicant":"Emergent BioSolutions Canada Inc.","BLA_Number":"125462","Proprietary_Name":"Bat","Proper_Name":"Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine)","License_Type":"351(a)","Strength":">4500U","Dosage_Form":"Solution","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/22\/2013","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2084","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/22\/2020"},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"125466","Proprietary_Name":"Novoeight","Proper_Name":"Antihemophilic Factor (Recombinant)","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/15\/2013","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1261","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"125466","Proprietary_Name":"Novoeight","Proper_Name":"Antihemophilic Factor (Recombinant)","License_Type":"351(a)","Strength":"250IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/15\/2013","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1261","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"125466","Proprietary_Name":"Novoeight","Proper_Name":"Antihemophilic Factor (Recombinant)","License_Type":"351(a)","Strength":"1000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/15\/2013","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1261","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"125466","Proprietary_Name":"Novoeight","Proper_Name":"Antihemophilic Factor (Recombinant)","License_Type":"351(a)","Strength":"1500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/15\/2013","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1261","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"125466","Proprietary_Name":"Novoeight","Proper_Name":"Antihemophilic Factor (Recombinant)","License_Type":"351(a)","Strength":"2000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/15\/2013","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1261","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"125466","Proprietary_Name":"Novoeight","Proper_Name":"Antihemophilic Factor (Recombinant)","License_Type":"351(a)","Strength":"3000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/15\/2013","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1261","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Stallergenes, SAS","BLA_Number":"125471","Proprietary_Name":"Oralair","Proper_Name":"Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass Mixed Pollens Allergen Extract","License_Type":"351(a)","Strength":"300 IR TABS\/CT","Dosage_Form":"Tablet","Route_of_Administration":"Sublingual","Product_Presentation":"Blister Pack","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/1\/2014","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1893","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK - Abello A\/S","BLA_Number":"125473","Proprietary_Name":"Grastek","Proper_Name":"Timothy Grass Pollen Allergen Extract","License_Type":"351(a)","Strength":"2800BAU\/TABLET","Dosage_Form":"Tablet","Route_of_Administration":"Sublingual","Product_Presentation":"Blister Pack","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/11\/2014","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1292","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK - Abello A\/S","BLA_Number":"125478","Proprietary_Name":"Ragwitek","Proper_Name":"Short Ragweed Pollen Allergen Extract","License_Type":"351(a)","Strength":"12 AMB A 1-UNITS\/Tablet","Dosage_Form":"Tablet","Route_of_Administration":"Sublingual","Product_Presentation":"Blister Pack","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/17\/2014","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1292","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bioverativ Therapeutics, Inc.","BLA_Number":"125487","Proprietary_Name":"Eloctate","Proper_Name":"Antihemophilic Factor (Recombinant), Fc Fusion protein","License_Type":"351(a)","Strength":"4000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/27\/2017","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"450","Submission_Type":"Supplement","License_Number":"2078","Product_Number":"10","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/6\/2021"},{"N\/R\/U":null,"Applicant":"Bioverativ Therapeutics, Inc.","BLA_Number":"125487","Proprietary_Name":"Eloctate","Proper_Name":"Antihemophilic Factor (Recombinant), Fc Fusion protein","License_Type":"351(a)","Strength":"6000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/27\/2017","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"450","Submission_Type":"Supplement","License_Number":"2078","Product_Number":"9","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/6\/2021"},{"N\/R\/U":null,"Applicant":"Bioverativ Therapeutics, Inc.","BLA_Number":"125487","Proprietary_Name":"Eloctate","Proper_Name":"Antihemophilic Factor (Recombinant), Fc Fusion protein","License_Type":"351(a)","Strength":"5000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/27\/2017","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"450","Submission_Type":"Supplement","License_Number":"2078","Product_Number":"8","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/6\/2021"},{"N\/R\/U":null,"Applicant":"Bioverativ Therapeutics, Inc.","BLA_Number":"125487","Proprietary_Name":"Eloctate","Proper_Name":"Antihemophilic Factor (Recombinant), Fc Fusion protein","License_Type":"351(a)","Strength":"250IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/6\/2014","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2078","Product_Number":"7","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/6\/2021"},{"N\/R\/U":null,"Applicant":"Bioverativ Therapeutics, Inc.","BLA_Number":"125487","Proprietary_Name":"Eloctate","Proper_Name":"Antihemophilic Factor (Recombinant), Fc Fusion protein","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/6\/2014","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2078","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/6\/2021"},{"N\/R\/U":null,"Applicant":"Bioverativ Therapeutics, Inc.","BLA_Number":"125487","Proprietary_Name":"Eloctate","Proper_Name":"Antihemophilic Factor (Recombinant), Fc Fusion protein","License_Type":"351(a)","Strength":"750IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/6\/2014","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2078","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/6\/2021"},{"N\/R\/U":null,"Applicant":"Bioverativ Therapeutics, Inc.","BLA_Number":"125487","Proprietary_Name":"Eloctate","Proper_Name":"Antihemophilic Factor (Recombinant), Fc Fusion protein","License_Type":"351(a)","Strength":"3000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/6\/2014","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2078","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/6\/2021"},{"N\/R\/U":null,"Applicant":"Bioverativ Therapeutics, Inc.","BLA_Number":"125487","Proprietary_Name":"Eloctate","Proper_Name":"Antihemophilic Factor (Recombinant), Fc Fusion protein","License_Type":"351(a)","Strength":"2000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/6\/2014","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2078","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/6\/2021"},{"N\/R\/U":null,"Applicant":"Bioverativ Therapeutics, Inc.","BLA_Number":"125487","Proprietary_Name":"Eloctate","Proper_Name":"Antihemophilic Factor (Recombinant), Fc Fusion protein","License_Type":"351(a)","Strength":"1000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/6\/2014","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2078","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/6\/2021"},{"N\/R\/U":null,"Applicant":"Bioverativ Therapeutics, Inc.","BLA_Number":"125487","Proprietary_Name":"Eloctate","Proper_Name":"Antihemophilic Factor (Recombinant), Fc Fusion protein","License_Type":"351(a)","Strength":"1500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/6\/2014","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2078","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/6\/2021"},{"N\/R\/U":null,"Applicant":"Rare Disease Therapeutics, Inc. (RDT)","BLA_Number":"125488","Proprietary_Name":"Anavip","Proper_Name":"Crotalidae Immune F(ab')2 (Equine)","License_Type":"351(a)","Strength":"MINIMUM 780 BOTHROPS ASPER, 790 C.SIMUS, 244 C.ADAMANTEUS, 147 C.ATROX, 185 C.SCUTULATUS, 28 AGKISTRODON CONTORTRIX, 61 A.PISCIVORUS LD50 NEUTRALIZING UNITS\/VIAL","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/6\/2015","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1860","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/6\/2022"},{"N\/R\/U":null,"Applicant":"Pharming Americas BV","BLA_Number":"125495","Proprietary_Name":"Ruconest","Proper_Name":"C1 Esterase Inhibitor (Recombinant)","License_Type":"351(a)","Strength":"2100IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/16\/2014","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2079","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":"7\/16\/2014","Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":"7\/16\/2026","Orphan_Exclusivity_Exp._Date":"7\/16\/2021"},{"N\/R\/U":null,"Applicant":"Bio Products Laboratory","BLA_Number":"125506","Proprietary_Name":"Coagadex","Proper_Name":"Coagulation Factor X (Human)","License_Type":"351(a)","Strength":"250IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/20\/2015","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1811","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"4\/14\/2030"},{"N\/R\/U":null,"Applicant":"Bio Products Laboratory","BLA_Number":"125506","Proprietary_Name":"Coagadex","Proper_Name":"Coagulation Factor X (Human)","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/20\/2015","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1811","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"4\/14\/2030"},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"125508","Proprietary_Name":"Gardasil 9","Proper_Name":"Human Papillomavirus 9-valent Vaccine, Recombinant","License_Type":"351(a)","Strength":"0.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-dose vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/10\/2014","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"125508","Proprietary_Name":"Gardasil 9","Proper_Name":"Human Papillomavirus 9-valent Vaccine, Recombinant","License_Type":"351(a)","Strength":"0.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/10\/2014","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Seqirus Inc.","BLA_Number":"125510","Proprietary_Name":"Fluad,Fluad Quadrivalent","Proper_Name":"Influenza Vaccine, Adjuvanted","License_Type":"351(a)","Strength":"60UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/21\/2020","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"143","Submission_Type":"Supplement","License_Number":"2049","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Seqirus Inc.","BLA_Number":"125510","Proprietary_Name":"Fluad","Proper_Name":"Influenza Vaccine, Adjuvanted","License_Type":"351(a)","Strength":"45UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Disc","Licensure":"Licensed","Approval_Date":"11\/24\/2015","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2049","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125512","Proprietary_Name":"Obizur","Proper_Name":"Antihemophilic Factor (Recombinant), Porcine Sequence","License_Type":"351(a)","Strength":"500U","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/23\/2014","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"10\/23\/2021"},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"125518","Proprietary_Name":"Imlygic","Proper_Name":"Talimogene laherparepvec","License_Type":"351(a)","Strength":"1 MILLION PFU\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Intralesional","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/27\/2015","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1080","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"10\/27\/2022"},{"N\/R\/U":null,"Applicant":"Amgen Inc.","BLA_Number":"125518","Proprietary_Name":"Imlygic","Proper_Name":"Talimogene laherparepvec","License_Type":"351(a)","Strength":"100 MILLION PFU\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Intralesional","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/27\/2015","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1080","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"10\/27\/2022"},{"N\/R\/U":null,"Applicant":"Mallinckrodt Pharma IP Trading DAC","BLA_Number":"125523","Proprietary_Name":"Raplixa","Proper_Name":"Fibrin Sealant (Human)","License_Type":"351(a)","Strength":"2G","Dosage_Form":"Powder","Route_of_Administration":"Topical","Product_Presentation":"Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"4\/30\/2015","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"2058","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Mallinckrodt Pharma IP Trading DAC","BLA_Number":"125523","Proprietary_Name":"Raplixa","Proper_Name":"Fibrin Sealant (Human)","License_Type":"351(a)","Strength":"1G","Dosage_Form":"Powder","Route_of_Administration":"Topical","Product_Presentation":"Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"4\/30\/2015","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"2058","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Mallinckrodt Pharma IP Trading DAC","BLA_Number":"125523","Proprietary_Name":"Raplixa","Proper_Name":"Fibrin Sealant (Human)","License_Type":"351(a)","Strength":"0.5G","Dosage_Form":"Powder","Route_of_Administration":"Topical","Product_Presentation":"Vial","Status":"Disc","Licensure":"Voluntarily Revoked","Approval_Date":"4\/30\/2015","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"2058","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Limited","BLA_Number":"125525","Proprietary_Name":"Quadracel","Proper_Name":"Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine","License_Type":"351(a)","Strength":"0.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/24\/2015","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1726","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline Biologicals","BLA_Number":"125546","Proprietary_Name":"Bexsero","Proper_Name":"Meningococcal Group B Vaccine","License_Type":"351(a)","Strength":"0.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/23\/2015","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1617","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Wyeth Pharmaceuticals LLC","BLA_Number":"125549","Proprietary_Name":"Trumenba","Proper_Name":"Meningococcal Group B Vaccine","License_Type":"351(a)","Strength":"0.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/29\/2014","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"3","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":"10\/29\/2014","Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":"10\/29\/2026","Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125555","Proprietary_Name":"Nuwiq","Proper_Name":"Antihemophilic Factor (Recombinant)","License_Type":"351(a)","Strength":"1500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/7\/2021","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"245","Submission_Type":"Supplement","License_Number":"1646","Product_Number":"8","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125555","Proprietary_Name":"Nuwiq","Proper_Name":"Antihemophilic Factor (Recombinant)","License_Type":"351(a)","Strength":"3000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/7\/2017","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"55","Submission_Type":"Supplement","License_Number":"1646","Product_Number":"7","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125555","Proprietary_Name":"Nuwiq","Proper_Name":"Antihemophilic Factor (Recombinant)","License_Type":"351(a)","Strength":"4000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/7\/2017","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"55","Submission_Type":"Supplement","License_Number":"1646","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125555","Proprietary_Name":"Nuwiq","Proper_Name":"Antihemophilic Factor (Recombinant)","License_Type":"351(a)","Strength":"2500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/7\/2017","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"55","Submission_Type":"Supplement","License_Number":"1646","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125555","Proprietary_Name":"Nuwiq","Proper_Name":"Antihemophilic Factor (Recombinant)","License_Type":"351(a)","Strength":"2000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/4\/2015","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1646","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125555","Proprietary_Name":"Nuwiq","Proper_Name":"Antihemophilic Factor (Recombinant)","License_Type":"351(a)","Strength":"250IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/4\/2015","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1646","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125555","Proprietary_Name":"Nuwiq","Proper_Name":"Antihemophilic Factor (Recombinant)","License_Type":"351(a)","Strength":"1000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/4\/2015","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1646","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125555","Proprietary_Name":"Nuwiq","Proper_Name":"Antihemophilic Factor (Recombinant)","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/4\/2015","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1646","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Emergent BioSolutions Canada Inc.","BLA_Number":"125562","Proprietary_Name":"Anthrasil","Proper_Name":"Anthrax Immune Globulin Intravenous (Human)","License_Type":"351(a)","Strength":">=60 U","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/24\/2015","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2084","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/24\/2022"},{"N\/R\/U":null,"Applicant":"MSP Vaccine Company","BLA_Number":"125563","Proprietary_Name":"Vaxelis","Proper_Name":"Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine","License_Type":"351(a)","Strength":"0.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/21\/2018","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2007","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125566","Proprietary_Name":"Adynovate","Proper_Name":"Antihemophilic Factor (Recombinant), PEGylated","License_Type":"351(a)","Strength":"3000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/13\/2017","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"152","Submission_Type":"Supplement","License_Number":"1898","Product_Number":"7","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125566","Proprietary_Name":"Adynovate","Proper_Name":"Antihemophilic Factor (Recombinant), PEGylated","License_Type":"351(a)","Strength":"750IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/25\/2016","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"104","Submission_Type":"Supplement","License_Number":"1898","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125566","Proprietary_Name":"Adynovate","Proper_Name":"Antihemophilic Factor (Recombinant), PEGylated","License_Type":"351(a)","Strength":"1500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/25\/2016","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"104","Submission_Type":"Supplement","License_Number":"1898","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125566","Proprietary_Name":"Adynovate","Proper_Name":"Antihemophilic Factor (Recombinant), PEGylated","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/13\/2015","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125566","Proprietary_Name":"Adynovate","Proper_Name":"Antihemophilic Factor (Recombinant), PEGylated","License_Type":"351(a)","Strength":"250IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/13\/2015","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125566","Proprietary_Name":"Adynovate","Proper_Name":"Antihemophilic Factor (Recombinant), PEGylated","License_Type":"351(a)","Strength":"2000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/13\/2015","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125566","Proprietary_Name":"Adynovate","Proper_Name":"Antihemophilic Factor (Recombinant), PEGylated","License_Type":"351(a)","Strength":"1000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/13\/2015","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bayer HealthCare LLC","BLA_Number":"125574","Proprietary_Name":"Kovaltry","Proper_Name":"Antihemophilic Factor (Recombinant), Full Length","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/16\/2016","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"8","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bayer HealthCare LLC","BLA_Number":"125574","Proprietary_Name":"Kovaltry","Proper_Name":"Antihemophilic Factor (Recombinant), Full Length","License_Type":"351(a)","Strength":"3000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/16\/2016","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"8","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bayer HealthCare LLC","BLA_Number":"125574","Proprietary_Name":"Kovaltry","Proper_Name":"Antihemophilic Factor (Recombinant), Full Length","License_Type":"351(a)","Strength":"2000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/16\/2016","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"8","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bayer HealthCare LLC","BLA_Number":"125574","Proprietary_Name":"Kovaltry","Proper_Name":"Antihemophilic Factor (Recombinant), Full Length","License_Type":"351(a)","Strength":"250IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/16\/2016","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"8","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bayer HealthCare LLC","BLA_Number":"125574","Proprietary_Name":"Kovaltry","Proper_Name":"Antihemophilic Factor (Recombinant), Full Length","License_Type":"351(a)","Strength":"1000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/16\/2016","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"8","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125577","Proprietary_Name":"Vonvendi","Proper_Name":"von Willebrand factor (Recombinant)","License_Type":"351(a)","Strength":"650IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/8\/2015","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"1\/28\/2029"},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125577","Proprietary_Name":"Vonvendi","Proper_Name":"von Willebrand factor (Recombinant)","License_Type":"351(a)","Strength":"1300IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/8\/2015","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"1\/28\/2029"},{"N\/R\/U":null,"Applicant":"SmartPractice Denmark ApS","BLA_Number":"125579","Proprietary_Name":"Rubber Panel T.R.U.E. Test","Proper_Name":"Rubber Panel Thin-Layer Rapid Use Epicutaneous Patch Test","License_Type":"351(a)","Strength":"PATCH TEST 5 ALLERGEN AND ALLERGEN MIX PATCHES AND A NEGATIVE CONTROL.","Dosage_Form":"Patch","Route_of_Administration":"Topical","Product_Presentation":"Blister Pack","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/3\/2017","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1888","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring Lengnau AG","BLA_Number":"125582","Proprietary_Name":"Idelvion","Proper_Name":"Coagulation Factor IX (Recombinant), Albumin Fusion Protein","License_Type":"351(a)","Strength":"3500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/30\/2018","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"116","Submission_Type":"Supplement","License_Number":"2009","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/4\/2023"},{"N\/R\/U":null,"Applicant":"CSL Behring Lengnau AG","BLA_Number":"125582","Proprietary_Name":"Idelvion","Proper_Name":"Coagulation Factor IX (Recombinant), Albumin Fusion Protein","License_Type":"351(a)","Strength":"250IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/4\/2016","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2009","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/4\/2023"},{"N\/R\/U":null,"Applicant":"CSL Behring Lengnau AG","BLA_Number":"125582","Proprietary_Name":"Idelvion","Proper_Name":"Coagulation Factor IX (Recombinant), Albumin Fusion Protein","License_Type":"351(a)","Strength":"2000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/4\/2016","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2009","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/4\/2023"},{"N\/R\/U":null,"Applicant":"CSL Behring Lengnau AG","BLA_Number":"125582","Proprietary_Name":"Idelvion","Proper_Name":"Coagulation Factor IX (Recombinant), Albumin Fusion Protein","License_Type":"351(a)","Strength":"1000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/4\/2016","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2009","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/4\/2023"},{"N\/R\/U":null,"Applicant":"CSL Behring Lengnau AG","BLA_Number":"125582","Proprietary_Name":"Idelvion","Proper_Name":"Coagulation Factor IX (Recombinant), Albumin Fusion Protein","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/4\/2016","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2009","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/4\/2023"},{"N\/R\/U":null,"Applicant":"Bloodworks","BLA_Number":"125585","Proprietary_Name":null,"Proper_Name":"HPC, Cord Blood","License_Type":"351(a)","Strength":"5X10^8 NUCLEATED CELLS CONTENT WITH 85% VIABILITY & 1.25X10^6 VIABLE CD34+ CELLS (PRE-CRYOPRESERVATION) ","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Bag","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/28\/2016","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2042","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"AstraZeneca AB","BLA_Number":"125586","Proprietary_Name":"Andexxa","Proper_Name":"Coagulation Factor Xa (Recombinant), Inactivated-zhzo","License_Type":"351(a)","Strength":"200MG","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/31\/2018","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"27","Submission_Type":"Supplement","License_Number":"2059","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/3\/2025"},{"N\/R\/U":null,"Applicant":"AstraZeneca AB","BLA_Number":"125586","Proprietary_Name":"Andexxa","Proper_Name":"Coagulation Factor Xa (Recombinant), Inactivated-zhzo","License_Type":"351(a)","Strength":"100MG","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/3\/2018","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2059","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/3\/2025"},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125587","Proprietary_Name":"Panzyga","Proper_Name":"Immune Globulin Intravenous (Human)-ifas","License_Type":"351(a)","Strength":"5G ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/2\/2018","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1646","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125587","Proprietary_Name":"Panzyga","Proper_Name":"Immune Globulin Intravenous (Human)-ifas","License_Type":"351(a)","Strength":"10G ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/2\/2018","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1646","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125587","Proprietary_Name":"Panzyga","Proper_Name":"Immune Globulin Intravenous (Human)-ifas","License_Type":"351(a)","Strength":"20G ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/2\/2018","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1646","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125587","Proprietary_Name":"Panzyga","Proper_Name":"Immune Globulin Intravenous (Human)-ifas","License_Type":"351(a)","Strength":"30 G ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/2\/2018","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1646","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125587","Proprietary_Name":"Panzyga","Proper_Name":"Immune Globulin Intravenous (Human)-ifas","License_Type":"351(a)","Strength":"2.5G ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/2\/2018","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1646","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125587","Proprietary_Name":"Panzyga","Proper_Name":"Immune Globulin Intravenous (Human)-ifas","License_Type":"351(a)","Strength":"1G ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/2\/2018","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1646","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ADMA Biologics, Inc.","BLA_Number":"125590","Proprietary_Name":"Asceniv","Proper_Name":"Immune Globulin Intravenous, Human-slra","License_Type":"351(a)","Strength":"5G","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/1\/2019","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2019","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring Lengnau AG","BLA_Number":"125591","Proprietary_Name":"Afstyla","Proper_Name":"Antihemophilic Factor (Recombinant), Single Chain","License_Type":"351(a)","Strength":"1500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/31\/2017","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"47","Submission_Type":"Supplement","License_Number":"2009","Product_Number":"7","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring Lengnau AG","BLA_Number":"125591","Proprietary_Name":"Afstyla","Proper_Name":"Antihemophilic Factor (Recombinant), Single Chain","License_Type":"351(a)","Strength":"2500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/31\/2017","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"47","Submission_Type":"Supplement","License_Number":"2009","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring Lengnau AG","BLA_Number":"125591","Proprietary_Name":"Afstyla","Proper_Name":"Antihemophilic Factor (Recombinant), Single Chain","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/25\/2016","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2009","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring Lengnau AG","BLA_Number":"125591","Proprietary_Name":"Afstyla","Proper_Name":"Antihemophilic Factor (Recombinant), Single Chain","License_Type":"351(a)","Strength":"2000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/25\/2016","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2009","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring Lengnau AG","BLA_Number":"125591","Proprietary_Name":"Afstyla","Proper_Name":"Antihemophilic Factor (Recombinant), Single Chain","License_Type":"351(a)","Strength":"250IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/25\/2016","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2009","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring Lengnau AG","BLA_Number":"125591","Proprietary_Name":"Afstyla","Proper_Name":"Antihemophilic Factor (Recombinant), Single Chain","License_Type":"351(a)","Strength":"1000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/25\/2016","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2009","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring Lengnau AG","BLA_Number":"125591","Proprietary_Name":"Afstyla","Proper_Name":"Antihemophilic Factor (Recombinant), Single Chain","License_Type":"351(a)","Strength":"3000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/25\/2016","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2009","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ALK - Abello A\/S","BLA_Number":"125592","Proprietary_Name":"Odactra","Proper_Name":"House Dust Mites (Dermatophagoides farinae and Dermatophagoides pteronyssinus) Allergen Extract","License_Type":"351(a)","Strength":"12 SQ-HDM\/ML","Dosage_Form":"Tablet","Route_of_Administration":"Sublingual","Product_Presentation":"Blister Pack","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/1\/2017","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1292","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Cleveland Cord Blood Center","BLA_Number":"125594","Proprietary_Name":"Clevecord","Proper_Name":"HPC, Cord Blood","License_Type":"351(a)","Strength":"5 x 10^8  TOTAL NUCLEATED CELLS WITH AT LEAST 1.25 x 106 VIABLE CD34+ CELLS","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Bag","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/1\/2016","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2026","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125596","Proprietary_Name":"Cuvitru","Proper_Name":"Immune Globulin Subcutaneous (Human), 20% Solution","License_Type":"351(a)","Strength":"10G\/50ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/7\/2019","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"272","Submission_Type":"Supplement","License_Number":"1898","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125596","Proprietary_Name":"Cuvitru","Proper_Name":"Immune Globulin Subcutaneous (Human), 20% Solution","License_Type":"351(a)","Strength":"4G\/20ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/13\/2016","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125596","Proprietary_Name":"Cuvitru","Proper_Name":"Immune Globulin Subcutaneous (Human), 20% Solution","License_Type":"351(a)","Strength":"8G\/40ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/13\/2016","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125596","Proprietary_Name":"Cuvitru","Proper_Name":"Immune Globulin Subcutaneous (Human), 20% Solution","License_Type":"351(a)","Strength":"2G\/10ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/13\/2016","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Takeda Pharmaceuticals U.S.A., Inc.","BLA_Number":"125596","Proprietary_Name":"Cuvitru","Proper_Name":"Immune Globulin Subcutaneous (Human), 20% Solution","License_Type":"351(a)","Strength":"1G\/5ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/13\/2016","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1898","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Emergent Travel Health, Inc.","BLA_Number":"125597","Proprietary_Name":"Vaxchora","Proper_Name":"Cholera Vaccine Live Oral","License_Type":"351(a)","Strength":"100ML","Dosage_Form":"Suspension","Route_of_Administration":"Oral","Product_Presentation":"Packet","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/23\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"123","Submission_Type":"Supplement","License_Number":"2199","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Emergent Travel Health, Inc.","BLA_Number":"125597","Proprietary_Name":"Vaxchora","Proper_Name":"Cholera Vaccine Live Oral","License_Type":"351(a)","Strength":"50ML","Dosage_Form":"Suspension","Route_of_Administration":"Oral","Product_Presentation":"Packet","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/23\/2020","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"123","Submission_Type":"Supplement","License_Number":"2199","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Emergent Travel Health, Inc.","BLA_Number":"125597","Proprietary_Name":"Vaxchora","Proper_Name":"Cholera Vaccine Live Oral","License_Type":"351(a)","Strength":"100ML","Dosage_Form":"Suspension","Route_of_Administration":"Oral","Product_Presentation":"Packet","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/10\/2016","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2199","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Vericel Corporation","BLA_Number":"125603","Proprietary_Name":"Maci","Proper_Name":"autologous cultured chondrocytes on porcine collagen membrane","License_Type":"351(a)","Strength":"500,000 CM2 CM2","Dosage_Form":"Cell Sheets","Route_of_Administration":"Implantation","Product_Presentation":"Pouch","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/13\/2016","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2010","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CSL Behring GmbH","BLA_Number":"125606","Proprietary_Name":"Haegarda","Proper_Name":"C1 Esterase Inhibitor Subcutaneous (Human)","License_Type":"351(a)","Strength":"3000IU","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/22\/2017","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1765","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/22\/2024"},{"N\/R\/U":null,"Applicant":"CSL Behring GmbH","BLA_Number":"125606","Proprietary_Name":"Haegarda","Proper_Name":"C1 Esterase Inhibitor Subcutaneous (Human)","License_Type":"351(a)","Strength":"2000IU","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/22\/2017","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1765","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/22\/2024"},{"N\/R\/U":null,"Applicant":"Spark Therapeutics, Inc.","BLA_Number":"125610","Proprietary_Name":"Luxturna","Proper_Name":"Voretigene Neparvovec","License_Type":"351(a)","Strength":"1.5X10 TO 11 ML","Dosage_Form":"Injection","Route_of_Administration":"Intraocular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/19\/2017","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2056","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"12\/19\/2024"},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"125611","Proprietary_Name":"Rebinyn","Proper_Name":"Coagulation Factor IX (Recombinant), GlycoPEGylated","License_Type":"351(a)","Strength":"3000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/11\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"242","Submission_Type":"Supplement","License_Number":"1261","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"125611","Proprietary_Name":"Rebinyn","Proper_Name":"Coagulation Factor IX (Recombinant), GlycoPEGylated","License_Type":"351(a)","Strength":"1000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/31\/2017","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1261","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"125611","Proprietary_Name":"Rebinyn","Proper_Name":"Coagulation Factor IX (Recombinant), GlycoPEGylated","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/31\/2017","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1261","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"125611","Proprietary_Name":"Rebinyn","Proper_Name":"Coagulation Factor IX (Recombinant), GlycoPEGylated","License_Type":"351(a)","Strength":"2000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/31\/2017","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1261","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125612","Proprietary_Name":"Fibryga","Proper_Name":"Fibrinogen (Human)","License_Type":"351(a)","Strength":"1G","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/7\/2017","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1646","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Kamada Ltd.","BLA_Number":"125613","Proprietary_Name":"Kedrab","Proper_Name":"Rabies Immune Globulin (Human)","License_Type":"351(a)","Strength":"150IU","Dosage_Form":"Solution","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/23\/2017","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1826","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline Biologicals","BLA_Number":"125614","Proprietary_Name":"Shingrix","Proper_Name":"Zoster Vaccine Recombinant, Adjuvanted","License_Type":"351(a)","Strength":"50UG","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/23\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":" ","Supplement_Number":"398","Submission_Type":"Supplement","License_Number":"1617","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline Biologicals","BLA_Number":"125614","Proprietary_Name":"Shingrix","Proper_Name":"Zoster Vaccine Recombinant, Adjuvanted","License_Type":"351(a)","Strength":"0.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/20\/2017","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1617","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Instituto Grifols, S.A.","BLA_Number":"125640","Proprietary_Name":"Vistaseal","Proper_Name":"Fibrin Sealant (Human)","License_Type":"351(a)","Strength":"6ML","Dosage_Form":"Frozen","Route_of_Administration":"Topical","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/1\/2017","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1181","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Instituto Grifols, S.A.","BLA_Number":"125640","Proprietary_Name":"Vistaseal","Proper_Name":"Fibrin Sealant (Human)","License_Type":"351(a)","Strength":"4ML","Dosage_Form":"Frozen","Route_of_Administration":"Topical","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/1\/2017","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1181","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Instituto Grifols, S.A.","BLA_Number":"125640","Proprietary_Name":"Vistaseal","Proper_Name":"Fibrin Sealant (Human)","License_Type":"351(a)","Strength":"2ML","Dosage_Form":"Frozen","Route_of_Administration":"Topical","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/1\/2017","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1181","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Instituto Grifols, S.A.","BLA_Number":"125640","Proprietary_Name":"Vistaseal","Proper_Name":"Fibrin Sealant (Human)","License_Type":"351(a)","Strength":"10ML","Dosage_Form":"Frozen","Route_of_Administration":"Topical","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/1\/2017","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1181","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Laboratoire Francais du Fractionnement et des Biotechnologies S.A.","BLA_Number":"125641","Proprietary_Name":"Sevenfact","Proper_Name":"coagulation factor VIIa (recombinant)-jncw","License_Type":"351(a)","Strength":"5MG","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/1\/2020","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"2061","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Laboratoire Francais du Fractionnement et des Biotechnologies S.A.","BLA_Number":"125641","Proprietary_Name":"Sevenfact","Proper_Name":"coagulation factor VIIa (recombinant)-jncw","License_Type":"351(a)","Strength":"1MG","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/1\/2020","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"2061","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Kite Pharma Inc.","BLA_Number":"125643","Proprietary_Name":"Yescarta","Proper_Name":"axicabtagene ciloleucel","License_Type":"351(a)","Strength":"2 \u00d7 10^6 CAR-POSITIVE VIABLE T CELLS PER KG OF BODY WEIGHT","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Bag","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/18\/2017","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2064","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"4\/1\/2029"},{"N\/R\/U":null,"Applicant":"Bio Products Laboratory","BLA_Number":"125644","Proprietary_Name":"Albuminex","Proper_Name":"Albumin (Human)-kjda","License_Type":"351(a)","Strength":"25G\/500ML","Dosage_Form":"Solution","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/19\/2018","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1811","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bio Products Laboratory","BLA_Number":"125644","Proprietary_Name":"Albuminex","Proper_Name":"Albumin (Human)-kjda","License_Type":"351(a)","Strength":"12.5G\/250ML","Dosage_Form":"Solution","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/19\/2018","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1811","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bio Products Laboratory","BLA_Number":"125644","Proprietary_Name":"Albuminex","Proper_Name":"Albumin (Human)-kjda","License_Type":"351(a)","Strength":"25G\/100ML","Dosage_Form":"Solution","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/19\/2018","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1811","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bio Products Laboratory","BLA_Number":"125644","Proprietary_Name":"Albuminex","Proper_Name":"Albumin (Human)-kjda","License_Type":"351(a)","Strength":"12.5G\/50ML","Dosage_Form":"Solution","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/19\/2018","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1811","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novartis Pharmaceuticals Corporation","BLA_Number":"125646","Proprietary_Name":"Kymriah","Proper_Name":"tisagenlecleucel","License_Type":"351(a)","Strength":" 0.6 to 6.0 x 10^8 CAR-POSITIVE VIABLE T CELLS ","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Bag","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/30\/2017","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1244","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/27\/2029"},{"N\/R\/U":null,"Applicant":"MD Anderson Cord Blood Bank","BLA_Number":"125657","Proprietary_Name":null,"Proper_Name":"Hematopoietic Progenitor Cells, Cord (HPC-C)","License_Type":"351(a)","Strength":"2.5X10E7\/KG CELL\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Bag","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/21\/2018","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2072","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ProMetic BioTherapeutics, Inc.","BLA_Number":"125659","Proprietary_Name":"Ryplazim","Proper_Name":"plasminogen, human-tvmh","License_Type":"351(a)","Strength":"68.8MG","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/4\/2021","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2065","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":"6\/4\/2021","Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":"6\/4\/2033","Orphan_Exclusivity_Exp._Date":"6\/4\/2028"},{"N\/R\/U":null,"Applicant":"Bayer HealthCare LLC","BLA_Number":"125661","Proprietary_Name":"Jivi","Proper_Name":"Antihemophilic factor (recombinant), PEGylated-aucl","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/29\/2018","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"8","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bayer HealthCare LLC","BLA_Number":"125661","Proprietary_Name":"Jivi","Proper_Name":"Antihemophilic factor (recombinant), PEGylated-aucl","License_Type":"351(a)","Strength":"2000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/29\/2018","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"8","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bayer HealthCare LLC","BLA_Number":"125661","Proprietary_Name":"Jivi","Proper_Name":"Antihemophilic factor (recombinant), PEGylated-aucl","License_Type":"351(a)","Strength":"3000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/29\/2018","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"8","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bayer HealthCare LLC","BLA_Number":"125661","Proprietary_Name":"Jivi","Proper_Name":"Antihemophilic factor (recombinant), PEGylated-aucl","License_Type":"351(a)","Strength":"1000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/29\/2018","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"8","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125668","Proprietary_Name":"Cutaquig","Proper_Name":"Immune Globulin Subcutaneous (Human)-hipp","License_Type":"351(a)","Strength":"4G\/24ML","Dosage_Form":"Solution","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/12\/2018","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1646","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125668","Proprietary_Name":"Cutaquig","Proper_Name":"Immune Globulin Subcutaneous (Human)-hipp","License_Type":"351(a)","Strength":"8G\/48ML","Dosage_Form":"Solution","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/12\/2018","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1646","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125668","Proprietary_Name":"Cutaquig","Proper_Name":"Immune Globulin Subcutaneous (Human)-hipp","License_Type":"351(a)","Strength":"2G\/12ML","Dosage_Form":"Solution","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/12\/2018","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1646","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125668","Proprietary_Name":"Cutaquig","Proper_Name":"Immune Globulin Subcutaneous (Human)-hipp","License_Type":"351(a)","Strength":"1G\/6ML","Dosage_Form":"Solution","Route_of_Administration":"Subcutaneous","Product_Presentation":"Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/12\/2018","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1646","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125668","Proprietary_Name":"Cutaquig","Proper_Name":"Immune Globulin Subcutaneous (Human)-hipp","License_Type":"351(a)","Strength":"3.3G\/20 ML","Dosage_Form":"Solution","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/12\/2018","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1646","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125668","Proprietary_Name":"Cutaquig","Proper_Name":"Immune Globulin Subcutaneous (Human)-hipp","License_Type":"351(a)","Strength":"1.65G\/10 ML","Dosage_Form":"Solution","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/12\/2018","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1646","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"125671","Proprietary_Name":"Esperoct","Proper_Name":"Antihemophilic Factor (Recombinant), GlycoPEGylated-exei","License_Type":"351(a)","Strength":"1500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/19\/2019","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1261","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"125671","Proprietary_Name":"Esperoct","Proper_Name":"Antihemophilic Factor (Recombinant), GlycoPEGylated-exei","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/19\/2019","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1261","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"125671","Proprietary_Name":"Esperoct","Proper_Name":"Antihemophilic Factor (Recombinant), GlycoPEGylated-exei","License_Type":"351(a)","Strength":"2000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/19\/2019","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1261","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"125671","Proprietary_Name":"Esperoct","Proper_Name":"Antihemophilic Factor (Recombinant), GlycoPEGylated-exei","License_Type":"351(a)","Strength":"1000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/19\/2019","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1261","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novo Nordisk Inc.","BLA_Number":"125671","Proprietary_Name":"Esperoct","Proper_Name":"Antihemophilic Factor (Recombinant), GlycoPEGylated-exei","License_Type":"351(a)","Strength":"3000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/19\/2019","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1261","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bavarian Nordic A\/S","BLA_Number":"125678","Proprietary_Name":"Jynneos","Proper_Name":"Smallpox and Monkeypox Vaccine, Live, Non-replicating","License_Type":"351(a)","Strength":"0.5 X 10E8 INFECTIOUS UNITS PER 0.5 ML DOSE U\/.5ML","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"9\/24\/2019","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2096","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Inc.","BLA_Number":"125682","Proprietary_Name":"Dengvaxia","Proper_Name":"Dengue Tetravalent Vaccine, Live","License_Type":"351(a)","Strength":"4.5-6.0 LOG10 CCID50 CCID50: CELL CULTURE INFECTIOUS DOSE 50","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/1\/2019","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1725","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":"5\/1\/2019","Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":"5\/1\/2031","Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"125683","Proprietary_Name":"Xembify","Proper_Name":"immune globulin subcutaneous, human-klhw","License_Type":"351(a)","Strength":"1GM MG\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/3\/2019","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"125683","Proprietary_Name":"Xembify","Proper_Name":"immune globulin subcutaneous, human-klhw","License_Type":"351(a)","Strength":"2GM MG\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/3\/2019","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"125683","Proprietary_Name":"Xembify","Proper_Name":"immune globulin subcutaneous, human-klhw","License_Type":"351(a)","Strength":"10GM MG\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/3\/2019","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"125683","Proprietary_Name":"Xembify","Proper_Name":"immune globulin subcutaneous, human-klhw","License_Type":"351(a)","Strength":"4GM MG\/ML","Dosage_Form":"Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/3\/2019","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Enzyvant Therapeutics GmbH","BLA_Number":"125685","Proprietary_Name":"Rethymic","Proper_Name":"allogeneic processed thymus tissue-agdc","License_Type":"351(a)","Strength":"SEMI-QUANTITATIVE","Dosage_Form":"For Suspension","Route_of_Administration":"Implantation","Product_Presentation":"Dish","Status":"Rx","Licensure":"Licensed","Approval_Date":"10\/8\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2100","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":"10\/8\/2021","Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":"10\/8\/2033","Orphan_Exclusivity_Exp._Date":"10\/8\/2028"},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"125690","Proprietary_Name":"Ervebo","Proper_Name":"Ebola Zaire Vaccine, Live","License_Type":"351(a)","Strength":"1ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/19\/2019","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":"12\/19\/2019","Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":"12\/19\/2031","Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Seqirus Inc.","BLA_Number":"125692","Proprietary_Name":"Audenz","Proper_Name":"Influenza A (H5N1) Monovalent Vaccine, Adjuvanted","License_Type":"351(a)","Strength":"7.5HA UG\/.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Multi-Dose Vial","Status":"Disc","Licensure":"Licensed","Approval_Date":"1\/31\/2020","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"2049","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Novartis Gene Therapies, Inc.","BLA_Number":"125694","Proprietary_Name":"Zolgensma","Proper_Name":"onasemnogene abeparvovec-xioi","License_Type":"351(a)","Strength":"1.1X10E14 VG\/KG VG\/KG=VECTOR GENOMES PER KILOGRAM","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/24\/2019","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2250","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":"5\/24\/2019","Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":"5\/24\/2031","Orphan_Exclusivity_Exp._Date":"5\/24\/2026"},{"N\/R\/U":null,"Applicant":"Aimmune Therapeutics, Inc.","BLA_Number":"125696","Proprietary_Name":"Palforzia","Proper_Name":"Peanut (Arachis hypogaea) Allergen Powder-dnfp","License_Type":"351(a)","Strength":"300MG","Dosage_Form":"Powder","Route_of_Administration":"Oral","Product_Presentation":"Sachet","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/31\/2020","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"2109","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Aimmune Therapeutics, Inc.","BLA_Number":"125696","Proprietary_Name":"Palforzia","Proper_Name":"Peanut (Arachis hypogaea) Allergen Powder-dnfp","License_Type":"351(a)","Strength":"100MG","Dosage_Form":"Powder","Route_of_Administration":"Oral","Product_Presentation":"Capsule","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/31\/2020","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"2109","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Aimmune Therapeutics, Inc.","BLA_Number":"125696","Proprietary_Name":"Palforzia","Proper_Name":"Peanut (Arachis hypogaea) Allergen Powder-dnfp","License_Type":"351(a)","Strength":"20MG","Dosage_Form":"Powder","Route_of_Administration":"Oral","Product_Presentation":"Capsule","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/31\/2020","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"2109","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Aimmune Therapeutics, Inc.","BLA_Number":"125696","Proprietary_Name":"Palforzia","Proper_Name":"Peanut (Arachis hypogaea) Allergen Powder-dnfp","License_Type":"351(a)","Strength":"10MG","Dosage_Form":"Powder","Route_of_Administration":"Oral","Product_Presentation":"Capsule","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/31\/2020","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"2109","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Aimmune Therapeutics, Inc.","BLA_Number":"125696","Proprietary_Name":"Palforzia","Proper_Name":"Peanut (Arachis hypogaea) Allergen Powder-dnfp","License_Type":"351(a)","Strength":"1MG","Dosage_Form":"Powder","Route_of_Administration":"Oral","Product_Presentation":"Capsule","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/31\/2020","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"2109","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Aimmune Therapeutics, Inc.","BLA_Number":"125696","Proprietary_Name":"Palforzia","Proper_Name":"Peanut (Arachis hypogaea) Allergen Powder-dnfp","License_Type":"351(a)","Strength":"0.5MG","Dosage_Form":"Powder","Route_of_Administration":"Oral","Product_Presentation":"Capsule","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/31\/2020","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"2109","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"U","Applicant":"Ferring Pharmaceuticals A\/S","BLA_Number":"125700","Proprietary_Name":"Adstiladrin","Proper_Name":"nadofaragene firadenovec-vncg","License_Type":"351(a)","Strength":"3x10^11 viral particles (vp)\/mL","Dosage_Form":"For Suspension","Route_of_Administration":"Intravesical","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"12\/16\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2222","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":"12\/16\/2022","Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":"12\/16\/2034","Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sanofi Pasteur Inc.","BLA_Number":"125701","Proprietary_Name":"Menquadfi","Proper_Name":"Meningococcal (Groups A, C, Y, W) Conjugate Vaccine","License_Type":"351(a)","Strength":"0.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/23\/2020","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"1725","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":"1\/14\/2005","Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":"1\/14\/2017","Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Kite Pharma Inc.","BLA_Number":"125703","Proprietary_Name":"Tecartus","Proper_Name":"Brexucabtagene Autoleucel","License_Type":"351(a)","Strength":"2\u00d710^6 CAR-positive viable T cells per kg body weight ","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Bag","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/24\/2020","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"2064","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"10\/1\/2028"},{"N\/R\/U":null,"Applicant":"Juno Therapeutics, Inc. a Bristol Myer-Squibb Company","BLA_Number":"125714","Proprietary_Name":"Breyanzi","Proper_Name":"lisocabtagene maraleucel","License_Type":"351(a)","Strength":"4.6ML\/VIAL","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/5\/2021","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"2156","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/24\/2029"},{"N\/R\/U":null,"Applicant":"Bluebird Bio Inc.","BLA_Number":"125717","Proprietary_Name":"Zynteglo","Proper_Name":"betibeglogene autotemcel","License_Type":"351(a)","Strength":"1.7-20 X 10^6CELL\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Bag","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/17\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2160","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":"8\/17\/2022","Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":"8\/17\/2034","Orphan_Exclusivity_Exp._Date":"8\/17\/2029"},{"N\/R\/U":"U","Applicant":"Biomarin Pharmaceutical Inc.","BLA_Number":"125720","Proprietary_Name":"Roctavian","Proper_Name":"valoctocogene roxaparvovec-rvox","License_Type":"351(a)","Strength":"16X 10E13GENOMES PER ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/29\/2023","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"1649","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/29\/2030"},{"N\/R\/U":null,"Applicant":"Stratatech Corporation","BLA_Number":"125730","Proprietary_Name":"StrataGraft","Proper_Name":"Allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen-dsat","License_Type":"351(a)","Strength":"100CM SQUARED","Dosage_Form":"Cell Sheets","Route_of_Administration":"Topical","Product_Presentation":"Pouch","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/15\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2144","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":"6\/15\/2021","Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":"6\/15\/2033","Orphan_Exclusivity_Exp._Date":"6\/15\/2028"},{"N\/R\/U":null,"Applicant":"Wyeth Pharmaceuticals LLC","BLA_Number":"125731","Proprietary_Name":"Prevnar 20","Proper_Name":"20-valent Pneumococcal Conjugate Vaccine","License_Type":"351(a)","Strength":"0.5 ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/8\/2021","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"3","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":"6\/8\/2021","Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":"6\/8\/2033","Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"CellTrans Inc.","BLA_Number":"125734","Proprietary_Name":"Lantidra","Proper_Name":"donislecel-jujn","License_Type":"351(a)","Strength":"1X10E6EQUIVALENT ISLET NUMBER (EIN)","Dosage_Form":"Suspension","Route_of_Administration":"Intravenous","Product_Presentation":"Bag","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/28\/2023","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"2213","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Celgene Corporation, a Bristol-Myers Squibb Company","BLA_Number":"125736","Proprietary_Name":"Abecma","Proper_Name":"idecabtagene vicleucel","License_Type":"351(a)","Strength":"150 TO 540 X 10^6 CHIMERIC ANTIGEN RECEPTOR (CAR)-POSITIVE T CELLS IN ONE OR MORE INFUSION","Dosage_Form":"Injection ","Route_of_Administration":"Intravenous","Product_Presentation":"Bag","Status":"Rx","Licensure":"Licensed","Approval_Date":"3\/3\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2252","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"3\/26\/2028"},{"N\/R\/U":null,"Applicant":"VBI Vaccines (Delaware), Inc.","BLA_Number":"125737","Proprietary_Name":"Prehevbrio","Proper_Name":"Hepatitis B Vaccine (Recombinant)","License_Type":"351(a)","Strength":"10UG\/ML","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/30\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2219","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Gamida Cell Ltd. ","BLA_Number":"125738","Proprietary_Name":"OMISIRGE","Proper_Name":"omidubicel-onlv","License_Type":"351(a)","Strength":">8.0x10^8 total viable cells, >8.7% CD34+ cells, >9.2x10^7 CD34+ cells with 81mL dil so","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Bag","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/17\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2223","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"4\/17\/2030"},{"N\/R\/U":null,"Applicant":"Gamida Cell Ltd. ","BLA_Number":"125738","Proprietary_Name":"OMISIRGE","Proper_Name":"omidubicel-onlv","License_Type":"351(a)","Strength":">4.0x10^8 total viable cells, >2.4x10^7 CD3+ cells with 41mL dil sol","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Bag","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/17\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2223","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"4\/17\/2030"},{"N\/R\/U":null,"Applicant":"Ferring Pharmaceuticals Inc.","BLA_Number":"125739","Proprietary_Name":"Rebyota","Proper_Name":"Fecal Microbiota Transplantation, Frozen Preparation","License_Type":"351(a)","Strength":"BETWEEN 1X10^8 AND 5X10^10CFU","Dosage_Form":"Suspension","Route_of_Administration":"Rectal","Product_Presentation":"Single-Use Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/30\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2112","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":"11\/30\/2022","Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":"11\/30\/2034","Orphan_Exclusivity_Exp._Date":"11\/30\/2029"},{"N\/R\/U":null,"Applicant":"Pfizer Ireland Pharmaceuticals","BLA_Number":"125740","Proprietary_Name":"Ticovac","Proper_Name":"Tick-Borne Encephalitis Vaccine","License_Type":"351(a)","Strength":"1.2UG\/0.25ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/13\/2021","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"2060","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Pfizer Ireland Pharmaceuticals","BLA_Number":"125740","Proprietary_Name":"Ticovac","Proper_Name":"Tick-Borne Encephalitis Vaccine","License_Type":"351(a)","Strength":"2.4UG\/0.5ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/13\/2021","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"2060","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Merck Sharp & Dohme LLC","BLA_Number":"125741","Proprietary_Name":"Vaxneuvance","Proper_Name":"Pneumococcal 15-valent Conjugate Vaccine","License_Type":"351(a)","Strength":"2.0UG","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/16\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"2","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":"7\/16\/2021","Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":"7\/16\/2033","Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"BioNTech Manufacturing GmbH","BLA_Number":"125742","Proprietary_Name":"Comirnaty","Proper_Name":"COVID-19 Vaccine, mRNA","License_Type":"351(a)","Strength":"30UG","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"8\/23\/2021","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2229","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Janssen Biotech, Inc.","BLA_Number":"125746","Proprietary_Name":"Carvykti","Proper_Name":"ciltacabtagene autoleucel","License_Type":"351(a)","Strength":"0.5 to 1.0x10^6 chimeric antigen receptor (CAR)-positive viable T cells per kg of body weight, with a maximum dose of 1x10^8 CAR-positive viable T cells in one infusion","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Bag","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/28\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1864","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":"2\/28\/2022","Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":"2\/28\/2034","Orphan_Exclusivity_Exp._Date":"2\/28\/2029"},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline Biologicals","BLA_Number":"125748","Proprietary_Name":"PRIORIX","Proper_Name":"Measles, Mumps and Rubella Virus Vaccine Live","License_Type":"351(a)","Strength":"3.4, 4.2 and 3.3LOG10","Dosage_Form":"For Injection","Route_of_Administration":"Subcutaneous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/3\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1617","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"ModernaTX, Inc. ","BLA_Number":"125752","Proprietary_Name":"Spikevax","Proper_Name":"COVID-19 Vaccine, mRNA","License_Type":"351(a)","Strength":"100UG","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"1\/31\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2256","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bluebird Bio Inc.","BLA_Number":"125755","Proprietary_Name":"Skysona","Proper_Name":"elivaldogene autotemcel","License_Type":"351(a)","Strength":"2-30 \u00d7 10^6 CELL\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Bag","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/16\/2022","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"2160","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":"9\/16\/2022","Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":"9\/16\/2034","Orphan_Exclusivity_Exp._Date":"9\/16\/2029"},{"N\/R\/U":null,"Applicant":"Seres Therapeutics, Inc.","BLA_Number":"125757","Proprietary_Name":"Vowst","Proper_Name":"Fecal Microbiota Spores","License_Type":"351(a)","Strength":"1X10 LOG 6 AND 3X10 LOG 7CFU\/TAB","Dosage_Form":"Capsule","Route_of_Administration":"Oral","Product_Presentation":"Bottle","Status":"Rx","Licensure":"Licensed","Approval_Date":"4\/26\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2262","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":"4\/26\/2023","Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":"4\/26\/2035","Orphan_Exclusivity_Exp._Date":"4\/26\/2030"},{"N\/R\/U":null,"Applicant":"Emergent Product Development Gaithersburg, Inc. ","BLA_Number":"125761","Proprietary_Name":"CYFENDUS","Proper_Name":"Anthrax Vaccine Adsorbed, Adjuvanted","License_Type":"351(a)","Strength":"100UG\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Multi-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/20\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2089","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Pfizer Inc.","BLA_Number":"125769","Proprietary_Name":"Abrysvo","Proper_Name":"Respiratory Syncytial Virus Vaccine","License_Type":"351(a)","Strength":"120UG","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/31\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2001","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Bioverativ Therapeutics, Inc.","BLA_Number":"125771","Proprietary_Name":"ALTUVIIIO","Proper_Name":"antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl","License_Type":"351(a)","Strength":"4000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/22\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2078","Product_Number":"7","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/22\/2030"},{"N\/R\/U":null,"Applicant":"Bioverativ Therapeutics, Inc.","BLA_Number":"125771","Proprietary_Name":"ALTUVIIIO","Proper_Name":"antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl","License_Type":"351(a)","Strength":"3000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/22\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2078","Product_Number":"6","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/22\/2030"},{"N\/R\/U":null,"Applicant":"Bioverativ Therapeutics, Inc.","BLA_Number":"125771","Proprietary_Name":"ALTUVIIIO","Proper_Name":"antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl","License_Type":"351(a)","Strength":"2000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/22\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2078","Product_Number":"5","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/22\/2030"},{"N\/R\/U":null,"Applicant":"Bioverativ Therapeutics, Inc.","BLA_Number":"125771","Proprietary_Name":"ALTUVIIIO","Proper_Name":"antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl","License_Type":"351(a)","Strength":"1000IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/22\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2078","Product_Number":"4","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/22\/2030"},{"N\/R\/U":null,"Applicant":"Bioverativ Therapeutics, Inc.","BLA_Number":"125771","Proprietary_Name":"ALTUVIIIO","Proper_Name":"antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl","License_Type":"351(a)","Strength":"750IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/22\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2078","Product_Number":"3","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/22\/2030"},{"N\/R\/U":null,"Applicant":"Bioverativ Therapeutics, Inc.","BLA_Number":"125771","Proprietary_Name":"ALTUVIIIO","Proper_Name":"antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/22\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2078","Product_Number":"2","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/22\/2030"},{"N\/R\/U":null,"Applicant":"Bioverativ Therapeutics, Inc.","BLA_Number":"125771","Proprietary_Name":"ALTUVIIIO","Proper_Name":"antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl","License_Type":"351(a)","Strength":"250IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"2\/22\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2078","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"2\/22\/2030"},{"N\/R\/U":null,"Applicant":"CSL Behring LLC","BLA_Number":"125772","Proprietary_Name":"Hemgenix","Proper_Name":"etranacogene dezaparvovec-drlb","License_Type":"351(a)","Strength":"1X10E13GENOME COPIES\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"11\/22\/2022","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1767","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":"11\/22\/2022","Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":"11\/22\/2034","Orphan_Exclusivity_Exp._Date":"11\/22\/2029"},{"N\/R\/U":null,"Applicant":"Krystal Biotech, Inc.","BLA_Number":"125774","Proprietary_Name":"VYJUVEK","Proper_Name":"beremagene geperpavec-svdt","License_Type":"351(a)","Strength":"5.0x10^9 PFU\/mL","Dosage_Form":"Gel","Route_of_Administration":"Topical","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/19\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2301","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"5\/19\/2030"},{"N\/R\/U":null,"Applicant":"GlaxoSmithKline Biologicals","BLA_Number":"125775","Proprietary_Name":"Arexvy","Proper_Name":"Respiratory Syncytial Virus Vaccine, Adjuvanted","License_Type":"351(a)","Strength":"120UG\/.5ML","Dosage_Form":"For Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"5\/3\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1617","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":"5\/3\/2023","Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":"5\/3\/2035","Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":"N","Applicant":"Octapharma Pharmazeutika Produktionsges.m.b.H.","BLA_Number":"125776","Proprietary_Name":"Balfaxar","Proper_Name":"Prothrombin complex concentrate, human-lans","License_Type":"351(a)","Strength":"500IU","Dosage_Form":"For Injection","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"7\/21\/2023","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":" ","Supplement_Number":"0","Submission_Type":"Original","License_Number":"1646","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null},{"N\/R\/U":null,"Applicant":"Sarepta Therapeutics, Inc.","BLA_Number":"125781","Proprietary_Name":"ELEVIDYS","Proper_Name":"delandistrogene moxeparvovec-rokl","License_Type":"351(a)","Strength":"1.33 \u00d710E14 vector genomes (vg)\/kg\/bodyweight(bw)","Dosage_Form":"Suspension","Route_of_Administration":"Intravenous","Product_Presentation":"Single-Dose Vial","Status":"Rx","Licensure":"Licensed","Approval_Date":"6\/22\/2023","Ref._Product_Proper_Name":null,"Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"2308","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":"6\/22\/2030"},{"N\/R\/U":null,"Applicant":"Grifols Therapeutics LLC","BLA_Number":"101146","Proprietary_Name":"Bayhep B, Hyperhep B S\/D","Proper_Name":"Hepatitis B Immune Globulin (Human)","License_Type":"351(a)","Strength":"220U\/ML","Dosage_Form":"Injection","Route_of_Administration":"Intramuscular","Product_Presentation":"Pre-Filled Syringe","Status":"Rx","Licensure":"Licensed","Approval_Date":"9\/23\/1977","Ref._Product_Proper_Name":" ","Ref._Product_Proprietary_Name":null,"Supplement_Number":"0","Submission_Type":"Original","License_Number":"1871","Product_Number":"1","Center":"CBER","Date_of_First_Licensure":null,"Exclusivity_Expiration_Date":null,"First_Interchangeable_Exclusivity_Exp._Date":null,"Ref._Product_Exclusivity_Exp._Date":null,"Orphan_Exclusivity_Exp._Date":null}]